data_1iva_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1iva _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.0 tttm . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 120.604 0.24 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.274 21.6 p 52.41 167.94 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 -174.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.8 mm -85.42 -62.17 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.673 0 C-N-CA 125.302 1.441 . . . . 0.0 110.852 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.268 . . 72.19 61.6 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 125.591 1.556 . . . . 0.0 114.051 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -179.5 131.71 0.11 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.4 128.34 35.47 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 166.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 72.58 39.83 0.68 Allowed 'General case' 0 CA--C 1.579 2.09 0 C-N-CA 124.284 1.033 . . . . 0.0 111.745 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.68 134.41 12.31 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -76.89 72.62 3.48 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 126.909 3.242 . . . . 0.0 112.869 -165.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.498 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 13.7 p -73.59 -177.72 2.81 Favored 'General case' 0 N--CA 1.489 1.501 1 CA-C-N 106.379 -4.918 . . . . 0.0 114.253 -172.316 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -152.64 154.5 35.46 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.425 1.107 . . . . 0.0 110.055 166.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -90.89 109.19 20.4 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 169.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.02 39.15 2.54 Favored Glycine 0 CA--C 1.558 2.768 0 CA-C-N 114.238 -1.346 . . . . 0.0 113.449 -166.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.81 -139.64 3.11 Favored Glycine 0 N--CA 1.473 1.149 0 CA-C-O 123.838 1.799 . . . . 0.0 109.544 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.07 143.11 91.07 Favored Pre-proline 0 CA--C 1.578 2.046 0 CA-C-N 111.823 -2.189 . . . . 0.0 108.9 166.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HB2' ' H ' ' A' ' 19' ' ' CYS . 31.4 Cg_endo -66.69 -127.86 0.0 OUTLIER 'Trans proline' 0 CA--C 1.567 2.159 0 C-N-CA 123.378 2.719 . . . . 0.0 111.805 171.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.408 ' H ' ' HB2' ' A' ' 18' ' ' PRO . 19.4 m -149.44 142.95 25.37 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 165.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -64.45 1.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.925 -169.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -139.77 93.71 2.69 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -173.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.77 100.07 2.56 Favored Glycine 0 N--CA 1.478 1.486 0 N-CA-C 105.938 -2.865 . . . . 0.0 105.938 -167.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -134.13 170.78 15.16 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 123.479 1.609 . . . . 0.0 114.922 -169.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.18 -81.44 0.16 Allowed Glycine 0 N--CA 1.476 1.366 0 CA-C-O 124.673 2.263 . . . . 0.0 110.099 -168.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.491 9.5 t 68.71 44.39 1.17 Allowed 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 109.008 -3.596 . . . . 0.0 116.708 -170.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 66.1 mt -78.36 143.23 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 166.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 97.1 m -92.31 172.95 8.07 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB2' ' H ' ' A' ' 29' ' ' ILE . 33.9 p -79.4 -150.43 0.06 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 114.009 -1.451 . . . . 0.0 110.844 176.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.425 ' H ' ' HB2' ' A' ' 28' ' ' SER 0.3 2.0 pp -98.65 56.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 122.934 1.35 . . . . 0.0 111.76 168.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.317 0.0 OUTLIER -168.64 -40.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.807 1.643 . . . . 0.0 112.839 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.07 50.87 3.53 Favored Glycine 0 N--CA 1.489 2.216 0 CA-C-N 120.476 1.489 . . . . 0.0 114.442 -170.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.61 ' HG1' ' H ' ' A' ' 33' ' ' ASN . 5.0 p -157.93 -72.17 0.09 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 124.444 2.069 . . . . 0.0 111.305 -168.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.61 ' H ' ' HG1' ' A' ' 32' ' ' THR 0.32 16.9 m-80 -70.31 39.43 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 131.127 3.771 . . . . 0.0 117.677 169.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.461 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 13.6 m -68.28 -157.4 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 112.873 -1.967 . . . . 0.0 113.459 -170.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -156.65 144.06 19.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 119.913 -1.742 . . . . 0.0 109.116 174.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.498 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 16.8 m -96.84 89.71 4.98 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? . . . . . 0 CA--C 1.569 1.684 0 N-CA-C 117.236 2.309 . . . . 0.0 117.236 -166.547 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.351 63.1 pttt . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 p 50.36 172.08 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mt -101.56 -63.62 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 C-N-CA 125.252 1.421 . . . . 0.0 110.74 -170.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.3 . . 78.65 60.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.707 1.603 . . . . 0.0 112.65 -169.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -160.16 122.73 3.36 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -73.02 123.15 22.95 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.915 1.286 . . . . 0.0 107.915 168.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.282 23.5 m-85 76.14 36.86 0.39 Allowed 'General case' 0 CA--C 1.581 2.139 0 C-N-CA 124.174 0.99 . . . . 0.0 111.18 -167.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.09 129.07 8.79 Favored Glycine 0 N--CA 1.479 1.511 0 O-C-N 121.12 -0.988 . . . . 0.0 111.138 -174.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.7 tpt85 -75.9 77.0 2.8 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-O 126.588 3.089 . . . . 0.0 109.633 -168.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.817 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -73.93 -179.7 3.86 Favored 'General case' 0 N--CA 1.489 1.482 1 CA-C-N 106.821 -4.718 . . . . 0.0 110.544 -169.012 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -142.37 159.74 41.64 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 114.066 -1.424 . . . . 0.0 108.085 163.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -100.23 97.8 8.55 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.51 46.34 0.92 Allowed Glycine 0 CA--C 1.555 2.543 0 CA-C-N 114.245 -1.343 . . . . 0.0 113.296 -167.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.6 -142.36 3.45 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-O 123.443 1.579 . . . . 0.0 110.349 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.61 142.82 94.49 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-N 112.38 -1.91 . . . . 0.0 109.263 167.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -68.23 -127.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.57 2.304 0 C-N-CA 123.063 2.508 . . . . 0.0 109.57 168.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.8 m -154.01 151.07 28.94 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 163.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.67 -60.35 1.72 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 114.044 -1.434 . . . . 0.0 111.874 -168.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -121.45 81.14 1.76 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -169.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.09 99.78 2.57 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -172.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -142.72 176.18 9.25 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 123.72 1.724 . . . . 0.0 114.573 -168.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.71 94.62 1.54 Allowed Glycine 0 N--CA 1.477 1.433 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -167.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.931 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 5.8 t -86.96 121.62 29.68 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 110.089 -3.055 . . . . 0.0 111.326 -168.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.507 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 15.6 mm -112.53 136.05 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 166.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.1 m -109.03 -171.84 1.93 Allowed 'General case' 0 CA--C 1.559 1.319 0 CA-C-N 112.73 -2.032 . . . . 0.0 113.912 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.554 ' HG ' HG12 ' A' ' 29' ' ' ILE . 2.3 t -115.99 -126.36 0.29 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.918 1.342 . . . . 0.0 110.0 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.554 HG12 ' HG ' ' A' ' 28' ' ' SER . 13.2 mm -71.82 -3.34 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 119.079 2.992 . . . . 0.0 119.079 -168.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 20.4 ptp -156.32 -13.0 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.39 -15.37 50.21 Favored Glycine 0 CA--C 1.556 2.636 0 CA-C-N 121.431 1.923 . . . . 0.0 114.83 -165.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.4 p -89.13 -146.59 0.16 Allowed 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 166.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 41.62 36.69 0.61 Allowed 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 169.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.931 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 2.0 t -99.2 -171.34 2.06 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 110.913 -2.858 . . . . 0.0 114.601 -161.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -159.6 148.52 17.86 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 112.22 -2.264 . . . . 0.0 110.56 172.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 13.9 m -103.77 91.57 4.06 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.9 mttt . . . . . 0 CA--C 1.568 1.669 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -169.169 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.308 8.3 p 57.73 169.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 117.411 2.375 . . . . 0.0 117.411 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.582 HG13 ' SG ' ' A' ' 19' ' ' CYS . 32.0 mm -96.6 -64.1 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 124.379 1.072 . . . . 0.0 110.234 -169.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.08 59.04 1.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -173.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -175.88 123.66 0.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -77.42 116.51 18.07 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.474 1.11 . . . . 0.0 109.552 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.309 10.1 m-85 75.71 48.19 0.09 Allowed 'General case' 0 CA--C 1.57 1.737 0 C-N-CA 124.897 1.279 . . . . 0.0 108.084 -167.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.47 -149.77 3.06 Favored Glycine 0 C--N 1.356 1.666 0 CA-C-O 118.472 -1.182 . . . . 0.0 110.541 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -143.78 76.97 1.54 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 124.373 2.035 . . . . 0.0 106.162 -169.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 15.1 p -95.36 -174.33 3.16 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 111.086 -2.779 . . . . 0.0 112.451 -170.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -150.4 142.65 24.19 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.538 167.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -86.33 103.86 15.31 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 168.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.54 50.0 1.47 Allowed Glycine 0 CA--C 1.559 2.783 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.754 -163.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.21 -134.28 1.71 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -169.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.99 132.04 93.82 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-N 112.284 -1.958 . . . . 0.0 110.761 170.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -63.47 -34.8 63.92 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 N-CA-C 122.213 3.889 . . . . 0.0 122.213 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.582 ' SG ' HG13 ' A' ' 5' ' ' ILE 0.368 80.2 m 82.31 144.75 0.07 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 111.766 -2.47 . . . . 0.0 108.056 -163.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.74 -68.53 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 118.456 2.761 . . . . 0.0 118.456 -161.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -111.36 68.5 0.67 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.472 0.653 . . . . 0.0 110.887 -166.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.91 78.13 0.27 Allowed Glycine 0 N--CA 1.484 1.885 0 CA-C-O 119.204 -0.776 . . . . 0.0 113.308 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.2 mtt85 -140.81 142.88 34.58 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.452 1.12 . . . . 0.0 111.81 -169.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.05 -86.0 0.02 OUTLIER Glycine 0 N--CA 1.482 1.762 0 N-CA-C 118.16 2.024 . . . . 0.0 118.16 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.55 ' HB2' ' SG ' ' A' ' 36' ' ' CYS 0.417 14.0 t 82.34 38.22 0.05 Allowed 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 109.807 -3.196 . . . . 0.0 115.935 -169.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.9 mt -73.99 143.54 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 123.383 1.563 . . . . 0.0 107.65 168.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.433 ' HA ' ' CB ' ' A' ' 34' ' ' CYS 0.259 96.4 m -93.38 -175.5 3.83 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 111.812 -2.449 . . . . 0.0 116.678 -169.458 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.37 -18.61 64.51 Favored 'General case' 0 N--CA 1.504 2.259 1 N-CA-C 122.297 4.184 . . . . 0.0 122.297 175.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.448 4.2 mp 89.06 77.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.526 0 CA-C-N 109.061 -3.7 . . . . 0.0 105.235 -166.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.2 tpt 177.21 -51.04 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.447 0 CA-C-N 111.144 -2.753 . . . . 0.0 106.986 -167.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.67 -27.33 13.59 Favored Glycine 0 CA--C 1.552 2.363 0 CA-C-O 118.849 -0.973 . . . . 0.0 113.541 -166.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.6 p -90.79 -168.82 2.18 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 167.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 44.98 45.52 8.76 Favored 'General case' 0 N--CA 1.511 2.617 0 CA-C-O 125.724 2.678 . . . . 0.0 117.549 168.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.473 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 3.7 m -90.08 -179.35 5.66 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 108.609 -3.905 . . . . 0.0 111.504 -166.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -141.72 147.24 37.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.38 -0.825 . . . . 0.0 110.202 168.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 25' ' ' CYS 0.314 1.5 m -93.03 77.89 4.65 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.189 -177.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.588 -1.196 . . . . 0.0 111.36 -172.467 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.191 0.519 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.347 20.9 p -136.88 -171.75 3.01 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-O 123.215 1.483 . . . . 0.0 114.85 -166.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.36 109.7 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.485 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 169.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.12 69.63 2.03 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.222 1.01 . . . . 0.0 110.204 172.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -165.45 122.33 1.46 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 -173.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -75.96 120.4 21.23 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.765 1.226 . . . . 0.0 109.674 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.314 5.6 m-85 77.99 29.01 0.5 Allowed 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 124.966 1.306 . . . . 0.0 113.601 -170.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' N ' ' H ' ' A' ' 36' ' ' CYS . . . -97.89 117.17 5.73 Favored Glycine 0 N--CA 1.469 0.846 0 O-C-N 120.89 -1.131 . . . . 0.0 112.868 -171.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -22.9 81.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 1 C-N-CA 131.909 4.084 . . . . 0.0 116.233 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.867 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 13.0 p -85.38 -178.87 6.83 Favored 'General case' 0 N--CA 1.491 1.609 1 CA-C-N 106.983 -4.644 . . . . 0.0 112.402 -171.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -146.14 155.17 42.55 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 122.884 1.326 . . . . 0.0 108.757 169.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 49.8 m0 -94.94 100.15 12.05 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.91 53.92 1.25 Allowed Glycine 0 CA--C 1.552 2.388 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.405 -166.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.07 -143.64 3.78 Favored Glycine 0 N--CA 1.477 1.371 0 CA-C-O 123.19 1.439 . . . . 0.0 110.737 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.69 132.53 95.23 Favored Pre-proline 0 CA--C 1.576 1.979 0 CA-C-N 112.848 -1.676 . . . . 0.0 110.522 170.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -51.73 -39.02 67.69 Favored 'Trans proline' 0 N--CA 1.498 1.755 1 N-CA-C 123.284 4.302 . . . . 0.0 123.284 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 16.3 m 90.52 139.65 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 111.405 -2.634 . . . . 0.0 104.842 -163.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -85.02 -64.39 1.17 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 120.576 3.547 . . . . 0.0 120.576 -162.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -127.82 80.85 1.98 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.886 0.851 . . . . 0.0 109.608 -164.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.29 66.85 1.98 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 115.152 -0.931 . . . . 0.0 114.391 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.6 mtt85 -141.58 156.44 45.69 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.834 1.302 . . . . 0.0 111.031 -169.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.62 -130.85 6.65 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-O 123.196 1.442 . . . . 0.0 112.029 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.471 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 48.9 t 166.13 107.91 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 102.815 -3.032 . . . . 0.0 102.815 173.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.521 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 29.8 mm -121.2 134.32 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 170.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 33' ' ' ASN . 33.0 m -107.84 -177.78 3.44 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-N 112.775 -2.011 . . . . 0.0 111.235 174.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 t -89.96 -173.34 3.84 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 124.561 2.124 . . . . 0.0 112.567 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 pp -93.38 63.9 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 110.681 -2.963 . . . . 0.0 108.889 166.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.2 tpt 177.71 -49.27 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 112.637 -2.074 . . . . 0.0 110.348 -168.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.35 18.13 69.71 Favored Glycine 0 CA--C 1.568 3.372 0 CA-C-O 118.962 -0.91 . . . . 0.0 114.725 -162.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.301 6.0 p -121.59 114.3 20.99 Favored 'General case' 0 N--CA 1.486 1.352 1 N-CA-C 96.065 -5.531 . . . . 0.0 96.065 158.462 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.447 ' CG ' ' H ' ' A' ' 34' ' ' CYS 0.304 48.9 p30 -145.45 -90.36 0.1 Allowed 'General case' 0 CA--C 1.559 1.313 1 N-CA-C 134.521 8.712 . . . . 0.0 134.521 -138.635 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.867 ' SG ' ' SG ' ' A' ' 12' ' ' CYS 0.27 0.1 OUTLIER -74.47 -174.61 2.1 Favored 'General case' 0 C--N 1.305 -1.367 1 CA-C-N 106.273 -4.967 . . . . 0.0 119.848 -143.839 . . . . . . . . 5 4 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -170.11 137.25 1.53 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 109.163 -3.653 . . . . 0.0 109.604 -173.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.433 ' H ' ' N ' ' A' ' 10' ' ' GLY . 10.6 m -84.44 94.41 8.51 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 173.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp . . . . . 0 CA--C 1.573 1.862 0 CA-C-O 117.272 -1.346 . . . . 0.0 112.051 -167.858 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.1 tttt . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 120.662 0.267 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.6 p 50.37 178.33 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.871 2.175 . . . . 0.0 116.871 -168.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.2 mt -128.04 127.14 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.57 71.01 0.75 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.257 1.027 . . . . 0.0 112.563 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.546 ' HD3' ' H ' ' A' ' 7' ' ' LYS 0.266 0.0 OUTLIER -125.41 177.04 6.4 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 124.845 2.26 . . . . 0.0 116.09 -168.171 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -118.08 100.73 7.72 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.316 -2.22 . . . . 0.0 105.913 158.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.328 1.1 m-85 79.18 63.4 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 122.885 2.584 . . . . 0.0 107.309 172.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -68.16 -165.22 3.21 Favored Glycine 0 C--N 1.351 1.413 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.553 171.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -134.66 75.28 1.57 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.93 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 27.7 p -75.36 -179.17 4.36 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 113.093 -1.867 . . . . 0.0 113.135 -169.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -143.89 151.96 40.51 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 122.994 1.378 . . . . 0.0 108.155 167.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.3 m0 -99.66 93.83 6.04 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 168.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.32 41.02 0.56 Allowed Glycine 0 CA--C 1.56 2.89 0 CA-C-N 113.456 -1.702 . . . . 0.0 112.732 -166.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.79 -142.59 3.43 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.65 139.33 91.29 Favored Pre-proline 0 N--CA 1.499 1.993 0 CA-C-N 113.236 -1.482 . . . . 0.0 107.978 166.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -66.02 -129.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.572 2.38 0 C-N-CA 123.026 2.484 . . . . 0.0 111.19 169.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.2 m -152.63 139.28 18.79 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 165.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.57 160.54 26.4 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 122.889 1.328 . . . . 0.0 111.649 -170.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 38.5 mtt85 47.59 59.63 4.02 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.09 100.37 0.24 Allowed Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.46 -0.775 . . . . 0.0 112.423 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -112.23 169.87 8.56 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -168.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.56 -87.47 1.89 Allowed Glycine 0 CA--C 1.536 1.383 0 CA-C-N 111.67 -2.513 . . . . 0.0 108.686 166.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' SG ' ' SG ' ' A' ' 34' ' ' CYS 0.415 22.4 t 65.66 55.96 0.96 Allowed 'General case' 0 CA--C 1.561 1.391 0 CA-C-N 110.49 -2.855 . . . . 0.0 113.749 -169.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.539 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 54.1 mt -83.2 133.85 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 167.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.1 m -119.34 178.82 4.39 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 118.137 2.643 . . . . 0.0 118.137 -166.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 p -159.5 153.16 22.8 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-O 124.499 2.095 . . . . 0.0 111.986 -167.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.327 2.4 mp 40.27 60.18 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 CA-C-N 109.97 -3.286 . . . . 0.0 113.416 -169.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.274 15.7 mmt 85.37 7.15 0.43 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.02 69.05 1.29 Allowed Glycine 0 N--CA 1.486 1.987 0 CA-C-N 122.122 2.237 . . . . 0.0 111.664 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 34' ' ' CYS . 30.1 p -149.96 -76.37 0.15 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 123.763 1.744 . . . . 0.0 109.94 -168.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.77 21.81 0.05 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 119.814 3.264 . . . . 0.0 119.814 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.93 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 8.6 t -59.75 -168.81 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 112.286 -2.233 . . . . 0.0 115.405 -167.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 49.2 mt-10 -149.28 144.54 26.55 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 169.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.697 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 18.2 m -101.21 116.65 33.31 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? . . . . . 0 CA--C 1.574 1.877 0 CA-C-N 119.988 1.267 . . . . 0.0 109.711 170.038 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.318 14.0 p -119.48 -167.47 1.42 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 126.688 1.995 . . . . 0.0 115.297 -169.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.468 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 21.9 mm -94.65 -70.44 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.723 0 C-N-CA 125.137 1.375 . . . . 0.0 107.94 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.52 67.38 0.65 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.849 1.66 . . . . 0.0 114.652 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -174.6 128.76 0.33 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.06 120.0 15.99 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.108 1.363 . . . . 0.0 109.603 171.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.308 2.2 m-85 72.31 44.6 0.42 Allowed 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 124.82 1.248 . . . . 0.0 109.485 -167.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.18 -150.7 2.57 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-O 118.221 -1.322 . . . . 0.0 110.806 173.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.4 mmt-85 -147.35 74.54 1.33 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -171.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.803 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -77.06 -177.38 4.44 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 123.284 1.516 . . . . 0.0 111.09 -169.504 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -141.97 125.34 16.58 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 166.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 52.1 m0 -76.26 111.69 11.96 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 169.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.31 47.03 5.36 Favored Glycine 0 CA--C 1.558 2.723 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.566 -165.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.72 -135.37 1.81 Allowed Glycine 0 N--CA 1.472 1.098 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -169.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.94 140.48 95.69 Favored Pre-proline 0 CA--C 1.573 1.828 0 CA-C-N 112.361 -1.919 . . . . 0.0 112.033 169.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.406 ' HB2' ' H ' ' A' ' 19' ' ' CYS . 28.4 Cg_endo -71.11 -128.05 0.01 OUTLIER 'Trans proline' 0 CA--C 1.567 2.126 0 C-N-CA 123.28 2.653 . . . . 0.0 110.774 167.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -150.2 8.97 0.64 Allowed 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 119.379 3.103 . . . . 0.0 119.379 167.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 79.41 -67.61 0.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 111.106 -2.77 . . . . 0.0 114.737 169.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -112.56 65.77 0.64 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.86 1.264 . . . . 0.0 110.687 -168.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.5 77.06 0.17 Allowed Glycine 0 CA--C 1.542 1.771 0 N-CA-C 116.673 1.429 . . . . 0.0 116.673 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.6 ttm105 -140.99 141.12 34.41 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 118.013 0.907 . . . . 0.0 111.613 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.35 105.1 3.05 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-O 125.021 2.456 . . . . 0.0 108.727 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.858 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 27.4 t -64.85 128.29 35.16 Favored 'General case' 0 CA--C 1.558 1.266 1 CA-C-N 107.887 -4.157 . . . . 0.0 112.489 170.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.463 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 29.6 mm -115.89 140.12 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 165.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 86.6 m -107.99 -174.71 2.59 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-N 113.831 -1.531 . . . . 0.0 114.786 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.81 -19.04 65.63 Favored 'General case' 0 N--CA 1.502 2.153 1 N-CA-C 122.155 4.132 . . . . 0.0 122.155 175.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.452 4.1 mp 86.91 75.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.487 0 CA-C-N 109.251 -3.613 . . . . 0.0 105.718 -167.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.7 ttt 176.27 -51.33 0.01 OUTLIER 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 111.333 -2.667 . . . . 0.0 106.772 -167.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.89 -32.7 6.19 Favored Glycine 0 CA--C 1.546 1.979 0 CA-C-O 118.585 -1.12 . . . . 0.0 113.709 -168.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 p -79.44 -170.61 2.39 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-O 124.67 2.176 . . . . 0.0 105.384 168.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.6 m120 36.75 55.36 1.17 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 126.117 2.865 . . . . 0.0 115.732 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.858 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 8.0 t -102.67 -163.9 1.04 Allowed 'General case' 0 C--N 1.312 -1.037 1 CA-C-N 108.097 -4.138 . . . . 0.0 113.96 -161.647 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.423 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 10.9 pt-20 -157.78 150.98 23.29 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 112.244 -2.253 . . . . 0.0 112.046 171.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 16.8 m -90.91 81.39 5.7 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt . . . . . 0 CA--C 1.567 1.628 0 CA-C-O 117.269 -1.348 . . . . 0.0 110.653 -169.083 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.4 p 51.63 169.02 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 118.542 2.793 . . . . 0.0 118.542 -170.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.407 ' H ' ' HA ' ' A' ' 19' ' ' CYS . 3.8 mt -115.42 107.53 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 -175.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.84 69.62 4.65 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.48 1.133 . . . . 0.0 110.831 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -160.48 112.91 2.0 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 104.281 -2.489 . . . . 0.0 104.281 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -75.79 126.55 31.23 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.894 1.278 . . . . 0.0 110.366 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.298 12.0 m-85 73.41 38.77 0.63 Allowed 'General case' 0 CA--C 1.58 2.108 0 C-N-CA 124.413 1.085 . . . . 0.0 111.149 -167.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.35 132.39 11.11 Favored Glycine 0 N--CA 1.483 1.795 0 O-C-N 120.946 -1.097 . . . . 0.0 110.403 -174.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -74.83 70.35 1.92 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 127.108 3.337 . . . . 0.0 112.457 -167.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.716 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 31.4 p -72.27 -174.78 1.37 Allowed 'General case' 0 N--CA 1.483 1.203 1 CA-C-N 106.088 -5.051 . . . . 0.0 114.232 -173.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -152.61 164.26 38.03 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.595 169.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -97.26 104.14 16.14 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 169.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.69 41.81 1.09 Allowed Glycine 0 CA--C 1.557 2.709 0 CA-C-N 113.904 -1.498 . . . . 0.0 113.025 -166.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.98 -146.66 4.4 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-O 123.417 1.565 . . . . 0.0 111.247 -175.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.11 132.32 88.34 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-N 112.791 -1.705 . . . . 0.0 108.275 167.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -54.89 -34.11 84.54 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 N-CA-C 121.915 3.775 . . . . 0.0 121.915 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.407 ' HA ' ' H ' ' A' ' 5' ' ' ILE 0.297 74.3 m 87.42 148.0 0.05 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 111.288 -2.687 . . . . 0.0 109.205 -165.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.09 176.31 5.17 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.869 -168.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . 0.254 32.6 ptt180 42.53 56.12 3.91 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 119.433 3.123 . . . . 0.0 119.433 167.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.02 102.64 0.1 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.28 161.97 36.6 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -167.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -178.78 120.25 0.69 Allowed Glycine 0 CA--C 1.529 0.96 0 N-CA-C 106.809 -2.516 . . . . 0.0 106.809 168.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 39.7 t -91.82 81.86 5.2 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 111.446 -2.377 . . . . 0.0 112.827 -169.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.557 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -75.75 134.9 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 168.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.5 m -118.39 178.11 4.57 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 112.944 -1.935 . . . . 0.0 114.523 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.288 57.9 m -79.11 -149.98 0.05 Allowed 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 125.149 1.38 . . . . 0.0 110.808 178.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.82 58.11 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.902 0.858 . . . . 0.0 108.88 169.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.93 -57.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.41 1.084 . . . . 0.0 111.712 -173.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.44 54.15 1.49 Allowed Glycine 0 CA--C 1.548 2.13 0 CA-C-O 119.278 -0.734 . . . . 0.0 112.777 -167.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.568 ' HG1' ' H ' ' A' ' 33' ' ' ASN . 3.8 p -153.73 -73.96 0.13 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 123.824 1.773 . . . . 0.0 111.364 -168.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.568 ' H ' ' HG1' ' A' ' 32' ' ' THR 0.314 8.6 m120 -67.34 33.53 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 129.679 3.191 . . . . 0.0 118.01 168.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 30.9 t -77.27 -150.62 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 111.839 -2.437 . . . . 0.0 113.731 -167.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -172.52 143.58 1.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.206 169.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 6.9 m -105.36 98.78 8.44 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.573 1.842 0 CA-C-O 116.943 -1.503 . . . . 0.0 112.802 -168.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.2 p -24.27 174.32 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.065 1 N-CA-C 127.247 6.017 . . . . 0.0 127.247 -168.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mt -109.19 117.3 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 127.823 2.449 . . . . 0.0 104.413 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.65 71.7 1.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.062 0.934 . . . . 0.0 110.25 173.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -169.82 123.2 0.74 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -76.11 128.5 35.1 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.869 1.267 . . . . 0.0 110.602 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.281 13.0 m-85 73.79 38.78 0.58 Allowed 'General case' 0 CA--C 1.578 2.055 0 C-N-CA 124.836 1.254 . . . . 0.0 110.689 -168.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.449 ' N ' ' H ' ' A' ' 36' ' ' CYS . . . -103.93 122.5 7.42 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.222 -0.924 . . . . 0.0 111.69 -169.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -33.58 82.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 1 C-N-CA 132.857 4.463 . . . . 0.0 115.246 -172.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 3.8 p -88.65 173.39 8.64 Favored 'General case' 0 N--CA 1.491 1.592 1 CA-C-N 107.471 -4.422 . . . . 0.0 113.8 -167.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -153.59 144.96 23.1 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.936 169.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -86.69 103.2 14.93 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 168.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.71 47.28 1.81 Allowed Glycine 0 CA--C 1.557 2.663 0 CA-C-N 114.526 -1.216 . . . . 0.0 112.733 -165.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.39 -141.4 3.48 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-O 123.29 1.494 . . . . 0.0 109.954 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.41 133.64 95.42 Favored Pre-proline 0 CA--C 1.577 1.985 0 CA-C-N 112.669 -1.765 . . . . 0.0 109.988 169.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -55.76 -35.37 93.35 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 N-CA-C 122.423 3.97 . . . . 0.0 122.423 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . 0.314 66.3 m 79.05 143.42 0.08 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 111.635 -2.53 . . . . 0.0 107.28 -163.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.47 -62.78 1.2 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -162.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -126.04 80.46 1.91 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.946 0.879 . . . . 0.0 109.089 -166.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.15 102.19 1.97 Allowed Glycine 0 N--CA 1.476 1.354 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.618 -176.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.54 165.94 18.95 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-O 123.588 1.661 . . . . 0.0 112.577 -169.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -156.88 -81.01 0.03 OUTLIER Glycine 0 N--CA 1.477 1.432 0 CA-C-O 124.31 2.061 . . . . 0.0 109.314 -169.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.415 19.9 t 79.34 50.79 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 109.202 -3.499 . . . . 0.0 115.166 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 76.9 mt -82.68 149.44 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 122.975 1.369 . . . . 0.0 107.421 167.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.464 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 69.3 m -93.14 171.25 9.06 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 -170.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.274 69.6 m -91.09 -147.14 0.2 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.348 1.459 . . . . 0.0 109.635 -174.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 mm -94.2 50.88 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 CA-C-O 122.859 1.314 . . . . 0.0 110.213 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.1 ttt -172.76 -52.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.865 1.266 . . . . 0.0 112.417 -169.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.39 50.3 2.41 Favored Glycine 0 CA--C 1.548 2.154 0 CA-C-N 118.741 0.701 . . . . 0.0 113.749 -168.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.4 p -151.94 -79.11 0.11 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.906 1.336 . . . . 0.0 109.136 -169.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.81 -26.87 68.82 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 121.214 3.783 . . . . 0.0 121.214 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' A' ' 12' ' ' CYS 0.376 6.7 m 37.27 -151.69 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 130.161 3.385 . . . . 0.0 117.714 172.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -175.75 133.57 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.449 ' H ' ' N ' ' A' ' 10' ' ' GLY . 6.1 m -89.73 95.47 10.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.193 -0.942 . . . . 0.0 109.246 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? . . . . . 0 CA--C 1.573 1.856 0 CA-C-O 116.763 -1.589 . . . . 0.0 112.027 -170.904 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.5 mttm . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.6 p 49.21 170.03 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 118.61 2.819 . . . . 0.0 118.61 -169.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mm -102.41 108.45 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.76 72.89 2.29 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.347 1.07 . . . . 0.0 110.053 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -176.6 123.9 0.16 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 -171.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -75.22 127.95 34.35 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 168.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.27 12.1 m-85 74.78 30.09 1.02 Allowed 'General case' 0 CA--C 1.579 2.093 0 C-N-CA 124.903 1.281 . . . . 0.0 113.607 -169.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.96 131.27 10.59 Favored Glycine 0 N--CA 1.474 1.227 0 O-C-N 120.91 -1.119 . . . . 0.0 112.237 -169.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -55.47 82.21 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 130.324 3.45 . . . . 0.0 114.69 -167.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.615 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 22.3 p -90.41 173.15 8.26 Favored 'General case' 0 N--CA 1.494 1.751 1 CA-C-N 106.374 -4.921 . . . . 0.0 113.242 -168.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -150.66 128.85 11.94 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.507 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -77.16 111.13 12.44 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 170.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.54 33.9 5.73 Favored Glycine 0 CA--C 1.559 2.807 0 CA-C-N 114.826 -1.079 . . . . 0.0 114.531 -166.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.24 -139.99 3.63 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-O 123.449 1.583 . . . . 0.0 109.667 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.55 137.26 97.03 Favored Pre-proline 0 CA--C 1.573 1.864 0 CA-C-N 112.42 -1.89 . . . . 0.0 109.772 168.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -66.92 -172.91 0.35 Allowed 'Trans proline' 0 CA--C 1.57 2.313 0 CA-C-N 123.546 2.302 . . . . 0.0 110.834 167.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.9 m -101.84 149.16 24.47 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 167.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.71 -60.17 1.76 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.865 -173.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -137.24 87.3 2.26 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.944 1.297 . . . . 0.0 108.128 -169.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.78 116.2 4.15 Favored Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -169.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -138.24 176.23 8.88 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -167.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.37 109.23 2.84 Favored Glycine 0 N--CA 1.475 1.263 0 CA-C-N 112.367 -2.197 . . . . 0.0 109.039 -170.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 53.8 t -109.77 75.66 0.95 Allowed 'General case' 0 CA--C 1.56 1.327 0 CA-C-N 111.837 -2.182 . . . . 0.0 111.587 -169.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.401 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 36.4 mm -89.45 144.58 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 169.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.537 ' N ' ' SG ' ' A' ' 34' ' ' CYS 0.304 6.5 m -105.75 161.8 14.09 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 125.023 1.452 . . . . 0.0 113.002 177.045 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.534 ' HA ' ' H ' ' A' ' 31' ' ' GLY 0.823 2.9 t 81.74 -176.52 0.05 OUTLIER 'General case' 0 C--N 1.353 0.736 0 N-CA-C 120.605 3.557 . . . . 0.0 120.605 156.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.311 4.1 mp 70.83 64.08 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.586 2.331 0 CA-C-N 108.468 -3.969 . . . . 0.0 104.002 -158.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.272 0.0 OUTLIER 136.33 -58.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 128.582 2.753 . . . . 0.0 104.073 -162.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.534 ' H ' ' HA ' ' A' ' 28' ' ' SER . . . 62.34 47.65 88.08 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 120.208 2.843 . . . . 0.0 120.208 -169.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.299 22.7 p -98.66 102.79 14.63 Favored 'General case' 0 CA--C 1.553 1.059 1 N-CA-C 94.359 -6.163 . . . . 0.0 94.359 151.798 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.423 ' HA ' ' HB3' ' A' ' 27' ' ' CYS 0.62 3.5 p-10 -87.82 70.89 9.59 Favored 'General case' 0 N--CA 1.439 -1.015 2 CA-C-N 105.29 -5.414 . . . . 0.0 122.177 -148.202 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.615 ' HB3' ' SG ' ' A' ' 12' ' ' CYS 0.414 59.3 m 123.19 171.24 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 3 CA-C-N 101.572 -7.104 . . . . 0.0 113.402 160.774 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -150.01 143.17 25.0 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 112.032 -2.349 . . . . 0.0 106.46 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 12.8 m -89.8 86.35 6.64 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -167.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.6 tptt . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.284 22.0 p 41.93 -171.46 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 118.87 2.915 . . . . 0.0 118.87 173.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.436 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 4.5 mm -113.22 -62.81 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.546 0 CA-C-N 113.449 -1.705 . . . . 0.0 110.25 -164.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.254 . . 66.11 60.64 0.64 Allowed 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 125.278 1.431 . . . . 0.0 114.572 -169.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -169.75 131.44 1.09 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 173.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -68.14 136.07 53.11 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 125.264 1.425 . . . . 0.0 110.235 169.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 66.34 34.61 6.29 Favored 'General case' 0 CA--C 1.581 2.169 0 C-N-CA 124.257 1.023 . . . . 0.0 112.093 -167.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.65 132.16 10.87 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -169.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -73.52 73.77 1.43 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 126.971 3.272 . . . . 0.0 112.116 -167.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 24.3 p -71.02 174.8 5.77 Favored 'General case' 0 N--CA 1.486 1.35 1 CA-C-N 106.056 -5.066 . . . . 0.0 114.074 -176.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.531 ' H ' ' CG ' ' A' ' 18' ' ' PRO . 17.9 ptpt -129.2 159.1 37.11 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 123.42 1.581 . . . . 0.0 111.158 171.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 52.6 m0 -104.61 91.29 3.8 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 168.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.91 -81.11 0.06 OUTLIER Glycine 0 N--CA 1.478 1.442 0 N-CA-C 106.491 -2.644 . . . . 0.0 106.491 -166.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.86 135.87 2.02 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 125.154 2.53 . . . . 0.0 118.093 163.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 m 168.64 -65.12 0.0 OUTLIER Pre-proline 0 CA--C 1.59 2.493 1 CA-C-N 107.266 -4.467 . . . . 0.0 101.393 -168.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.531 ' CG ' ' H ' ' A' ' 13' ' ' LYS 1.105 0.6 OUTLIER -24.85 155.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.827 2 N-CA-C 135.587 9.033 . . . . 0.0 135.587 -156.146 . . . . . . . . 5 4 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.436 ' SG ' ' HB ' ' A' ' 5' ' ' ILE 0.345 31.4 m -23.92 117.5 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.272 2 CA-C-N 105.167 -5.47 . . . . 0.0 114.873 -156.667 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.33 156.13 39.43 Favored 'General case' 0 C--N 1.297 -1.708 1 CA-C-N 106.378 -4.919 . . . . 0.0 109.373 -163.239 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 58.39 49.28 11.08 Favored 'General case' 0 CA--C 1.586 2.339 0 CA-C-N 112.989 -1.914 . . . . 0.0 113.768 -173.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.23 142.48 6.77 Favored Glycine 0 CA--C 1.556 2.642 0 N-CA-C 115.316 0.886 . . . . 0.0 115.316 -169.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.53 162.81 40.91 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -153.52 105.52 0.28 Allowed Glycine 0 N--CA 1.475 1.268 0 N-CA-C 105.751 -2.94 . . . . 0.0 105.751 164.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.87 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 54.0 t -99.07 125.09 44.51 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 110.787 -2.707 . . . . 0.0 109.568 -174.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.537 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 23.6 mm -117.27 134.07 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 166.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.576 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 68.2 m -121.56 173.25 7.53 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -172.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 p -120.05 135.42 54.94 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 125.072 1.349 . . . . 0.0 111.085 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.296 9.6 mt -5.61 56.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.39 2 CA-C-N 108.264 -4.062 . . . . 0.0 116.571 -168.659 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.8 tpt 172.57 -56.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 113.076 -1.875 . . . . 0.0 113.765 -167.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.36 53.0 1.64 Allowed Glycine 0 CA--C 1.552 2.362 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -163.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 34' ' ' CYS . 99.6 m -150.77 -69.8 0.18 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 123.124 1.44 . . . . 0.0 111.665 -167.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.283 9.6 m-80 -71.23 30.16 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 118.466 2.765 . . . . 0.0 118.466 169.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.87 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 17.7 t -76.47 -156.79 0.07 Allowed 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 112.496 -2.138 . . . . 0.0 115.061 -166.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.08 147.62 4.74 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 113.658 -1.61 . . . . 0.0 110.666 168.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 20.2 m -100.16 95.89 7.12 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt . . . . . 0 CA--C 1.576 1.969 0 CA-C-O 117.54 -1.219 . . . . 0.0 112.555 -169.195 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.7 tttt . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.2 p 54.41 170.75 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.577 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 31.7 mm -99.47 103.96 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 175.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.46 66.26 1.99 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.234 1.016 . . . . 0.0 112.456 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -174.89 119.83 0.21 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -170.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -75.18 129.38 37.41 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.908 1.283 . . . . 0.0 108.535 169.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 72.47 44.13 0.43 Allowed 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -166.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.524 ' N ' ' H ' ' A' ' 36' ' ' CYS . . . -81.49 -148.03 6.13 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-O 117.428 -1.762 . . . . 0.0 111.416 -173.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -144.75 75.92 1.47 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -175.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 17.2 p -97.76 -175.44 3.17 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 112.737 -2.029 . . . . 0.0 113.563 -168.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -153.5 160.63 42.58 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.227 -1.352 . . . . 0.0 110.065 166.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -95.9 108.01 20.34 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 169.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.62 38.83 2.0 Allowed Glycine 0 CA--C 1.558 2.764 0 CA-C-N 113.896 -1.502 . . . . 0.0 113.312 -166.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.03 -140.17 3.86 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 123.637 1.687 . . . . 0.0 110.05 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.463 ' CG2' HG12 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -62.3 166.13 7.45 Favored Pre-proline 0 CA--C 1.596 2.748 0 CA-C-N 112.052 -2.074 . . . . 0.0 113.0 168.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -62.39 -30.96 81.18 Favored 'Trans proline' 0 CA--C 1.568 2.222 0 N-CA-C 122.401 3.962 . . . . 0.0 122.401 169.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.577 ' SG ' ' HB ' ' A' ' 5' ' ' ILE 0.323 6.2 t 78.54 139.64 0.07 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 111.649 -2.523 . . . . 0.0 107.138 -162.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.74 -64.28 1.16 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -164.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . 0.29 40.8 mtm105 -92.11 -130.37 0.11 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.811 1.291 . . . . 0.0 109.116 -168.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.65 94.93 0.25 Allowed Glycine 0 N--CA 1.486 1.994 0 CA-C-N 112.799 -2.0 . . . . 0.0 111.048 169.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -106.47 169.05 8.75 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 123.948 1.832 . . . . 0.0 115.646 -165.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.28 103.62 0.21 Allowed Glycine 0 N--CA 1.471 0.988 0 N-CA-C 105.484 -3.046 . . . . 0.0 105.484 169.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.7 t -88.33 77.33 8.2 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 111.006 -2.597 . . . . 0.0 111.631 -169.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.1 mm -82.36 144.99 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 168.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.458 ' SG ' ' N ' ' A' ' 32' ' ' THR . 3.1 t -110.58 -176.09 2.89 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -176.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.315 42.5 m -101.97 -142.18 0.35 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.849 1.66 . . . . 0.0 109.195 -169.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.4 mm -72.87 -5.82 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -174.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.0 mmt -141.49 -24.63 0.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.423 ' HA2' ' SG ' ' A' ' 27' ' ' CYS . . . 91.3 58.05 1.5 Allowed Glycine 0 CA--C 1.551 2.283 0 CA-C-N 121.084 1.766 . . . . 0.0 110.929 -166.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.458 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 17.7 p -149.06 -74.93 0.17 Allowed 'General case' 0 CA--C 1.563 1.451 0 CA-C-O 124.2 1.952 . . . . 0.0 111.832 -168.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.358 33.5 m-20 -88.24 40.76 0.97 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 130.381 3.472 . . . . 0.0 115.303 -174.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.437 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 3.2 m -64.06 -167.47 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 112.328 -2.215 . . . . 0.0 115.518 -166.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -136.73 150.48 48.44 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.375 -0.828 . . . . 0.0 110.856 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.524 ' H ' ' N ' ' A' ' 10' ' ' GLY . 13.2 m -87.13 52.32 2.48 Favored 'General case' 0 N--CA 1.52 3.074 0 CA-C-O 123.96 1.838 . . . . 0.0 112.364 169.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.428 0.1 OUTLIER . . . . . 0 CA--C 1.557 1.248 0 C-N-CA 127.178 2.191 . . . . 0.0 115.134 169.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.823 0.344 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.5 p 54.75 -178.15 0.03 OUTLIER 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 173.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.552 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 6.1 mm -133.47 114.09 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 -171.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.6 65.84 4.41 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.01 0.91 . . . . 0.0 112.003 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -163.18 122.67 2.16 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.4 127.25 31.55 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.534 0.734 . . . . 0.0 110.617 167.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.4 ' H ' ' HB2' ' A' ' 36' ' ' CYS . 6.2 m-85 69.59 39.68 1.51 Allowed 'General case' 0 CA--C 1.576 1.968 0 C-N-CA 123.546 0.739 . . . . 0.0 111.831 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.56 126.3 7.33 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -78.83 70.92 5.25 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 127.048 3.308 . . . . 0.0 111.823 -166.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.1 p -74.43 -167.18 0.51 Allowed 'General case' 0 CA--C 1.562 1.404 1 CA-C-N 106.288 -4.96 . . . . 0.0 113.782 -167.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.617 ' HB2' ' SG ' ' A' ' 34' ' ' CYS 0.389 0.1 OUTLIER 105.68 90.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 127.49 2.316 . . . . 0.0 106.841 173.851 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . 0.341 69.7 m95 -107.61 -140.42 0.37 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 110.502 -3.045 . . . . 0.0 102.963 -169.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.13 43.61 3.15 Favored Glycine 1 CA--C 1.585 4.433 0 N-CA-C 105.836 -2.906 . . . . 0.0 105.836 149.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.87 136.58 0.0 OUTLIER Glycine 0 CA--C 1.557 2.677 0 C-N-CA 126.926 2.203 . . . . 0.0 114.027 -162.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 m -134.66 134.96 22.65 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 170.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -48.44 -37.13 32.55 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 N-CA-C 119.999 3.038 . . . . 0.0 119.999 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.552 ' SG ' ' HB ' ' A' ' 5' ' ' ILE 0.258 16.6 t 74.32 141.4 0.07 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.997 -1.91 . . . . 0.0 106.982 -164.166 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 160.15 19.12 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 113.219 -1.81 . . . . 0.0 112.859 -165.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.6 mtt85 63.81 62.99 0.86 Allowed 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 112.795 -2.002 . . . . 0.0 113.177 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.44 68.81 1.52 Allowed Glycine 0 CA--C 1.545 1.911 0 N-CA-C 115.911 1.125 . . . . 0.0 115.911 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.28 161.41 42.09 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-O 123.222 1.487 . . . . 0.0 112.353 -172.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.86 118.68 1.27 Allowed Glycine 0 N--CA 1.478 1.47 1 N-CA-C 102.935 -4.066 . . . . 0.0 102.935 166.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.616 9.1 t -45.38 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 125.441 1.318 . . . . 0.0 113.857 -166.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.275 60.6 mt 74.13 150.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 123.286 1.517 . . . . 0.0 110.855 172.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.443 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 90.6 m -90.64 171.09 9.62 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 119.454 3.131 . . . . 0.0 119.454 -169.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.336 13.3 m -94.79 -142.85 0.25 Allowed 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 126.706 2.002 . . . . 0.0 108.928 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.25 1.9 pp -96.74 59.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 123.132 1.444 . . . . 0.0 111.32 168.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.9 ttt -161.52 -46.27 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.608 -1.633 . . . . 0.0 113.01 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.41 38.25 11.16 Favored Glycine 0 CA--C 1.556 2.638 0 CA-C-O 119.336 -0.702 . . . . 0.0 113.434 -165.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 m -162.28 -59.84 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 123.762 1.744 . . . . 0.0 111.465 -167.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.374 26.0 m-20 -79.11 45.87 0.66 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 129.781 3.232 . . . . 0.0 114.932 171.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.617 ' SG ' ' HB2' ' A' ' 13' ' ' LYS 0.267 36.3 m -69.54 -167.14 0.12 Allowed 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.415 -167.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -163.15 138.11 6.48 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 119.709 -1.869 . . . . 0.0 108.812 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.4 ' HB2' ' H ' ' A' ' 9' ' ' TYR . 20.9 m -51.69 -47.84 63.73 Favored 'General case' 0 N--CA 1.512 2.652 0 CA-C-O 125.557 2.599 . . . . 0.0 117.861 175.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.391 23.0 mtmm . . . . . 0 CA--C 1.578 2.027 1 CA-C-N 105.727 -5.215 . . . . 0.0 109.57 -165.13 . . . . . . . . 2 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.1 tptm . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.6 p 50.59 178.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 119.04 2.978 . . . . 0.0 119.04 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mt -134.32 119.01 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 -170.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.284 . . -77.38 10.87 2.24 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 119.274 3.065 . . . . 0.0 119.274 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.932 30.7 mtmm 92.39 -136.53 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 1 N-CA-C 124.527 5.01 . . . . 0.0 124.527 161.166 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.442 0.0 OUTLIER 6.3 83.37 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 1 CA-C-N 108.215 -4.084 . . . . 0.0 116.934 -149.461 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.316 29.7 m-85 80.79 62.78 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 -163.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.26 -167.95 0.7 Allowed Glycine 0 CA--C 1.568 3.384 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 168.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -144.66 72.86 1.35 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 121.06 2.43 . . . . 0.0 104.636 -176.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.859 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 28.9 p -88.98 174.03 8.14 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 112.304 -2.225 . . . . 0.0 114.0 -165.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -166.42 126.93 1.67 Allowed 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 103.114 -2.921 . . . . 0.0 103.114 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -79.5 99.78 7.41 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 172.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.73 38.51 1.06 Allowed Glycine 0 CA--C 1.569 3.421 0 CA-C-N 112.393 -2.185 . . . . 0.0 111.525 -163.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -162.44 -149.18 5.59 Favored Glycine 0 N--CA 1.48 1.633 0 C-N-CA 125.376 1.465 . . . . 0.0 109.819 -170.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.18 128.52 92.52 Favored Pre-proline 0 N--CA 1.501 2.088 0 CA-C-O 118.189 -0.91 . . . . 0.0 109.321 169.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -63.01 -38.77 44.24 Favored 'Trans proline' 0 N--CA 1.495 1.575 1 N-CA-C 123.207 4.272 . . . . 0.0 123.207 -171.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . 0.331 71.6 m 90.93 144.44 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.451 0 CA-C-N 111.166 -2.743 . . . . 0.0 105.015 -160.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . 0.255 0.1 OUTLIER -85.51 -66.94 0.84 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 119.439 3.126 . . . . 0.0 119.439 -161.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -109.09 67.16 0.65 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -166.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.83 92.92 0.27 Allowed Glycine 0 N--CA 1.49 2.234 0 CA-C-O 119.423 -0.654 . . . . 0.0 112.346 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.59 165.09 11.79 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 -166.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.87 106.27 0.32 Allowed Glycine 0 N--CA 1.471 0.995 0 N-CA-C 106.743 -2.543 . . . . 0.0 106.743 166.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 25.4 t -99.53 94.24 6.29 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 110.032 -3.084 . . . . 0.0 110.676 -173.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.502 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 29.6 mm -92.09 139.28 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 167.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.419 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 79.2 m -117.49 -176.85 3.1 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 -167.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.434 ' HG ' ' H ' ' A' ' 29' ' ' ILE . 36.0 t -145.49 163.85 33.41 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 125.699 2.666 . . . . 0.0 107.689 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.434 ' H ' ' HG ' ' A' ' 28' ' ' SER 0.345 7.6 mt 36.71 52.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 1 CA-C-N 108.275 -4.057 . . . . 0.0 114.415 179.684 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.6 tpt 72.61 44.48 0.39 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 125.441 1.496 . . . . 0.0 114.547 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.71 65.06 2.61 Favored Glycine 0 N--CA 1.491 2.346 0 O-C-N 120.321 -1.487 . . . . 0.0 113.074 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.779 ' HG1' ' H ' ' A' ' 33' ' ' ASN . 39.8 p -146.05 -81.51 0.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 124.011 1.862 . . . . 0.0 110.932 -166.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.779 ' H ' ' HG1' ' A' ' 32' ' ' THR 0.335 9.1 m120 -70.73 35.75 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 131.093 3.757 . . . . 0.0 118.119 172.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.859 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 7.2 t -71.5 -176.7 1.62 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 124.439 2.066 . . . . 0.0 114.326 -167.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -144.45 153.93 42.42 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 111.22 -2.718 . . . . 0.0 109.828 170.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.59 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 36.2 m -104.26 90.05 3.44 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 171.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp . . . . . 0 CA--C 1.568 1.653 0 CA-C-O 117.657 -1.163 . . . . 0.0 111.482 -169.752 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.25 95.5 mttt . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.318 30.0 p -28.74 -179.11 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.032 1 N-CA-C 125.172 5.249 . . . . 0.0 125.172 177.427 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.422 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 23.8 mm -99.24 110.23 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 174.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.54 67.16 2.4 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.242 1.02 . . . . 0.0 111.363 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -166.4 123.19 1.31 Allowed 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -70.25 130.41 41.95 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 167.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.257 0.0 OUTLIER 69.6 46.81 0.69 Allowed 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 122.964 1.364 . . . . 0.0 109.061 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.32 -152.59 15.73 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 113.615 -1.629 . . . . 0.0 109.802 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -142.21 75.64 1.5 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 -175.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 28.5 p -91.03 -171.66 3.07 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 112.641 -2.072 . . . . 0.0 112.525 -169.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -153.37 141.91 20.81 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.811 169.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -93.15 99.01 11.67 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.15 -62.98 0.52 Allowed Glycine 0 N--CA 1.484 1.867 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.782 -164.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.41 -142.67 0.3 Allowed Glycine 0 CA--C 1.539 1.587 0 CA-C-N 112.083 -2.058 . . . . 0.0 113.368 167.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.56 138.04 94.95 Favored Pre-proline 0 N--CA 1.495 1.821 0 CA-C-N 113.484 -1.358 . . . . 0.0 111.889 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HB2' ' H ' ' A' ' 19' ' ' CYS . 23.7 Cg_endo -64.55 -131.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.573 2.429 0 C-N-CA 123.426 2.751 . . . . 0.0 112.34 169.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.422 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 4.3 t -148.81 146.81 28.17 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 164.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.29 -63.15 1.39 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 121.507 3.891 . . . . 0.0 121.507 -162.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -94.86 70.1 3.38 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.289 1.042 . . . . 0.0 112.715 -164.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.64 62.58 4.92 Favored Glycine 0 N--CA 1.486 2.004 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.925 -176.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -136.48 163.63 30.06 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 123.963 1.84 . . . . 0.0 112.222 -167.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.87 121.11 2.16 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 106.095 -2.802 . . . . 0.0 106.095 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.664 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 2.9 t -75.44 89.33 2.66 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 109.214 -3.493 . . . . 0.0 110.642 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.456 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 37.5 mm -81.5 136.41 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 122.852 1.311 . . . . 0.0 107.655 172.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.4 m -119.07 -179.0 3.7 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 111.925 -2.398 . . . . 0.0 114.985 -169.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.291 69.6 m -90.78 -144.85 0.18 Allowed 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.942 1.297 . . . . 0.0 109.844 -172.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.4 mm -71.34 -0.63 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.578 2.024 0 N-CA-C 117.596 2.443 . . . . 0.0 117.596 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.9 tpt -148.63 -31.36 0.26 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -172.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.81 61.14 1.11 Allowed Glycine 0 N--CA 1.488 2.119 0 CA-C-N 120.796 1.634 . . . . 0.0 111.671 -167.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.448 ' C ' ' H ' ' A' ' 34' ' ' CYS . 6.3 p -151.22 -78.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 123.849 1.785 . . . . 0.0 111.25 -167.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.336 37.2 m-80 -71.58 34.91 0.06 Allowed 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 129.953 3.301 . . . . 0.0 118.006 170.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 45.9 t -74.48 -168.52 0.69 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 112.259 -2.246 . . . . 0.0 113.495 -168.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -148.45 162.54 39.38 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 112.837 -1.983 . . . . 0.0 112.142 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.9 m -83.54 56.92 3.79 Favored 'General case' 0 N--CA 1.523 3.183 0 CA-C-O 124.75 2.214 . . . . 0.0 108.847 163.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.477 1.6 ptmm? . . . . . 0 CA--C 1.558 1.253 1 N-CA-C 125.424 5.342 . . . . 0.0 125.424 -163.648 . . . . . . . . 2 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.8 tttm . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.976 0.417 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.6 p 51.54 171.17 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 118.249 2.685 . . . . 0.0 118.249 -169.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mt -121.78 121.41 64.25 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -172.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.55 52.22 1.1 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 116.963 2.209 . . . . 0.0 116.963 -173.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HE3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -122.89 -179.62 4.32 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 127.079 2.152 . . . . 0.0 110.119 175.303 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -115.0 136.43 53.14 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.277 -1.783 . . . . 0.0 106.545 157.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 71.66 35.83 1.35 Allowed 'General case' 0 CA--C 1.58 2.118 0 CA-C-N 122.451 2.387 . . . . 0.0 111.987 168.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.503 ' N ' ' H ' ' A' ' 36' ' ' CYS . . . -118.78 125.96 6.62 Favored Glycine 0 N--CA 1.464 0.543 0 O-C-N 120.548 -1.345 . . . . 0.0 112.949 -168.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -3.9 79.37 0.0 OUTLIER 'General case' 0 C--O 1.236 0.361 1 C-N-CA 132.378 4.271 . . . . 0.0 116.912 169.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.981 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 15.5 p -94.05 -178.46 4.64 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 108.461 -3.972 . . . . 0.0 112.515 -173.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.35 153.96 31.29 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.255 1.026 . . . . 0.0 109.551 167.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -82.96 117.51 22.83 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.136 -173.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.21 39.64 18.7 Favored Glycine 0 CA--C 1.555 2.561 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -167.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.43 -146.87 9.33 Favored Glycine 0 N--CA 1.477 1.393 0 CA-C-O 123.198 1.444 . . . . 0.0 112.822 -174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.17 131.83 95.12 Favored Pre-proline 0 CA--C 1.573 1.864 0 CA-C-N 112.586 -1.807 . . . . 0.0 108.469 168.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -47.97 -36.3 27.17 Favored 'Trans proline' 0 N--CA 1.498 1.74 1 N-CA-C 122.595 4.036 . . . . 0.0 122.595 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.4 m 83.48 131.8 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 111.072 -2.785 . . . . 0.0 106.53 -165.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -56.74 3.33 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.944 -168.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -124.62 72.46 1.21 Allowed 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 124.713 1.205 . . . . 0.0 109.752 -170.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.5 73.58 0.51 Allowed Glycine 0 N--CA 1.482 1.735 0 C-N-CA 123.776 0.703 . . . . 0.0 113.107 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -90.23 174.07 7.8 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 170.73 -96.29 0.11 Allowed Glycine 0 N--CA 1.478 1.444 0 CA-C-O 123.732 1.74 . . . . 0.0 109.545 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.667 ' SG ' ' SG ' ' A' ' 34' ' ' CYS 0.39 5.7 t 93.95 94.32 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 109.536 -3.332 . . . . 0.0 110.648 173.549 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.619 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 31.0 mm -119.92 141.31 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 166.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.5 m -136.88 144.92 43.79 Favored 'General case' 0 CA--C 1.58 2.129 1 N-CA-C 123.461 4.615 . . . . 0.0 123.461 -168.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.539 10.2 p 61.11 -84.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 163.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.305 2.1 mp -38.83 -40.09 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.664 0 CA-C-N 108.969 -3.742 . . . . 0.0 116.438 168.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 37.3 ttp -143.49 -24.9 0.58 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.351 -1.75 . . . . 0.0 113.154 166.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -43.08 -47.91 6.46 Favored Glycine 0 CA--C 1.558 2.724 0 CA-C-O 125.919 2.955 . . . . 0.0 118.451 164.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.776 0.4 OUTLIER 64.86 100.16 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.888 1 CA-C-N 107.42 -4.39 . . . . 0.0 111.552 -169.507 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.811 0.6 OUTLIER 20.37 55.6 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.928 0 CA-C-N 108.802 -3.817 . . . . 0.0 118.445 -155.427 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.981 ' SG ' ' SG ' ' A' ' 12' ' ' CYS 0.409 0.1 OUTLIER 46.99 173.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 1 CA-C-N 106.528 -4.851 . . . . 0.0 119.573 -168.165 . . . . . . . . 5 4 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -158.67 141.67 14.65 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 109.975 -3.284 . . . . 0.0 108.642 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.503 ' H ' ' N ' ' A' ' 10' ' ' GLY . 90.4 m -83.41 81.55 8.67 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 120.885 1.675 . . . . 0.0 107.387 169.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.084 -1.436 . . . . 0.0 109.592 -169.166 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.402 ' HA ' HG23 ' A' ' 17' ' ' THR 0.302 27.8 p -46.83 -174.43 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.997 1 N-CA-C 122.355 4.205 . . . . 0.0 122.355 -177.006 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.498 HG13 ' SG ' ' A' ' 36' ' ' CYS . 24.5 mm -70.79 -49.88 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 C-N-CA 127.533 2.333 . . . . 0.0 111.342 173.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.284 . . 68.71 52.67 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 126.114 1.765 . . . . 0.0 114.215 -171.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -178.66 125.66 0.1 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -176.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -73.49 118.32 16.31 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 166.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.466 ' H ' ' HB2' ' A' ' 36' ' ' CYS 0.356 0.0 OUTLIER 75.86 80.44 0.1 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 176.614 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' H ' ' H ' ' A' ' 36' ' ' CYS . . . -172.66 120.31 0.81 Allowed Glycine 0 N--CA 1.471 1.007 0 CA-C-N 109.323 -3.58 . . . . 0.0 115.364 -165.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . 0.35 20.6 tpt85 1.08 70.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 131.116 3.767 . . . . 0.0 119.26 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.7 p -88.97 170.33 10.77 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 110.04 -3.255 . . . . 0.0 112.647 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -140.62 154.85 46.61 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.566 171.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -97.51 95.12 7.42 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 105.485 -2.042 . . . . 0.0 105.485 170.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.83 54.76 0.91 Allowed Glycine 0 CA--C 1.552 2.359 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.979 -167.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.04 -142.81 3.5 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-O 123.214 1.452 . . . . 0.0 110.172 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.402 HG23 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -58.46 143.9 79.71 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-N 112.777 -1.711 . . . . 0.0 111.167 168.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.436 ' HB2' ' H ' ' A' ' 19' ' ' CYS . 40.3 Cg_endo -65.06 -132.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.572 2.416 0 C-N-CA 123.0 2.466 . . . . 0.0 110.818 167.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.436 ' H ' ' HB2' ' A' ' 18' ' ' PRO . 59.6 m -152.82 142.31 21.74 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 166.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.41 -55.88 3.69 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 113.349 -1.751 . . . . 0.0 113.545 -168.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -132.44 82.12 1.99 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.835 1.254 . . . . 0.0 109.025 -169.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.82 110.47 3.36 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -133.04 175.88 8.98 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.818 1.785 . . . . 0.0 115.818 -167.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.02 -81.53 0.13 Allowed Glycine 0 N--CA 1.474 1.188 0 CA-C-N 112.331 -2.213 . . . . 0.0 109.554 -168.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.317 16.4 t 79.81 102.13 0.06 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 109.739 -3.231 . . . . 0.0 109.343 -170.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.2 mm -131.54 152.25 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 169.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.464 ' HA ' ' CB ' ' A' ' 34' ' ' CYS 0.347 85.5 m -77.54 150.95 34.73 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 176.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.319 41.1 m -152.9 176.03 12.28 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 126.161 1.784 . . . . 0.0 109.229 -165.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.328 3.9 mp 38.04 63.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 C-N-CA 126.476 1.91 . . . . 0.0 112.257 -173.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.285 16.2 mmt 91.07 -6.84 0.27 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 126.141 1.777 . . . . 0.0 115.044 -169.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.37 58.85 3.23 Favored Glycine 0 CA--C 1.557 2.664 0 CA-C-N 122.772 2.533 . . . . 0.0 109.059 -165.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.3 m -151.57 -52.17 0.12 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 124.657 1.183 . . . . 0.0 112.673 -163.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -61.28 -77.1 0.05 OUTLIER 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 124.806 2.241 . . . . 0.0 111.935 169.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.464 ' CB ' ' HA ' ' A' ' 27' ' ' CYS 0.272 2.4 m 79.65 167.23 0.18 Allowed 'General case' 0 CA--C 1.557 1.228 1 CA-C-N 107.337 -4.483 . . . . 0.0 110.094 -167.829 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -160.91 153.3 20.45 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.99 1.316 . . . . 0.0 107.616 -170.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.498 ' SG ' HG13 ' A' ' 5' ' ' ILE . 87.6 m -67.94 67.41 0.11 Allowed 'General case' 0 N--CA 1.508 2.448 0 CA-C-O 124.652 2.167 . . . . 0.0 114.696 171.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.446 34.8 ttmt . . . . . 0 CA--C 1.572 1.797 1 N-CA-C 123.244 4.535 . . . . 0.0 123.244 -169.511 . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt . . . . . 0 CA--C 1.552 1.039 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.338 65.7 pttt 54.34 86.95 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 171.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.0 tttm 66.2 89.26 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.673 1.189 . . . . 0.0 110.959 -171.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.274 21.6 p 52.41 167.94 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 -174.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.8 mm -85.42 -62.17 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.673 0 C-N-CA 125.302 1.441 . . . . 0.0 110.852 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.268 . . 72.19 61.6 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 125.591 1.556 . . . . 0.0 114.051 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -179.5 131.71 0.11 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.4 128.34 35.47 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 166.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 72.58 39.83 0.68 Allowed 'General case' 0 CA--C 1.579 2.09 0 C-N-CA 124.284 1.033 . . . . 0.0 111.745 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.68 134.41 12.31 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -76.89 72.62 3.48 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 126.909 3.242 . . . . 0.0 112.869 -165.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.498 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 13.7 p -73.59 -177.72 2.81 Favored 'General case' 0 N--CA 1.489 1.501 1 CA-C-N 106.379 -4.918 . . . . 0.0 114.253 -172.316 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -152.64 154.5 35.46 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.425 1.107 . . . . 0.0 110.055 166.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -90.89 109.19 20.4 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 169.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.02 39.15 2.54 Favored Glycine 0 CA--C 1.558 2.768 0 CA-C-N 114.238 -1.346 . . . . 0.0 113.449 -166.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.81 -139.64 3.11 Favored Glycine 0 N--CA 1.473 1.149 0 CA-C-O 123.838 1.799 . . . . 0.0 109.544 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.07 143.11 91.07 Favored Pre-proline 0 CA--C 1.578 2.046 0 CA-C-N 111.823 -2.189 . . . . 0.0 108.9 166.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HB2' ' H ' ' A' ' 19' ' ' CYS . 31.4 Cg_endo -66.69 -127.86 0.0 OUTLIER 'Trans proline' 0 CA--C 1.567 2.159 0 C-N-CA 123.378 2.719 . . . . 0.0 111.805 171.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.408 ' H ' ' HB2' ' A' ' 18' ' ' PRO . 19.4 m -149.44 142.95 25.37 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 165.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -64.45 1.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.925 -169.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.497 ' HA ' ' HE2' ' A' ' 43' ' ' GLU . 14.7 ptm180 -139.77 93.71 2.69 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -173.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.77 100.07 2.56 Favored Glycine 0 N--CA 1.478 1.486 0 N-CA-C 105.938 -2.865 . . . . 0.0 105.938 -167.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -134.13 170.78 15.16 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 123.479 1.609 . . . . 0.0 114.922 -169.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.18 -81.44 0.16 Allowed Glycine 0 N--CA 1.476 1.366 0 CA-C-O 124.673 2.263 . . . . 0.0 110.099 -168.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.491 9.5 t 68.71 44.39 1.17 Allowed 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 109.008 -3.596 . . . . 0.0 116.708 -170.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 66.1 mt -78.36 143.23 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 166.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 97.1 m -92.31 172.95 8.07 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB2' ' H ' ' A' ' 29' ' ' ILE . 33.9 p -79.4 -150.43 0.06 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 114.009 -1.451 . . . . 0.0 110.844 176.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.425 ' H ' ' HB2' ' A' ' 28' ' ' SER 0.3 2.0 pp -98.65 56.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 122.934 1.35 . . . . 0.0 111.76 168.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.317 0.0 OUTLIER -168.64 -40.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.807 1.643 . . . . 0.0 112.839 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.07 50.87 3.53 Favored Glycine 0 N--CA 1.489 2.216 0 CA-C-N 120.476 1.489 . . . . 0.0 114.442 -170.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.61 ' HG1' ' H ' ' A' ' 33' ' ' ASN . 5.0 p -157.93 -72.17 0.09 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 124.444 2.069 . . . . 0.0 111.305 -168.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.61 ' H ' ' HG1' ' A' ' 32' ' ' THR 0.32 16.9 m-80 -70.31 39.43 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 131.127 3.771 . . . . 0.0 117.677 169.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.461 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 13.6 m -68.28 -157.4 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 112.873 -1.967 . . . . 0.0 113.459 -170.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -156.65 144.06 19.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 119.913 -1.742 . . . . 0.0 109.116 174.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.498 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 16.8 m -96.84 89.71 4.98 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -47.49 153.7 0.97 Allowed Pre-proline 0 CA--C 1.569 1.684 0 N-CA-C 117.236 2.309 . . . . 0.0 117.236 -166.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.22 109.89 2.96 Favored 'Trans proline' 0 CA--C 1.564 2.022 0 C-N-CA 122.126 1.884 . . . . 0.0 113.954 -164.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -163.02 109.77 1.19 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 118.594 0.634 . . . . 0.0 111.098 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.275 52.0 tp -103.8 -67.72 0.88 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 123.921 1.819 . . . . 0.0 113.659 171.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.315 30.1 pt -81.88 24.67 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-N 110.98 -2.827 . . . . 0.0 116.125 167.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.4 mtt -136.56 21.82 3.14 Favored 'General case' 0 CA--C 1.581 2.151 0 C-N-CA 125.741 1.616 . . . . 0.0 111.906 166.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.705 ' HG2' ' H ' ' A' ' 44' ' ' GLY 0.475 22.2 tt0 -108.84 -102.45 0.37 Allowed 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 -173.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.705 ' H ' ' HG2' ' A' ' 43' ' ' GLU . . . -99.91 -5.55 54.92 Favored Glycine 0 CA--C 1.554 2.483 0 N-CA-C 117.837 1.895 . . . . 0.0 117.837 169.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.1 mt -94.76 -69.34 0.76 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 120.555 2.178 . . . . 0.0 110.86 -173.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.26 -67.36 0.39 Allowed Glycine 0 N--CA 1.482 1.725 0 CA-C-N 119.243 0.928 . . . . 0.0 113.487 -177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -110.0 -59.83 1.88 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.196 0.998 . . . . 0.0 112.675 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 123.916 1.817 . . . . 0.0 110.654 -170.626 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt . . . . . 0 CA--C 1.552 1.028 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -76.13 -58.15 3.45 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.559 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.351 63.1 pttt 53.05 72.71 0.4 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 172.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.9 p 50.36 172.08 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mt -101.56 -63.62 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 C-N-CA 125.252 1.421 . . . . 0.0 110.74 -170.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.3 . . 78.65 60.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.707 1.603 . . . . 0.0 112.65 -169.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -160.16 122.73 3.36 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -73.02 123.15 22.95 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.915 1.286 . . . . 0.0 107.915 168.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.282 23.5 m-85 76.14 36.86 0.39 Allowed 'General case' 0 CA--C 1.581 2.139 0 C-N-CA 124.174 0.99 . . . . 0.0 111.18 -167.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.09 129.07 8.79 Favored Glycine 0 N--CA 1.479 1.511 0 O-C-N 121.12 -0.988 . . . . 0.0 111.138 -174.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.7 tpt85 -75.9 77.0 2.8 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-O 126.588 3.089 . . . . 0.0 109.633 -168.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.817 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -73.93 -179.7 3.86 Favored 'General case' 0 N--CA 1.489 1.482 1 CA-C-N 106.821 -4.718 . . . . 0.0 110.544 -169.012 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -142.37 159.74 41.64 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 114.066 -1.424 . . . . 0.0 108.085 163.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -100.23 97.8 8.55 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.51 46.34 0.92 Allowed Glycine 0 CA--C 1.555 2.543 0 CA-C-N 114.245 -1.343 . . . . 0.0 113.296 -167.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.6 -142.36 3.45 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-O 123.443 1.579 . . . . 0.0 110.349 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.61 142.82 94.49 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-N 112.38 -1.91 . . . . 0.0 109.263 167.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -68.23 -127.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.57 2.304 0 C-N-CA 123.063 2.508 . . . . 0.0 109.57 168.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.8 m -154.01 151.07 28.94 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 163.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.67 -60.35 1.72 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 114.044 -1.434 . . . . 0.0 111.874 -168.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -121.45 81.14 1.76 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -169.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.09 99.78 2.57 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -172.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -142.72 176.18 9.25 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 123.72 1.724 . . . . 0.0 114.573 -168.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.71 94.62 1.54 Allowed Glycine 0 N--CA 1.477 1.433 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -167.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.931 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 5.8 t -86.96 121.62 29.68 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 110.089 -3.055 . . . . 0.0 111.326 -168.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.507 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 15.6 mm -112.53 136.05 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 166.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.1 m -109.03 -171.84 1.93 Allowed 'General case' 0 CA--C 1.559 1.319 0 CA-C-N 112.73 -2.032 . . . . 0.0 113.912 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.554 ' HG ' HG12 ' A' ' 29' ' ' ILE . 2.3 t -115.99 -126.36 0.29 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.918 1.342 . . . . 0.0 110.0 -176.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.554 HG12 ' HG ' ' A' ' 28' ' ' SER . 13.2 mm -71.82 -3.34 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 119.079 2.992 . . . . 0.0 119.079 -168.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 20.4 ptp -156.32 -13.0 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.39 -15.37 50.21 Favored Glycine 0 CA--C 1.556 2.636 0 CA-C-N 121.431 1.923 . . . . 0.0 114.83 -165.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.4 p -89.13 -146.59 0.16 Allowed 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 166.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 41.62 36.69 0.61 Allowed 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 169.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.931 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 2.0 t -99.2 -171.34 2.06 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 110.913 -2.858 . . . . 0.0 114.601 -161.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -159.6 148.52 17.86 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 112.22 -2.264 . . . . 0.0 110.56 172.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 13.9 m -103.77 91.57 4.06 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -50.52 141.16 17.37 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -169.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -58.18 167.01 5.0 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.181 2.587 . . . . 0.0 117.037 -165.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 161.91 28.49 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.371 1.1 pp -63.22 -18.08 63.14 Favored 'General case' 0 N--CA 1.501 2.102 1 N-CA-C 122.41 4.226 . . . . 0.0 122.41 -169.844 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.2 mm -99.62 48.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-N 114.119 -1.401 . . . . 0.0 109.357 167.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 ttt -169.58 -30.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 126.588 1.955 . . . . 0.0 112.364 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.712 ' HG2' ' H ' ' A' ' 44' ' ' GLY 0.506 38.6 tt0 -80.39 -117.87 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 128.113 2.565 . . . . 0.0 107.571 -177.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.712 ' H ' ' HG2' ' A' ' 43' ' ' GLU . . . -89.64 65.34 3.04 Favored Glycine 0 CA--C 1.544 1.853 0 C-N-CA 124.311 0.958 . . . . 0.0 113.012 169.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -71.43 -42.37 68.33 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 116.129 1.899 . . . . 0.0 116.129 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.29 88.3 0.15 Allowed Glycine 0 N--CA 1.478 1.453 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.3 mt -101.12 -61.86 1.32 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.495 0.718 . . . . 0.0 111.014 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 123.883 1.801 . . . . 0.0 112.792 -179.842 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 CA--C 1.554 1.118 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.434 58.7 pttt 48.03 -159.03 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 117.739 2.496 . . . . 0.0 117.739 173.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.43 89.15 2.56 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.308 8.3 p 57.73 169.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 117.411 2.375 . . . . 0.0 117.411 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.582 HG13 ' SG ' ' A' ' 19' ' ' CYS . 32.0 mm -96.6 -64.1 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 124.379 1.072 . . . . 0.0 110.234 -169.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.08 59.04 1.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -173.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -175.88 123.66 0.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -77.42 116.51 18.07 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.474 1.11 . . . . 0.0 109.552 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.309 10.1 m-85 75.71 48.19 0.09 Allowed 'General case' 0 CA--C 1.57 1.737 0 C-N-CA 124.897 1.279 . . . . 0.0 108.084 -167.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.47 -149.77 3.06 Favored Glycine 0 C--N 1.356 1.666 0 CA-C-O 118.472 -1.182 . . . . 0.0 110.541 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -143.78 76.97 1.54 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 124.373 2.035 . . . . 0.0 106.162 -169.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 15.1 p -95.36 -174.33 3.16 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 111.086 -2.779 . . . . 0.0 112.451 -170.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -150.4 142.65 24.19 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.538 167.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -86.33 103.86 15.31 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 168.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.54 50.0 1.47 Allowed Glycine 0 CA--C 1.559 2.783 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.754 -163.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.21 -134.28 1.71 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -169.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.99 132.04 93.82 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-N 112.284 -1.958 . . . . 0.0 110.761 170.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -63.47 -34.8 63.92 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 N-CA-C 122.213 3.889 . . . . 0.0 122.213 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.582 ' SG ' HG13 ' A' ' 5' ' ' ILE 0.368 80.2 m 82.31 144.75 0.07 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 111.766 -2.47 . . . . 0.0 108.056 -163.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.74 -68.53 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 118.456 2.761 . . . . 0.0 118.456 -161.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -111.36 68.5 0.67 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.472 0.653 . . . . 0.0 110.887 -166.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.91 78.13 0.27 Allowed Glycine 0 N--CA 1.484 1.885 0 CA-C-O 119.204 -0.776 . . . . 0.0 113.308 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.2 mtt85 -140.81 142.88 34.58 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.452 1.12 . . . . 0.0 111.81 -169.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.05 -86.0 0.02 OUTLIER Glycine 0 N--CA 1.482 1.762 0 N-CA-C 118.16 2.024 . . . . 0.0 118.16 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.55 ' HB2' ' SG ' ' A' ' 36' ' ' CYS 0.417 14.0 t 82.34 38.22 0.05 Allowed 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 109.807 -3.196 . . . . 0.0 115.935 -169.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.9 mt -73.99 143.54 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 123.383 1.563 . . . . 0.0 107.65 168.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.433 ' HA ' ' CB ' ' A' ' 34' ' ' CYS 0.259 96.4 m -93.38 -175.5 3.83 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 111.812 -2.449 . . . . 0.0 116.678 -169.458 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.37 -18.61 64.51 Favored 'General case' 0 N--CA 1.504 2.259 1 N-CA-C 122.297 4.184 . . . . 0.0 122.297 175.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.448 4.2 mp 89.06 77.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.526 0 CA-C-N 109.061 -3.7 . . . . 0.0 105.235 -166.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.2 tpt 177.21 -51.04 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.447 0 CA-C-N 111.144 -2.753 . . . . 0.0 106.986 -167.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.67 -27.33 13.59 Favored Glycine 0 CA--C 1.552 2.363 0 CA-C-O 118.849 -0.973 . . . . 0.0 113.541 -166.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.6 p -90.79 -168.82 2.18 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 167.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 44.98 45.52 8.76 Favored 'General case' 0 N--CA 1.511 2.617 0 CA-C-O 125.724 2.678 . . . . 0.0 117.549 168.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.473 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 3.7 m -90.08 -179.35 5.66 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 108.609 -3.905 . . . . 0.0 111.504 -166.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -141.72 147.24 37.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.38 -0.825 . . . . 0.0 110.202 168.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 25' ' ' CYS 0.314 1.5 m -93.03 77.89 4.65 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.189 -177.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -48.86 130.2 14.66 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-O 117.588 -1.196 . . . . 0.0 111.36 -172.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -36.79 -52.42 1.27 Allowed 'Trans proline' 0 CA--C 1.563 1.963 1 N-CA-C 122.839 4.131 . . . . 0.0 122.839 -162.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -121.15 126.94 50.98 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.813 0.845 . . . . 0.0 111.201 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 tt -93.27 101.7 13.96 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 123.659 1.695 . . . . 0.0 107.291 167.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.265 0.2 OUTLIER -149.29 56.88 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 CA-C-N 111.175 -2.739 . . . . 0.0 108.265 167.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . 0.334 22.1 ptm 159.26 -44.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 126.558 1.943 . . . . 0.0 111.829 -171.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -72.05 -3.44 23.0 Favored 'General case' 0 CA--C 1.561 1.366 1 N-CA-C 122.33 4.196 . . . . 0.0 122.33 -169.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.12 78.35 0.06 OUTLIER Glycine 0 CA--C 1.536 1.405 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.916 169.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 67.79 100.86 0.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.738 1.215 . . . . 0.0 110.605 -171.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.63 60.26 3.95 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 115.396 0.918 . . . . 0.0 115.396 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -155.12 -57.18 0.1 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.406 1.082 . . . . 0.0 110.105 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 124.07 1.891 . . . . 0.0 107.433 176.42 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? . . . . . 0 CA--C 1.549 0.934 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp 72.39 105.09 0.07 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.803 1.241 . . . . 0.0 111.126 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm 65.8 79.98 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 124.581 1.152 . . . . 0.0 110.062 -169.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.347 20.9 p -136.88 -171.75 3.01 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-O 123.215 1.483 . . . . 0.0 114.85 -166.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.36 109.7 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.485 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 169.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.12 69.63 2.03 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.222 1.01 . . . . 0.0 110.204 172.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -165.45 122.33 1.46 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 -173.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -75.96 120.4 21.23 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.765 1.226 . . . . 0.0 109.674 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.314 5.6 m-85 77.99 29.01 0.5 Allowed 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 124.966 1.306 . . . . 0.0 113.601 -170.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' N ' ' H ' ' A' ' 36' ' ' CYS . . . -97.89 117.17 5.73 Favored Glycine 0 N--CA 1.469 0.846 0 O-C-N 120.89 -1.131 . . . . 0.0 112.868 -171.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -22.9 81.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 1 C-N-CA 131.909 4.084 . . . . 0.0 116.233 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.867 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 13.0 p -85.38 -178.87 6.83 Favored 'General case' 0 N--CA 1.491 1.609 1 CA-C-N 106.983 -4.644 . . . . 0.0 112.402 -171.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -146.14 155.17 42.55 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 122.884 1.326 . . . . 0.0 108.757 169.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 49.8 m0 -94.94 100.15 12.05 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.91 53.92 1.25 Allowed Glycine 0 CA--C 1.552 2.388 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.405 -166.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.07 -143.64 3.78 Favored Glycine 0 N--CA 1.477 1.371 0 CA-C-O 123.19 1.439 . . . . 0.0 110.737 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.69 132.53 95.23 Favored Pre-proline 0 CA--C 1.576 1.979 0 CA-C-N 112.848 -1.676 . . . . 0.0 110.522 170.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -51.73 -39.02 67.69 Favored 'Trans proline' 0 N--CA 1.498 1.755 1 N-CA-C 123.284 4.302 . . . . 0.0 123.284 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 16.3 m 90.52 139.65 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 111.405 -2.634 . . . . 0.0 104.842 -163.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -85.02 -64.39 1.17 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 120.576 3.547 . . . . 0.0 120.576 -162.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -127.82 80.85 1.98 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.886 0.851 . . . . 0.0 109.608 -164.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.29 66.85 1.98 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 115.152 -0.931 . . . . 0.0 114.391 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.6 mtt85 -141.58 156.44 45.69 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.834 1.302 . . . . 0.0 111.031 -169.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.62 -130.85 6.65 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-O 123.196 1.442 . . . . 0.0 112.029 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.471 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 48.9 t 166.13 107.91 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 102.815 -3.032 . . . . 0.0 102.815 173.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.521 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 29.8 mm -121.2 134.32 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 170.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 33' ' ' ASN . 33.0 m -107.84 -177.78 3.44 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-N 112.775 -2.011 . . . . 0.0 111.235 174.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 t -89.96 -173.34 3.84 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 124.561 2.124 . . . . 0.0 112.567 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 pp -93.38 63.9 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 110.681 -2.963 . . . . 0.0 108.889 166.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.2 tpt 177.71 -49.27 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 112.637 -2.074 . . . . 0.0 110.348 -168.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.35 18.13 69.71 Favored Glycine 0 CA--C 1.568 3.372 0 CA-C-O 118.962 -0.91 . . . . 0.0 114.725 -162.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.301 6.0 p -121.59 114.3 20.99 Favored 'General case' 0 N--CA 1.486 1.352 1 N-CA-C 96.065 -5.531 . . . . 0.0 96.065 158.462 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.447 ' CG ' ' H ' ' A' ' 34' ' ' CYS 0.304 48.9 p30 -145.45 -90.36 0.1 Allowed 'General case' 0 CA--C 1.559 1.313 1 N-CA-C 134.521 8.712 . . . . 0.0 134.521 -138.635 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.867 ' SG ' ' SG ' ' A' ' 12' ' ' CYS 0.27 0.1 OUTLIER -74.47 -174.61 2.1 Favored 'General case' 0 C--N 1.305 -1.367 1 CA-C-N 106.273 -4.967 . . . . 0.0 119.848 -143.839 . . . . . . . . 5 4 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -170.11 137.25 1.53 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 109.163 -3.653 . . . . 0.0 109.604 -173.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.433 ' H ' ' N ' ' A' ' 10' ' ' GLY . 10.6 m -84.44 94.41 8.51 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 173.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -55.43 125.04 58.14 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-O 117.272 -1.346 . . . . 0.0 112.051 -167.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -42.51 -49.92 6.06 Favored 'Trans proline' 0 C--N 1.369 1.633 0 N-CA-C 122.146 3.864 . . . . 0.0 122.146 -164.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -145.98 103.75 3.78 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.298 60.3 tp -104.19 -74.37 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 124.026 1.869 . . . . 0.0 113.587 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.251 35.8 pt -77.86 24.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 CA-C-N 110.157 -3.202 . . . . 0.0 117.014 169.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.2 mmt -116.69 -50.54 2.61 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 126.089 1.756 . . . . 0.0 108.903 166.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -69.89 -0.7 7.77 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 120.503 3.52 . . . . 0.0 120.503 166.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.5 85.23 0.14 Allowed Glycine 0 CA--C 1.538 1.516 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.774 169.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.43 -9.67 3.26 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 171.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.47 -85.19 0.15 Allowed Glycine 0 N--CA 1.479 1.539 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -171.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -75.25 -33.64 61.32 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 169.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 124.039 1.876 . . . . 0.0 113.248 177.603 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.5 tptm . . . . . 0 CA--C 1.555 1.169 0 CA-C-O 121.161 0.505 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 81.5 tttt 74.11 100.02 0.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.042 1.337 . . . . 0.0 110.593 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.1 tttt 60.85 78.27 0.29 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 124.676 1.19 . . . . 0.0 111.4 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.6 p 50.37 178.33 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.871 2.175 . . . . 0.0 116.871 -168.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.2 mt -128.04 127.14 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.57 71.01 0.75 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.257 1.027 . . . . 0.0 112.563 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.546 ' HD3' ' H ' ' A' ' 7' ' ' LYS 0.266 0.0 OUTLIER -125.41 177.04 6.4 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 124.845 2.26 . . . . 0.0 116.09 -168.171 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -118.08 100.73 7.72 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.316 -2.22 . . . . 0.0 105.913 158.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.328 1.1 m-85 79.18 63.4 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 122.885 2.584 . . . . 0.0 107.309 172.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 35' ' ' GLU . . . -68.16 -165.22 3.21 Favored Glycine 0 C--N 1.351 1.413 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.553 171.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -134.66 75.28 1.57 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.93 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 27.7 p -75.36 -179.17 4.36 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 113.093 -1.867 . . . . 0.0 113.135 -169.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -143.89 151.96 40.51 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 122.994 1.378 . . . . 0.0 108.155 167.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.3 m0 -99.66 93.83 6.04 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 168.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.32 41.02 0.56 Allowed Glycine 0 CA--C 1.56 2.89 0 CA-C-N 113.456 -1.702 . . . . 0.0 112.732 -166.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.79 -142.59 3.43 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.65 139.33 91.29 Favored Pre-proline 0 N--CA 1.499 1.993 0 CA-C-N 113.236 -1.482 . . . . 0.0 107.978 166.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -66.02 -129.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.572 2.38 0 C-N-CA 123.026 2.484 . . . . 0.0 111.19 169.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.2 m -152.63 139.28 18.79 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 165.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.57 160.54 26.4 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 122.889 1.328 . . . . 0.0 111.649 -170.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 38.5 mtt85 47.59 59.63 4.02 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.09 100.37 0.24 Allowed Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.46 -0.775 . . . . 0.0 112.423 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -112.23 169.87 8.56 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -168.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.56 -87.47 1.89 Allowed Glycine 0 CA--C 1.536 1.383 0 CA-C-N 111.67 -2.513 . . . . 0.0 108.686 166.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' SG ' ' SG ' ' A' ' 34' ' ' CYS 0.415 22.4 t 65.66 55.96 0.96 Allowed 'General case' 0 CA--C 1.561 1.391 0 CA-C-N 110.49 -2.855 . . . . 0.0 113.749 -169.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.539 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 54.1 mt -83.2 133.85 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 167.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.1 m -119.34 178.82 4.39 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 118.137 2.643 . . . . 0.0 118.137 -166.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 p -159.5 153.16 22.8 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-O 124.499 2.095 . . . . 0.0 111.986 -167.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.327 2.4 mp 40.27 60.18 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 CA-C-N 109.97 -3.286 . . . . 0.0 113.416 -169.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.274 15.7 mmt 85.37 7.15 0.43 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.02 69.05 1.29 Allowed Glycine 0 N--CA 1.486 1.987 0 CA-C-N 122.122 2.237 . . . . 0.0 111.664 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 34' ' ' CYS . 30.1 p -149.96 -76.37 0.15 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 123.763 1.744 . . . . 0.0 109.94 -168.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.77 21.81 0.05 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 119.814 3.264 . . . . 0.0 119.814 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.93 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 8.6 t -59.75 -168.81 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 112.286 -2.233 . . . . 0.0 115.405 -167.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 49.2 mt-10 -149.28 144.54 26.55 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 169.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.697 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 18.2 m -101.21 116.65 33.31 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -61.25 138.1 94.49 Favored Pre-proline 0 CA--C 1.574 1.877 0 CA-C-N 119.988 1.267 . . . . 0.0 109.711 170.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -51.53 162.3 1.58 Allowed 'Trans proline' 0 CA--C 1.556 1.624 0 N-CA-C 120.384 3.186 . . . . 0.0 120.384 -162.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.42 156.48 31.12 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.198 167.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 tt -71.8 100.4 2.37 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 123.768 1.746 . . . . 0.0 112.272 -168.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.0 pt -146.17 67.84 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-N 110.461 -3.063 . . . . 0.0 105.207 169.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . 0.306 18.3 ttt 73.67 57.63 0.1 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.715 1.206 . . . . 0.0 112.423 -168.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.631 ' HG2' ' H ' ' A' ' 44' ' ' GLY 0.417 18.4 tt0 -99.59 -155.58 0.51 Allowed 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 101.671 -3.455 . . . . 0.0 101.671 165.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.631 ' H ' ' HG2' ' A' ' 43' ' ' GLU . . . 76.46 -57.8 3.33 Favored Glycine 0 CA--C 1.549 2.172 0 C-N-CA 124.713 1.149 . . . . 0.0 114.866 -170.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.68 103.77 6.55 Favored 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 101.867 -3.383 . . . . 0.0 101.867 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.5 94.29 1.83 Allowed Glycine 0 N--CA 1.482 1.726 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.232 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.23 -66.46 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.761 -171.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 124.066 1.889 . . . . 0.0 112.58 -175.097 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 85.3 tttt . . . . . 0 CA--C 1.555 1.169 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -94.47 -52.37 4.35 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.548 0.739 . . . . 0.0 112.764 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -136.22 98.54 3.88 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.318 14.0 p -119.48 -167.47 1.42 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 126.688 1.995 . . . . 0.0 115.297 -169.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.468 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 21.9 mm -94.65 -70.44 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.723 0 C-N-CA 125.137 1.375 . . . . 0.0 107.94 176.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.52 67.38 0.65 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.849 1.66 . . . . 0.0 114.652 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -174.6 128.76 0.33 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.06 120.0 15.99 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.108 1.363 . . . . 0.0 109.603 171.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.308 2.2 m-85 72.31 44.6 0.42 Allowed 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 124.82 1.248 . . . . 0.0 109.485 -167.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.18 -150.7 2.57 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-O 118.221 -1.322 . . . . 0.0 110.806 173.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.4 mmt-85 -147.35 74.54 1.33 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -171.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.803 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -77.06 -177.38 4.44 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 123.284 1.516 . . . . 0.0 111.09 -169.504 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -141.97 125.34 16.58 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 166.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 52.1 m0 -76.26 111.69 11.96 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 169.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.31 47.03 5.36 Favored Glycine 0 CA--C 1.558 2.723 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.566 -165.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.72 -135.37 1.81 Allowed Glycine 0 N--CA 1.472 1.098 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -169.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.94 140.48 95.69 Favored Pre-proline 0 CA--C 1.573 1.828 0 CA-C-N 112.361 -1.919 . . . . 0.0 112.033 169.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.406 ' HB2' ' H ' ' A' ' 19' ' ' CYS . 28.4 Cg_endo -71.11 -128.05 0.01 OUTLIER 'Trans proline' 0 CA--C 1.567 2.126 0 C-N-CA 123.28 2.653 . . . . 0.0 110.774 167.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -150.2 8.97 0.64 Allowed 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 119.379 3.103 . . . . 0.0 119.379 167.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 79.41 -67.61 0.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 111.106 -2.77 . . . . 0.0 114.737 169.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -112.56 65.77 0.64 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.86 1.264 . . . . 0.0 110.687 -168.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.5 77.06 0.17 Allowed Glycine 0 CA--C 1.542 1.771 0 N-CA-C 116.673 1.429 . . . . 0.0 116.673 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.6 ttm105 -140.99 141.12 34.41 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 118.013 0.907 . . . . 0.0 111.613 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.35 105.1 3.05 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-O 125.021 2.456 . . . . 0.0 108.727 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.858 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 27.4 t -64.85 128.29 35.16 Favored 'General case' 0 CA--C 1.558 1.266 1 CA-C-N 107.887 -4.157 . . . . 0.0 112.489 170.015 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.463 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 29.6 mm -115.89 140.12 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 165.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 86.6 m -107.99 -174.71 2.59 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-N 113.831 -1.531 . . . . 0.0 114.786 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.81 -19.04 65.63 Favored 'General case' 0 N--CA 1.502 2.153 1 N-CA-C 122.155 4.132 . . . . 0.0 122.155 175.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.452 4.1 mp 86.91 75.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.487 0 CA-C-N 109.251 -3.613 . . . . 0.0 105.718 -167.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.7 ttt 176.27 -51.33 0.01 OUTLIER 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 111.333 -2.667 . . . . 0.0 106.772 -167.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.89 -32.7 6.19 Favored Glycine 0 CA--C 1.546 1.979 0 CA-C-O 118.585 -1.12 . . . . 0.0 113.709 -168.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 p -79.44 -170.61 2.39 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-O 124.67 2.176 . . . . 0.0 105.384 168.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.6 m120 36.75 55.36 1.17 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 126.117 2.865 . . . . 0.0 115.732 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.858 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 8.0 t -102.67 -163.9 1.04 Allowed 'General case' 0 C--N 1.312 -1.037 1 CA-C-N 108.097 -4.138 . . . . 0.0 113.96 -161.647 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.423 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 10.9 pt-20 -157.78 150.98 23.29 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 112.244 -2.253 . . . . 0.0 112.046 171.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 16.8 m -90.91 81.39 5.7 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -55.96 121.52 41.16 Favored Pre-proline 0 CA--C 1.567 1.628 0 CA-C-O 117.269 -1.348 . . . . 0.0 110.653 -169.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.72 127.91 19.97 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 123.393 2.729 . . . . 0.0 118.575 -164.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -118.48 149.87 40.56 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.67 0.748 . . . . 0.0 109.302 170.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.13 94.45 5.37 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 124.372 2.034 . . . . 0.0 112.197 -167.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.315 89.0 mt -140.54 -81.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 109.737 -3.392 . . . . 0.0 103.527 171.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 23.5 mmt -85.88 11.34 11.54 Favored 'General case' 0 CA--C 1.575 1.907 0 CA-C-N 109.909 -3.314 . . . . 0.0 115.588 167.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -102.45 140.13 37.15 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 101.215 -3.624 . . . . 0.0 101.215 166.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.32 -56.74 5.07 Favored Glycine 0 CA--C 1.548 2.154 1 CA-C-N 108.123 -4.126 . . . . 0.0 115.287 175.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.12 85.89 2.21 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.38 1.072 . . . . 0.0 108.136 -177.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.75 -83.89 0.11 Allowed Glycine 0 N--CA 1.479 1.566 0 O-C-N 121.969 -0.457 . . . . 0.0 112.083 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.469 2.9 pp 51.51 54.49 10.95 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.859 1.663 . . . . 0.0 115.25 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 123.803 1.763 . . . . 0.0 112.136 -176.85 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 61.2 tttm . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.44 25.49 6.29 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? 60.81 85.77 0.11 Allowed 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 124.919 1.288 . . . . 0.0 112.005 -176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.4 p 51.63 169.02 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 118.542 2.793 . . . . 0.0 118.542 -170.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' H ' ' HA ' ' A' ' 19' ' ' CYS . 3.8 mt -115.42 107.53 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 -175.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.84 69.62 4.65 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.48 1.133 . . . . 0.0 110.831 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -160.48 112.91 2.0 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 104.281 -2.489 . . . . 0.0 104.281 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -75.79 126.55 31.23 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.894 1.278 . . . . 0.0 110.366 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.298 12.0 m-85 73.41 38.77 0.63 Allowed 'General case' 0 CA--C 1.58 2.108 0 C-N-CA 124.413 1.085 . . . . 0.0 111.149 -167.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.35 132.39 11.11 Favored Glycine 0 N--CA 1.483 1.795 0 O-C-N 120.946 -1.097 . . . . 0.0 110.403 -174.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -74.83 70.35 1.92 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 127.108 3.337 . . . . 0.0 112.457 -167.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.716 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 31.4 p -72.27 -174.78 1.37 Allowed 'General case' 0 N--CA 1.483 1.203 1 CA-C-N 106.088 -5.051 . . . . 0.0 114.232 -173.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -152.61 164.26 38.03 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.595 169.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -97.26 104.14 16.14 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 169.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.69 41.81 1.09 Allowed Glycine 0 CA--C 1.557 2.709 0 CA-C-N 113.904 -1.498 . . . . 0.0 113.025 -166.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.98 -146.66 4.4 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-O 123.417 1.565 . . . . 0.0 111.247 -175.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.11 132.32 88.34 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-N 112.791 -1.705 . . . . 0.0 108.275 167.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -54.89 -34.11 84.54 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 N-CA-C 121.915 3.775 . . . . 0.0 121.915 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.407 ' HA ' ' H ' ' A' ' 5' ' ' ILE 0.297 74.3 m 87.42 148.0 0.05 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 111.288 -2.687 . . . . 0.0 109.205 -165.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.09 176.31 5.17 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.869 -168.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . 0.254 32.6 ptt180 42.53 56.12 3.91 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 119.433 3.123 . . . . 0.0 119.433 167.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.02 102.64 0.1 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.28 161.97 36.6 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -167.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -178.78 120.25 0.69 Allowed Glycine 0 CA--C 1.529 0.96 0 N-CA-C 106.809 -2.516 . . . . 0.0 106.809 168.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 39.7 t -91.82 81.86 5.2 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 111.446 -2.377 . . . . 0.0 112.827 -169.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.557 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -75.75 134.9 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 168.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.5 m -118.39 178.11 4.57 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 112.944 -1.935 . . . . 0.0 114.523 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.288 57.9 m -79.11 -149.98 0.05 Allowed 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 125.149 1.38 . . . . 0.0 110.808 178.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.82 58.11 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.902 0.858 . . . . 0.0 108.88 169.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.93 -57.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.41 1.084 . . . . 0.0 111.712 -173.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.44 54.15 1.49 Allowed Glycine 0 CA--C 1.548 2.13 0 CA-C-O 119.278 -0.734 . . . . 0.0 112.777 -167.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.568 ' HG1' ' H ' ' A' ' 33' ' ' ASN . 3.8 p -153.73 -73.96 0.13 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 123.824 1.773 . . . . 0.0 111.364 -168.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.568 ' H ' ' HG1' ' A' ' 32' ' ' THR 0.314 8.6 m120 -67.34 33.53 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 129.679 3.191 . . . . 0.0 118.01 168.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 30.9 t -77.27 -150.62 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 111.839 -2.437 . . . . 0.0 113.731 -167.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -172.52 143.58 1.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.206 169.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 6.9 m -105.36 98.78 8.44 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.17 131.86 68.88 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-O 116.943 -1.503 . . . . 0.0 112.802 -168.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -38.38 -54.43 1.49 Allowed 'Trans proline' 0 CA--C 1.561 1.842 0 N-CA-C 121.661 3.677 . . . . 0.0 121.661 -165.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -135.51 121.02 19.31 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 173.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.9 tt -89.51 100.57 13.34 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-O 123.852 1.787 . . . . 0.0 108.011 169.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.8 tp -144.35 47.07 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.93 0 CA-C-N 110.842 -2.89 . . . . 0.0 110.397 169.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 48.9 ttp -176.75 -59.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.175 1.39 . . . . 0.0 109.145 -170.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.9 -18.15 64.94 Favored 'General case' 0 N--CA 1.482 1.173 1 N-CA-C 122.731 4.345 . . . . 0.0 122.731 -169.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.3 74.04 0.24 Allowed Glycine 0 N--CA 1.479 1.556 0 CA-C-N 113.492 -1.686 . . . . 0.0 112.453 169.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -117.04 86.4 2.5 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.21 85.35 0.77 Allowed Glycine 0 N--CA 1.479 1.566 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -174.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.6 mt -129.51 -68.52 0.72 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.536 0.734 . . . . 0.0 109.599 -172.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 123.987 1.851 . . . . 0.0 110.077 179.482 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -75.9 110.44 10.35 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 119.152 0.887 . . . . 0.0 109.974 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -148.43 99.72 3.06 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 -169.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.2 p -24.27 174.32 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.065 1 N-CA-C 127.247 6.017 . . . . 0.0 127.247 -168.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mt -109.19 117.3 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 127.823 2.449 . . . . 0.0 104.413 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.65 71.7 1.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.062 0.934 . . . . 0.0 110.25 173.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -169.82 123.2 0.74 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -76.11 128.5 35.1 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.869 1.267 . . . . 0.0 110.602 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.281 13.0 m-85 73.79 38.78 0.58 Allowed 'General case' 0 CA--C 1.578 2.055 0 C-N-CA 124.836 1.254 . . . . 0.0 110.689 -168.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.449 ' N ' ' H ' ' A' ' 36' ' ' CYS . . . -103.93 122.5 7.42 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.222 -0.924 . . . . 0.0 111.69 -169.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -33.58 82.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 1 C-N-CA 132.857 4.463 . . . . 0.0 115.246 -172.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 3.8 p -88.65 173.39 8.64 Favored 'General case' 0 N--CA 1.491 1.592 1 CA-C-N 107.471 -4.422 . . . . 0.0 113.8 -167.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -153.59 144.96 23.1 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.936 169.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -86.69 103.2 14.93 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 168.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.71 47.28 1.81 Allowed Glycine 0 CA--C 1.557 2.663 0 CA-C-N 114.526 -1.216 . . . . 0.0 112.733 -165.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.39 -141.4 3.48 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-O 123.29 1.494 . . . . 0.0 109.954 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.41 133.64 95.42 Favored Pre-proline 0 CA--C 1.577 1.985 0 CA-C-N 112.669 -1.765 . . . . 0.0 109.988 169.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -55.76 -35.37 93.35 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 N-CA-C 122.423 3.97 . . . . 0.0 122.423 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . 0.314 66.3 m 79.05 143.42 0.08 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 111.635 -2.53 . . . . 0.0 107.28 -163.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.47 -62.78 1.2 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -162.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -126.04 80.46 1.91 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.946 0.879 . . . . 0.0 109.089 -166.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.15 102.19 1.97 Allowed Glycine 0 N--CA 1.476 1.354 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.618 -176.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.54 165.94 18.95 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-O 123.588 1.661 . . . . 0.0 112.577 -169.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -156.88 -81.01 0.03 OUTLIER Glycine 0 N--CA 1.477 1.432 0 CA-C-O 124.31 2.061 . . . . 0.0 109.314 -169.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.415 19.9 t 79.34 50.79 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 109.202 -3.499 . . . . 0.0 115.166 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 76.9 mt -82.68 149.44 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 122.975 1.369 . . . . 0.0 107.421 167.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.464 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 69.3 m -93.14 171.25 9.06 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 -170.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.274 69.6 m -91.09 -147.14 0.2 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.348 1.459 . . . . 0.0 109.635 -174.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 mm -94.2 50.88 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 CA-C-O 122.859 1.314 . . . . 0.0 110.213 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.1 ttt -172.76 -52.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.865 1.266 . . . . 0.0 112.417 -169.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.39 50.3 2.41 Favored Glycine 0 CA--C 1.548 2.154 0 CA-C-N 118.741 0.701 . . . . 0.0 113.749 -168.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.4 p -151.94 -79.11 0.11 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.906 1.336 . . . . 0.0 109.136 -169.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.81 -26.87 68.82 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 121.214 3.783 . . . . 0.0 121.214 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.519 ' HB2' ' SG ' ' A' ' 12' ' ' CYS 0.376 6.7 m 37.27 -151.69 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 130.161 3.385 . . . . 0.0 117.714 172.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -175.75 133.57 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.449 ' H ' ' N ' ' A' ' 10' ' ' GLY . 6.1 m -89.73 95.47 10.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.193 -0.942 . . . . 0.0 109.246 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -51.21 129.58 31.52 Favored Pre-proline 0 CA--C 1.573 1.856 0 CA-C-O 116.763 -1.589 . . . . 0.0 112.027 -170.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.251 80.7 Cg_exo -28.63 -61.02 0.1 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 N-CA-C 122.321 3.931 . . . . 0.0 122.321 -164.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.253 36.9 ptt180 -152.65 102.44 2.71 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 118.891 0.769 . . . . 0.0 109.641 168.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 tt -103.32 106.69 17.27 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 165.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.505 HG13 ' H ' ' A' ' 42' ' ' MET 0.363 6.5 pt -127.9 -91.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 -177.272 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.505 ' H ' HG13 ' A' ' 41' ' ' ILE . 23.5 mmt -112.39 72.58 0.78 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 110.205 -3.18 . . . . 0.0 103.719 162.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . 0.728 3.5 pt-20 5.99 85.4 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.03 1 N-CA-C 122.487 4.254 . . . . 0.0 122.487 -166.227 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.64 24.87 76.05 Favored Glycine 0 CA--C 1.553 2.426 0 CA-C-N 110.292 -3.14 . . . . 0.0 119.467 -174.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt -136.2 80.45 1.83 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 120.52 2.16 . . . . 0.0 108.972 -171.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.18 -104.65 0.18 Allowed Glycine 0 N--CA 1.477 1.377 0 O-C-N 122.024 -0.423 . . . . 0.0 112.483 170.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.255 1.1 pt? -149.83 -61.17 0.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.048 -169.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 123.923 1.821 . . . . 0.0 110.183 -177.207 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? 73.85 112.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.839 1.256 . . . . 0.0 110.988 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 66.5 89.16 0.1 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 124.679 1.192 . . . . 0.0 110.275 -172.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.6 p 49.21 170.03 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 118.61 2.819 . . . . 0.0 118.61 -169.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mm -102.41 108.45 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.76 72.89 2.29 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.347 1.07 . . . . 0.0 110.053 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -176.6 123.9 0.16 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 -171.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -75.22 127.95 34.35 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 168.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.27 12.1 m-85 74.78 30.09 1.02 Allowed 'General case' 0 CA--C 1.579 2.093 0 C-N-CA 124.903 1.281 . . . . 0.0 113.607 -169.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.96 131.27 10.59 Favored Glycine 0 N--CA 1.474 1.227 0 O-C-N 120.91 -1.119 . . . . 0.0 112.237 -169.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -55.47 82.21 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 130.324 3.45 . . . . 0.0 114.69 -167.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.615 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 22.3 p -90.41 173.15 8.26 Favored 'General case' 0 N--CA 1.494 1.751 1 CA-C-N 106.374 -4.921 . . . . 0.0 113.242 -168.654 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -150.66 128.85 11.94 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.507 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -77.16 111.13 12.44 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 170.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.54 33.9 5.73 Favored Glycine 0 CA--C 1.559 2.807 0 CA-C-N 114.826 -1.079 . . . . 0.0 114.531 -166.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.24 -139.99 3.63 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-O 123.449 1.583 . . . . 0.0 109.667 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.55 137.26 97.03 Favored Pre-proline 0 CA--C 1.573 1.864 0 CA-C-N 112.42 -1.89 . . . . 0.0 109.772 168.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -66.92 -172.91 0.35 Allowed 'Trans proline' 0 CA--C 1.57 2.313 0 CA-C-N 123.546 2.302 . . . . 0.0 110.834 167.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.9 m -101.84 149.16 24.47 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 167.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.71 -60.17 1.76 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.865 -173.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -137.24 87.3 2.26 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.944 1.297 . . . . 0.0 108.128 -169.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.78 116.2 4.15 Favored Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -169.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -138.24 176.23 8.88 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -167.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.37 109.23 2.84 Favored Glycine 0 N--CA 1.475 1.263 0 CA-C-N 112.367 -2.197 . . . . 0.0 109.039 -170.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 34' ' ' CYS . 53.8 t -109.77 75.66 0.95 Allowed 'General case' 0 CA--C 1.56 1.327 0 CA-C-N 111.837 -2.182 . . . . 0.0 111.587 -169.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.401 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 36.4 mm -89.45 144.58 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 169.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.537 ' N ' ' SG ' ' A' ' 34' ' ' CYS 0.304 6.5 m -105.75 161.8 14.09 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 125.023 1.452 . . . . 0.0 113.002 177.045 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.534 ' HA ' ' H ' ' A' ' 31' ' ' GLY 0.823 2.9 t 81.74 -176.52 0.05 OUTLIER 'General case' 0 C--N 1.353 0.736 0 N-CA-C 120.605 3.557 . . . . 0.0 120.605 156.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.311 4.1 mp 70.83 64.08 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.586 2.331 0 CA-C-N 108.468 -3.969 . . . . 0.0 104.002 -158.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.272 0.0 OUTLIER 136.33 -58.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 128.582 2.753 . . . . 0.0 104.073 -162.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.534 ' H ' ' HA ' ' A' ' 28' ' ' SER . . . 62.34 47.65 88.08 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 120.208 2.843 . . . . 0.0 120.208 -169.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.299 22.7 p -98.66 102.79 14.63 Favored 'General case' 0 CA--C 1.553 1.059 1 N-CA-C 94.359 -6.163 . . . . 0.0 94.359 151.798 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.423 ' HA ' ' HB3' ' A' ' 27' ' ' CYS 0.62 3.5 p-10 -87.82 70.89 9.59 Favored 'General case' 0 N--CA 1.439 -1.015 2 CA-C-N 105.29 -5.414 . . . . 0.0 122.177 -148.202 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.615 ' HB3' ' SG ' ' A' ' 12' ' ' CYS 0.414 59.3 m 123.19 171.24 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 3 CA-C-N 101.572 -7.104 . . . . 0.0 113.402 160.774 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -150.01 143.17 25.0 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 112.032 -2.349 . . . . 0.0 106.46 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 12.8 m -89.8 86.35 6.64 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -45.08 145.61 1.67 Allowed Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -167.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -61.19 -73.32 0.02 OUTLIER 'Trans proline' 0 CA--C 1.562 1.9 0 C-N-CA 122.964 2.443 . . . . 0.0 116.226 -163.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.375 27.1 ptt85 41.22 98.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 118.434 2.753 . . . . 0.0 118.434 173.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.8 tt -93.01 105.42 17.53 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 123.779 1.752 . . . . 0.0 108.108 169.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.6 tp -130.43 66.3 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.618 0 CA-C-N 111.103 -2.771 . . . . 0.0 104.601 166.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . 0.468 11.7 ptt? 64.04 10.07 5.11 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 117.386 2.365 . . . . 0.0 117.386 -167.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -80.38 -1.53 41.69 Favored 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 121.058 3.725 . . . . 0.0 121.058 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.75 -53.6 1.4 Allowed Glycine 0 CA--C 1.546 2.01 0 C-N-CA 125.088 1.328 . . . . 0.0 114.045 169.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.68 93.82 3.0 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.3 -88.89 0.08 OUTLIER Glycine 0 N--CA 1.478 1.497 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 pp -76.59 -34.07 58.43 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 171.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 122.829 1.3 . . . . 0.0 107.988 173.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 121.588 0.709 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.354 51.0 tttp 83.94 -76.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.113 1.365 . . . . 0.0 113.206 173.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -124.95 87.17 2.67 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.284 22.0 p 41.93 -171.46 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 118.87 2.915 . . . . 0.0 118.87 173.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.436 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 4.5 mm -113.22 -62.81 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.546 0 CA-C-N 113.449 -1.705 . . . . 0.0 110.25 -164.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.254 . . 66.11 60.64 0.64 Allowed 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 125.278 1.431 . . . . 0.0 114.572 -169.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -169.75 131.44 1.09 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 173.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -68.14 136.07 53.11 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 125.264 1.425 . . . . 0.0 110.235 169.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 66.34 34.61 6.29 Favored 'General case' 0 CA--C 1.581 2.169 0 C-N-CA 124.257 1.023 . . . . 0.0 112.093 -167.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.65 132.16 10.87 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -169.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -73.52 73.77 1.43 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 126.971 3.272 . . . . 0.0 112.116 -167.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 24.3 p -71.02 174.8 5.77 Favored 'General case' 0 N--CA 1.486 1.35 1 CA-C-N 106.056 -5.066 . . . . 0.0 114.074 -176.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.531 ' H ' ' CG ' ' A' ' 18' ' ' PRO . 17.9 ptpt -129.2 159.1 37.11 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 123.42 1.581 . . . . 0.0 111.158 171.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 52.6 m0 -104.61 91.29 3.8 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 168.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.91 -81.11 0.06 OUTLIER Glycine 0 N--CA 1.478 1.442 0 N-CA-C 106.491 -2.644 . . . . 0.0 106.491 -166.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.86 135.87 2.02 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 125.154 2.53 . . . . 0.0 118.093 163.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 m 168.64 -65.12 0.0 OUTLIER Pre-proline 0 CA--C 1.59 2.493 1 CA-C-N 107.266 -4.467 . . . . 0.0 101.393 -168.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.531 ' CG ' ' H ' ' A' ' 13' ' ' LYS 1.105 0.6 OUTLIER -24.85 155.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.827 2 N-CA-C 135.587 9.033 . . . . 0.0 135.587 -156.146 . . . . . . . . 5 4 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.436 ' SG ' ' HB ' ' A' ' 5' ' ' ILE 0.345 31.4 m -23.92 117.5 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.272 2 CA-C-N 105.167 -5.47 . . . . 0.0 114.873 -156.667 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.33 156.13 39.43 Favored 'General case' 0 C--N 1.297 -1.708 1 CA-C-N 106.378 -4.919 . . . . 0.0 109.373 -163.239 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 58.39 49.28 11.08 Favored 'General case' 0 CA--C 1.586 2.339 0 CA-C-N 112.989 -1.914 . . . . 0.0 113.768 -173.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.23 142.48 6.77 Favored Glycine 0 CA--C 1.556 2.642 0 N-CA-C 115.316 0.886 . . . . 0.0 115.316 -169.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.53 162.81 40.91 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -153.52 105.52 0.28 Allowed Glycine 0 N--CA 1.475 1.268 0 N-CA-C 105.751 -2.94 . . . . 0.0 105.751 164.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.87 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 54.0 t -99.07 125.09 44.51 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 110.787 -2.707 . . . . 0.0 109.568 -174.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.537 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 23.6 mm -117.27 134.07 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 166.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.576 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 68.2 m -121.56 173.25 7.53 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -172.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 p -120.05 135.42 54.94 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 125.072 1.349 . . . . 0.0 111.085 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.296 9.6 mt -5.61 56.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.39 2 CA-C-N 108.264 -4.062 . . . . 0.0 116.571 -168.659 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.8 tpt 172.57 -56.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 113.076 -1.875 . . . . 0.0 113.765 -167.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.36 53.0 1.64 Allowed Glycine 0 CA--C 1.552 2.362 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -163.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 34' ' ' CYS . 99.6 m -150.77 -69.8 0.18 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 123.124 1.44 . . . . 0.0 111.665 -167.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.283 9.6 m-80 -71.23 30.16 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 118.466 2.765 . . . . 0.0 118.466 169.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.87 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 17.7 t -76.47 -156.79 0.07 Allowed 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 112.496 -2.138 . . . . 0.0 115.061 -166.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.08 147.62 4.74 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 113.658 -1.61 . . . . 0.0 110.666 168.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 20.2 m -100.16 95.89 7.12 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -54.07 131.73 59.34 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 117.54 -1.219 . . . . 0.0 112.555 -169.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -47.92 135.32 23.36 Favored 'Trans proline' 0 CA--C 1.556 1.605 0 C-N-CA 124.299 3.333 . . . . 0.0 119.162 -164.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.2 mtp-105 -115.47 -177.34 3.12 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.661 1.22 . . . . 0.0 111.276 -176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.275 35.1 tp -101.12 -65.22 0.99 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 124.378 2.037 . . . . 0.0 116.395 -174.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.285 28.2 pt -74.03 15.45 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 110.152 -3.203 . . . . 0.0 118.098 174.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.2 ptm -142.34 33.61 1.49 Allowed 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 124.554 1.141 . . . . 0.0 113.658 166.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . 0.427 29.1 tt0 -110.76 -87.92 0.52 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 -172.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.06 63.38 1.02 Allowed Glycine 0 CA--C 1.545 1.907 0 CA-C-N 113.209 -1.814 . . . . 0.0 113.844 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.358 0.8 OUTLIER 42.9 58.24 3.31 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 117.748 2.499 . . . . 0.0 117.748 -178.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.84 -71.42 0.27 Allowed Glycine 0 N--CA 1.481 1.652 0 O-C-N 122.287 -0.258 . . . . 0.0 112.634 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.265 56.3 mt 68.85 64.98 0.3 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.781 1.232 . . . . 0.0 111.472 -171.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 124.034 1.873 . . . . 0.0 110.093 -177.817 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -96.32 112.65 24.32 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.7 tttt 66.2 92.76 0.07 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.692 1.197 . . . . 0.0 111.705 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.2 p 54.41 170.75 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.577 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 31.7 mm -99.47 103.96 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 175.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.46 66.26 1.99 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.234 1.016 . . . . 0.0 112.456 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -174.89 119.83 0.21 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -170.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -75.18 129.38 37.41 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.908 1.283 . . . . 0.0 108.535 169.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 72.47 44.13 0.43 Allowed 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -166.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.524 ' N ' ' H ' ' A' ' 36' ' ' CYS . . . -81.49 -148.03 6.13 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-O 117.428 -1.762 . . . . 0.0 111.416 -173.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -144.75 75.92 1.47 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -175.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 17.2 p -97.76 -175.44 3.17 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 112.737 -2.029 . . . . 0.0 113.563 -168.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -153.5 160.63 42.58 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.227 -1.352 . . . . 0.0 110.065 166.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -95.9 108.01 20.34 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 169.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.62 38.83 2.0 Allowed Glycine 0 CA--C 1.558 2.764 0 CA-C-N 113.896 -1.502 . . . . 0.0 113.312 -166.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.03 -140.17 3.86 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 123.637 1.687 . . . . 0.0 110.05 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.463 ' CG2' HG12 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -62.3 166.13 7.45 Favored Pre-proline 0 CA--C 1.596 2.748 0 CA-C-N 112.052 -2.074 . . . . 0.0 113.0 168.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -62.39 -30.96 81.18 Favored 'Trans proline' 0 CA--C 1.568 2.222 0 N-CA-C 122.401 3.962 . . . . 0.0 122.401 169.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.577 ' SG ' ' HB ' ' A' ' 5' ' ' ILE 0.323 6.2 t 78.54 139.64 0.07 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 111.649 -2.523 . . . . 0.0 107.138 -162.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.74 -64.28 1.16 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -164.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . 0.29 40.8 mtm105 -92.11 -130.37 0.11 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.811 1.291 . . . . 0.0 109.116 -168.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.65 94.93 0.25 Allowed Glycine 0 N--CA 1.486 1.994 0 CA-C-N 112.799 -2.0 . . . . 0.0 111.048 169.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -106.47 169.05 8.75 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 123.948 1.832 . . . . 0.0 115.646 -165.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.28 103.62 0.21 Allowed Glycine 0 N--CA 1.471 0.988 0 N-CA-C 105.484 -3.046 . . . . 0.0 105.484 169.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.7 t -88.33 77.33 8.2 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 111.006 -2.597 . . . . 0.0 111.631 -169.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.1 mm -82.36 144.99 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 168.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.458 ' SG ' ' N ' ' A' ' 32' ' ' THR . 3.1 t -110.58 -176.09 2.89 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -176.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.315 42.5 m -101.97 -142.18 0.35 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.849 1.66 . . . . 0.0 109.195 -169.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.4 mm -72.87 -5.82 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -174.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.0 mmt -141.49 -24.63 0.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.423 ' HA2' ' SG ' ' A' ' 27' ' ' CYS . . . 91.3 58.05 1.5 Allowed Glycine 0 CA--C 1.551 2.283 0 CA-C-N 121.084 1.766 . . . . 0.0 110.929 -166.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.458 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 17.7 p -149.06 -74.93 0.17 Allowed 'General case' 0 CA--C 1.563 1.451 0 CA-C-O 124.2 1.952 . . . . 0.0 111.832 -168.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.358 33.5 m-20 -88.24 40.76 0.97 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 130.381 3.472 . . . . 0.0 115.303 -174.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.437 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 3.2 m -64.06 -167.47 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 112.328 -2.215 . . . . 0.0 115.518 -166.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -136.73 150.48 48.44 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.375 -0.828 . . . . 0.0 110.856 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.524 ' H ' ' N ' ' A' ' 10' ' ' GLY . 13.2 m -87.13 52.32 2.48 Favored 'General case' 0 N--CA 1.52 3.074 0 CA-C-O 123.96 1.838 . . . . 0.0 112.364 169.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.428 0.1 OUTLIER 98.42 93.31 0.01 OUTLIER Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 127.178 2.191 . . . . 0.0 115.134 169.281 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.07 170.47 15.09 Favored 'Trans proline' 0 CA--C 1.559 1.744 0 C-N-CA 123.262 2.641 . . . . 0.0 113.747 169.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -71.18 145.97 49.38 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 171.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.434 2.7 pt? -63.22 -33.06 74.67 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 121.296 3.813 . . . . 0.0 121.296 -176.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.329 1.9 pp -80.4 6.96 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 N-CA-C 118.344 2.72 . . . . 0.0 118.344 168.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.0 mmt -147.2 50.43 1.09 Allowed 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 125.985 1.714 . . . . 0.0 108.369 167.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -72.01 131.5 42.99 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-O 127.055 3.312 . . . . 0.0 110.642 -171.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.35 38.91 89.23 Favored Glycine 0 CA--C 1.558 2.744 1 CA-C-N 104.94 -5.573 . . . . 0.0 116.853 -167.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.26 7.1 tp 67.06 87.64 0.12 Allowed 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 125.316 1.446 . . . . 0.0 113.333 -175.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.1 106.15 1.24 Allowed Glycine 0 CA--C 1.54 1.628 0 N-CA-C 114.336 0.494 . . . . 0.0 114.336 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -98.14 -63.61 1.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.384 0.674 . . . . 0.0 110.312 169.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 122.837 1.303 . . . . 0.0 108.924 178.386 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 61.9 mttp . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -110.26 106.75 16.27 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? 67.16 87.24 0.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.615 1.166 . . . . 0.0 111.413 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.5 p 54.75 -178.15 0.03 OUTLIER 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 173.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.552 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 6.1 mm -133.47 114.09 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 -171.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.6 65.84 4.41 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.01 0.91 . . . . 0.0 112.003 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -163.18 122.67 2.16 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.4 127.25 31.55 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.534 0.734 . . . . 0.0 110.617 167.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.4 ' H ' ' HB2' ' A' ' 36' ' ' CYS . 6.2 m-85 69.59 39.68 1.51 Allowed 'General case' 0 CA--C 1.576 1.968 0 C-N-CA 123.546 0.739 . . . . 0.0 111.831 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.56 126.3 7.33 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -78.83 70.92 5.25 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 127.048 3.308 . . . . 0.0 111.823 -166.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.1 p -74.43 -167.18 0.51 Allowed 'General case' 0 CA--C 1.562 1.404 1 CA-C-N 106.288 -4.96 . . . . 0.0 113.782 -167.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.617 ' HB2' ' SG ' ' A' ' 34' ' ' CYS 0.389 0.1 OUTLIER 105.68 90.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 127.49 2.316 . . . . 0.0 106.841 173.851 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . 0.341 69.7 m95 -107.61 -140.42 0.37 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 110.502 -3.045 . . . . 0.0 102.963 -169.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.13 43.61 3.15 Favored Glycine 1 CA--C 1.585 4.433 0 N-CA-C 105.836 -2.906 . . . . 0.0 105.836 149.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.87 136.58 0.0 OUTLIER Glycine 0 CA--C 1.557 2.677 0 C-N-CA 126.926 2.203 . . . . 0.0 114.027 -162.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 m -134.66 134.96 22.65 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 170.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -48.44 -37.13 32.55 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 N-CA-C 119.999 3.038 . . . . 0.0 119.999 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.552 ' SG ' ' HB ' ' A' ' 5' ' ' ILE 0.258 16.6 t 74.32 141.4 0.07 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.997 -1.91 . . . . 0.0 106.982 -164.166 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 160.15 19.12 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 113.219 -1.81 . . . . 0.0 112.859 -165.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.6 mtt85 63.81 62.99 0.86 Allowed 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 112.795 -2.002 . . . . 0.0 113.177 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.44 68.81 1.52 Allowed Glycine 0 CA--C 1.545 1.911 0 N-CA-C 115.911 1.125 . . . . 0.0 115.911 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.28 161.41 42.09 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-O 123.222 1.487 . . . . 0.0 112.353 -172.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.86 118.68 1.27 Allowed Glycine 0 N--CA 1.478 1.47 1 N-CA-C 102.935 -4.066 . . . . 0.0 102.935 166.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.616 9.1 t -45.38 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 125.441 1.318 . . . . 0.0 113.857 -166.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.275 60.6 mt 74.13 150.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 123.286 1.517 . . . . 0.0 110.855 172.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.443 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 90.6 m -90.64 171.09 9.62 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 119.454 3.131 . . . . 0.0 119.454 -169.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.336 13.3 m -94.79 -142.85 0.25 Allowed 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 126.706 2.002 . . . . 0.0 108.928 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.25 1.9 pp -96.74 59.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 123.132 1.444 . . . . 0.0 111.32 168.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.9 ttt -161.52 -46.27 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.608 -1.633 . . . . 0.0 113.01 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.41 38.25 11.16 Favored Glycine 0 CA--C 1.556 2.638 0 CA-C-O 119.336 -0.702 . . . . 0.0 113.434 -165.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 m -162.28 -59.84 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 123.762 1.744 . . . . 0.0 111.465 -167.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.374 26.0 m-20 -79.11 45.87 0.66 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 129.781 3.232 . . . . 0.0 114.932 171.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.617 ' SG ' ' HB2' ' A' ' 13' ' ' LYS 0.267 36.3 m -69.54 -167.14 0.12 Allowed 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.415 -167.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -163.15 138.11 6.48 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 119.709 -1.869 . . . . 0.0 108.812 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.4 ' HB2' ' H ' ' A' ' 9' ' ' TYR . 20.9 m -51.69 -47.84 63.73 Favored 'General case' 0 N--CA 1.512 2.652 0 CA-C-O 125.557 2.599 . . . . 0.0 117.861 175.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.391 23.0 mtmm 86.83 171.63 0.05 OUTLIER Pre-proline 0 CA--C 1.578 2.027 1 CA-C-N 105.727 -5.215 . . . . 0.0 109.57 -165.13 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -78.41 114.55 3.53 Favored 'Trans proline' 0 C--N 1.37 1.668 0 CA-C-N 124.681 2.707 . . . . 0.0 113.824 -167.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -76.54 155.59 33.58 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.492 169.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 tt -77.95 100.48 6.44 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 124.233 1.968 . . . . 0.0 111.321 -170.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.8 tt -149.65 42.07 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.085 0 CA-C-N 110.189 -3.187 . . . . 0.0 110.148 168.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 13.5 tpt 176.97 -53.88 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.666 1.587 . . . . 0.0 109.76 -167.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.73 -2.22 8.8 Favored 'General case' 0 CA--C 1.556 1.177 1 N-CA-C 123.317 4.562 . . . . 0.0 123.317 -168.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.72 77.32 0.06 OUTLIER Glycine 0 CA--C 1.535 1.294 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.021 169.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.54 81.44 1.4 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.56 -79.64 0.18 Allowed Glycine 0 N--CA 1.479 1.563 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -172.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.0 mt -79.91 -55.58 4.87 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.231 0.612 . . . . 0.0 111.869 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 122.8 1.286 . . . . 0.0 111.602 175.814 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt . . . . . 0 CA--C 1.555 1.14 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -95.27 -93.69 0.19 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -175.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -153.56 78.87 1.15 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.608 1.094 . . . . 0.0 108.464 171.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.6 p 50.59 178.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 119.04 2.978 . . . . 0.0 119.04 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mt -134.32 119.01 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 -170.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.284 . . -77.38 10.87 2.24 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 119.274 3.065 . . . . 0.0 119.274 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.932 30.7 mtmm 92.39 -136.53 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 1 N-CA-C 124.527 5.01 . . . . 0.0 124.527 161.166 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.442 0.0 OUTLIER 6.3 83.37 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 1 CA-C-N 108.215 -4.084 . . . . 0.0 116.934 -149.461 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.316 29.7 m-85 80.79 62.78 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 -163.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.26 -167.95 0.7 Allowed Glycine 0 CA--C 1.568 3.384 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 168.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -144.66 72.86 1.35 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 121.06 2.43 . . . . 0.0 104.636 -176.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.859 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 28.9 p -88.98 174.03 8.14 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 112.304 -2.225 . . . . 0.0 114.0 -165.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -166.42 126.93 1.67 Allowed 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 103.114 -2.921 . . . . 0.0 103.114 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -79.5 99.78 7.41 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 172.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.73 38.51 1.06 Allowed Glycine 0 CA--C 1.569 3.421 0 CA-C-N 112.393 -2.185 . . . . 0.0 111.525 -163.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -162.44 -149.18 5.59 Favored Glycine 0 N--CA 1.48 1.633 0 C-N-CA 125.376 1.465 . . . . 0.0 109.819 -170.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.18 128.52 92.52 Favored Pre-proline 0 N--CA 1.501 2.088 0 CA-C-O 118.189 -0.91 . . . . 0.0 109.321 169.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -63.01 -38.77 44.24 Favored 'Trans proline' 0 N--CA 1.495 1.575 1 N-CA-C 123.207 4.272 . . . . 0.0 123.207 -171.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . 0.331 71.6 m 90.93 144.44 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.451 0 CA-C-N 111.166 -2.743 . . . . 0.0 105.015 -160.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . 0.255 0.1 OUTLIER -85.51 -66.94 0.84 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 119.439 3.126 . . . . 0.0 119.439 -161.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -109.09 67.16 0.65 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -166.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.83 92.92 0.27 Allowed Glycine 0 N--CA 1.49 2.234 0 CA-C-O 119.423 -0.654 . . . . 0.0 112.346 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.59 165.09 11.79 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 -166.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.87 106.27 0.32 Allowed Glycine 0 N--CA 1.471 0.995 0 N-CA-C 106.743 -2.543 . . . . 0.0 106.743 166.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 25.4 t -99.53 94.24 6.29 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 110.032 -3.084 . . . . 0.0 110.676 -173.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.502 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 29.6 mm -92.09 139.28 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 167.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.419 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 79.2 m -117.49 -176.85 3.1 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 -167.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.434 ' HG ' ' H ' ' A' ' 29' ' ' ILE . 36.0 t -145.49 163.85 33.41 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 125.699 2.666 . . . . 0.0 107.689 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.434 ' H ' ' HG ' ' A' ' 28' ' ' SER 0.345 7.6 mt 36.71 52.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 1 CA-C-N 108.275 -4.057 . . . . 0.0 114.415 179.684 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.6 tpt 72.61 44.48 0.39 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 125.441 1.496 . . . . 0.0 114.547 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.71 65.06 2.61 Favored Glycine 0 N--CA 1.491 2.346 0 O-C-N 120.321 -1.487 . . . . 0.0 113.074 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.779 ' HG1' ' H ' ' A' ' 33' ' ' ASN . 39.8 p -146.05 -81.51 0.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 124.011 1.862 . . . . 0.0 110.932 -166.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.779 ' H ' ' HG1' ' A' ' 32' ' ' THR 0.335 9.1 m120 -70.73 35.75 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 131.093 3.757 . . . . 0.0 118.119 172.2 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.859 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 7.2 t -71.5 -176.7 1.62 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 124.439 2.066 . . . . 0.0 114.326 -167.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -144.45 153.93 42.42 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 111.22 -2.718 . . . . 0.0 109.828 170.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.59 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 36.2 m -104.26 90.05 3.44 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 171.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -56.98 136.05 80.06 Favored Pre-proline 0 CA--C 1.568 1.653 0 CA-C-O 117.657 -1.163 . . . . 0.0 111.482 -169.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -35.01 -46.34 0.61 Allowed 'Trans proline' 0 CA--C 1.558 1.702 1 N-CA-C 123.469 4.373 . . . . 0.0 123.469 -164.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.24 118.33 14.4 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.27 0.628 . . . . 0.0 110.95 -173.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.9 tt -100.05 101.41 12.48 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 165.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.6 tt -148.77 67.44 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 CA-C-N 111.499 -2.592 . . . . 0.0 105.23 169.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . 0.257 3.5 tmm? 71.74 76.0 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.99 1.316 . . . . 0.0 109.984 -168.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.737 ' HG2' ' H ' ' A' ' 44' ' ' GLY 0.488 20.6 tt0 -102.73 -107.54 0.26 Allowed 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.737 ' H ' ' HG2' ' A' ' 43' ' ' GLU . . . -151.14 56.22 0.46 Allowed Glycine 0 CA--C 1.543 1.796 0 CA-C-N 115.158 -0.928 . . . . 0.0 114.573 170.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.1 tp 52.87 87.76 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 174.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.29 63.28 0.29 Allowed Glycine 0 CA--C 1.543 1.791 0 CA-C-N 116.442 -0.345 . . . . 0.0 113.212 169.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.0 mt -134.75 -14.3 2.16 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 124.013 1.863 . . . . 0.0 110.497 175.972 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.407 ' HB2' ' HG1' ' A' ' 17' ' ' THR . 75.0 mmtt . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -85.76 143.47 28.31 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.211 0.605 . . . . 0.0 111.548 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.25 95.5 mttt 76.23 100.06 0.07 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.008 1.323 . . . . 0.0 110.614 177.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . 0.318 30.0 p -28.74 -179.11 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.032 1 N-CA-C 125.172 5.249 . . . . 0.0 125.172 177.427 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.422 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 23.8 mm -99.24 110.23 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 174.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.54 67.16 2.4 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.242 1.02 . . . . 0.0 111.363 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -166.4 123.19 1.31 Allowed 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -70.25 130.41 41.95 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 167.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.257 0.0 OUTLIER 69.6 46.81 0.69 Allowed 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 122.964 1.364 . . . . 0.0 109.061 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.32 -152.59 15.73 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 113.615 -1.629 . . . . 0.0 109.802 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -142.21 75.64 1.5 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 -175.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 28.5 p -91.03 -171.66 3.07 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 112.641 -2.072 . . . . 0.0 112.525 -169.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -153.37 141.91 20.81 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.811 169.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -93.15 99.01 11.67 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.15 -62.98 0.52 Allowed Glycine 0 N--CA 1.484 1.867 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.782 -164.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.41 -142.67 0.3 Allowed Glycine 0 CA--C 1.539 1.587 0 CA-C-N 112.083 -2.058 . . . . 0.0 113.368 167.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.407 ' HG1' ' HB2' ' A' ' 1' ' ' LYS . 0.2 OUTLIER -61.56 138.04 94.95 Favored Pre-proline 0 N--CA 1.495 1.821 0 CA-C-N 113.484 -1.358 . . . . 0.0 111.889 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HB2' ' H ' ' A' ' 19' ' ' CYS . 23.7 Cg_endo -64.55 -131.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.573 2.429 0 C-N-CA 123.426 2.751 . . . . 0.0 112.34 169.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.422 ' SG ' ' HB ' ' A' ' 5' ' ' ILE . 4.3 t -148.81 146.81 28.17 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 164.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.29 -63.15 1.39 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 121.507 3.891 . . . . 0.0 121.507 -162.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -94.86 70.1 3.38 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.289 1.042 . . . . 0.0 112.715 -164.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.64 62.58 4.92 Favored Glycine 0 N--CA 1.486 2.004 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.925 -176.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -136.48 163.63 30.06 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 123.963 1.84 . . . . 0.0 112.222 -167.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.87 121.11 2.16 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 106.095 -2.802 . . . . 0.0 106.095 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.664 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 2.9 t -75.44 89.33 2.66 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 109.214 -3.493 . . . . 0.0 110.642 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.456 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 37.5 mm -81.5 136.41 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 122.852 1.311 . . . . 0.0 107.655 172.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.4 m -119.07 -179.0 3.7 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 111.925 -2.398 . . . . 0.0 114.985 -169.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.291 69.6 m -90.78 -144.85 0.18 Allowed 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.942 1.297 . . . . 0.0 109.844 -172.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.4 mm -71.34 -0.63 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.578 2.024 0 N-CA-C 117.596 2.443 . . . . 0.0 117.596 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.9 tpt -148.63 -31.36 0.26 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -172.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.81 61.14 1.11 Allowed Glycine 0 N--CA 1.488 2.119 0 CA-C-N 120.796 1.634 . . . . 0.0 111.671 -167.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.448 ' C ' ' H ' ' A' ' 34' ' ' CYS . 6.3 p -151.22 -78.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 123.849 1.785 . . . . 0.0 111.25 -167.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.336 37.2 m-80 -71.58 34.91 0.06 Allowed 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 129.953 3.301 . . . . 0.0 118.006 170.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 45.9 t -74.48 -168.52 0.69 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 112.259 -2.246 . . . . 0.0 113.495 -168.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -148.45 162.54 39.38 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 112.837 -1.983 . . . . 0.0 112.142 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.9 m -83.54 56.92 3.79 Favored 'General case' 0 N--CA 1.523 3.183 0 CA-C-O 124.75 2.214 . . . . 0.0 108.847 163.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.477 1.6 ptmm? 30.79 125.31 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.253 1 N-CA-C 125.424 5.342 . . . . 0.0 125.424 -163.648 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.94 152.6 76.83 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 123.646 2.897 . . . . 0.0 114.183 170.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.265 10.3 mtm105 77.7 140.4 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.546 1.138 . . . . 0.0 112.246 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.1 tt -100.59 102.76 13.99 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 124.033 1.873 . . . . 0.0 106.824 169.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.47 HG13 ' H ' ' A' ' 42' ' ' MET 0.443 17.9 pt -116.53 -83.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 110.442 -3.072 . . . . 0.0 107.292 169.127 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.47 ' H ' HG13 ' A' ' 41' ' ' ILE . 60.3 mtt -120.26 77.68 1.28 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 110.808 -2.906 . . . . 0.0 106.505 165.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.71 113.39 1.62 Allowed 'General case' 0 C--N 1.356 0.884 0 CA-C-O 126.192 2.901 . . . . 0.0 115.011 -168.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.77 -60.07 0.44 Allowed Glycine 0 CA--C 1.541 1.685 1 CA-C-N 105.788 -5.187 . . . . 0.0 115.115 -168.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.65 -73.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 118.157 0.979 . . . . 0.0 110.927 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.77 -84.56 0.22 Allowed Glycine 0 N--CA 1.478 1.459 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.81 -62.39 1.36 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.886 0.875 . . . . 0.0 109.666 175.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 122.775 1.274 . . . . 0.0 111.389 174.953 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 65.6 pttt . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 121.145 0.498 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? 70.68 98.93 0.06 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.847 1.259 . . . . 0.0 110.4 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.8 tttm 61.08 74.34 0.45 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.455 1.102 . . . . 0.0 111.888 -173.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.6 p 51.54 171.17 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 118.249 2.685 . . . . 0.0 118.249 -169.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mt -121.78 121.41 64.25 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -172.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.55 52.22 1.1 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 116.963 2.209 . . . . 0.0 116.963 -173.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HE3' ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -122.89 -179.62 4.32 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 127.079 2.152 . . . . 0.0 110.119 175.303 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -115.0 136.43 53.14 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.277 -1.783 . . . . 0.0 106.545 157.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 71.66 35.83 1.35 Allowed 'General case' 0 CA--C 1.58 2.118 0 CA-C-N 122.451 2.387 . . . . 0.0 111.987 168.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.503 ' N ' ' H ' ' A' ' 36' ' ' CYS . . . -118.78 125.96 6.62 Favored Glycine 0 N--CA 1.464 0.543 0 O-C-N 120.548 -1.345 . . . . 0.0 112.949 -168.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -3.9 79.37 0.0 OUTLIER 'General case' 0 C--O 1.236 0.361 1 C-N-CA 132.378 4.271 . . . . 0.0 116.912 169.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.981 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 15.5 p -94.05 -178.46 4.64 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 108.461 -3.972 . . . . 0.0 112.515 -173.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.35 153.96 31.29 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.255 1.026 . . . . 0.0 109.551 167.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -82.96 117.51 22.83 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.136 -173.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.21 39.64 18.7 Favored Glycine 0 CA--C 1.555 2.561 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -167.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.43 -146.87 9.33 Favored Glycine 0 N--CA 1.477 1.393 0 CA-C-O 123.198 1.444 . . . . 0.0 112.822 -174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.17 131.83 95.12 Favored Pre-proline 0 CA--C 1.573 1.864 0 CA-C-N 112.586 -1.807 . . . . 0.0 108.469 168.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -47.97 -36.3 27.17 Favored 'Trans proline' 0 N--CA 1.498 1.74 1 N-CA-C 122.595 4.036 . . . . 0.0 122.595 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.4 m 83.48 131.8 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 111.072 -2.785 . . . . 0.0 106.53 -165.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -56.74 3.33 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.944 -168.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -124.62 72.46 1.21 Allowed 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 124.713 1.205 . . . . 0.0 109.752 -170.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.5 73.58 0.51 Allowed Glycine 0 N--CA 1.482 1.735 0 C-N-CA 123.776 0.703 . . . . 0.0 113.107 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -90.23 174.07 7.8 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 170.73 -96.29 0.11 Allowed Glycine 0 N--CA 1.478 1.444 0 CA-C-O 123.732 1.74 . . . . 0.0 109.545 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.667 ' SG ' ' SG ' ' A' ' 34' ' ' CYS 0.39 5.7 t 93.95 94.32 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 109.536 -3.332 . . . . 0.0 110.648 173.549 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.619 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 31.0 mm -119.92 141.31 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 166.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.5 m -136.88 144.92 43.79 Favored 'General case' 0 CA--C 1.58 2.129 1 N-CA-C 123.461 4.615 . . . . 0.0 123.461 -168.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.539 10.2 p 61.11 -84.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 163.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.305 2.1 mp -38.83 -40.09 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.664 0 CA-C-N 108.969 -3.742 . . . . 0.0 116.438 168.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 37.3 ttp -143.49 -24.9 0.58 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.351 -1.75 . . . . 0.0 113.154 166.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -43.08 -47.91 6.46 Favored Glycine 0 CA--C 1.558 2.724 0 CA-C-O 125.919 2.955 . . . . 0.0 118.451 164.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.776 0.4 OUTLIER 64.86 100.16 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.888 1 CA-C-N 107.42 -4.39 . . . . 0.0 111.552 -169.507 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.811 0.6 OUTLIER 20.37 55.6 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.928 0 CA-C-N 108.802 -3.817 . . . . 0.0 118.445 -155.427 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.981 ' SG ' ' SG ' ' A' ' 12' ' ' CYS 0.409 0.1 OUTLIER 46.99 173.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 1 CA-C-N 106.528 -4.851 . . . . 0.0 119.573 -168.165 . . . . . . . . 5 4 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -158.67 141.67 14.65 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 109.975 -3.284 . . . . 0.0 108.642 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.503 ' H ' ' N ' ' A' ' 10' ' ' GLY . 90.4 m -83.41 81.55 8.67 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 120.885 1.675 . . . . 0.0 107.387 169.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -66.17 127.45 93.23 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-O 117.084 -1.436 . . . . 0.0 109.592 -169.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -42.57 140.0 2.88 Favored 'Trans proline' 0 CA--C 1.562 1.912 0 N-CA-C 121.89 3.766 . . . . 0.0 121.89 -161.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.403 0.1 OUTLIER 16.45 82.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 1 N-CA-C 121.981 4.067 . . . . 0.0 121.981 179.685 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 tp -106.77 112.25 25.14 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 166.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.366 35.7 mm -111.6 -87.45 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 124.081 1.896 . . . . 0.0 106.952 -171.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.5 ttt -99.11 -9.98 23.13 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 109.703 -3.408 . . . . 0.0 114.991 167.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -64.46 -1.01 1.52 Allowed 'General case' 0 CA--C 1.563 1.458 1 N-CA-C 122.148 4.129 . . . . 0.0 122.148 176.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.57 -76.19 0.03 OUTLIER Glycine 0 CA--C 1.54 1.6 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.384 172.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 mp -133.59 -78.3 0.48 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.67 -99.7 0.17 Allowed Glycine 0 CA--C 1.537 1.423 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 pp -85.41 -32.41 22.36 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 122.817 1.294 . . . . 0.0 110.307 179.971 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.489 ' HG3' ' H ' ' A' ' 3' ' ' LYS 0.277 56.9 pttt -99.01 -92.3 0.27 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 118.427 -0.797 . . . . 0.0 109.14 175.589 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.489 ' H ' ' HG3' ' A' ' 2' ' ' LYS . 32.6 mmtp -141.3 89.27 2.22 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.402 ' HA ' HG23 ' A' ' 17' ' ' THR 0.302 27.8 p -46.83 -174.43 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.997 1 N-CA-C 122.355 4.205 . . . . 0.0 122.355 -177.006 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.498 HG13 ' SG ' ' A' ' 36' ' ' CYS . 24.5 mm -70.79 -49.88 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 C-N-CA 127.533 2.333 . . . . 0.0 111.342 173.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.284 . . 68.71 52.67 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 126.114 1.765 . . . . 0.0 114.215 -171.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -178.66 125.66 0.1 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -176.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -73.49 118.32 16.31 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 166.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.466 ' H ' ' HB2' ' A' ' 36' ' ' CYS 0.356 0.0 OUTLIER 75.86 80.44 0.1 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 176.614 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' H ' ' H ' ' A' ' 36' ' ' CYS . . . -172.66 120.31 0.81 Allowed Glycine 0 N--CA 1.471 1.007 0 CA-C-N 109.323 -3.58 . . . . 0.0 115.364 -165.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . 0.35 20.6 tpt85 1.08 70.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 131.116 3.767 . . . . 0.0 119.26 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.7 p -88.97 170.33 10.77 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 110.04 -3.255 . . . . 0.0 112.647 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -140.62 154.85 46.61 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.566 171.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -97.51 95.12 7.42 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 105.485 -2.042 . . . . 0.0 105.485 170.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.83 54.76 0.91 Allowed Glycine 0 CA--C 1.552 2.359 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.979 -167.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.04 -142.81 3.5 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-O 123.214 1.452 . . . . 0.0 110.172 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.402 HG23 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -58.46 143.9 79.71 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-N 112.777 -1.711 . . . . 0.0 111.167 168.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.436 ' HB2' ' H ' ' A' ' 19' ' ' CYS . 40.3 Cg_endo -65.06 -132.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.572 2.416 0 C-N-CA 123.0 2.466 . . . . 0.0 110.818 167.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.436 ' H ' ' HB2' ' A' ' 18' ' ' PRO . 59.6 m -152.82 142.31 21.74 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 166.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.41 -55.88 3.69 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 113.349 -1.751 . . . . 0.0 113.545 -168.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -132.44 82.12 1.99 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.835 1.254 . . . . 0.0 109.025 -169.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.82 110.47 3.36 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -133.04 175.88 8.98 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.818 1.785 . . . . 0.0 115.818 -167.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.02 -81.53 0.13 Allowed Glycine 0 N--CA 1.474 1.188 0 CA-C-N 112.331 -2.213 . . . . 0.0 109.554 -168.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.317 16.4 t 79.81 102.13 0.06 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 109.739 -3.231 . . . . 0.0 109.343 -170.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.2 mm -131.54 152.25 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 169.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.464 ' HA ' ' CB ' ' A' ' 34' ' ' CYS 0.347 85.5 m -77.54 150.95 34.73 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 176.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.319 41.1 m -152.9 176.03 12.28 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 126.161 1.784 . . . . 0.0 109.229 -165.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.328 3.9 mp 38.04 63.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 C-N-CA 126.476 1.91 . . . . 0.0 112.257 -173.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.285 16.2 mmt 91.07 -6.84 0.27 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 126.141 1.777 . . . . 0.0 115.044 -169.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.37 58.85 3.23 Favored Glycine 0 CA--C 1.557 2.664 0 CA-C-N 122.772 2.533 . . . . 0.0 109.059 -165.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.3 m -151.57 -52.17 0.12 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 124.657 1.183 . . . . 0.0 112.673 -163.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -61.28 -77.1 0.05 OUTLIER 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 124.806 2.241 . . . . 0.0 111.935 169.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.464 ' CB ' ' HA ' ' A' ' 27' ' ' CYS 0.272 2.4 m 79.65 167.23 0.18 Allowed 'General case' 0 CA--C 1.557 1.228 1 CA-C-N 107.337 -4.483 . . . . 0.0 110.094 -167.829 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -160.91 153.3 20.45 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.99 1.316 . . . . 0.0 107.616 -170.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.498 ' SG ' HG13 ' A' ' 5' ' ' ILE . 87.6 m -67.94 67.41 0.11 Allowed 'General case' 0 N--CA 1.508 2.448 0 CA-C-O 124.652 2.167 . . . . 0.0 114.696 171.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.446 34.8 ttmt 46.84 91.97 0.06 OUTLIER Pre-proline 0 CA--C 1.572 1.797 1 N-CA-C 123.244 4.535 . . . . 0.0 123.244 -169.511 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -87.67 -34.6 0.11 Allowed 'Trans proline' 0 CA--C 1.561 1.825 0 C-N-CA 123.792 2.995 . . . . 0.0 118.072 172.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.332 38.7 mmt180 79.65 148.67 0.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.815 1.246 . . . . 0.0 109.741 -166.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.253 6.3 tp -13.04 103.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 119.643 3.201 . . . . 0.0 119.643 -165.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.3 tt -152.17 62.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-N 112.58 -2.1 . . . . 0.0 107.41 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 64.5 mtt 57.71 66.47 1.12 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 124.819 1.248 . . . . 0.0 111.472 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.67 ' HG2' ' H ' ' A' ' 44' ' ' GLY 0.492 13.1 tt0 -118.96 -98.74 0.45 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 -167.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.67 ' H ' ' HG2' ' A' ' 43' ' ' GLU . . . -74.13 -58.24 4.43 Favored Glycine 0 CA--C 1.547 2.092 0 CA-C-N 114.156 -1.384 . . . . 0.0 115.419 174.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.76 -79.25 0.49 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.2 -104.15 0.17 Allowed Glycine 0 CA--C 1.535 1.326 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -120.31 -57.83 1.9 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.675 -177.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 123.922 1.82 . . . . 0.0 112.583 179.288 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.0 tttm . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 120.604 0.24 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HA ' HG22 ' A' ' 17' ' ' THR 0.274 21.6 p 52.41 167.94 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 -174.72 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.8 mm -85.42 -62.17 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.673 0 C-N-CA 125.302 1.441 . . . . 0.0 110.852 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.268 . . 72.19 61.6 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 125.591 1.556 . . . . 0.0 114.051 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -179.5 131.71 0.11 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.4 128.34 35.47 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 166.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 72.58 39.83 0.68 Allowed 'General case' 0 CA--C 1.579 2.09 0 C-N-CA 124.284 1.033 . . . . 0.0 111.745 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.68 134.41 12.31 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -76.89 72.62 3.48 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 126.909 3.242 . . . . 0.0 112.869 -165.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 13.7 p -73.59 -177.72 2.81 Favored 'General case' 0 N--CA 1.489 1.501 1 CA-C-N 106.379 -4.918 . . . . 0.0 114.253 -172.316 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -152.64 154.5 35.46 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.425 1.107 . . . . 0.0 110.055 166.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -90.89 109.19 20.4 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 169.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.02 39.15 2.54 Favored Glycine 0 CA--C 1.558 2.768 0 CA-C-N 114.238 -1.346 . . . . 0.0 113.449 -166.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.81 -139.64 3.11 Favored Glycine 0 N--CA 1.473 1.149 0 CA-C-O 123.838 1.799 . . . . 0.0 109.544 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -70.07 143.11 91.07 Favored Pre-proline 0 CA--C 1.578 2.046 0 CA-C-N 111.823 -2.189 . . . . 0.0 108.9 166.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.69 -127.86 0.0 OUTLIER 'Trans proline' 0 CA--C 1.567 2.159 0 C-N-CA 123.378 2.719 . . . . 0.0 111.805 171.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.4 m -149.44 142.95 25.37 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 165.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -64.45 1.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.925 -169.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -139.77 93.71 2.69 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -173.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.77 100.07 2.56 Favored Glycine 0 N--CA 1.478 1.486 0 N-CA-C 105.938 -2.865 . . . . 0.0 105.938 -167.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -134.13 170.78 15.16 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 123.479 1.609 . . . . 0.0 114.922 -169.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.18 -81.44 0.16 Allowed Glycine 0 N--CA 1.476 1.366 0 CA-C-O 124.673 2.263 . . . . 0.0 110.099 -168.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.491 9.5 t 68.71 44.39 1.17 Allowed 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 109.008 -3.596 . . . . 0.0 116.708 -170.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 66.1 mt -78.36 143.23 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 166.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 97.1 m -92.31 172.95 8.07 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.9 p -79.4 -150.43 0.06 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 114.009 -1.451 . . . . 0.0 110.844 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.3 2.0 pp -98.65 56.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 122.934 1.35 . . . . 0.0 111.76 168.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.317 0.0 OUTLIER -168.64 -40.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.807 1.643 . . . . 0.0 112.839 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.07 50.87 3.53 Favored Glycine 0 N--CA 1.489 2.216 0 CA-C-N 120.476 1.489 . . . . 0.0 114.442 -170.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.0 p -157.93 -72.17 0.09 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 124.444 2.069 . . . . 0.0 111.305 -168.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.32 16.9 m-80 -70.31 39.43 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 131.127 3.771 . . . . 0.0 117.677 169.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 13.6 m -68.28 -157.4 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 112.873 -1.967 . . . . 0.0 113.459 -170.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -156.65 144.06 19.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 119.913 -1.742 . . . . 0.0 109.116 174.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 16.8 m -96.84 89.71 4.98 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? . . . . . 0 CA--C 1.569 1.684 0 N-CA-C 117.236 2.309 . . . . 0.0 117.236 -166.547 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.351 63.1 pttt . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.431 ' HA ' HG22 ' A' ' 17' ' ' THR . 17.9 p 50.36 172.08 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mt -101.56 -63.62 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 C-N-CA 125.252 1.421 . . . . 0.0 110.74 -170.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.3 . . 78.65 60.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.707 1.603 . . . . 0.0 112.65 -169.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -160.16 122.73 3.36 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -73.02 123.15 22.95 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.915 1.286 . . . . 0.0 107.915 168.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.282 23.5 m-85 76.14 36.86 0.39 Allowed 'General case' 0 CA--C 1.581 2.139 0 C-N-CA 124.174 0.99 . . . . 0.0 111.18 -167.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.09 129.07 8.79 Favored Glycine 0 N--CA 1.479 1.511 0 O-C-N 121.12 -0.988 . . . . 0.0 111.138 -174.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.7 tpt85 -75.9 77.0 2.8 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-O 126.588 3.089 . . . . 0.0 109.633 -168.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.817 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -73.93 -179.7 3.86 Favored 'General case' 0 N--CA 1.489 1.482 1 CA-C-N 106.821 -4.718 . . . . 0.0 110.544 -169.012 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -142.37 159.74 41.64 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 114.066 -1.424 . . . . 0.0 108.085 163.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -100.23 97.8 8.55 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.51 46.34 0.92 Allowed Glycine 0 CA--C 1.555 2.543 0 CA-C-N 114.245 -1.343 . . . . 0.0 113.296 -167.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.6 -142.36 3.45 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-O 123.443 1.579 . . . . 0.0 110.349 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.431 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -68.61 142.82 94.49 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-N 112.38 -1.91 . . . . 0.0 109.263 167.608 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD2' HG22 ' A' ' 17' ' ' THR . 22.3 Cg_endo -68.23 -127.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.57 2.304 0 C-N-CA 123.063 2.508 . . . . 0.0 109.57 168.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.8 m -154.01 151.07 28.94 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 163.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.67 -60.35 1.72 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 114.044 -1.434 . . . . 0.0 111.874 -168.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -121.45 81.14 1.76 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -169.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.09 99.78 2.57 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -172.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -142.72 176.18 9.25 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 123.72 1.724 . . . . 0.0 114.573 -168.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.71 94.62 1.54 Allowed Glycine 0 N--CA 1.477 1.433 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -167.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.931 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 5.8 t -86.96 121.62 29.68 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 110.089 -3.055 . . . . 0.0 111.326 -168.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.507 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 15.6 mm -112.53 136.05 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 166.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.1 m -109.03 -171.84 1.93 Allowed 'General case' 0 CA--C 1.559 1.319 0 CA-C-N 112.73 -2.032 . . . . 0.0 113.912 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 t -115.99 -126.36 0.29 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.918 1.342 . . . . 0.0 110.0 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.2 mm -71.82 -3.34 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 119.079 2.992 . . . . 0.0 119.079 -168.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 20.4 ptp -156.32 -13.0 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.39 -15.37 50.21 Favored Glycine 0 CA--C 1.556 2.636 0 CA-C-N 121.431 1.923 . . . . 0.0 114.83 -165.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.4 p -89.13 -146.59 0.16 Allowed 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 166.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 41.62 36.69 0.61 Allowed 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 169.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.931 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 2.0 t -99.2 -171.34 2.06 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 110.913 -2.858 . . . . 0.0 114.601 -161.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -159.6 148.52 17.86 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 112.22 -2.264 . . . . 0.0 110.56 172.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 13.9 m -103.77 91.57 4.06 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.9 mttt . . . . . 0 CA--C 1.568 1.669 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -169.169 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.479 ' HA ' HG22 ' A' ' 17' ' ' THR 0.308 8.3 p 57.73 169.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 117.411 2.375 . . . . 0.0 117.411 -177.178 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.592 HG13 ' SG ' ' A' ' 19' ' ' CYS . 32.0 mm -96.6 -64.1 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 124.379 1.072 . . . . 0.0 110.234 -169.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.08 59.04 1.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -173.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -175.88 123.66 0.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -77.42 116.51 18.07 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.474 1.11 . . . . 0.0 109.552 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.309 10.1 m-85 75.71 48.19 0.09 Allowed 'General case' 0 CA--C 1.57 1.737 0 C-N-CA 124.897 1.279 . . . . 0.0 108.084 -167.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.47 -149.77 3.06 Favored Glycine 0 C--N 1.356 1.666 0 CA-C-O 118.472 -1.182 . . . . 0.0 110.541 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -143.78 76.97 1.54 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 124.373 2.035 . . . . 0.0 106.162 -169.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 15.1 p -95.36 -174.33 3.16 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 111.086 -2.779 . . . . 0.0 112.451 -170.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -150.4 142.65 24.19 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.538 167.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -86.33 103.86 15.31 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 168.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.54 50.0 1.47 Allowed Glycine 0 CA--C 1.559 2.783 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.754 -163.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.21 -134.28 1.71 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -169.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -66.99 132.04 93.82 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-N 112.284 -1.958 . . . . 0.0 110.761 170.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -63.47 -34.8 63.92 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 N-CA-C 122.213 3.889 . . . . 0.0 122.213 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.592 ' SG ' HG13 ' A' ' 5' ' ' ILE 0.368 80.2 m 82.31 144.75 0.07 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 111.766 -2.47 . . . . 0.0 108.056 -163.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.74 -68.53 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 118.456 2.761 . . . . 0.0 118.456 -161.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.464 ' HE ' HH12 ' A' ' 23' ' ' ARG . 73.1 mtm180 -111.36 68.5 0.67 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.472 0.653 . . . . 0.0 110.887 -166.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.91 78.13 0.27 Allowed Glycine 0 N--CA 1.484 1.885 0 CA-C-O 119.204 -0.776 . . . . 0.0 113.308 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.464 HH12 ' HE ' ' A' ' 21' ' ' ARG . 40.2 mtt85 -140.81 142.88 34.58 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.452 1.12 . . . . 0.0 111.81 -169.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.05 -86.0 0.02 OUTLIER Glycine 0 N--CA 1.482 1.762 0 N-CA-C 118.16 2.024 . . . . 0.0 118.16 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 36' ' ' CYS 0.417 14.0 t 82.34 38.22 0.05 Allowed 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 109.807 -3.196 . . . . 0.0 115.935 -169.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.9 mt -73.99 143.54 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 123.383 1.563 . . . . 0.0 107.65 168.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 34' ' ' CYS 0.259 96.4 m -93.38 -175.5 3.83 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 111.812 -2.449 . . . . 0.0 116.678 -169.458 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.37 -18.61 64.51 Favored 'General case' 0 N--CA 1.504 2.259 1 N-CA-C 122.297 4.184 . . . . 0.0 122.297 175.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.448 4.2 mp 89.06 77.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.526 0 CA-C-N 109.061 -3.7 . . . . 0.0 105.235 -166.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.2 tpt 177.21 -51.04 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.447 0 CA-C-N 111.144 -2.753 . . . . 0.0 106.986 -167.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.67 -27.33 13.59 Favored Glycine 0 CA--C 1.552 2.363 0 CA-C-O 118.849 -0.973 . . . . 0.0 113.541 -166.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.6 p -90.79 -168.82 2.18 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 167.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 44.98 45.52 8.76 Favored 'General case' 0 N--CA 1.511 2.617 0 CA-C-O 125.724 2.678 . . . . 0.0 117.549 168.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 3.7 m -90.08 -179.35 5.66 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 108.609 -3.905 . . . . 0.0 111.504 -166.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -141.72 147.24 37.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.38 -0.825 . . . . 0.0 110.202 168.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 25' ' ' CYS 0.314 1.5 m -93.03 77.89 4.65 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.189 -177.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.588 -1.196 . . . . 0.0 111.36 -172.467 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.191 0.519 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.59 ' HA ' HG22 ' A' ' 17' ' ' THR 0.347 20.9 p -136.88 -171.75 3.01 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-O 123.215 1.483 . . . . 0.0 114.85 -166.771 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.36 109.7 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.485 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 169.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.12 69.63 2.03 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.222 1.01 . . . . 0.0 110.204 172.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -165.45 122.33 1.46 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 -173.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -75.96 120.4 21.23 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.765 1.226 . . . . 0.0 109.674 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.314 5.6 m-85 77.99 29.01 0.5 Allowed 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 124.966 1.306 . . . . 0.0 113.601 -170.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.89 117.17 5.73 Favored Glycine 0 N--CA 1.469 0.846 0 O-C-N 120.89 -1.131 . . . . 0.0 112.868 -171.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -22.9 81.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 1 C-N-CA 131.909 4.084 . . . . 0.0 116.233 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.867 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 13.0 p -85.38 -178.87 6.83 Favored 'General case' 0 N--CA 1.491 1.609 1 CA-C-N 106.983 -4.644 . . . . 0.0 112.402 -171.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -146.14 155.17 42.55 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 122.884 1.326 . . . . 0.0 108.757 169.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 49.8 m0 -94.94 100.15 12.05 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.91 53.92 1.25 Allowed Glycine 0 CA--C 1.552 2.388 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.405 -166.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.07 -143.64 3.78 Favored Glycine 0 N--CA 1.477 1.371 0 CA-C-O 123.19 1.439 . . . . 0.0 110.737 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -63.69 132.53 95.23 Favored Pre-proline 0 CA--C 1.576 1.979 0 CA-C-N 112.848 -1.676 . . . . 0.0 110.522 170.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -51.73 -39.02 67.69 Favored 'Trans proline' 0 N--CA 1.498 1.755 1 N-CA-C 123.284 4.302 . . . . 0.0 123.284 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 16.3 m 90.52 139.65 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 111.405 -2.634 . . . . 0.0 104.842 -163.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -85.02 -64.39 1.17 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 120.576 3.547 . . . . 0.0 120.576 -162.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -127.82 80.85 1.98 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.886 0.851 . . . . 0.0 109.608 -164.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.29 66.85 1.98 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 115.152 -0.931 . . . . 0.0 114.391 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.6 mtt85 -141.58 156.44 45.69 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.834 1.302 . . . . 0.0 111.031 -169.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.62 -130.85 6.65 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-O 123.196 1.442 . . . . 0.0 112.029 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.471 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 48.9 t 166.13 107.91 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 102.815 -3.032 . . . . 0.0 102.815 173.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.521 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 29.8 mm -121.2 134.32 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 170.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 33' ' ' ASN . 33.0 m -107.84 -177.78 3.44 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-N 112.775 -2.011 . . . . 0.0 111.235 174.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 t -89.96 -173.34 3.84 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 124.561 2.124 . . . . 0.0 112.567 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 pp -93.38 63.9 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 110.681 -2.963 . . . . 0.0 108.889 166.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.2 tpt 177.71 -49.27 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 112.637 -2.074 . . . . 0.0 110.348 -168.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.35 18.13 69.71 Favored Glycine 0 CA--C 1.568 3.372 0 CA-C-O 118.962 -0.91 . . . . 0.0 114.725 -162.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.301 6.0 p -121.59 114.3 20.99 Favored 'General case' 0 N--CA 1.486 1.352 1 N-CA-C 96.065 -5.531 . . . . 0.0 96.065 158.462 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 27' ' ' CYS 0.304 48.9 p30 -145.45 -90.36 0.1 Allowed 'General case' 0 CA--C 1.559 1.313 1 N-CA-C 134.521 8.712 . . . . 0.0 134.521 -138.635 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.867 ' SG ' ' SG ' ' A' ' 12' ' ' CYS 0.27 0.1 OUTLIER -74.47 -174.61 2.1 Favored 'General case' 0 C--N 1.305 -1.367 1 CA-C-N 106.273 -4.967 . . . . 0.0 119.848 -143.839 . . . . . . . . 5 4 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -170.11 137.25 1.53 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 109.163 -3.653 . . . . 0.0 109.604 -173.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.6 m -84.44 94.41 8.51 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 173.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp . . . . . 0 CA--C 1.573 1.862 0 CA-C-O 117.272 -1.346 . . . . 0.0 112.051 -167.858 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.1 tttt . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 120.662 0.267 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.6 p 50.37 178.33 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.871 2.175 . . . . 0.0 116.871 -168.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.2 mt -128.04 127.14 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.57 71.01 0.75 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.257 1.027 . . . . 0.0 112.563 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -125.41 177.04 6.4 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 124.845 2.26 . . . . 0.0 116.09 -168.171 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -118.08 100.73 7.72 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.316 -2.22 . . . . 0.0 105.913 158.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.328 1.1 m-85 79.18 63.4 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 122.885 2.584 . . . . 0.0 107.309 172.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.16 -165.22 3.21 Favored Glycine 0 C--N 1.351 1.413 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.553 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -134.66 75.28 1.57 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.93 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 27.7 p -75.36 -179.17 4.36 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 113.093 -1.867 . . . . 0.0 113.135 -169.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -143.89 151.96 40.51 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 122.994 1.378 . . . . 0.0 108.155 167.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.3 m0 -99.66 93.83 6.04 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 168.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.32 41.02 0.56 Allowed Glycine 0 CA--C 1.56 2.89 0 CA-C-N 113.456 -1.702 . . . . 0.0 112.732 -166.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.79 -142.59 3.43 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.65 139.33 91.29 Favored Pre-proline 0 N--CA 1.499 1.993 0 CA-C-N 113.236 -1.482 . . . . 0.0 107.978 166.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -66.02 -129.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.572 2.38 0 C-N-CA 123.026 2.484 . . . . 0.0 111.19 169.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.2 m -152.63 139.28 18.79 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 165.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.57 160.54 26.4 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 122.889 1.328 . . . . 0.0 111.649 -170.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 38.5 mtt85 47.59 59.63 4.02 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.09 100.37 0.24 Allowed Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.46 -0.775 . . . . 0.0 112.423 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -112.23 169.87 8.56 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -168.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.56 -87.47 1.89 Allowed Glycine 0 CA--C 1.536 1.383 0 CA-C-N 111.67 -2.513 . . . . 0.0 108.686 166.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' SG ' ' SG ' ' A' ' 34' ' ' CYS 0.415 22.4 t 65.66 55.96 0.96 Allowed 'General case' 0 CA--C 1.561 1.391 0 CA-C-N 110.49 -2.855 . . . . 0.0 113.749 -169.159 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.539 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 54.1 mt -83.2 133.85 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 167.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.1 m -119.34 178.82 4.39 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 118.137 2.643 . . . . 0.0 118.137 -166.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 p -159.5 153.16 22.8 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-O 124.499 2.095 . . . . 0.0 111.986 -167.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.327 2.4 mp 40.27 60.18 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 CA-C-N 109.97 -3.286 . . . . 0.0 113.416 -169.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.274 15.7 mmt 85.37 7.15 0.43 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.02 69.05 1.29 Allowed Glycine 0 N--CA 1.486 1.987 0 CA-C-N 122.122 2.237 . . . . 0.0 111.664 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.1 p -149.96 -76.37 0.15 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 123.763 1.744 . . . . 0.0 109.94 -168.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.77 21.81 0.05 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 119.814 3.264 . . . . 0.0 119.814 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.93 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 8.6 t -59.75 -168.81 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 112.286 -2.233 . . . . 0.0 115.405 -167.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -149.28 144.54 26.55 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.704 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 18.2 m -101.21 116.65 33.31 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? . . . . . 0 CA--C 1.574 1.877 0 CA-C-N 119.988 1.267 . . . . 0.0 109.711 170.038 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.638 ' HA ' HG22 ' A' ' 17' ' ' THR 0.318 14.0 p -119.48 -167.47 1.42 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 126.688 1.995 . . . . 0.0 115.297 -169.542 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.9 mm -94.65 -70.44 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.723 0 C-N-CA 125.137 1.375 . . . . 0.0 107.94 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.52 67.38 0.65 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.849 1.66 . . . . 0.0 114.652 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -174.6 128.76 0.33 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.06 120.0 15.99 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.108 1.363 . . . . 0.0 109.603 171.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.308 2.2 m-85 72.31 44.6 0.42 Allowed 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 124.82 1.248 . . . . 0.0 109.485 -167.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -75.18 -150.7 2.57 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-O 118.221 -1.322 . . . . 0.0 110.806 173.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.4 mmt-85 -147.35 74.54 1.33 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -171.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.803 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -77.06 -177.38 4.44 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 123.284 1.516 . . . . 0.0 111.09 -169.504 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -141.97 125.34 16.58 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 166.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 52.1 m0 -76.26 111.69 11.96 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 169.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.31 47.03 5.36 Favored Glycine 0 CA--C 1.558 2.723 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.566 -165.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.72 -135.37 1.81 Allowed Glycine 0 N--CA 1.472 1.098 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -169.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -61.94 140.48 95.69 Favored Pre-proline 0 CA--C 1.573 1.828 0 CA-C-N 112.361 -1.919 . . . . 0.0 112.033 169.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -71.11 -128.05 0.01 OUTLIER 'Trans proline' 0 CA--C 1.567 2.126 0 C-N-CA 123.28 2.653 . . . . 0.0 110.774 167.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.2 8.97 0.64 Allowed 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 119.379 3.103 . . . . 0.0 119.379 167.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 79.41 -67.61 0.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 111.106 -2.77 . . . . 0.0 114.737 169.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -112.56 65.77 0.64 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.86 1.264 . . . . 0.0 110.687 -168.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.5 77.06 0.17 Allowed Glycine 0 CA--C 1.542 1.771 0 N-CA-C 116.673 1.429 . . . . 0.0 116.673 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.6 ttm105 -140.99 141.12 34.41 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 118.013 0.907 . . . . 0.0 111.613 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.35 105.1 3.05 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-O 125.021 2.456 . . . . 0.0 108.727 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.858 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 27.4 t -64.85 128.29 35.16 Favored 'General case' 0 CA--C 1.558 1.266 1 CA-C-N 107.887 -4.157 . . . . 0.0 112.489 170.015 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.463 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 29.6 mm -115.89 140.12 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 165.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 86.6 m -107.99 -174.71 2.59 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-N 113.831 -1.531 . . . . 0.0 114.786 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.81 -19.04 65.63 Favored 'General case' 0 N--CA 1.502 2.153 1 N-CA-C 122.155 4.132 . . . . 0.0 122.155 175.27 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.452 4.1 mp 86.91 75.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.487 0 CA-C-N 109.251 -3.613 . . . . 0.0 105.718 -167.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.7 ttt 176.27 -51.33 0.01 OUTLIER 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 111.333 -2.667 . . . . 0.0 106.772 -167.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.89 -32.7 6.19 Favored Glycine 0 CA--C 1.546 1.979 0 CA-C-O 118.585 -1.12 . . . . 0.0 113.709 -168.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 p -79.44 -170.61 2.39 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-O 124.67 2.176 . . . . 0.0 105.384 168.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 36.75 55.36 1.17 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 126.117 2.865 . . . . 0.0 115.732 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.858 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 8.0 t -102.67 -163.9 1.04 Allowed 'General case' 0 C--N 1.312 -1.037 1 CA-C-N 108.097 -4.138 . . . . 0.0 113.96 -161.647 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.423 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 10.9 pt-20 -157.78 150.98 23.29 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 112.244 -2.253 . . . . 0.0 112.046 171.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.404 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 16.8 m -90.91 81.39 5.7 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 169.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt . . . . . 0 CA--C 1.567 1.628 0 CA-C-O 117.269 -1.348 . . . . 0.0 110.653 -169.083 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.504 ' HA ' HG22 ' A' ' 17' ' ' THR . 16.4 p 51.63 169.02 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 118.542 2.793 . . . . 0.0 118.542 -170.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt -115.42 107.53 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.84 69.62 4.65 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.48 1.133 . . . . 0.0 110.831 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -160.48 112.91 2.0 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 104.281 -2.489 . . . . 0.0 104.281 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -75.79 126.55 31.23 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.894 1.278 . . . . 0.0 110.366 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.298 12.0 m-85 73.41 38.77 0.63 Allowed 'General case' 0 CA--C 1.58 2.108 0 C-N-CA 124.413 1.085 . . . . 0.0 111.149 -167.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.35 132.39 11.11 Favored Glycine 0 N--CA 1.483 1.795 0 O-C-N 120.946 -1.097 . . . . 0.0 110.403 -174.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -74.83 70.35 1.92 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 127.108 3.337 . . . . 0.0 112.457 -167.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.716 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 31.4 p -72.27 -174.78 1.37 Allowed 'General case' 0 N--CA 1.483 1.203 1 CA-C-N 106.088 -5.051 . . . . 0.0 114.232 -173.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -152.61 164.26 38.03 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.595 169.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -97.26 104.14 16.14 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 169.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.69 41.81 1.09 Allowed Glycine 0 CA--C 1.557 2.709 0 CA-C-N 113.904 -1.498 . . . . 0.0 113.025 -166.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.98 -146.66 4.4 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-O 123.417 1.565 . . . . 0.0 111.247 -175.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.504 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -70.11 132.32 88.34 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-N 112.791 -1.705 . . . . 0.0 108.275 167.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -54.89 -34.11 84.54 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 N-CA-C 121.915 3.775 . . . . 0.0 121.915 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . 0.297 74.3 m 87.42 148.0 0.05 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 111.288 -2.687 . . . . 0.0 109.205 -165.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.09 176.31 5.17 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.869 -168.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . 0.254 32.6 ptt180 42.53 56.12 3.91 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 119.433 3.123 . . . . 0.0 119.433 167.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.02 102.64 0.1 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.28 161.97 36.6 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -167.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -178.78 120.25 0.69 Allowed Glycine 0 CA--C 1.529 0.96 0 N-CA-C 106.809 -2.516 . . . . 0.0 106.809 168.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 39.7 t -91.82 81.86 5.2 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 111.446 -2.377 . . . . 0.0 112.827 -169.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.557 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -75.75 134.9 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 168.293 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.5 m -118.39 178.11 4.57 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 112.944 -1.935 . . . . 0.0 114.523 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.288 57.9 m -79.11 -149.98 0.05 Allowed 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 125.149 1.38 . . . . 0.0 110.808 178.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.82 58.11 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.902 0.858 . . . . 0.0 108.88 169.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.93 -57.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.41 1.084 . . . . 0.0 111.712 -173.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.44 54.15 1.49 Allowed Glycine 0 CA--C 1.548 2.13 0 CA-C-O 119.278 -0.734 . . . . 0.0 112.777 -167.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.8 p -153.73 -73.96 0.13 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 123.824 1.773 . . . . 0.0 111.364 -168.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.314 8.6 m120 -67.34 33.53 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 129.679 3.191 . . . . 0.0 118.01 168.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 30.9 t -77.27 -150.62 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 111.839 -2.437 . . . . 0.0 113.731 -167.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -172.52 143.58 1.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.206 169.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 6.9 m -105.36 98.78 8.44 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.573 1.842 0 CA-C-O 116.943 -1.503 . . . . 0.0 112.802 -168.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.67 ' HA ' HG22 ' A' ' 17' ' ' THR . 17.2 p -24.27 174.32 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.065 1 N-CA-C 127.247 6.017 . . . . 0.0 127.247 -168.311 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mt -109.19 117.3 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 127.823 2.449 . . . . 0.0 104.413 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.65 71.7 1.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.062 0.934 . . . . 0.0 110.25 173.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -169.82 123.2 0.74 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -76.11 128.5 35.1 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.869 1.267 . . . . 0.0 110.602 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.281 13.0 m-85 73.79 38.78 0.58 Allowed 'General case' 0 CA--C 1.578 2.055 0 C-N-CA 124.836 1.254 . . . . 0.0 110.689 -168.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.93 122.5 7.42 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.222 -0.924 . . . . 0.0 111.69 -169.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -33.58 82.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 1 C-N-CA 132.857 4.463 . . . . 0.0 115.246 -172.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 3.8 p -88.65 173.39 8.64 Favored 'General case' 0 N--CA 1.491 1.592 1 CA-C-N 107.471 -4.422 . . . . 0.0 113.8 -167.467 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -153.59 144.96 23.1 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.936 169.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -86.69 103.2 14.93 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 168.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.71 47.28 1.81 Allowed Glycine 0 CA--C 1.557 2.663 0 CA-C-N 114.526 -1.216 . . . . 0.0 112.733 -165.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.39 -141.4 3.48 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-O 123.29 1.494 . . . . 0.0 109.954 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.67 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -65.41 133.64 95.42 Favored Pre-proline 0 CA--C 1.577 1.985 0 CA-C-N 112.669 -1.765 . . . . 0.0 109.988 169.393 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -55.76 -35.37 93.35 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 N-CA-C 122.423 3.97 . . . . 0.0 122.423 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . 0.314 66.3 m 79.05 143.42 0.08 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 111.635 -2.53 . . . . 0.0 107.28 -163.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.47 -62.78 1.2 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -162.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -126.04 80.46 1.91 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.946 0.879 . . . . 0.0 109.089 -166.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.15 102.19 1.97 Allowed Glycine 0 N--CA 1.476 1.354 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.618 -176.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.54 165.94 18.95 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-O 123.588 1.661 . . . . 0.0 112.577 -169.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -156.88 -81.01 0.03 OUTLIER Glycine 0 N--CA 1.477 1.432 0 CA-C-O 124.31 2.061 . . . . 0.0 109.314 -169.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.415 19.9 t 79.34 50.79 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 109.202 -3.499 . . . . 0.0 115.166 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 76.9 mt -82.68 149.44 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 122.975 1.369 . . . . 0.0 107.421 167.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.419 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 69.3 m -93.14 171.25 9.06 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 -170.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.274 69.6 m -91.09 -147.14 0.2 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.348 1.459 . . . . 0.0 109.635 -174.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 mm -94.2 50.88 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 CA-C-O 122.859 1.314 . . . . 0.0 110.213 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.1 ttt -172.76 -52.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.865 1.266 . . . . 0.0 112.417 -169.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.39 50.3 2.41 Favored Glycine 0 CA--C 1.548 2.154 0 CA-C-N 118.741 0.701 . . . . 0.0 113.749 -168.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.4 p -151.94 -79.11 0.11 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.906 1.336 . . . . 0.0 109.136 -169.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.81 -26.87 68.82 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 121.214 3.783 . . . . 0.0 121.214 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.534 ' HB2' ' SG ' ' A' ' 12' ' ' CYS 0.376 6.7 m 37.27 -151.69 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 130.161 3.385 . . . . 0.0 117.714 172.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -175.75 133.57 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.1 m -89.73 95.47 10.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.193 -0.942 . . . . 0.0 109.246 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? . . . . . 0 CA--C 1.573 1.856 0 CA-C-O 116.763 -1.589 . . . . 0.0 112.027 -170.904 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.5 mttm . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.444 ' HA ' HG22 ' A' ' 17' ' ' THR . 25.6 p 49.21 170.03 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 118.61 2.819 . . . . 0.0 118.61 -169.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mm -102.41 108.45 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.76 72.89 2.29 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.347 1.07 . . . . 0.0 110.053 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -176.6 123.9 0.16 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 -171.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -75.22 127.95 34.35 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 168.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.27 12.1 m-85 74.78 30.09 1.02 Allowed 'General case' 0 CA--C 1.579 2.093 0 C-N-CA 124.903 1.281 . . . . 0.0 113.607 -169.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.96 131.27 10.59 Favored Glycine 0 N--CA 1.474 1.227 0 O-C-N 120.91 -1.119 . . . . 0.0 112.237 -169.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -55.47 82.21 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 130.324 3.45 . . . . 0.0 114.69 -167.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.521 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 22.3 p -90.41 173.15 8.26 Favored 'General case' 0 N--CA 1.494 1.751 1 CA-C-N 106.374 -4.921 . . . . 0.0 113.242 -168.654 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -150.66 128.85 11.94 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.507 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -77.16 111.13 12.44 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 170.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.54 33.9 5.73 Favored Glycine 0 CA--C 1.559 2.807 0 CA-C-N 114.826 -1.079 . . . . 0.0 114.531 -166.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.24 -139.99 3.63 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-O 123.449 1.583 . . . . 0.0 109.667 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -63.55 137.26 97.03 Favored Pre-proline 0 CA--C 1.573 1.864 0 CA-C-N 112.42 -1.89 . . . . 0.0 109.772 168.432 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -66.92 -172.91 0.35 Allowed 'Trans proline' 0 CA--C 1.57 2.313 0 CA-C-N 123.546 2.302 . . . . 0.0 110.834 167.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.9 m -101.84 149.16 24.47 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 167.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.71 -60.17 1.76 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.865 -173.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -137.24 87.3 2.26 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.944 1.297 . . . . 0.0 108.128 -169.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.78 116.2 4.15 Favored Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -169.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -138.24 176.23 8.88 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -167.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.37 109.23 2.84 Favored Glycine 0 N--CA 1.475 1.263 0 CA-C-N 112.367 -2.197 . . . . 0.0 109.039 -170.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.8 t -109.77 75.66 0.95 Allowed 'General case' 0 CA--C 1.56 1.327 0 CA-C-N 111.837 -2.182 . . . . 0.0 111.587 -169.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.401 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 36.4 mm -89.45 144.58 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 169.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 34' ' ' CYS 0.304 6.5 m -105.75 161.8 14.09 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 125.023 1.452 . . . . 0.0 113.002 177.045 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.642 ' HA ' ' H ' ' A' ' 31' ' ' GLY 0.823 2.9 t 81.74 -176.52 0.05 OUTLIER 'General case' 0 C--N 1.353 0.736 0 N-CA-C 120.605 3.557 . . . . 0.0 120.605 156.503 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.311 4.1 mp 70.83 64.08 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.586 2.331 0 CA-C-N 108.468 -3.969 . . . . 0.0 104.002 -158.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.272 0.0 OUTLIER 136.33 -58.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 128.582 2.753 . . . . 0.0 104.073 -162.488 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.642 ' H ' ' HA ' ' A' ' 28' ' ' SER . . . 62.34 47.65 88.08 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 120.208 2.843 . . . . 0.0 120.208 -169.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.299 22.7 p -98.66 102.79 14.63 Favored 'General case' 0 CA--C 1.553 1.059 1 N-CA-C 94.359 -6.163 . . . . 0.0 94.359 151.798 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.404 ' O ' ' SG ' ' A' ' 27' ' ' CYS 0.62 3.5 p-10 -87.82 70.89 9.59 Favored 'General case' 0 N--CA 1.439 -1.015 2 CA-C-N 105.29 -5.414 . . . . 0.0 122.177 -148.202 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 27' ' ' CYS 0.414 59.3 m 123.19 171.24 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 3 CA-C-N 101.572 -7.104 . . . . 0.0 113.402 160.774 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -150.01 143.17 25.0 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 112.032 -2.349 . . . . 0.0 106.46 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 12.8 m -89.8 86.35 6.64 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -167.994 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.6 tptt . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.585 ' HA ' HG22 ' A' ' 17' ' ' THR 0.284 22.0 p 41.93 -171.46 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 118.87 2.915 . . . . 0.0 118.87 173.054 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.415 HG13 ' SG ' ' A' ' 19' ' ' CYS . 4.5 mm -113.22 -62.81 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.546 0 CA-C-N 113.449 -1.705 . . . . 0.0 110.25 -164.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.254 . . 66.11 60.64 0.64 Allowed 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 125.278 1.431 . . . . 0.0 114.572 -169.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -169.75 131.44 1.09 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 173.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -68.14 136.07 53.11 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 125.264 1.425 . . . . 0.0 110.235 169.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 66.34 34.61 6.29 Favored 'General case' 0 CA--C 1.581 2.169 0 C-N-CA 124.257 1.023 . . . . 0.0 112.093 -167.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.65 132.16 10.87 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -169.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -73.52 73.77 1.43 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 126.971 3.272 . . . . 0.0 112.116 -167.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 24.3 p -71.02 174.8 5.77 Favored 'General case' 0 N--CA 1.486 1.35 1 CA-C-N 106.056 -5.066 . . . . 0.0 114.074 -176.177 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.985 ' H ' ' HG2' ' A' ' 18' ' ' PRO . 17.9 ptpt -129.2 159.1 37.11 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 123.42 1.581 . . . . 0.0 111.158 171.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 52.6 m0 -104.61 91.29 3.8 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 168.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.91 -81.11 0.06 OUTLIER Glycine 0 N--CA 1.478 1.442 0 N-CA-C 106.491 -2.644 . . . . 0.0 106.491 -166.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.86 135.87 2.02 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 125.154 2.53 . . . . 0.0 118.093 163.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.645 ' HB ' ' HD3' ' A' ' 18' ' ' PRO . 14.8 m 168.64 -65.12 0.0 OUTLIER Pre-proline 0 CA--C 1.59 2.493 1 CA-C-N 107.266 -4.467 . . . . 0.0 101.393 -168.146 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.985 ' HG2' ' H ' ' A' ' 13' ' ' LYS 1.105 0.6 OUTLIER -24.85 155.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.827 2 N-CA-C 135.587 9.033 . . . . 0.0 135.587 -156.146 . . . . . . . . 5 4 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.439 ' H ' ' HB3' ' A' ' 18' ' ' PRO 0.345 31.4 m -23.92 117.5 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.272 2 CA-C-N 105.167 -5.47 . . . . 0.0 114.873 -156.667 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.33 156.13 39.43 Favored 'General case' 0 C--N 1.297 -1.708 1 CA-C-N 106.378 -4.919 . . . . 0.0 109.373 -163.239 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 58.39 49.28 11.08 Favored 'General case' 0 CA--C 1.586 2.339 0 CA-C-N 112.989 -1.914 . . . . 0.0 113.768 -173.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.23 142.48 6.77 Favored Glycine 0 CA--C 1.556 2.642 0 N-CA-C 115.316 0.886 . . . . 0.0 115.316 -169.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.53 162.81 40.91 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -153.52 105.52 0.28 Allowed Glycine 0 N--CA 1.475 1.268 0 N-CA-C 105.751 -2.94 . . . . 0.0 105.751 164.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.87 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 54.0 t -99.07 125.09 44.51 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 110.787 -2.707 . . . . 0.0 109.568 -174.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.537 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 23.6 mm -117.27 134.07 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 166.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.576 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 68.2 m -121.56 173.25 7.53 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -172.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 p -120.05 135.42 54.94 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 125.072 1.349 . . . . 0.0 111.085 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.296 9.6 mt -5.61 56.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.39 2 CA-C-N 108.264 -4.062 . . . . 0.0 116.571 -168.659 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.8 tpt 172.57 -56.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 113.076 -1.875 . . . . 0.0 113.765 -167.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.36 53.0 1.64 Allowed Glycine 0 CA--C 1.552 2.362 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -163.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 99.6 m -150.77 -69.8 0.18 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 123.124 1.44 . . . . 0.0 111.665 -167.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.283 9.6 m-80 -71.23 30.16 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 118.466 2.765 . . . . 0.0 118.466 169.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.87 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 17.7 t -76.47 -156.79 0.07 Allowed 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 112.496 -2.138 . . . . 0.0 115.061 -166.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.08 147.62 4.74 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 113.658 -1.61 . . . . 0.0 110.666 168.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 20.2 m -100.16 95.89 7.12 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt . . . . . 0 CA--C 1.576 1.969 0 CA-C-O 117.54 -1.219 . . . . 0.0 112.555 -169.195 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.7 tttt . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.2 p 54.41 170.75 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.526 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 31.7 mm -99.47 103.96 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 175.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.46 66.26 1.99 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.234 1.016 . . . . 0.0 112.456 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -174.89 119.83 0.21 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -170.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -75.18 129.38 37.41 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.908 1.283 . . . . 0.0 108.535 169.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 72.47 44.13 0.43 Allowed 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -166.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.498 ' N ' ' H ' ' A' ' 36' ' ' CYS . . . -81.49 -148.03 6.13 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-O 117.428 -1.762 . . . . 0.0 111.416 -173.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -144.75 75.92 1.47 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -175.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.2 p -97.76 -175.44 3.17 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 112.737 -2.029 . . . . 0.0 113.563 -168.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -153.5 160.63 42.58 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.227 -1.352 . . . . 0.0 110.065 166.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -95.9 108.01 20.34 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 169.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.62 38.83 2.0 Allowed Glycine 0 CA--C 1.558 2.764 0 CA-C-N 113.896 -1.502 . . . . 0.0 113.312 -166.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.03 -140.17 3.86 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 123.637 1.687 . . . . 0.0 110.05 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.599 HG23 ' H ' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -62.3 166.13 7.45 Favored Pre-proline 0 CA--C 1.596 2.748 0 CA-C-N 112.052 -2.074 . . . . 0.0 113.0 168.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -62.39 -30.96 81.18 Favored 'Trans proline' 0 CA--C 1.568 2.222 0 N-CA-C 122.401 3.962 . . . . 0.0 122.401 169.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.599 ' H ' HG23 ' A' ' 17' ' ' THR 0.323 6.2 t 78.54 139.64 0.07 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 111.649 -2.523 . . . . 0.0 107.138 -162.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.74 -64.28 1.16 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -164.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . 0.29 40.8 mtm105 -92.11 -130.37 0.11 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.811 1.291 . . . . 0.0 109.116 -168.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.65 94.93 0.25 Allowed Glycine 0 N--CA 1.486 1.994 0 CA-C-N 112.799 -2.0 . . . . 0.0 111.048 169.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -106.47 169.05 8.75 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 123.948 1.832 . . . . 0.0 115.646 -165.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.28 103.62 0.21 Allowed Glycine 0 N--CA 1.471 0.988 0 N-CA-C 105.484 -3.046 . . . . 0.0 105.484 169.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.7 t -88.33 77.33 8.2 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 111.006 -2.597 . . . . 0.0 111.631 -169.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.1 mm -82.36 144.99 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 168.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 32' ' ' THR . 3.1 t -110.58 -176.09 2.89 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -176.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.315 42.5 m -101.97 -142.18 0.35 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.849 1.66 . . . . 0.0 109.195 -169.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.4 mm -72.87 -5.82 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -174.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.0 mmt -141.49 -24.63 0.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.431 ' HA2' ' SG ' ' A' ' 27' ' ' CYS . . . 91.3 58.05 1.5 Allowed Glycine 0 CA--C 1.551 2.283 0 CA-C-N 121.084 1.766 . . . . 0.0 110.929 -166.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.439 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 17.7 p -149.06 -74.93 0.17 Allowed 'General case' 0 CA--C 1.563 1.451 0 CA-C-O 124.2 1.952 . . . . 0.0 111.832 -168.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.358 33.5 m-20 -88.24 40.76 0.97 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 130.381 3.472 . . . . 0.0 115.303 -174.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -64.06 -167.47 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 112.328 -2.215 . . . . 0.0 115.518 -166.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -136.73 150.48 48.44 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.375 -0.828 . . . . 0.0 110.856 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.498 ' H ' ' N ' ' A' ' 10' ' ' GLY . 13.2 m -87.13 52.32 2.48 Favored 'General case' 0 N--CA 1.52 3.074 0 CA-C-O 123.96 1.838 . . . . 0.0 112.364 169.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.428 0.1 OUTLIER . . . . . 0 CA--C 1.557 1.248 0 C-N-CA 127.178 2.191 . . . . 0.0 115.134 169.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.823 0.344 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.468 ' HA ' HG22 ' A' ' 17' ' ' THR . 11.5 p 54.75 -178.15 0.03 OUTLIER 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 173.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.521 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 6.1 mm -133.47 114.09 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 -171.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.6 65.84 4.41 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.01 0.91 . . . . 0.0 112.003 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -163.18 122.67 2.16 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.4 127.25 31.55 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.534 0.734 . . . . 0.0 110.617 167.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 69.59 39.68 1.51 Allowed 'General case' 0 CA--C 1.576 1.968 0 C-N-CA 123.546 0.739 . . . . 0.0 111.831 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.56 126.3 7.33 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -78.83 70.92 5.25 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 127.048 3.308 . . . . 0.0 111.823 -166.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.1 p -74.43 -167.18 0.51 Allowed 'General case' 0 CA--C 1.562 1.404 1 CA-C-N 106.288 -4.96 . . . . 0.0 113.782 -167.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 34' ' ' CYS 0.389 0.1 OUTLIER 105.68 90.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 127.49 2.316 . . . . 0.0 106.841 173.851 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.494 ' NE1' HD11 ' A' ' 5' ' ' ILE 0.341 69.7 m95 -107.61 -140.42 0.37 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 110.502 -3.045 . . . . 0.0 102.963 -169.445 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.13 43.61 3.15 Favored Glycine 1 CA--C 1.585 4.433 0 N-CA-C 105.836 -2.906 . . . . 0.0 105.836 149.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.87 136.58 0.0 OUTLIER Glycine 0 CA--C 1.557 2.677 0 C-N-CA 126.926 2.203 . . . . 0.0 114.027 -162.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 4' ' ' CYS . 2.5 m -134.66 134.96 22.65 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 170.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -48.44 -37.13 32.55 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 N-CA-C 119.999 3.038 . . . . 0.0 119.999 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.521 ' SG ' ' HB ' ' A' ' 5' ' ' ILE 0.258 16.6 t 74.32 141.4 0.07 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.997 -1.91 . . . . 0.0 106.982 -164.166 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 160.15 19.12 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 113.219 -1.81 . . . . 0.0 112.859 -165.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.6 mtt85 63.81 62.99 0.86 Allowed 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 112.795 -2.002 . . . . 0.0 113.177 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.44 68.81 1.52 Allowed Glycine 0 CA--C 1.545 1.911 0 N-CA-C 115.911 1.125 . . . . 0.0 115.911 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.28 161.41 42.09 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-O 123.222 1.487 . . . . 0.0 112.353 -172.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.86 118.68 1.27 Allowed Glycine 0 N--CA 1.478 1.47 1 N-CA-C 102.935 -4.066 . . . . 0.0 102.935 166.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.616 9.1 t -45.38 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 125.441 1.318 . . . . 0.0 113.857 -166.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.275 60.6 mt 74.13 150.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 123.286 1.517 . . . . 0.0 110.855 172.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 90.6 m -90.64 171.09 9.62 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 119.454 3.131 . . . . 0.0 119.454 -169.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.336 13.3 m -94.79 -142.85 0.25 Allowed 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 126.706 2.002 . . . . 0.0 108.928 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.25 1.9 pp -96.74 59.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 123.132 1.444 . . . . 0.0 111.32 168.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.9 ttt -161.52 -46.27 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.608 -1.633 . . . . 0.0 113.01 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.41 38.25 11.16 Favored Glycine 0 CA--C 1.556 2.638 0 CA-C-O 119.336 -0.702 . . . . 0.0 113.434 -165.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 m -162.28 -59.84 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 123.762 1.744 . . . . 0.0 111.465 -167.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.374 26.0 m-20 -79.11 45.87 0.66 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 129.781 3.232 . . . . 0.0 114.932 171.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 13' ' ' LYS 0.267 36.3 m -69.54 -167.14 0.12 Allowed 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.415 -167.517 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -163.15 138.11 6.48 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 119.709 -1.869 . . . . 0.0 108.812 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.9 m -51.69 -47.84 63.73 Favored 'General case' 0 N--CA 1.512 2.652 0 CA-C-O 125.557 2.599 . . . . 0.0 117.861 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.391 23.0 mtmm . . . . . 0 CA--C 1.578 2.027 1 CA-C-N 105.727 -5.215 . . . . 0.0 109.57 -165.13 . . . . . . . . 2 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.1 tptm . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.441 ' HA ' HG22 ' A' ' 17' ' ' THR . 13.6 p 50.59 178.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 119.04 2.978 . . . . 0.0 119.04 173.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mt -134.32 119.01 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 -170.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.284 . . -77.38 10.87 2.24 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 119.274 3.065 . . . . 0.0 119.274 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.932 30.7 mtmm 92.39 -136.53 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 1 N-CA-C 124.527 5.01 . . . . 0.0 124.527 161.166 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.442 0.0 OUTLIER 6.3 83.37 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 1 CA-C-N 108.215 -4.084 . . . . 0.0 116.934 -149.461 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.316 29.7 m-85 80.79 62.78 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 -163.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.26 -167.95 0.7 Allowed Glycine 0 CA--C 1.568 3.384 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 168.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -144.66 72.86 1.35 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 121.06 2.43 . . . . 0.0 104.636 -176.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.859 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 28.9 p -88.98 174.03 8.14 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 112.304 -2.225 . . . . 0.0 114.0 -165.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -166.42 126.93 1.67 Allowed 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 103.114 -2.921 . . . . 0.0 103.114 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -79.5 99.78 7.41 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 172.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.73 38.51 1.06 Allowed Glycine 0 CA--C 1.569 3.421 0 CA-C-N 112.393 -2.185 . . . . 0.0 111.525 -163.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -162.44 -149.18 5.59 Favored Glycine 0 N--CA 1.48 1.633 0 C-N-CA 125.376 1.465 . . . . 0.0 109.819 -170.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -69.18 128.52 92.52 Favored Pre-proline 0 N--CA 1.501 2.088 0 CA-C-O 118.189 -0.91 . . . . 0.0 109.321 169.913 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -63.01 -38.77 44.24 Favored 'Trans proline' 0 N--CA 1.495 1.575 1 N-CA-C 123.207 4.272 . . . . 0.0 123.207 -171.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . 0.331 71.6 m 90.93 144.44 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.451 0 CA-C-N 111.166 -2.743 . . . . 0.0 105.015 -160.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . 0.255 0.1 OUTLIER -85.51 -66.94 0.84 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 119.439 3.126 . . . . 0.0 119.439 -161.901 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -109.09 67.16 0.65 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -166.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.83 92.92 0.27 Allowed Glycine 0 N--CA 1.49 2.234 0 CA-C-O 119.423 -0.654 . . . . 0.0 112.346 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.59 165.09 11.79 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 -166.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.87 106.27 0.32 Allowed Glycine 0 N--CA 1.471 0.995 0 N-CA-C 106.743 -2.543 . . . . 0.0 106.743 166.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 25.4 t -99.53 94.24 6.29 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 110.032 -3.084 . . . . 0.0 110.676 -173.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.502 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 29.6 mm -92.09 139.28 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 167.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.419 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 79.2 m -117.49 -176.85 3.1 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 -167.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.0 t -145.49 163.85 33.41 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 125.699 2.666 . . . . 0.0 107.689 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.345 7.6 mt 36.71 52.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 1 CA-C-N 108.275 -4.057 . . . . 0.0 114.415 179.684 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.6 tpt 72.61 44.48 0.39 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 125.441 1.496 . . . . 0.0 114.547 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.71 65.06 2.61 Favored Glycine 0 N--CA 1.491 2.346 0 O-C-N 120.321 -1.487 . . . . 0.0 113.074 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.8 p -146.05 -81.51 0.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 124.011 1.862 . . . . 0.0 110.932 -166.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.335 9.1 m120 -70.73 35.75 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 131.093 3.757 . . . . 0.0 118.119 172.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.859 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 7.2 t -71.5 -176.7 1.62 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 124.439 2.066 . . . . 0.0 114.326 -167.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -144.45 153.93 42.42 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 111.22 -2.718 . . . . 0.0 109.828 170.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.595 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 36.2 m -104.26 90.05 3.44 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 171.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp . . . . . 0 CA--C 1.568 1.653 0 CA-C-O 117.657 -1.163 . . . . 0.0 111.482 -169.752 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.25 95.5 mttt . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.64 ' HA ' HG22 ' A' ' 17' ' ' THR 0.318 30.0 p -28.74 -179.11 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.032 1 N-CA-C 125.172 5.249 . . . . 0.0 125.172 177.427 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.8 mm -99.24 110.23 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.54 67.16 2.4 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.242 1.02 . . . . 0.0 111.363 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -166.4 123.19 1.31 Allowed 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -70.25 130.41 41.95 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 167.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.257 0.0 OUTLIER 69.6 46.81 0.69 Allowed 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 122.964 1.364 . . . . 0.0 109.061 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -84.32 -152.59 15.73 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 113.615 -1.629 . . . . 0.0 109.802 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -142.21 75.64 1.5 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 -175.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 28.5 p -91.03 -171.66 3.07 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 112.641 -2.072 . . . . 0.0 112.525 -169.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -153.37 141.91 20.81 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.811 169.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -93.15 99.01 11.67 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.15 -62.98 0.52 Allowed Glycine 0 N--CA 1.484 1.867 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.782 -164.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.41 -142.67 0.3 Allowed Glycine 0 CA--C 1.539 1.587 0 CA-C-N 112.083 -2.058 . . . . 0.0 113.368 167.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -61.56 138.04 94.95 Favored Pre-proline 0 N--CA 1.495 1.821 0 CA-C-N 113.484 -1.358 . . . . 0.0 111.889 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -64.55 -131.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.573 2.429 0 C-N-CA 123.426 2.751 . . . . 0.0 112.34 169.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.3 t -148.81 146.81 28.17 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 164.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.29 -63.15 1.39 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 121.507 3.891 . . . . 0.0 121.507 -162.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.412 ' HE ' HH12 ' A' ' 23' ' ' ARG . 75.8 mtm180 -94.86 70.1 3.38 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.289 1.042 . . . . 0.0 112.715 -164.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.64 62.58 4.92 Favored Glycine 0 N--CA 1.486 2.004 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.925 -176.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.412 HH12 ' HE ' ' A' ' 21' ' ' ARG . 68.8 mtt180 -136.48 163.63 30.06 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 123.963 1.84 . . . . 0.0 112.222 -167.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.87 121.11 2.16 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 106.095 -2.802 . . . . 0.0 106.095 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.664 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 2.9 t -75.44 89.33 2.66 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 109.214 -3.493 . . . . 0.0 110.642 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.456 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 37.5 mm -81.5 136.41 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 122.852 1.311 . . . . 0.0 107.655 172.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.4 m -119.07 -179.0 3.7 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 111.925 -2.398 . . . . 0.0 114.985 -169.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.291 69.6 m -90.78 -144.85 0.18 Allowed 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.942 1.297 . . . . 0.0 109.844 -172.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.4 mm -71.34 -0.63 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.578 2.024 0 N-CA-C 117.596 2.443 . . . . 0.0 117.596 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.9 tpt -148.63 -31.36 0.26 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -172.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.81 61.14 1.11 Allowed Glycine 0 N--CA 1.488 2.119 0 CA-C-N 120.796 1.634 . . . . 0.0 111.671 -167.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.3 p -151.22 -78.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 123.849 1.785 . . . . 0.0 111.25 -167.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.336 37.2 m-80 -71.58 34.91 0.06 Allowed 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 129.953 3.301 . . . . 0.0 118.006 170.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 45.9 t -74.48 -168.52 0.69 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 112.259 -2.246 . . . . 0.0 113.495 -168.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -148.45 162.54 39.38 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 112.837 -1.983 . . . . 0.0 112.142 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.463 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 87.9 m -83.54 56.92 3.79 Favored 'General case' 0 N--CA 1.523 3.183 0 CA-C-O 124.75 2.214 . . . . 0.0 108.847 163.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.477 1.6 ptmm? . . . . . 0 CA--C 1.558 1.253 1 N-CA-C 125.424 5.342 . . . . 0.0 125.424 -163.648 . . . . . . . . 2 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.8 tttm . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.976 0.417 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.488 ' HA ' HG22 ' A' ' 17' ' ' THR . 14.6 p 51.54 171.17 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 118.249 2.685 . . . . 0.0 118.249 -169.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.708 HG22 ' HG3' ' A' ' 7' ' ' LYS . 5.0 mt -121.78 121.41 64.25 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -172.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.55 52.22 1.1 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 116.963 2.209 . . . . 0.0 116.963 -173.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.708 ' HG3' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -122.89 -179.62 4.32 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 127.079 2.152 . . . . 0.0 110.119 175.303 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -115.0 136.43 53.14 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.277 -1.783 . . . . 0.0 106.545 157.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 71.66 35.83 1.35 Allowed 'General case' 0 CA--C 1.58 2.118 0 CA-C-N 122.451 2.387 . . . . 0.0 111.987 168.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.78 125.96 6.62 Favored Glycine 0 N--CA 1.464 0.543 0 O-C-N 120.548 -1.345 . . . . 0.0 112.949 -168.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.413 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 11.4 mpt_? -3.9 79.37 0.0 OUTLIER 'General case' 0 C--O 1.236 0.361 1 C-N-CA 132.378 4.271 . . . . 0.0 116.912 169.292 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.981 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 15.5 p -94.05 -178.46 4.64 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 108.461 -3.972 . . . . 0.0 112.515 -173.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.35 153.96 31.29 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.255 1.026 . . . . 0.0 109.551 167.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -82.96 117.51 22.83 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.136 -173.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.21 39.64 18.7 Favored Glycine 0 CA--C 1.555 2.561 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -167.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.43 -146.87 9.33 Favored Glycine 0 N--CA 1.477 1.393 0 CA-C-O 123.198 1.444 . . . . 0.0 112.822 -174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -64.17 131.83 95.12 Favored Pre-proline 0 CA--C 1.573 1.864 0 CA-C-N 112.586 -1.807 . . . . 0.0 108.469 168.601 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -47.97 -36.3 27.17 Favored 'Trans proline' 0 N--CA 1.498 1.74 1 N-CA-C 122.595 4.036 . . . . 0.0 122.595 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.4 m 83.48 131.8 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 111.072 -2.785 . . . . 0.0 106.53 -165.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -56.74 3.33 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.944 -168.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -124.62 72.46 1.21 Allowed 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 124.713 1.205 . . . . 0.0 109.752 -170.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.5 73.58 0.51 Allowed Glycine 0 N--CA 1.482 1.735 0 C-N-CA 123.776 0.703 . . . . 0.0 113.107 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -90.23 174.07 7.8 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 170.73 -96.29 0.11 Allowed Glycine 0 N--CA 1.478 1.444 0 CA-C-O 123.732 1.74 . . . . 0.0 109.545 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.667 ' SG ' ' SG ' ' A' ' 34' ' ' CYS 0.39 5.7 t 93.95 94.32 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 109.536 -3.332 . . . . 0.0 110.648 173.549 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.619 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 31.0 mm -119.92 141.31 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 166.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.631 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 12.5 m -136.88 144.92 43.79 Favored 'General case' 0 CA--C 1.58 2.129 1 N-CA-C 123.461 4.615 . . . . 0.0 123.461 -168.878 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.539 10.2 p 61.11 -84.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 163.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.305 2.1 mp -38.83 -40.09 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.664 0 CA-C-N 108.969 -3.742 . . . . 0.0 116.438 168.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 37.3 ttp -143.49 -24.9 0.58 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.351 -1.75 . . . . 0.0 113.154 166.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 27' ' ' CYS . . . -43.08 -47.91 6.46 Favored Glycine 0 CA--C 1.558 2.724 0 CA-C-O 125.919 2.955 . . . . 0.0 118.451 164.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.776 0.4 OUTLIER 64.86 100.16 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.888 1 CA-C-N 107.42 -4.39 . . . . 0.0 111.552 -169.507 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.811 0.6 OUTLIER 20.37 55.6 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.928 0 CA-C-N 108.802 -3.817 . . . . 0.0 118.445 -155.427 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.981 ' SG ' ' SG ' ' A' ' 12' ' ' CYS 0.409 0.1 OUTLIER 46.99 173.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 1 CA-C-N 106.528 -4.851 . . . . 0.0 119.573 -168.165 . . . . . . . . 5 4 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -158.67 141.67 14.65 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 109.975 -3.284 . . . . 0.0 108.642 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 90.4 m -83.41 81.55 8.67 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 120.885 1.675 . . . . 0.0 107.387 169.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.084 -1.436 . . . . 0.0 109.592 -169.166 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.584 ' HA ' HG22 ' A' ' 17' ' ' THR 0.302 27.8 p -46.83 -174.43 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.997 1 N-CA-C 122.355 4.205 . . . . 0.0 122.355 -177.006 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.505 HG13 ' SG ' ' A' ' 36' ' ' CYS . 24.5 mm -70.79 -49.88 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 C-N-CA 127.533 2.333 . . . . 0.0 111.342 173.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.284 . . 68.71 52.67 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 126.114 1.765 . . . . 0.0 114.215 -171.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -178.66 125.66 0.1 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -176.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -73.49 118.32 16.31 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 166.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.356 0.0 OUTLIER 75.86 80.44 0.1 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 176.614 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.609 ' H ' ' H ' ' A' ' 36' ' ' CYS . . . -172.66 120.31 0.81 Allowed Glycine 0 N--CA 1.471 1.007 0 CA-C-N 109.323 -3.58 . . . . 0.0 115.364 -165.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . 0.35 20.6 tpt85 1.08 70.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 131.116 3.767 . . . . 0.0 119.26 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.7 p -88.97 170.33 10.77 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 110.04 -3.255 . . . . 0.0 112.647 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -140.62 154.85 46.61 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.566 171.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -97.51 95.12 7.42 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 105.485 -2.042 . . . . 0.0 105.485 170.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.83 54.76 0.91 Allowed Glycine 0 CA--C 1.552 2.359 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.979 -167.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.04 -142.81 3.5 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-O 123.214 1.452 . . . . 0.0 110.172 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -58.46 143.9 79.71 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-N 112.777 -1.711 . . . . 0.0 111.167 168.94 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.06 -132.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.572 2.416 0 C-N-CA 123.0 2.466 . . . . 0.0 110.818 167.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.6 m -152.82 142.31 21.74 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 166.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.41 -55.88 3.69 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 113.349 -1.751 . . . . 0.0 113.545 -168.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -132.44 82.12 1.99 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.835 1.254 . . . . 0.0 109.025 -169.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.82 110.47 3.36 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -133.04 175.88 8.98 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.818 1.785 . . . . 0.0 115.818 -167.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.02 -81.53 0.13 Allowed Glycine 0 N--CA 1.474 1.188 0 CA-C-N 112.331 -2.213 . . . . 0.0 109.554 -168.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.317 16.4 t 79.81 102.13 0.06 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 109.739 -3.231 . . . . 0.0 109.343 -170.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.2 mm -131.54 152.25 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 169.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 34' ' ' CYS 0.347 85.5 m -77.54 150.95 34.73 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 176.18 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.319 41.1 m -152.9 176.03 12.28 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 126.161 1.784 . . . . 0.0 109.229 -165.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.328 3.9 mp 38.04 63.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 C-N-CA 126.476 1.91 . . . . 0.0 112.257 -173.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.285 16.2 mmt 91.07 -6.84 0.27 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 126.141 1.777 . . . . 0.0 115.044 -169.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.37 58.85 3.23 Favored Glycine 0 CA--C 1.557 2.664 0 CA-C-N 122.772 2.533 . . . . 0.0 109.059 -165.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.3 m -151.57 -52.17 0.12 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 124.657 1.183 . . . . 0.0 112.673 -163.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -61.28 -77.1 0.05 OUTLIER 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 124.806 2.241 . . . . 0.0 111.935 169.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 27' ' ' CYS 0.272 2.4 m 79.65 167.23 0.18 Allowed 'General case' 0 CA--C 1.557 1.228 1 CA-C-N 107.337 -4.483 . . . . 0.0 110.094 -167.829 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -160.91 153.3 20.45 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.99 1.316 . . . . 0.0 107.616 -170.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.609 ' H ' ' H ' ' A' ' 10' ' ' GLY . 87.6 m -67.94 67.41 0.11 Allowed 'General case' 0 N--CA 1.508 2.448 0 CA-C-O 124.652 2.167 . . . . 0.0 114.696 171.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.446 34.8 ttmt . . . . . 0 CA--C 1.572 1.797 1 N-CA-C 123.244 4.535 . . . . 0.0 123.244 -169.511 . . . . . . . . 2 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt . . . . . 0 CA--C 1.552 1.039 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.338 65.7 pttt 54.34 86.95 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 171.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.0 tttm 66.2 89.26 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.673 1.189 . . . . 0.0 110.959 -171.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HA ' HG22 ' A' ' 17' ' ' THR 0.274 21.6 p 52.41 167.94 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 -174.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.8 mm -85.42 -62.17 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.673 0 C-N-CA 125.302 1.441 . . . . 0.0 110.852 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.268 . . 72.19 61.6 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 125.591 1.556 . . . . 0.0 114.051 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -179.5 131.71 0.11 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.4 128.34 35.47 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 166.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 72.58 39.83 0.68 Allowed 'General case' 0 CA--C 1.579 2.09 0 C-N-CA 124.284 1.033 . . . . 0.0 111.745 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.68 134.41 12.31 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -76.89 72.62 3.48 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 126.909 3.242 . . . . 0.0 112.869 -165.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 13.7 p -73.59 -177.72 2.81 Favored 'General case' 0 N--CA 1.489 1.501 1 CA-C-N 106.379 -4.918 . . . . 0.0 114.253 -172.316 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -152.64 154.5 35.46 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.425 1.107 . . . . 0.0 110.055 166.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -90.89 109.19 20.4 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 169.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.02 39.15 2.54 Favored Glycine 0 CA--C 1.558 2.768 0 CA-C-N 114.238 -1.346 . . . . 0.0 113.449 -166.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.81 -139.64 3.11 Favored Glycine 0 N--CA 1.473 1.149 0 CA-C-O 123.838 1.799 . . . . 0.0 109.544 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -70.07 143.11 91.07 Favored Pre-proline 0 CA--C 1.578 2.046 0 CA-C-N 111.823 -2.189 . . . . 0.0 108.9 166.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.69 -127.86 0.0 OUTLIER 'Trans proline' 0 CA--C 1.567 2.159 0 C-N-CA 123.378 2.719 . . . . 0.0 111.805 171.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.4 m -149.44 142.95 25.37 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 165.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -64.45 1.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.925 -169.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -139.77 93.71 2.69 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -173.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.77 100.07 2.56 Favored Glycine 0 N--CA 1.478 1.486 0 N-CA-C 105.938 -2.865 . . . . 0.0 105.938 -167.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -134.13 170.78 15.16 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 123.479 1.609 . . . . 0.0 114.922 -169.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.18 -81.44 0.16 Allowed Glycine 0 N--CA 1.476 1.366 0 CA-C-O 124.673 2.263 . . . . 0.0 110.099 -168.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.491 9.5 t 68.71 44.39 1.17 Allowed 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 109.008 -3.596 . . . . 0.0 116.708 -170.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 66.1 mt -78.36 143.23 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 166.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 97.1 m -92.31 172.95 8.07 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.9 p -79.4 -150.43 0.06 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 114.009 -1.451 . . . . 0.0 110.844 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.3 2.0 pp -98.65 56.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 122.934 1.35 . . . . 0.0 111.76 168.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.317 0.0 OUTLIER -168.64 -40.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.807 1.643 . . . . 0.0 112.839 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.07 50.87 3.53 Favored Glycine 0 N--CA 1.489 2.216 0 CA-C-N 120.476 1.489 . . . . 0.0 114.442 -170.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.0 p -157.93 -72.17 0.09 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 124.444 2.069 . . . . 0.0 111.305 -168.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.32 16.9 m-80 -70.31 39.43 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 131.127 3.771 . . . . 0.0 117.677 169.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 13.6 m -68.28 -157.4 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 112.873 -1.967 . . . . 0.0 113.459 -170.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -156.65 144.06 19.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 119.913 -1.742 . . . . 0.0 109.116 174.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 16.8 m -96.84 89.71 4.98 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -47.49 153.7 0.97 Allowed Pre-proline 0 CA--C 1.569 1.684 0 N-CA-C 117.236 2.309 . . . . 0.0 117.236 -166.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.22 109.89 2.96 Favored 'Trans proline' 0 CA--C 1.564 2.022 0 C-N-CA 122.126 1.884 . . . . 0.0 113.954 -164.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -163.02 109.77 1.19 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 118.594 0.634 . . . . 0.0 111.098 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.275 52.0 tp -103.8 -67.72 0.88 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 123.921 1.819 . . . . 0.0 113.659 171.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.315 30.1 pt -81.88 24.67 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-N 110.98 -2.827 . . . . 0.0 116.125 167.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.4 mtt -136.56 21.82 3.14 Favored 'General case' 0 CA--C 1.581 2.151 0 C-N-CA 125.741 1.616 . . . . 0.0 111.906 166.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.505 ' HG2' ' H ' ' A' ' 44' ' ' GLY 0.475 22.2 tt0 -108.84 -102.45 0.37 Allowed 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 -173.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.505 ' H ' ' HG2' ' A' ' 43' ' ' GLU . . . -99.91 -5.55 54.92 Favored Glycine 0 CA--C 1.554 2.483 0 N-CA-C 117.837 1.895 . . . . 0.0 117.837 169.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.1 mt -94.76 -69.34 0.76 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 120.555 2.178 . . . . 0.0 110.86 -173.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.26 -67.36 0.39 Allowed Glycine 0 N--CA 1.482 1.725 0 CA-C-N 119.243 0.928 . . . . 0.0 113.487 -177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -110.0 -59.83 1.88 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.196 0.998 . . . . 0.0 112.675 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 123.916 1.817 . . . . 0.0 110.654 -170.626 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt . . . . . 0 CA--C 1.552 1.028 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -76.13 -58.15 3.45 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.559 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.351 63.1 pttt 53.05 72.71 0.4 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 172.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.431 ' HA ' HG22 ' A' ' 17' ' ' THR . 17.9 p 50.36 172.08 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mt -101.56 -63.62 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 C-N-CA 125.252 1.421 . . . . 0.0 110.74 -170.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.3 . . 78.65 60.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.707 1.603 . . . . 0.0 112.65 -169.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -160.16 122.73 3.36 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -73.02 123.15 22.95 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.915 1.286 . . . . 0.0 107.915 168.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.282 23.5 m-85 76.14 36.86 0.39 Allowed 'General case' 0 CA--C 1.581 2.139 0 C-N-CA 124.174 0.99 . . . . 0.0 111.18 -167.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.09 129.07 8.79 Favored Glycine 0 N--CA 1.479 1.511 0 O-C-N 121.12 -0.988 . . . . 0.0 111.138 -174.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.7 tpt85 -75.9 77.0 2.8 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-O 126.588 3.089 . . . . 0.0 109.633 -168.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.817 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -73.93 -179.7 3.86 Favored 'General case' 0 N--CA 1.489 1.482 1 CA-C-N 106.821 -4.718 . . . . 0.0 110.544 -169.012 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -142.37 159.74 41.64 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 114.066 -1.424 . . . . 0.0 108.085 163.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -100.23 97.8 8.55 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.51 46.34 0.92 Allowed Glycine 0 CA--C 1.555 2.543 0 CA-C-N 114.245 -1.343 . . . . 0.0 113.296 -167.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.6 -142.36 3.45 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-O 123.443 1.579 . . . . 0.0 110.349 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.431 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -68.61 142.82 94.49 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-N 112.38 -1.91 . . . . 0.0 109.263 167.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD2' HG22 ' A' ' 17' ' ' THR . 22.3 Cg_endo -68.23 -127.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.57 2.304 0 C-N-CA 123.063 2.508 . . . . 0.0 109.57 168.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.8 m -154.01 151.07 28.94 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 163.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.67 -60.35 1.72 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 114.044 -1.434 . . . . 0.0 111.874 -168.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -121.45 81.14 1.76 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -169.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.09 99.78 2.57 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -172.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -142.72 176.18 9.25 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 123.72 1.724 . . . . 0.0 114.573 -168.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.71 94.62 1.54 Allowed Glycine 0 N--CA 1.477 1.433 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -167.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.931 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 5.8 t -86.96 121.62 29.68 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 110.089 -3.055 . . . . 0.0 111.326 -168.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.507 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 15.6 mm -112.53 136.05 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 166.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.1 m -109.03 -171.84 1.93 Allowed 'General case' 0 CA--C 1.559 1.319 0 CA-C-N 112.73 -2.032 . . . . 0.0 113.912 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 t -115.99 -126.36 0.29 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.918 1.342 . . . . 0.0 110.0 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.2 mm -71.82 -3.34 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 119.079 2.992 . . . . 0.0 119.079 -168.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 20.4 ptp -156.32 -13.0 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.39 -15.37 50.21 Favored Glycine 0 CA--C 1.556 2.636 0 CA-C-N 121.431 1.923 . . . . 0.0 114.83 -165.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.4 p -89.13 -146.59 0.16 Allowed 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 166.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 41.62 36.69 0.61 Allowed 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 169.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.931 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 2.0 t -99.2 -171.34 2.06 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 110.913 -2.858 . . . . 0.0 114.601 -161.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -159.6 148.52 17.86 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 112.22 -2.264 . . . . 0.0 110.56 172.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 13.9 m -103.77 91.57 4.06 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -50.52 141.16 17.37 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -169.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -58.18 167.01 5.0 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.181 2.587 . . . . 0.0 117.037 -165.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 161.91 28.49 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.371 1.1 pp -63.22 -18.08 63.14 Favored 'General case' 0 N--CA 1.501 2.102 1 N-CA-C 122.41 4.226 . . . . 0.0 122.41 -169.844 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.2 mm -99.62 48.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-N 114.119 -1.401 . . . . 0.0 109.357 167.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 ttt -169.58 -30.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 126.588 1.955 . . . . 0.0 112.364 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.522 ' HG2' ' H ' ' A' ' 44' ' ' GLY 0.506 38.6 tt0 -80.39 -117.87 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 128.113 2.565 . . . . 0.0 107.571 -177.093 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.522 ' H ' ' HG2' ' A' ' 43' ' ' GLU . . . -89.64 65.34 3.04 Favored Glycine 0 CA--C 1.544 1.853 0 C-N-CA 124.311 0.958 . . . . 0.0 113.012 169.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -71.43 -42.37 68.33 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 116.129 1.899 . . . . 0.0 116.129 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.29 88.3 0.15 Allowed Glycine 0 N--CA 1.478 1.453 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.3 mt -101.12 -61.86 1.32 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.495 0.718 . . . . 0.0 111.014 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 123.883 1.801 . . . . 0.0 112.792 -179.842 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 CA--C 1.554 1.118 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.434 58.7 pttt 48.03 -159.03 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 117.739 2.496 . . . . 0.0 117.739 173.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.43 89.15 2.56 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.479 ' HA ' HG22 ' A' ' 17' ' ' THR 0.308 8.3 p 57.73 169.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 117.411 2.375 . . . . 0.0 117.411 -177.178 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.592 HG13 ' SG ' ' A' ' 19' ' ' CYS . 32.0 mm -96.6 -64.1 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 124.379 1.072 . . . . 0.0 110.234 -169.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.08 59.04 1.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -173.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -175.88 123.66 0.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -77.42 116.51 18.07 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.474 1.11 . . . . 0.0 109.552 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.309 10.1 m-85 75.71 48.19 0.09 Allowed 'General case' 0 CA--C 1.57 1.737 0 C-N-CA 124.897 1.279 . . . . 0.0 108.084 -167.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.47 -149.77 3.06 Favored Glycine 0 C--N 1.356 1.666 0 CA-C-O 118.472 -1.182 . . . . 0.0 110.541 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -143.78 76.97 1.54 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 124.373 2.035 . . . . 0.0 106.162 -169.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 15.1 p -95.36 -174.33 3.16 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 111.086 -2.779 . . . . 0.0 112.451 -170.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -150.4 142.65 24.19 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.538 167.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -86.33 103.86 15.31 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 168.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.54 50.0 1.47 Allowed Glycine 0 CA--C 1.559 2.783 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.754 -163.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.21 -134.28 1.71 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -169.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -66.99 132.04 93.82 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-N 112.284 -1.958 . . . . 0.0 110.761 170.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -63.47 -34.8 63.92 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 N-CA-C 122.213 3.889 . . . . 0.0 122.213 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.592 ' SG ' HG13 ' A' ' 5' ' ' ILE 0.368 80.2 m 82.31 144.75 0.07 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 111.766 -2.47 . . . . 0.0 108.056 -163.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.74 -68.53 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 118.456 2.761 . . . . 0.0 118.456 -161.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.464 ' HE ' HH12 ' A' ' 23' ' ' ARG . 73.1 mtm180 -111.36 68.5 0.67 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.472 0.653 . . . . 0.0 110.887 -166.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.91 78.13 0.27 Allowed Glycine 0 N--CA 1.484 1.885 0 CA-C-O 119.204 -0.776 . . . . 0.0 113.308 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.464 HH12 ' HE ' ' A' ' 21' ' ' ARG . 40.2 mtt85 -140.81 142.88 34.58 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.452 1.12 . . . . 0.0 111.81 -169.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.05 -86.0 0.02 OUTLIER Glycine 0 N--CA 1.482 1.762 0 N-CA-C 118.16 2.024 . . . . 0.0 118.16 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 36' ' ' CYS 0.417 14.0 t 82.34 38.22 0.05 Allowed 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 109.807 -3.196 . . . . 0.0 115.935 -169.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.9 mt -73.99 143.54 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 123.383 1.563 . . . . 0.0 107.65 168.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 34' ' ' CYS 0.259 96.4 m -93.38 -175.5 3.83 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 111.812 -2.449 . . . . 0.0 116.678 -169.458 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.37 -18.61 64.51 Favored 'General case' 0 N--CA 1.504 2.259 1 N-CA-C 122.297 4.184 . . . . 0.0 122.297 175.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.448 4.2 mp 89.06 77.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.526 0 CA-C-N 109.061 -3.7 . . . . 0.0 105.235 -166.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.2 tpt 177.21 -51.04 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.447 0 CA-C-N 111.144 -2.753 . . . . 0.0 106.986 -167.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.67 -27.33 13.59 Favored Glycine 0 CA--C 1.552 2.363 0 CA-C-O 118.849 -0.973 . . . . 0.0 113.541 -166.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.6 p -90.79 -168.82 2.18 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 167.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 44.98 45.52 8.76 Favored 'General case' 0 N--CA 1.511 2.617 0 CA-C-O 125.724 2.678 . . . . 0.0 117.549 168.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 3.7 m -90.08 -179.35 5.66 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 108.609 -3.905 . . . . 0.0 111.504 -166.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -141.72 147.24 37.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.38 -0.825 . . . . 0.0 110.202 168.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 25' ' ' CYS 0.314 1.5 m -93.03 77.89 4.65 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.189 -177.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -48.86 130.2 14.66 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-O 117.588 -1.196 . . . . 0.0 111.36 -172.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -36.79 -52.42 1.27 Allowed 'Trans proline' 0 CA--C 1.563 1.963 1 N-CA-C 122.839 4.131 . . . . 0.0 122.839 -162.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -121.15 126.94 50.98 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.813 0.845 . . . . 0.0 111.201 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 tt -93.27 101.7 13.96 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 123.659 1.695 . . . . 0.0 107.291 167.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.265 0.2 OUTLIER -149.29 56.88 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 CA-C-N 111.175 -2.739 . . . . 0.0 108.265 167.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . 0.334 22.1 ptm 159.26 -44.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 126.558 1.943 . . . . 0.0 111.829 -171.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -72.05 -3.44 23.0 Favored 'General case' 0 CA--C 1.561 1.366 1 N-CA-C 122.33 4.196 . . . . 0.0 122.33 -169.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.12 78.35 0.06 OUTLIER Glycine 0 CA--C 1.536 1.405 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.916 169.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 67.79 100.86 0.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.738 1.215 . . . . 0.0 110.605 -171.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.63 60.26 3.95 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 115.396 0.918 . . . . 0.0 115.396 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -155.12 -57.18 0.1 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.406 1.082 . . . . 0.0 110.105 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 124.07 1.891 . . . . 0.0 107.433 176.42 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? . . . . . 0 CA--C 1.549 0.934 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp 72.39 105.09 0.07 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.803 1.241 . . . . 0.0 111.126 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm 65.8 79.98 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 124.581 1.152 . . . . 0.0 110.062 -169.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.59 ' HA ' HG22 ' A' ' 17' ' ' THR 0.347 20.9 p -136.88 -171.75 3.01 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-O 123.215 1.483 . . . . 0.0 114.85 -166.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.36 109.7 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.485 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 169.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.12 69.63 2.03 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.222 1.01 . . . . 0.0 110.204 172.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -165.45 122.33 1.46 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 -173.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -75.96 120.4 21.23 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.765 1.226 . . . . 0.0 109.674 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.314 5.6 m-85 77.99 29.01 0.5 Allowed 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 124.966 1.306 . . . . 0.0 113.601 -170.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.89 117.17 5.73 Favored Glycine 0 N--CA 1.469 0.846 0 O-C-N 120.89 -1.131 . . . . 0.0 112.868 -171.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -22.9 81.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 1 C-N-CA 131.909 4.084 . . . . 0.0 116.233 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.867 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 13.0 p -85.38 -178.87 6.83 Favored 'General case' 0 N--CA 1.491 1.609 1 CA-C-N 106.983 -4.644 . . . . 0.0 112.402 -171.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -146.14 155.17 42.55 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 122.884 1.326 . . . . 0.0 108.757 169.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 49.8 m0 -94.94 100.15 12.05 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.91 53.92 1.25 Allowed Glycine 0 CA--C 1.552 2.388 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.405 -166.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.07 -143.64 3.78 Favored Glycine 0 N--CA 1.477 1.371 0 CA-C-O 123.19 1.439 . . . . 0.0 110.737 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -63.69 132.53 95.23 Favored Pre-proline 0 CA--C 1.576 1.979 0 CA-C-N 112.848 -1.676 . . . . 0.0 110.522 170.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -51.73 -39.02 67.69 Favored 'Trans proline' 0 N--CA 1.498 1.755 1 N-CA-C 123.284 4.302 . . . . 0.0 123.284 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 16.3 m 90.52 139.65 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 111.405 -2.634 . . . . 0.0 104.842 -163.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -85.02 -64.39 1.17 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 120.576 3.547 . . . . 0.0 120.576 -162.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -127.82 80.85 1.98 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.886 0.851 . . . . 0.0 109.608 -164.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.29 66.85 1.98 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 115.152 -0.931 . . . . 0.0 114.391 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.6 mtt85 -141.58 156.44 45.69 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.834 1.302 . . . . 0.0 111.031 -169.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.62 -130.85 6.65 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-O 123.196 1.442 . . . . 0.0 112.029 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.471 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 48.9 t 166.13 107.91 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 102.815 -3.032 . . . . 0.0 102.815 173.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.521 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 29.8 mm -121.2 134.32 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 170.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 33' ' ' ASN . 33.0 m -107.84 -177.78 3.44 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-N 112.775 -2.011 . . . . 0.0 111.235 174.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 t -89.96 -173.34 3.84 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 124.561 2.124 . . . . 0.0 112.567 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 pp -93.38 63.9 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 110.681 -2.963 . . . . 0.0 108.889 166.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.2 tpt 177.71 -49.27 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 112.637 -2.074 . . . . 0.0 110.348 -168.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.35 18.13 69.71 Favored Glycine 0 CA--C 1.568 3.372 0 CA-C-O 118.962 -0.91 . . . . 0.0 114.725 -162.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.301 6.0 p -121.59 114.3 20.99 Favored 'General case' 0 N--CA 1.486 1.352 1 N-CA-C 96.065 -5.531 . . . . 0.0 96.065 158.462 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 27' ' ' CYS 0.304 48.9 p30 -145.45 -90.36 0.1 Allowed 'General case' 0 CA--C 1.559 1.313 1 N-CA-C 134.521 8.712 . . . . 0.0 134.521 -138.635 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.867 ' SG ' ' SG ' ' A' ' 12' ' ' CYS 0.27 0.1 OUTLIER -74.47 -174.61 2.1 Favored 'General case' 0 C--N 1.305 -1.367 1 CA-C-N 106.273 -4.967 . . . . 0.0 119.848 -143.839 . . . . . . . . 5 4 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -170.11 137.25 1.53 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 109.163 -3.653 . . . . 0.0 109.604 -173.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.6 m -84.44 94.41 8.51 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 173.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -55.43 125.04 58.14 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-O 117.272 -1.346 . . . . 0.0 112.051 -167.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -42.51 -49.92 6.06 Favored 'Trans proline' 0 C--N 1.369 1.633 0 N-CA-C 122.146 3.864 . . . . 0.0 122.146 -164.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -145.98 103.75 3.78 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.298 60.3 tp -104.19 -74.37 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 124.026 1.869 . . . . 0.0 113.587 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.251 35.8 pt -77.86 24.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 CA-C-N 110.157 -3.202 . . . . 0.0 117.014 169.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.2 mmt -116.69 -50.54 2.61 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 126.089 1.756 . . . . 0.0 108.903 166.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -69.89 -0.7 7.77 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 120.503 3.52 . . . . 0.0 120.503 166.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.5 85.23 0.14 Allowed Glycine 0 CA--C 1.538 1.516 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.774 169.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.43 -9.67 3.26 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 171.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.47 -85.19 0.15 Allowed Glycine 0 N--CA 1.479 1.539 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -171.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 47' ' ' LEU . 2.2 pt? -75.25 -33.64 61.32 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 169.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 124.039 1.876 . . . . 0.0 113.248 177.603 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.5 tptm . . . . . 0 CA--C 1.555 1.169 0 CA-C-O 121.161 0.505 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 81.5 tttt 74.11 100.02 0.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.042 1.337 . . . . 0.0 110.593 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.1 tttt 60.85 78.27 0.29 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 124.676 1.19 . . . . 0.0 111.4 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.6 p 50.37 178.33 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.871 2.175 . . . . 0.0 116.871 -168.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.2 mt -128.04 127.14 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.57 71.01 0.75 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.257 1.027 . . . . 0.0 112.563 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -125.41 177.04 6.4 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 124.845 2.26 . . . . 0.0 116.09 -168.171 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -118.08 100.73 7.72 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.316 -2.22 . . . . 0.0 105.913 158.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.328 1.1 m-85 79.18 63.4 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 122.885 2.584 . . . . 0.0 107.309 172.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.16 -165.22 3.21 Favored Glycine 0 C--N 1.351 1.413 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.553 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -134.66 75.28 1.57 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.93 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 27.7 p -75.36 -179.17 4.36 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 113.093 -1.867 . . . . 0.0 113.135 -169.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -143.89 151.96 40.51 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 122.994 1.378 . . . . 0.0 108.155 167.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.3 m0 -99.66 93.83 6.04 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 168.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.32 41.02 0.56 Allowed Glycine 0 CA--C 1.56 2.89 0 CA-C-N 113.456 -1.702 . . . . 0.0 112.732 -166.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.79 -142.59 3.43 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.65 139.33 91.29 Favored Pre-proline 0 N--CA 1.499 1.993 0 CA-C-N 113.236 -1.482 . . . . 0.0 107.978 166.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -66.02 -129.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.572 2.38 0 C-N-CA 123.026 2.484 . . . . 0.0 111.19 169.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.2 m -152.63 139.28 18.79 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 165.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.57 160.54 26.4 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 122.889 1.328 . . . . 0.0 111.649 -170.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 38.5 mtt85 47.59 59.63 4.02 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.09 100.37 0.24 Allowed Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.46 -0.775 . . . . 0.0 112.423 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -112.23 169.87 8.56 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -168.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.56 -87.47 1.89 Allowed Glycine 0 CA--C 1.536 1.383 0 CA-C-N 111.67 -2.513 . . . . 0.0 108.686 166.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' SG ' ' SG ' ' A' ' 34' ' ' CYS 0.415 22.4 t 65.66 55.96 0.96 Allowed 'General case' 0 CA--C 1.561 1.391 0 CA-C-N 110.49 -2.855 . . . . 0.0 113.749 -169.159 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.539 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 54.1 mt -83.2 133.85 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 167.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.1 m -119.34 178.82 4.39 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 118.137 2.643 . . . . 0.0 118.137 -166.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 p -159.5 153.16 22.8 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-O 124.499 2.095 . . . . 0.0 111.986 -167.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.327 2.4 mp 40.27 60.18 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 CA-C-N 109.97 -3.286 . . . . 0.0 113.416 -169.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.274 15.7 mmt 85.37 7.15 0.43 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.02 69.05 1.29 Allowed Glycine 0 N--CA 1.486 1.987 0 CA-C-N 122.122 2.237 . . . . 0.0 111.664 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.1 p -149.96 -76.37 0.15 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 123.763 1.744 . . . . 0.0 109.94 -168.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.77 21.81 0.05 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 119.814 3.264 . . . . 0.0 119.814 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.93 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 8.6 t -59.75 -168.81 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 112.286 -2.233 . . . . 0.0 115.405 -167.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -149.28 144.54 26.55 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.704 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 18.2 m -101.21 116.65 33.31 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -61.25 138.1 94.49 Favored Pre-proline 0 CA--C 1.574 1.877 0 CA-C-N 119.988 1.267 . . . . 0.0 109.711 170.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -51.53 162.3 1.58 Allowed 'Trans proline' 0 CA--C 1.556 1.624 0 N-CA-C 120.384 3.186 . . . . 0.0 120.384 -162.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.42 156.48 31.12 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.198 167.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 tt -71.8 100.4 2.37 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 123.768 1.746 . . . . 0.0 112.272 -168.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.0 pt -146.17 67.84 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-N 110.461 -3.063 . . . . 0.0 105.207 169.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . 0.306 18.3 ttt 73.67 57.63 0.1 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.715 1.206 . . . . 0.0 112.423 -168.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' A' ' 44' ' ' GLY 0.417 18.4 tt0 -99.59 -155.58 0.51 Allowed 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 101.671 -3.455 . . . . 0.0 101.671 165.396 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.503 ' H ' ' HG2' ' A' ' 43' ' ' GLU . . . 76.46 -57.8 3.33 Favored Glycine 0 CA--C 1.549 2.172 0 C-N-CA 124.713 1.149 . . . . 0.0 114.866 -170.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.68 103.77 6.55 Favored 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 101.867 -3.383 . . . . 0.0 101.867 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.5 94.29 1.83 Allowed Glycine 0 N--CA 1.482 1.726 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.232 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.23 -66.46 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.761 -171.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 124.066 1.889 . . . . 0.0 112.58 -175.097 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 85.3 tttt . . . . . 0 CA--C 1.555 1.169 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -94.47 -52.37 4.35 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.548 0.739 . . . . 0.0 112.764 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -136.22 98.54 3.88 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.638 ' HA ' HG22 ' A' ' 17' ' ' THR 0.318 14.0 p -119.48 -167.47 1.42 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 126.688 1.995 . . . . 0.0 115.297 -169.542 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.9 mm -94.65 -70.44 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.723 0 C-N-CA 125.137 1.375 . . . . 0.0 107.94 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.52 67.38 0.65 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.849 1.66 . . . . 0.0 114.652 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -174.6 128.76 0.33 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.06 120.0 15.99 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.108 1.363 . . . . 0.0 109.603 171.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.308 2.2 m-85 72.31 44.6 0.42 Allowed 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 124.82 1.248 . . . . 0.0 109.485 -167.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -75.18 -150.7 2.57 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-O 118.221 -1.322 . . . . 0.0 110.806 173.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.4 mmt-85 -147.35 74.54 1.33 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -171.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.803 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -77.06 -177.38 4.44 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 123.284 1.516 . . . . 0.0 111.09 -169.504 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -141.97 125.34 16.58 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 166.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 52.1 m0 -76.26 111.69 11.96 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 169.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.31 47.03 5.36 Favored Glycine 0 CA--C 1.558 2.723 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.566 -165.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.72 -135.37 1.81 Allowed Glycine 0 N--CA 1.472 1.098 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -169.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -61.94 140.48 95.69 Favored Pre-proline 0 CA--C 1.573 1.828 0 CA-C-N 112.361 -1.919 . . . . 0.0 112.033 169.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -71.11 -128.05 0.01 OUTLIER 'Trans proline' 0 CA--C 1.567 2.126 0 C-N-CA 123.28 2.653 . . . . 0.0 110.774 167.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.2 8.97 0.64 Allowed 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 119.379 3.103 . . . . 0.0 119.379 167.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 79.41 -67.61 0.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 111.106 -2.77 . . . . 0.0 114.737 169.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -112.56 65.77 0.64 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.86 1.264 . . . . 0.0 110.687 -168.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.5 77.06 0.17 Allowed Glycine 0 CA--C 1.542 1.771 0 N-CA-C 116.673 1.429 . . . . 0.0 116.673 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.6 ttm105 -140.99 141.12 34.41 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 118.013 0.907 . . . . 0.0 111.613 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.35 105.1 3.05 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-O 125.021 2.456 . . . . 0.0 108.727 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.858 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 27.4 t -64.85 128.29 35.16 Favored 'General case' 0 CA--C 1.558 1.266 1 CA-C-N 107.887 -4.157 . . . . 0.0 112.489 170.015 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.463 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 29.6 mm -115.89 140.12 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 165.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 86.6 m -107.99 -174.71 2.59 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-N 113.831 -1.531 . . . . 0.0 114.786 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.81 -19.04 65.63 Favored 'General case' 0 N--CA 1.502 2.153 1 N-CA-C 122.155 4.132 . . . . 0.0 122.155 175.27 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.452 4.1 mp 86.91 75.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.487 0 CA-C-N 109.251 -3.613 . . . . 0.0 105.718 -167.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.7 ttt 176.27 -51.33 0.01 OUTLIER 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 111.333 -2.667 . . . . 0.0 106.772 -167.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.89 -32.7 6.19 Favored Glycine 0 CA--C 1.546 1.979 0 CA-C-O 118.585 -1.12 . . . . 0.0 113.709 -168.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 p -79.44 -170.61 2.39 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-O 124.67 2.176 . . . . 0.0 105.384 168.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 36.75 55.36 1.17 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 126.117 2.865 . . . . 0.0 115.732 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.858 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 8.0 t -102.67 -163.9 1.04 Allowed 'General case' 0 C--N 1.312 -1.037 1 CA-C-N 108.097 -4.138 . . . . 0.0 113.96 -161.647 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.423 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 10.9 pt-20 -157.78 150.98 23.29 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 112.244 -2.253 . . . . 0.0 112.046 171.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.404 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 16.8 m -90.91 81.39 5.7 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 169.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -55.96 121.52 41.16 Favored Pre-proline 0 CA--C 1.567 1.628 0 CA-C-O 117.269 -1.348 . . . . 0.0 110.653 -169.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.72 127.91 19.97 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 123.393 2.729 . . . . 0.0 118.575 -164.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -118.48 149.87 40.56 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.67 0.748 . . . . 0.0 109.302 170.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.13 94.45 5.37 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 124.372 2.034 . . . . 0.0 112.197 -167.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.315 89.0 mt -140.54 -81.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 109.737 -3.392 . . . . 0.0 103.527 171.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 23.5 mmt -85.88 11.34 11.54 Favored 'General case' 0 CA--C 1.575 1.907 0 CA-C-N 109.909 -3.314 . . . . 0.0 115.588 167.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -102.45 140.13 37.15 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 101.215 -3.624 . . . . 0.0 101.215 166.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.32 -56.74 5.07 Favored Glycine 0 CA--C 1.548 2.154 1 CA-C-N 108.123 -4.126 . . . . 0.0 115.287 175.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.12 85.89 2.21 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.38 1.072 . . . . 0.0 108.136 -177.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.75 -83.89 0.11 Allowed Glycine 0 N--CA 1.479 1.566 0 O-C-N 121.969 -0.457 . . . . 0.0 112.083 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.469 2.9 pp 51.51 54.49 10.95 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.859 1.663 . . . . 0.0 115.25 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 123.803 1.763 . . . . 0.0 112.136 -176.85 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 61.2 tttm . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.44 25.49 6.29 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? 60.81 85.77 0.11 Allowed 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 124.919 1.288 . . . . 0.0 112.005 -176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.504 ' HA ' HG22 ' A' ' 17' ' ' THR . 16.4 p 51.63 169.02 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 118.542 2.793 . . . . 0.0 118.542 -170.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt -115.42 107.53 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.84 69.62 4.65 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.48 1.133 . . . . 0.0 110.831 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -160.48 112.91 2.0 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 104.281 -2.489 . . . . 0.0 104.281 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -75.79 126.55 31.23 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.894 1.278 . . . . 0.0 110.366 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.298 12.0 m-85 73.41 38.77 0.63 Allowed 'General case' 0 CA--C 1.58 2.108 0 C-N-CA 124.413 1.085 . . . . 0.0 111.149 -167.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.35 132.39 11.11 Favored Glycine 0 N--CA 1.483 1.795 0 O-C-N 120.946 -1.097 . . . . 0.0 110.403 -174.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -74.83 70.35 1.92 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 127.108 3.337 . . . . 0.0 112.457 -167.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.716 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 31.4 p -72.27 -174.78 1.37 Allowed 'General case' 0 N--CA 1.483 1.203 1 CA-C-N 106.088 -5.051 . . . . 0.0 114.232 -173.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -152.61 164.26 38.03 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.595 169.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -97.26 104.14 16.14 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 169.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.69 41.81 1.09 Allowed Glycine 0 CA--C 1.557 2.709 0 CA-C-N 113.904 -1.498 . . . . 0.0 113.025 -166.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.98 -146.66 4.4 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-O 123.417 1.565 . . . . 0.0 111.247 -175.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.504 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -70.11 132.32 88.34 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-N 112.791 -1.705 . . . . 0.0 108.275 167.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -54.89 -34.11 84.54 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 N-CA-C 121.915 3.775 . . . . 0.0 121.915 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . 0.297 74.3 m 87.42 148.0 0.05 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 111.288 -2.687 . . . . 0.0 109.205 -165.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.09 176.31 5.17 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.869 -168.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . 0.254 32.6 ptt180 42.53 56.12 3.91 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 119.433 3.123 . . . . 0.0 119.433 167.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.02 102.64 0.1 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.28 161.97 36.6 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -167.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -178.78 120.25 0.69 Allowed Glycine 0 CA--C 1.529 0.96 0 N-CA-C 106.809 -2.516 . . . . 0.0 106.809 168.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 39.7 t -91.82 81.86 5.2 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 111.446 -2.377 . . . . 0.0 112.827 -169.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.557 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -75.75 134.9 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 168.293 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.5 m -118.39 178.11 4.57 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 112.944 -1.935 . . . . 0.0 114.523 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.288 57.9 m -79.11 -149.98 0.05 Allowed 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 125.149 1.38 . . . . 0.0 110.808 178.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.82 58.11 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.902 0.858 . . . . 0.0 108.88 169.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.93 -57.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.41 1.084 . . . . 0.0 111.712 -173.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.44 54.15 1.49 Allowed Glycine 0 CA--C 1.548 2.13 0 CA-C-O 119.278 -0.734 . . . . 0.0 112.777 -167.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.8 p -153.73 -73.96 0.13 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 123.824 1.773 . . . . 0.0 111.364 -168.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.314 8.6 m120 -67.34 33.53 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 129.679 3.191 . . . . 0.0 118.01 168.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 30.9 t -77.27 -150.62 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 111.839 -2.437 . . . . 0.0 113.731 -167.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -172.52 143.58 1.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.206 169.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 6.9 m -105.36 98.78 8.44 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.17 131.86 68.88 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-O 116.943 -1.503 . . . . 0.0 112.802 -168.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -38.38 -54.43 1.49 Allowed 'Trans proline' 0 CA--C 1.561 1.842 0 N-CA-C 121.661 3.677 . . . . 0.0 121.661 -165.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -135.51 121.02 19.31 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 173.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.9 tt -89.51 100.57 13.34 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-O 123.852 1.787 . . . . 0.0 108.011 169.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.8 tp -144.35 47.07 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.93 0 CA-C-N 110.842 -2.89 . . . . 0.0 110.397 169.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 48.9 ttp -176.75 -59.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.175 1.39 . . . . 0.0 109.145 -170.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.9 -18.15 64.94 Favored 'General case' 0 N--CA 1.482 1.173 1 N-CA-C 122.731 4.345 . . . . 0.0 122.731 -169.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.3 74.04 0.24 Allowed Glycine 0 N--CA 1.479 1.556 0 CA-C-N 113.492 -1.686 . . . . 0.0 112.453 169.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -117.04 86.4 2.5 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.21 85.35 0.77 Allowed Glycine 0 N--CA 1.479 1.566 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -174.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.6 mt -129.51 -68.52 0.72 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.536 0.734 . . . . 0.0 109.599 -172.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 123.987 1.851 . . . . 0.0 110.077 179.482 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -75.9 110.44 10.35 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 119.152 0.887 . . . . 0.0 109.974 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -148.43 99.72 3.06 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 -169.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.67 ' HA ' HG22 ' A' ' 17' ' ' THR . 17.2 p -24.27 174.32 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.065 1 N-CA-C 127.247 6.017 . . . . 0.0 127.247 -168.311 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mt -109.19 117.3 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 127.823 2.449 . . . . 0.0 104.413 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.65 71.7 1.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.062 0.934 . . . . 0.0 110.25 173.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -169.82 123.2 0.74 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -76.11 128.5 35.1 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.869 1.267 . . . . 0.0 110.602 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.281 13.0 m-85 73.79 38.78 0.58 Allowed 'General case' 0 CA--C 1.578 2.055 0 C-N-CA 124.836 1.254 . . . . 0.0 110.689 -168.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.93 122.5 7.42 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.222 -0.924 . . . . 0.0 111.69 -169.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -33.58 82.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 1 C-N-CA 132.857 4.463 . . . . 0.0 115.246 -172.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 3.8 p -88.65 173.39 8.64 Favored 'General case' 0 N--CA 1.491 1.592 1 CA-C-N 107.471 -4.422 . . . . 0.0 113.8 -167.467 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -153.59 144.96 23.1 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.936 169.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -86.69 103.2 14.93 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 168.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.71 47.28 1.81 Allowed Glycine 0 CA--C 1.557 2.663 0 CA-C-N 114.526 -1.216 . . . . 0.0 112.733 -165.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.39 -141.4 3.48 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-O 123.29 1.494 . . . . 0.0 109.954 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.67 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -65.41 133.64 95.42 Favored Pre-proline 0 CA--C 1.577 1.985 0 CA-C-N 112.669 -1.765 . . . . 0.0 109.988 169.393 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -55.76 -35.37 93.35 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 N-CA-C 122.423 3.97 . . . . 0.0 122.423 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . 0.314 66.3 m 79.05 143.42 0.08 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 111.635 -2.53 . . . . 0.0 107.28 -163.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.47 -62.78 1.2 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -162.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -126.04 80.46 1.91 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.946 0.879 . . . . 0.0 109.089 -166.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.15 102.19 1.97 Allowed Glycine 0 N--CA 1.476 1.354 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.618 -176.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.54 165.94 18.95 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-O 123.588 1.661 . . . . 0.0 112.577 -169.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -156.88 -81.01 0.03 OUTLIER Glycine 0 N--CA 1.477 1.432 0 CA-C-O 124.31 2.061 . . . . 0.0 109.314 -169.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.415 19.9 t 79.34 50.79 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 109.202 -3.499 . . . . 0.0 115.166 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 76.9 mt -82.68 149.44 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 122.975 1.369 . . . . 0.0 107.421 167.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.419 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 69.3 m -93.14 171.25 9.06 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 -170.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.274 69.6 m -91.09 -147.14 0.2 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.348 1.459 . . . . 0.0 109.635 -174.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 mm -94.2 50.88 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 CA-C-O 122.859 1.314 . . . . 0.0 110.213 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.1 ttt -172.76 -52.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.865 1.266 . . . . 0.0 112.417 -169.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.39 50.3 2.41 Favored Glycine 0 CA--C 1.548 2.154 0 CA-C-N 118.741 0.701 . . . . 0.0 113.749 -168.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.4 p -151.94 -79.11 0.11 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.906 1.336 . . . . 0.0 109.136 -169.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.81 -26.87 68.82 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 121.214 3.783 . . . . 0.0 121.214 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.534 ' HB2' ' SG ' ' A' ' 12' ' ' CYS 0.376 6.7 m 37.27 -151.69 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 130.161 3.385 . . . . 0.0 117.714 172.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -175.75 133.57 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.1 m -89.73 95.47 10.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.193 -0.942 . . . . 0.0 109.246 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -51.21 129.58 31.52 Favored Pre-proline 0 CA--C 1.573 1.856 0 CA-C-O 116.763 -1.589 . . . . 0.0 112.027 -170.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.251 80.7 Cg_exo -28.63 -61.02 0.1 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 N-CA-C 122.321 3.931 . . . . 0.0 122.321 -164.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.253 36.9 ptt180 -152.65 102.44 2.71 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 118.891 0.769 . . . . 0.0 109.641 168.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 tt -103.32 106.69 17.27 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 165.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.363 6.5 pt -127.9 -91.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 -177.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 23.5 mmt -112.39 72.58 0.78 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 110.205 -3.18 . . . . 0.0 103.719 162.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . 0.728 3.5 pt-20 5.99 85.4 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.03 1 N-CA-C 122.487 4.254 . . . . 0.0 122.487 -166.227 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.64 24.87 76.05 Favored Glycine 0 CA--C 1.553 2.426 0 CA-C-N 110.292 -3.14 . . . . 0.0 119.467 -174.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt -136.2 80.45 1.83 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 120.52 2.16 . . . . 0.0 108.972 -171.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.18 -104.65 0.18 Allowed Glycine 0 N--CA 1.477 1.377 0 O-C-N 122.024 -0.423 . . . . 0.0 112.483 170.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.255 1.1 pt? -149.83 -61.17 0.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.048 -169.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 123.923 1.821 . . . . 0.0 110.183 -177.207 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? 73.85 112.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.839 1.256 . . . . 0.0 110.988 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 66.5 89.16 0.1 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 124.679 1.192 . . . . 0.0 110.275 -172.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.444 ' HA ' HG22 ' A' ' 17' ' ' THR . 25.6 p 49.21 170.03 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 118.61 2.819 . . . . 0.0 118.61 -169.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mm -102.41 108.45 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.76 72.89 2.29 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.347 1.07 . . . . 0.0 110.053 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -176.6 123.9 0.16 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 -171.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -75.22 127.95 34.35 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 168.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.27 12.1 m-85 74.78 30.09 1.02 Allowed 'General case' 0 CA--C 1.579 2.093 0 C-N-CA 124.903 1.281 . . . . 0.0 113.607 -169.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.96 131.27 10.59 Favored Glycine 0 N--CA 1.474 1.227 0 O-C-N 120.91 -1.119 . . . . 0.0 112.237 -169.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -55.47 82.21 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 130.324 3.45 . . . . 0.0 114.69 -167.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.521 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 22.3 p -90.41 173.15 8.26 Favored 'General case' 0 N--CA 1.494 1.751 1 CA-C-N 106.374 -4.921 . . . . 0.0 113.242 -168.654 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -150.66 128.85 11.94 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.507 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -77.16 111.13 12.44 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 170.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.54 33.9 5.73 Favored Glycine 0 CA--C 1.559 2.807 0 CA-C-N 114.826 -1.079 . . . . 0.0 114.531 -166.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.24 -139.99 3.63 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-O 123.449 1.583 . . . . 0.0 109.667 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -63.55 137.26 97.03 Favored Pre-proline 0 CA--C 1.573 1.864 0 CA-C-N 112.42 -1.89 . . . . 0.0 109.772 168.432 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -66.92 -172.91 0.35 Allowed 'Trans proline' 0 CA--C 1.57 2.313 0 CA-C-N 123.546 2.302 . . . . 0.0 110.834 167.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.9 m -101.84 149.16 24.47 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 167.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.71 -60.17 1.76 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.865 -173.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -137.24 87.3 2.26 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.944 1.297 . . . . 0.0 108.128 -169.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.78 116.2 4.15 Favored Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -169.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -138.24 176.23 8.88 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -167.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.37 109.23 2.84 Favored Glycine 0 N--CA 1.475 1.263 0 CA-C-N 112.367 -2.197 . . . . 0.0 109.039 -170.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.8 t -109.77 75.66 0.95 Allowed 'General case' 0 CA--C 1.56 1.327 0 CA-C-N 111.837 -2.182 . . . . 0.0 111.587 -169.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.401 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 36.4 mm -89.45 144.58 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 169.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 34' ' ' CYS 0.304 6.5 m -105.75 161.8 14.09 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 125.023 1.452 . . . . 0.0 113.002 177.045 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.642 ' HA ' ' H ' ' A' ' 31' ' ' GLY 0.823 2.9 t 81.74 -176.52 0.05 OUTLIER 'General case' 0 C--N 1.353 0.736 0 N-CA-C 120.605 3.557 . . . . 0.0 120.605 156.503 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.311 4.1 mp 70.83 64.08 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.586 2.331 0 CA-C-N 108.468 -3.969 . . . . 0.0 104.002 -158.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.272 0.0 OUTLIER 136.33 -58.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 128.582 2.753 . . . . 0.0 104.073 -162.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.642 ' H ' ' HA ' ' A' ' 28' ' ' SER . . . 62.34 47.65 88.08 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 120.208 2.843 . . . . 0.0 120.208 -169.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.299 22.7 p -98.66 102.79 14.63 Favored 'General case' 0 CA--C 1.553 1.059 1 N-CA-C 94.359 -6.163 . . . . 0.0 94.359 151.798 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.404 ' O ' ' SG ' ' A' ' 27' ' ' CYS 0.62 3.5 p-10 -87.82 70.89 9.59 Favored 'General case' 0 N--CA 1.439 -1.015 2 CA-C-N 105.29 -5.414 . . . . 0.0 122.177 -148.202 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 27' ' ' CYS 0.414 59.3 m 123.19 171.24 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 3 CA-C-N 101.572 -7.104 . . . . 0.0 113.402 160.774 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -150.01 143.17 25.0 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 112.032 -2.349 . . . . 0.0 106.46 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 12.8 m -89.8 86.35 6.64 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -45.08 145.61 1.67 Allowed Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -167.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -61.19 -73.32 0.02 OUTLIER 'Trans proline' 0 CA--C 1.562 1.9 0 C-N-CA 122.964 2.443 . . . . 0.0 116.226 -163.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.375 27.1 ptt85 41.22 98.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 118.434 2.753 . . . . 0.0 118.434 173.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.8 tt -93.01 105.42 17.53 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 123.779 1.752 . . . . 0.0 108.108 169.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.6 tp -130.43 66.3 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.618 0 CA-C-N 111.103 -2.771 . . . . 0.0 104.601 166.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . 0.468 11.7 ptt? 64.04 10.07 5.11 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 117.386 2.365 . . . . 0.0 117.386 -167.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -80.38 -1.53 41.69 Favored 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 121.058 3.725 . . . . 0.0 121.058 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.75 -53.6 1.4 Allowed Glycine 0 CA--C 1.546 2.01 0 C-N-CA 125.088 1.328 . . . . 0.0 114.045 169.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.68 93.82 3.0 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.3 -88.89 0.08 OUTLIER Glycine 0 N--CA 1.478 1.497 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 pp -76.59 -34.07 58.43 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 171.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 122.829 1.3 . . . . 0.0 107.988 173.974 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 121.588 0.709 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.354 51.0 tttp 83.94 -76.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.113 1.365 . . . . 0.0 113.206 173.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -124.95 87.17 2.67 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.585 ' HA ' HG22 ' A' ' 17' ' ' THR 0.284 22.0 p 41.93 -171.46 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 118.87 2.915 . . . . 0.0 118.87 173.054 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.415 HG13 ' SG ' ' A' ' 19' ' ' CYS . 4.5 mm -113.22 -62.81 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.546 0 CA-C-N 113.449 -1.705 . . . . 0.0 110.25 -164.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.254 . . 66.11 60.64 0.64 Allowed 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 125.278 1.431 . . . . 0.0 114.572 -169.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -169.75 131.44 1.09 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 173.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -68.14 136.07 53.11 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 125.264 1.425 . . . . 0.0 110.235 169.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 66.34 34.61 6.29 Favored 'General case' 0 CA--C 1.581 2.169 0 C-N-CA 124.257 1.023 . . . . 0.0 112.093 -167.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.65 132.16 10.87 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -169.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -73.52 73.77 1.43 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 126.971 3.272 . . . . 0.0 112.116 -167.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 24.3 p -71.02 174.8 5.77 Favored 'General case' 0 N--CA 1.486 1.35 1 CA-C-N 106.056 -5.066 . . . . 0.0 114.074 -176.177 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.985 ' H ' ' HG2' ' A' ' 18' ' ' PRO . 17.9 ptpt -129.2 159.1 37.11 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 123.42 1.581 . . . . 0.0 111.158 171.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 52.6 m0 -104.61 91.29 3.8 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 168.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.91 -81.11 0.06 OUTLIER Glycine 0 N--CA 1.478 1.442 0 N-CA-C 106.491 -2.644 . . . . 0.0 106.491 -166.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.86 135.87 2.02 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 125.154 2.53 . . . . 0.0 118.093 163.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.645 ' HB ' ' HD3' ' A' ' 18' ' ' PRO . 14.8 m 168.64 -65.12 0.0 OUTLIER Pre-proline 0 CA--C 1.59 2.493 1 CA-C-N 107.266 -4.467 . . . . 0.0 101.393 -168.146 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.985 ' HG2' ' H ' ' A' ' 13' ' ' LYS 1.105 0.6 OUTLIER -24.85 155.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.827 2 N-CA-C 135.587 9.033 . . . . 0.0 135.587 -156.146 . . . . . . . . 5 4 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.439 ' H ' ' HB3' ' A' ' 18' ' ' PRO 0.345 31.4 m -23.92 117.5 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.272 2 CA-C-N 105.167 -5.47 . . . . 0.0 114.873 -156.667 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.33 156.13 39.43 Favored 'General case' 0 C--N 1.297 -1.708 1 CA-C-N 106.378 -4.919 . . . . 0.0 109.373 -163.239 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 58.39 49.28 11.08 Favored 'General case' 0 CA--C 1.586 2.339 0 CA-C-N 112.989 -1.914 . . . . 0.0 113.768 -173.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.23 142.48 6.77 Favored Glycine 0 CA--C 1.556 2.642 0 N-CA-C 115.316 0.886 . . . . 0.0 115.316 -169.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.53 162.81 40.91 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -153.52 105.52 0.28 Allowed Glycine 0 N--CA 1.475 1.268 0 N-CA-C 105.751 -2.94 . . . . 0.0 105.751 164.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.87 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 54.0 t -99.07 125.09 44.51 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 110.787 -2.707 . . . . 0.0 109.568 -174.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.537 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 23.6 mm -117.27 134.07 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 166.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.576 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 68.2 m -121.56 173.25 7.53 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -172.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 p -120.05 135.42 54.94 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 125.072 1.349 . . . . 0.0 111.085 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.296 9.6 mt -5.61 56.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.39 2 CA-C-N 108.264 -4.062 . . . . 0.0 116.571 -168.659 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.8 tpt 172.57 -56.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 113.076 -1.875 . . . . 0.0 113.765 -167.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.36 53.0 1.64 Allowed Glycine 0 CA--C 1.552 2.362 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -163.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 99.6 m -150.77 -69.8 0.18 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 123.124 1.44 . . . . 0.0 111.665 -167.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.283 9.6 m-80 -71.23 30.16 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 118.466 2.765 . . . . 0.0 118.466 169.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.87 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 17.7 t -76.47 -156.79 0.07 Allowed 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 112.496 -2.138 . . . . 0.0 115.061 -166.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.08 147.62 4.74 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 113.658 -1.61 . . . . 0.0 110.666 168.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 20.2 m -100.16 95.89 7.12 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -54.07 131.73 59.34 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 117.54 -1.219 . . . . 0.0 112.555 -169.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -47.92 135.32 23.36 Favored 'Trans proline' 0 CA--C 1.556 1.605 0 C-N-CA 124.299 3.333 . . . . 0.0 119.162 -164.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.2 mtp-105 -115.47 -177.34 3.12 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.661 1.22 . . . . 0.0 111.276 -176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.275 35.1 tp -101.12 -65.22 0.99 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 124.378 2.037 . . . . 0.0 116.395 -174.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.285 28.2 pt -74.03 15.45 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 110.152 -3.203 . . . . 0.0 118.098 174.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.2 ptm -142.34 33.61 1.49 Allowed 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 124.554 1.141 . . . . 0.0 113.658 166.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . 0.427 29.1 tt0 -110.76 -87.92 0.52 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 -172.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.06 63.38 1.02 Allowed Glycine 0 CA--C 1.545 1.907 0 CA-C-N 113.209 -1.814 . . . . 0.0 113.844 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.358 0.8 OUTLIER 42.9 58.24 3.31 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 117.748 2.499 . . . . 0.0 117.748 -178.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.84 -71.42 0.27 Allowed Glycine 0 N--CA 1.481 1.652 0 O-C-N 122.287 -0.258 . . . . 0.0 112.634 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.265 56.3 mt 68.85 64.98 0.3 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.781 1.232 . . . . 0.0 111.472 -171.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 124.034 1.873 . . . . 0.0 110.093 -177.817 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -96.32 112.65 24.32 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.7 tttt 66.2 92.76 0.07 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.692 1.197 . . . . 0.0 111.705 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.2 p 54.41 170.75 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.526 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 31.7 mm -99.47 103.96 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 175.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.46 66.26 1.99 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.234 1.016 . . . . 0.0 112.456 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -174.89 119.83 0.21 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -170.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -75.18 129.38 37.41 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.908 1.283 . . . . 0.0 108.535 169.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 72.47 44.13 0.43 Allowed 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -166.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.498 ' N ' ' H ' ' A' ' 36' ' ' CYS . . . -81.49 -148.03 6.13 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-O 117.428 -1.762 . . . . 0.0 111.416 -173.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -144.75 75.92 1.47 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -175.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.2 p -97.76 -175.44 3.17 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 112.737 -2.029 . . . . 0.0 113.563 -168.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -153.5 160.63 42.58 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.227 -1.352 . . . . 0.0 110.065 166.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -95.9 108.01 20.34 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 169.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.62 38.83 2.0 Allowed Glycine 0 CA--C 1.558 2.764 0 CA-C-N 113.896 -1.502 . . . . 0.0 113.312 -166.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.03 -140.17 3.86 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 123.637 1.687 . . . . 0.0 110.05 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.599 HG23 ' H ' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -62.3 166.13 7.45 Favored Pre-proline 0 CA--C 1.596 2.748 0 CA-C-N 112.052 -2.074 . . . . 0.0 113.0 168.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -62.39 -30.96 81.18 Favored 'Trans proline' 0 CA--C 1.568 2.222 0 N-CA-C 122.401 3.962 . . . . 0.0 122.401 169.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.599 ' H ' HG23 ' A' ' 17' ' ' THR 0.323 6.2 t 78.54 139.64 0.07 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 111.649 -2.523 . . . . 0.0 107.138 -162.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.74 -64.28 1.16 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -164.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . 0.29 40.8 mtm105 -92.11 -130.37 0.11 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.811 1.291 . . . . 0.0 109.116 -168.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.65 94.93 0.25 Allowed Glycine 0 N--CA 1.486 1.994 0 CA-C-N 112.799 -2.0 . . . . 0.0 111.048 169.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -106.47 169.05 8.75 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 123.948 1.832 . . . . 0.0 115.646 -165.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.28 103.62 0.21 Allowed Glycine 0 N--CA 1.471 0.988 0 N-CA-C 105.484 -3.046 . . . . 0.0 105.484 169.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.7 t -88.33 77.33 8.2 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 111.006 -2.597 . . . . 0.0 111.631 -169.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.1 mm -82.36 144.99 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 168.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 32' ' ' THR . 3.1 t -110.58 -176.09 2.89 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -176.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.315 42.5 m -101.97 -142.18 0.35 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.849 1.66 . . . . 0.0 109.195 -169.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.4 mm -72.87 -5.82 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -174.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.0 mmt -141.49 -24.63 0.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.431 ' HA2' ' SG ' ' A' ' 27' ' ' CYS . . . 91.3 58.05 1.5 Allowed Glycine 0 CA--C 1.551 2.283 0 CA-C-N 121.084 1.766 . . . . 0.0 110.929 -166.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.439 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 17.7 p -149.06 -74.93 0.17 Allowed 'General case' 0 CA--C 1.563 1.451 0 CA-C-O 124.2 1.952 . . . . 0.0 111.832 -168.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.358 33.5 m-20 -88.24 40.76 0.97 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 130.381 3.472 . . . . 0.0 115.303 -174.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -64.06 -167.47 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 112.328 -2.215 . . . . 0.0 115.518 -166.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -136.73 150.48 48.44 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.375 -0.828 . . . . 0.0 110.856 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.498 ' H ' ' N ' ' A' ' 10' ' ' GLY . 13.2 m -87.13 52.32 2.48 Favored 'General case' 0 N--CA 1.52 3.074 0 CA-C-O 123.96 1.838 . . . . 0.0 112.364 169.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.428 0.1 OUTLIER 98.42 93.31 0.01 OUTLIER Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 127.178 2.191 . . . . 0.0 115.134 169.281 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.07 170.47 15.09 Favored 'Trans proline' 0 CA--C 1.559 1.744 0 C-N-CA 123.262 2.641 . . . . 0.0 113.747 169.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -71.18 145.97 49.38 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 171.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 40' ' ' LEU 0.434 2.7 pt? -63.22 -33.06 74.67 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 121.296 3.813 . . . . 0.0 121.296 -176.471 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.329 1.9 pp -80.4 6.96 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 N-CA-C 118.344 2.72 . . . . 0.0 118.344 168.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.0 mmt -147.2 50.43 1.09 Allowed 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 125.985 1.714 . . . . 0.0 108.369 167.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -72.01 131.5 42.99 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-O 127.055 3.312 . . . . 0.0 110.642 -171.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.35 38.91 89.23 Favored Glycine 0 CA--C 1.558 2.744 1 CA-C-N 104.94 -5.573 . . . . 0.0 116.853 -167.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.26 7.1 tp 67.06 87.64 0.12 Allowed 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 125.316 1.446 . . . . 0.0 113.333 -175.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.1 106.15 1.24 Allowed Glycine 0 CA--C 1.54 1.628 0 N-CA-C 114.336 0.494 . . . . 0.0 114.336 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -98.14 -63.61 1.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.384 0.674 . . . . 0.0 110.312 169.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 122.837 1.303 . . . . 0.0 108.924 178.386 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 61.9 mttp . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -110.26 106.75 16.27 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? 67.16 87.24 0.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.615 1.166 . . . . 0.0 111.413 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.468 ' HA ' HG22 ' A' ' 17' ' ' THR . 11.5 p 54.75 -178.15 0.03 OUTLIER 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 173.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.521 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 6.1 mm -133.47 114.09 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 -171.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.6 65.84 4.41 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.01 0.91 . . . . 0.0 112.003 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -163.18 122.67 2.16 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.4 127.25 31.55 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.534 0.734 . . . . 0.0 110.617 167.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 69.59 39.68 1.51 Allowed 'General case' 0 CA--C 1.576 1.968 0 C-N-CA 123.546 0.739 . . . . 0.0 111.831 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.56 126.3 7.33 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -78.83 70.92 5.25 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 127.048 3.308 . . . . 0.0 111.823 -166.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.1 p -74.43 -167.18 0.51 Allowed 'General case' 0 CA--C 1.562 1.404 1 CA-C-N 106.288 -4.96 . . . . 0.0 113.782 -167.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 34' ' ' CYS 0.389 0.1 OUTLIER 105.68 90.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 127.49 2.316 . . . . 0.0 106.841 173.851 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.494 ' NE1' HD11 ' A' ' 5' ' ' ILE 0.341 69.7 m95 -107.61 -140.42 0.37 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 110.502 -3.045 . . . . 0.0 102.963 -169.445 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.13 43.61 3.15 Favored Glycine 1 CA--C 1.585 4.433 0 N-CA-C 105.836 -2.906 . . . . 0.0 105.836 149.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.87 136.58 0.0 OUTLIER Glycine 0 CA--C 1.557 2.677 0 C-N-CA 126.926 2.203 . . . . 0.0 114.027 -162.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 4' ' ' CYS . 2.5 m -134.66 134.96 22.65 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 170.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -48.44 -37.13 32.55 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 N-CA-C 119.999 3.038 . . . . 0.0 119.999 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.521 ' SG ' ' HB ' ' A' ' 5' ' ' ILE 0.258 16.6 t 74.32 141.4 0.07 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.997 -1.91 . . . . 0.0 106.982 -164.166 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 160.15 19.12 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 113.219 -1.81 . . . . 0.0 112.859 -165.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.6 mtt85 63.81 62.99 0.86 Allowed 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 112.795 -2.002 . . . . 0.0 113.177 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.44 68.81 1.52 Allowed Glycine 0 CA--C 1.545 1.911 0 N-CA-C 115.911 1.125 . . . . 0.0 115.911 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.28 161.41 42.09 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-O 123.222 1.487 . . . . 0.0 112.353 -172.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.86 118.68 1.27 Allowed Glycine 0 N--CA 1.478 1.47 1 N-CA-C 102.935 -4.066 . . . . 0.0 102.935 166.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.616 9.1 t -45.38 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 125.441 1.318 . . . . 0.0 113.857 -166.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.275 60.6 mt 74.13 150.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 123.286 1.517 . . . . 0.0 110.855 172.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 90.6 m -90.64 171.09 9.62 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 119.454 3.131 . . . . 0.0 119.454 -169.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.336 13.3 m -94.79 -142.85 0.25 Allowed 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 126.706 2.002 . . . . 0.0 108.928 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.25 1.9 pp -96.74 59.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 123.132 1.444 . . . . 0.0 111.32 168.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.9 ttt -161.52 -46.27 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.608 -1.633 . . . . 0.0 113.01 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.41 38.25 11.16 Favored Glycine 0 CA--C 1.556 2.638 0 CA-C-O 119.336 -0.702 . . . . 0.0 113.434 -165.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 m -162.28 -59.84 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 123.762 1.744 . . . . 0.0 111.465 -167.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.374 26.0 m-20 -79.11 45.87 0.66 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 129.781 3.232 . . . . 0.0 114.932 171.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 13' ' ' LYS 0.267 36.3 m -69.54 -167.14 0.12 Allowed 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.415 -167.517 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -163.15 138.11 6.48 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 119.709 -1.869 . . . . 0.0 108.812 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.9 m -51.69 -47.84 63.73 Favored 'General case' 0 N--CA 1.512 2.652 0 CA-C-O 125.557 2.599 . . . . 0.0 117.861 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.391 23.0 mtmm 86.83 171.63 0.05 OUTLIER Pre-proline 0 CA--C 1.578 2.027 1 CA-C-N 105.727 -5.215 . . . . 0.0 109.57 -165.13 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -78.41 114.55 3.53 Favored 'Trans proline' 0 C--N 1.37 1.668 0 CA-C-N 124.681 2.707 . . . . 0.0 113.824 -167.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -76.54 155.59 33.58 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.492 169.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 tt -77.95 100.48 6.44 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 124.233 1.968 . . . . 0.0 111.321 -170.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.8 tt -149.65 42.07 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.085 0 CA-C-N 110.189 -3.187 . . . . 0.0 110.148 168.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 13.5 tpt 176.97 -53.88 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.666 1.587 . . . . 0.0 109.76 -167.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.73 -2.22 8.8 Favored 'General case' 0 CA--C 1.556 1.177 1 N-CA-C 123.317 4.562 . . . . 0.0 123.317 -168.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.72 77.32 0.06 OUTLIER Glycine 0 CA--C 1.535 1.294 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.021 169.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.54 81.44 1.4 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.56 -79.64 0.18 Allowed Glycine 0 N--CA 1.479 1.563 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -172.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.0 mt -79.91 -55.58 4.87 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.231 0.612 . . . . 0.0 111.869 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 122.8 1.286 . . . . 0.0 111.602 175.814 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt . . . . . 0 CA--C 1.555 1.14 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -95.27 -93.69 0.19 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -175.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -153.56 78.87 1.15 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.608 1.094 . . . . 0.0 108.464 171.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.441 ' HA ' HG22 ' A' ' 17' ' ' THR . 13.6 p 50.59 178.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 119.04 2.978 . . . . 0.0 119.04 173.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mt -134.32 119.01 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 -170.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.284 . . -77.38 10.87 2.24 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 119.274 3.065 . . . . 0.0 119.274 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.932 30.7 mtmm 92.39 -136.53 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 1 N-CA-C 124.527 5.01 . . . . 0.0 124.527 161.166 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.442 0.0 OUTLIER 6.3 83.37 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 1 CA-C-N 108.215 -4.084 . . . . 0.0 116.934 -149.461 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.316 29.7 m-85 80.79 62.78 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 -163.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.26 -167.95 0.7 Allowed Glycine 0 CA--C 1.568 3.384 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 168.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -144.66 72.86 1.35 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 121.06 2.43 . . . . 0.0 104.636 -176.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.859 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 28.9 p -88.98 174.03 8.14 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 112.304 -2.225 . . . . 0.0 114.0 -165.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -166.42 126.93 1.67 Allowed 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 103.114 -2.921 . . . . 0.0 103.114 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -79.5 99.78 7.41 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 172.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.73 38.51 1.06 Allowed Glycine 0 CA--C 1.569 3.421 0 CA-C-N 112.393 -2.185 . . . . 0.0 111.525 -163.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -162.44 -149.18 5.59 Favored Glycine 0 N--CA 1.48 1.633 0 C-N-CA 125.376 1.465 . . . . 0.0 109.819 -170.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -69.18 128.52 92.52 Favored Pre-proline 0 N--CA 1.501 2.088 0 CA-C-O 118.189 -0.91 . . . . 0.0 109.321 169.913 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -63.01 -38.77 44.24 Favored 'Trans proline' 0 N--CA 1.495 1.575 1 N-CA-C 123.207 4.272 . . . . 0.0 123.207 -171.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . 0.331 71.6 m 90.93 144.44 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.451 0 CA-C-N 111.166 -2.743 . . . . 0.0 105.015 -160.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . 0.255 0.1 OUTLIER -85.51 -66.94 0.84 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 119.439 3.126 . . . . 0.0 119.439 -161.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -109.09 67.16 0.65 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -166.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.83 92.92 0.27 Allowed Glycine 0 N--CA 1.49 2.234 0 CA-C-O 119.423 -0.654 . . . . 0.0 112.346 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.59 165.09 11.79 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 -166.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.87 106.27 0.32 Allowed Glycine 0 N--CA 1.471 0.995 0 N-CA-C 106.743 -2.543 . . . . 0.0 106.743 166.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 25.4 t -99.53 94.24 6.29 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 110.032 -3.084 . . . . 0.0 110.676 -173.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.502 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 29.6 mm -92.09 139.28 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 167.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.419 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 79.2 m -117.49 -176.85 3.1 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 -167.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.0 t -145.49 163.85 33.41 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 125.699 2.666 . . . . 0.0 107.689 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.345 7.6 mt 36.71 52.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 1 CA-C-N 108.275 -4.057 . . . . 0.0 114.415 179.684 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.6 tpt 72.61 44.48 0.39 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 125.441 1.496 . . . . 0.0 114.547 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.71 65.06 2.61 Favored Glycine 0 N--CA 1.491 2.346 0 O-C-N 120.321 -1.487 . . . . 0.0 113.074 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.8 p -146.05 -81.51 0.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 124.011 1.862 . . . . 0.0 110.932 -166.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.335 9.1 m120 -70.73 35.75 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 131.093 3.757 . . . . 0.0 118.119 172.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.859 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 7.2 t -71.5 -176.7 1.62 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 124.439 2.066 . . . . 0.0 114.326 -167.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -144.45 153.93 42.42 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 111.22 -2.718 . . . . 0.0 109.828 170.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.595 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 36.2 m -104.26 90.05 3.44 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 171.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -56.98 136.05 80.06 Favored Pre-proline 0 CA--C 1.568 1.653 0 CA-C-O 117.657 -1.163 . . . . 0.0 111.482 -169.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -35.01 -46.34 0.61 Allowed 'Trans proline' 0 CA--C 1.558 1.702 1 N-CA-C 123.469 4.373 . . . . 0.0 123.469 -164.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.24 118.33 14.4 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.27 0.628 . . . . 0.0 110.95 -173.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.9 tt -100.05 101.41 12.48 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 165.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.6 tt -148.77 67.44 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 CA-C-N 111.499 -2.592 . . . . 0.0 105.23 169.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . 0.257 3.5 tmm? 71.74 76.0 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.99 1.316 . . . . 0.0 109.984 -168.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.526 ' HG2' ' H ' ' A' ' 44' ' ' GLY 0.488 20.6 tt0 -102.73 -107.54 0.26 Allowed 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.526 ' H ' ' HG2' ' A' ' 43' ' ' GLU . . . -151.14 56.22 0.46 Allowed Glycine 0 CA--C 1.543 1.796 0 CA-C-N 115.158 -0.928 . . . . 0.0 114.573 170.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.1 tp 52.87 87.76 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 174.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.29 63.28 0.29 Allowed Glycine 0 CA--C 1.543 1.791 0 CA-C-N 116.442 -0.345 . . . . 0.0 113.212 169.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.0 mt -134.75 -14.3 2.16 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 124.013 1.863 . . . . 0.0 110.497 175.972 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -85.76 143.47 28.31 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.211 0.605 . . . . 0.0 111.548 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.25 95.5 mttt 76.23 100.06 0.07 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.008 1.323 . . . . 0.0 110.614 177.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.64 ' HA ' HG22 ' A' ' 17' ' ' THR 0.318 30.0 p -28.74 -179.11 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.032 1 N-CA-C 125.172 5.249 . . . . 0.0 125.172 177.427 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.8 mm -99.24 110.23 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.54 67.16 2.4 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.242 1.02 . . . . 0.0 111.363 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -166.4 123.19 1.31 Allowed 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -70.25 130.41 41.95 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 167.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.257 0.0 OUTLIER 69.6 46.81 0.69 Allowed 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 122.964 1.364 . . . . 0.0 109.061 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -84.32 -152.59 15.73 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 113.615 -1.629 . . . . 0.0 109.802 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -142.21 75.64 1.5 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 -175.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 28.5 p -91.03 -171.66 3.07 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 112.641 -2.072 . . . . 0.0 112.525 -169.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -153.37 141.91 20.81 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.811 169.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -93.15 99.01 11.67 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.15 -62.98 0.52 Allowed Glycine 0 N--CA 1.484 1.867 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.782 -164.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.41 -142.67 0.3 Allowed Glycine 0 CA--C 1.539 1.587 0 CA-C-N 112.083 -2.058 . . . . 0.0 113.368 167.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -61.56 138.04 94.95 Favored Pre-proline 0 N--CA 1.495 1.821 0 CA-C-N 113.484 -1.358 . . . . 0.0 111.889 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -64.55 -131.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.573 2.429 0 C-N-CA 123.426 2.751 . . . . 0.0 112.34 169.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.3 t -148.81 146.81 28.17 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 164.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.29 -63.15 1.39 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 121.507 3.891 . . . . 0.0 121.507 -162.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.412 ' HE ' HH12 ' A' ' 23' ' ' ARG . 75.8 mtm180 -94.86 70.1 3.38 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.289 1.042 . . . . 0.0 112.715 -164.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.64 62.58 4.92 Favored Glycine 0 N--CA 1.486 2.004 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.925 -176.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.412 HH12 ' HE ' ' A' ' 21' ' ' ARG . 68.8 mtt180 -136.48 163.63 30.06 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 123.963 1.84 . . . . 0.0 112.222 -167.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.87 121.11 2.16 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 106.095 -2.802 . . . . 0.0 106.095 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.664 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 2.9 t -75.44 89.33 2.66 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 109.214 -3.493 . . . . 0.0 110.642 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.456 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 37.5 mm -81.5 136.41 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 122.852 1.311 . . . . 0.0 107.655 172.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.4 m -119.07 -179.0 3.7 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 111.925 -2.398 . . . . 0.0 114.985 -169.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.291 69.6 m -90.78 -144.85 0.18 Allowed 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.942 1.297 . . . . 0.0 109.844 -172.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.4 mm -71.34 -0.63 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.578 2.024 0 N-CA-C 117.596 2.443 . . . . 0.0 117.596 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.9 tpt -148.63 -31.36 0.26 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -172.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.81 61.14 1.11 Allowed Glycine 0 N--CA 1.488 2.119 0 CA-C-N 120.796 1.634 . . . . 0.0 111.671 -167.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.3 p -151.22 -78.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 123.849 1.785 . . . . 0.0 111.25 -167.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.336 37.2 m-80 -71.58 34.91 0.06 Allowed 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 129.953 3.301 . . . . 0.0 118.006 170.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 45.9 t -74.48 -168.52 0.69 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 112.259 -2.246 . . . . 0.0 113.495 -168.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -148.45 162.54 39.38 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 112.837 -1.983 . . . . 0.0 112.142 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.463 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 87.9 m -83.54 56.92 3.79 Favored 'General case' 0 N--CA 1.523 3.183 0 CA-C-O 124.75 2.214 . . . . 0.0 108.847 163.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.477 1.6 ptmm? 30.79 125.31 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.253 1 N-CA-C 125.424 5.342 . . . . 0.0 125.424 -163.648 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.94 152.6 76.83 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 123.646 2.897 . . . . 0.0 114.183 170.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.265 10.3 mtm105 77.7 140.4 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.546 1.138 . . . . 0.0 112.246 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.1 tt -100.59 102.76 13.99 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 124.033 1.873 . . . . 0.0 106.824 169.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.468 HG13 ' H ' ' A' ' 42' ' ' MET 0.443 17.9 pt -116.53 -83.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 110.442 -3.072 . . . . 0.0 107.292 169.127 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.468 ' H ' HG13 ' A' ' 41' ' ' ILE . 60.3 mtt -120.26 77.68 1.28 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 110.808 -2.906 . . . . 0.0 106.505 165.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.71 113.39 1.62 Allowed 'General case' 0 C--N 1.356 0.884 0 CA-C-O 126.192 2.901 . . . . 0.0 115.011 -168.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.77 -60.07 0.44 Allowed Glycine 0 CA--C 1.541 1.685 1 CA-C-N 105.788 -5.187 . . . . 0.0 115.115 -168.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.65 -73.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 118.157 0.979 . . . . 0.0 110.927 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.77 -84.56 0.22 Allowed Glycine 0 N--CA 1.478 1.459 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.81 -62.39 1.36 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.886 0.875 . . . . 0.0 109.666 175.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 122.775 1.274 . . . . 0.0 111.389 174.953 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 65.6 pttt . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 121.145 0.498 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? 70.68 98.93 0.06 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.847 1.259 . . . . 0.0 110.4 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.8 tttm 61.08 74.34 0.45 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.455 1.102 . . . . 0.0 111.888 -173.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.488 ' HA ' HG22 ' A' ' 17' ' ' THR . 14.6 p 51.54 171.17 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 118.249 2.685 . . . . 0.0 118.249 -169.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.708 HG22 ' HG3' ' A' ' 7' ' ' LYS . 5.0 mt -121.78 121.41 64.25 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -172.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.55 52.22 1.1 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 116.963 2.209 . . . . 0.0 116.963 -173.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.708 ' HG3' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -122.89 -179.62 4.32 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 127.079 2.152 . . . . 0.0 110.119 175.303 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -115.0 136.43 53.14 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.277 -1.783 . . . . 0.0 106.545 157.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 71.66 35.83 1.35 Allowed 'General case' 0 CA--C 1.58 2.118 0 CA-C-N 122.451 2.387 . . . . 0.0 111.987 168.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.78 125.96 6.62 Favored Glycine 0 N--CA 1.464 0.543 0 O-C-N 120.548 -1.345 . . . . 0.0 112.949 -168.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.413 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 11.4 mpt_? -3.9 79.37 0.0 OUTLIER 'General case' 0 C--O 1.236 0.361 1 C-N-CA 132.378 4.271 . . . . 0.0 116.912 169.292 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.981 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 15.5 p -94.05 -178.46 4.64 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 108.461 -3.972 . . . . 0.0 112.515 -173.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.35 153.96 31.29 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.255 1.026 . . . . 0.0 109.551 167.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -82.96 117.51 22.83 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.136 -173.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.21 39.64 18.7 Favored Glycine 0 CA--C 1.555 2.561 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -167.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.43 -146.87 9.33 Favored Glycine 0 N--CA 1.477 1.393 0 CA-C-O 123.198 1.444 . . . . 0.0 112.822 -174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -64.17 131.83 95.12 Favored Pre-proline 0 CA--C 1.573 1.864 0 CA-C-N 112.586 -1.807 . . . . 0.0 108.469 168.601 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -47.97 -36.3 27.17 Favored 'Trans proline' 0 N--CA 1.498 1.74 1 N-CA-C 122.595 4.036 . . . . 0.0 122.595 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.4 m 83.48 131.8 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 111.072 -2.785 . . . . 0.0 106.53 -165.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -56.74 3.33 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.944 -168.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -124.62 72.46 1.21 Allowed 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 124.713 1.205 . . . . 0.0 109.752 -170.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.5 73.58 0.51 Allowed Glycine 0 N--CA 1.482 1.735 0 C-N-CA 123.776 0.703 . . . . 0.0 113.107 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -90.23 174.07 7.8 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 170.73 -96.29 0.11 Allowed Glycine 0 N--CA 1.478 1.444 0 CA-C-O 123.732 1.74 . . . . 0.0 109.545 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.667 ' SG ' ' SG ' ' A' ' 34' ' ' CYS 0.39 5.7 t 93.95 94.32 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 109.536 -3.332 . . . . 0.0 110.648 173.549 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.619 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 31.0 mm -119.92 141.31 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 166.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.631 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 12.5 m -136.88 144.92 43.79 Favored 'General case' 0 CA--C 1.58 2.129 1 N-CA-C 123.461 4.615 . . . . 0.0 123.461 -168.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.539 10.2 p 61.11 -84.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 163.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.305 2.1 mp -38.83 -40.09 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.664 0 CA-C-N 108.969 -3.742 . . . . 0.0 116.438 168.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 37.3 ttp -143.49 -24.9 0.58 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.351 -1.75 . . . . 0.0 113.154 166.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 27' ' ' CYS . . . -43.08 -47.91 6.46 Favored Glycine 0 CA--C 1.558 2.724 0 CA-C-O 125.919 2.955 . . . . 0.0 118.451 164.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.776 0.4 OUTLIER 64.86 100.16 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.888 1 CA-C-N 107.42 -4.39 . . . . 0.0 111.552 -169.507 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.811 0.6 OUTLIER 20.37 55.6 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.928 0 CA-C-N 108.802 -3.817 . . . . 0.0 118.445 -155.427 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.981 ' SG ' ' SG ' ' A' ' 12' ' ' CYS 0.409 0.1 OUTLIER 46.99 173.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 1 CA-C-N 106.528 -4.851 . . . . 0.0 119.573 -168.165 . . . . . . . . 5 4 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -158.67 141.67 14.65 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 109.975 -3.284 . . . . 0.0 108.642 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 90.4 m -83.41 81.55 8.67 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 120.885 1.675 . . . . 0.0 107.387 169.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -66.17 127.45 93.23 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-O 117.084 -1.436 . . . . 0.0 109.592 -169.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -42.57 140.0 2.88 Favored 'Trans proline' 0 CA--C 1.562 1.912 0 N-CA-C 121.89 3.766 . . . . 0.0 121.89 -161.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.403 0.1 OUTLIER 16.45 82.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 1 N-CA-C 121.981 4.067 . . . . 0.0 121.981 179.685 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 tp -106.77 112.25 25.14 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 166.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.366 35.7 mm -111.6 -87.45 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 124.081 1.896 . . . . 0.0 106.952 -171.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.5 ttt -99.11 -9.98 23.13 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 109.703 -3.408 . . . . 0.0 114.991 167.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -64.46 -1.01 1.52 Allowed 'General case' 0 CA--C 1.563 1.458 1 N-CA-C 122.148 4.129 . . . . 0.0 122.148 176.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.57 -76.19 0.03 OUTLIER Glycine 0 CA--C 1.54 1.6 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.384 172.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 mp -133.59 -78.3 0.48 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.67 -99.7 0.17 Allowed Glycine 0 CA--C 1.537 1.423 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 pp -85.41 -32.41 22.36 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 122.817 1.294 . . . . 0.0 110.307 179.971 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.431 ' HG3' ' H ' ' A' ' 3' ' ' LYS 0.277 56.9 pttt -99.01 -92.3 0.27 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 118.427 -0.797 . . . . 0.0 109.14 175.589 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.431 ' H ' ' HG3' ' A' ' 2' ' ' LYS . 32.6 mmtp -141.3 89.27 2.22 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.584 ' HA ' HG22 ' A' ' 17' ' ' THR 0.302 27.8 p -46.83 -174.43 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.997 1 N-CA-C 122.355 4.205 . . . . 0.0 122.355 -177.006 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.505 HG13 ' SG ' ' A' ' 36' ' ' CYS . 24.5 mm -70.79 -49.88 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 C-N-CA 127.533 2.333 . . . . 0.0 111.342 173.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.284 . . 68.71 52.67 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 126.114 1.765 . . . . 0.0 114.215 -171.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -178.66 125.66 0.1 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -176.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -73.49 118.32 16.31 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 166.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.356 0.0 OUTLIER 75.86 80.44 0.1 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 176.614 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.609 ' H ' ' H ' ' A' ' 36' ' ' CYS . . . -172.66 120.31 0.81 Allowed Glycine 0 N--CA 1.471 1.007 0 CA-C-N 109.323 -3.58 . . . . 0.0 115.364 -165.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . 0.35 20.6 tpt85 1.08 70.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 131.116 3.767 . . . . 0.0 119.26 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.7 p -88.97 170.33 10.77 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 110.04 -3.255 . . . . 0.0 112.647 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -140.62 154.85 46.61 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.566 171.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -97.51 95.12 7.42 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 105.485 -2.042 . . . . 0.0 105.485 170.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.83 54.76 0.91 Allowed Glycine 0 CA--C 1.552 2.359 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.979 -167.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.04 -142.81 3.5 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-O 123.214 1.452 . . . . 0.0 110.172 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -58.46 143.9 79.71 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-N 112.777 -1.711 . . . . 0.0 111.167 168.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.06 -132.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.572 2.416 0 C-N-CA 123.0 2.466 . . . . 0.0 110.818 167.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.6 m -152.82 142.31 21.74 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 166.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.41 -55.88 3.69 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 113.349 -1.751 . . . . 0.0 113.545 -168.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -132.44 82.12 1.99 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.835 1.254 . . . . 0.0 109.025 -169.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.82 110.47 3.36 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -133.04 175.88 8.98 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.818 1.785 . . . . 0.0 115.818 -167.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.02 -81.53 0.13 Allowed Glycine 0 N--CA 1.474 1.188 0 CA-C-N 112.331 -2.213 . . . . 0.0 109.554 -168.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.317 16.4 t 79.81 102.13 0.06 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 109.739 -3.231 . . . . 0.0 109.343 -170.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.2 mm -131.54 152.25 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 169.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 34' ' ' CYS 0.347 85.5 m -77.54 150.95 34.73 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 176.18 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.319 41.1 m -152.9 176.03 12.28 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 126.161 1.784 . . . . 0.0 109.229 -165.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.328 3.9 mp 38.04 63.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 C-N-CA 126.476 1.91 . . . . 0.0 112.257 -173.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.285 16.2 mmt 91.07 -6.84 0.27 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 126.141 1.777 . . . . 0.0 115.044 -169.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.37 58.85 3.23 Favored Glycine 0 CA--C 1.557 2.664 0 CA-C-N 122.772 2.533 . . . . 0.0 109.059 -165.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.3 m -151.57 -52.17 0.12 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 124.657 1.183 . . . . 0.0 112.673 -163.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -61.28 -77.1 0.05 OUTLIER 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 124.806 2.241 . . . . 0.0 111.935 169.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 27' ' ' CYS 0.272 2.4 m 79.65 167.23 0.18 Allowed 'General case' 0 CA--C 1.557 1.228 1 CA-C-N 107.337 -4.483 . . . . 0.0 110.094 -167.829 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -160.91 153.3 20.45 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.99 1.316 . . . . 0.0 107.616 -170.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.609 ' H ' ' H ' ' A' ' 10' ' ' GLY . 87.6 m -67.94 67.41 0.11 Allowed 'General case' 0 N--CA 1.508 2.448 0 CA-C-O 124.652 2.167 . . . . 0.0 114.696 171.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.446 34.8 ttmt 46.84 91.97 0.06 OUTLIER Pre-proline 0 CA--C 1.572 1.797 1 N-CA-C 123.244 4.535 . . . . 0.0 123.244 -169.511 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -87.67 -34.6 0.11 Allowed 'Trans proline' 0 CA--C 1.561 1.825 0 C-N-CA 123.792 2.995 . . . . 0.0 118.072 172.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.332 38.7 mmt180 79.65 148.67 0.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.815 1.246 . . . . 0.0 109.741 -166.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.253 6.3 tp -13.04 103.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 119.643 3.201 . . . . 0.0 119.643 -165.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.3 tt -152.17 62.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-N 112.58 -2.1 . . . . 0.0 107.41 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 64.5 mtt 57.71 66.47 1.12 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 124.819 1.248 . . . . 0.0 111.472 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . 0.492 13.1 tt0 -118.96 -98.74 0.45 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 -167.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.13 -58.24 4.43 Favored Glycine 0 CA--C 1.547 2.092 0 CA-C-N 114.156 -1.384 . . . . 0.0 115.419 174.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.76 -79.25 0.49 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.2 -104.15 0.17 Allowed Glycine 0 CA--C 1.535 1.326 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -120.31 -57.83 1.9 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.675 -177.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 123.922 1.82 . . . . 0.0 112.583 179.288 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.0 tttm . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 120.604 0.24 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HA ' HG22 ' A' ' 17' ' ' THR 0.274 21.6 p 52.41 167.94 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 -174.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.8 mm -85.42 -62.17 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.673 0 C-N-CA 125.302 1.441 . . . . 0.0 110.852 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.268 . . 72.19 61.6 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 125.591 1.556 . . . . 0.0 114.051 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -179.5 131.71 0.11 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.4 128.34 35.47 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 166.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 72.58 39.83 0.68 Allowed 'General case' 0 CA--C 1.579 2.09 0 C-N-CA 124.284 1.033 . . . . 0.0 111.745 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.68 134.41 12.31 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -76.89 72.62 3.48 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 126.909 3.242 . . . . 0.0 112.869 -165.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 13.7 p -73.59 -177.72 2.81 Favored 'General case' 0 N--CA 1.489 1.501 1 CA-C-N 106.379 -4.918 . . . . 0.0 114.253 -172.316 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -152.64 154.5 35.46 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.425 1.107 . . . . 0.0 110.055 166.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -90.89 109.19 20.4 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 169.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.02 39.15 2.54 Favored Glycine 0 CA--C 1.558 2.768 0 CA-C-N 114.238 -1.346 . . . . 0.0 113.449 -166.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.81 -139.64 3.11 Favored Glycine 0 N--CA 1.473 1.149 0 CA-C-O 123.838 1.799 . . . . 0.0 109.544 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -70.07 143.11 91.07 Favored Pre-proline 0 CA--C 1.578 2.046 0 CA-C-N 111.823 -2.189 . . . . 0.0 108.9 166.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.69 -127.86 0.0 OUTLIER 'Trans proline' 0 CA--C 1.567 2.159 0 C-N-CA 123.378 2.719 . . . . 0.0 111.805 171.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.4 m -149.44 142.95 25.37 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 165.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -64.45 1.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.925 -169.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -139.77 93.71 2.69 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -173.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.77 100.07 2.56 Favored Glycine 0 N--CA 1.478 1.486 0 N-CA-C 105.938 -2.865 . . . . 0.0 105.938 -167.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -134.13 170.78 15.16 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 123.479 1.609 . . . . 0.0 114.922 -169.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.18 -81.44 0.16 Allowed Glycine 0 N--CA 1.476 1.366 0 CA-C-O 124.673 2.263 . . . . 0.0 110.099 -168.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.491 9.5 t 68.71 44.39 1.17 Allowed 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 109.008 -3.596 . . . . 0.0 116.708 -170.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 66.1 mt -78.36 143.23 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 166.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 97.1 m -92.31 172.95 8.07 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.9 p -79.4 -150.43 0.06 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 114.009 -1.451 . . . . 0.0 110.844 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.3 2.0 pp -98.65 56.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 122.934 1.35 . . . . 0.0 111.76 168.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.317 0.0 OUTLIER -168.64 -40.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.807 1.643 . . . . 0.0 112.839 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.07 50.87 3.53 Favored Glycine 0 N--CA 1.489 2.216 0 CA-C-N 120.476 1.489 . . . . 0.0 114.442 -170.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.0 p -157.93 -72.17 0.09 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 124.444 2.069 . . . . 0.0 111.305 -168.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.32 16.9 m-80 -70.31 39.43 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 131.127 3.771 . . . . 0.0 117.677 169.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 13.6 m -68.28 -157.4 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 112.873 -1.967 . . . . 0.0 113.459 -170.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -156.65 144.06 19.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 119.913 -1.742 . . . . 0.0 109.116 174.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 16.8 m -96.84 89.71 4.98 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? . . . . . 0 CA--C 1.569 1.684 0 N-CA-C 117.236 2.309 . . . . 0.0 117.236 -166.547 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.351 63.1 pttt . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.431 ' HA ' HG22 ' A' ' 17' ' ' THR . 17.9 p 50.36 172.08 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mt -101.56 -63.62 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 C-N-CA 125.252 1.421 . . . . 0.0 110.74 -170.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.3 . . 78.65 60.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.707 1.603 . . . . 0.0 112.65 -169.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -160.16 122.73 3.36 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -73.02 123.15 22.95 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.915 1.286 . . . . 0.0 107.915 168.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.282 23.5 m-85 76.14 36.86 0.39 Allowed 'General case' 0 CA--C 1.581 2.139 0 C-N-CA 124.174 0.99 . . . . 0.0 111.18 -167.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.09 129.07 8.79 Favored Glycine 0 N--CA 1.479 1.511 0 O-C-N 121.12 -0.988 . . . . 0.0 111.138 -174.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.7 tpt85 -75.9 77.0 2.8 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-O 126.588 3.089 . . . . 0.0 109.633 -168.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.817 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -73.93 -179.7 3.86 Favored 'General case' 0 N--CA 1.489 1.482 1 CA-C-N 106.821 -4.718 . . . . 0.0 110.544 -169.012 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -142.37 159.74 41.64 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 114.066 -1.424 . . . . 0.0 108.085 163.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -100.23 97.8 8.55 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.51 46.34 0.92 Allowed Glycine 0 CA--C 1.555 2.543 0 CA-C-N 114.245 -1.343 . . . . 0.0 113.296 -167.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.6 -142.36 3.45 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-O 123.443 1.579 . . . . 0.0 110.349 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.431 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -68.61 142.82 94.49 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-N 112.38 -1.91 . . . . 0.0 109.263 167.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD2' HG22 ' A' ' 17' ' ' THR . 22.3 Cg_endo -68.23 -127.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.57 2.304 0 C-N-CA 123.063 2.508 . . . . 0.0 109.57 168.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.8 m -154.01 151.07 28.94 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 163.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.67 -60.35 1.72 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 114.044 -1.434 . . . . 0.0 111.874 -168.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -121.45 81.14 1.76 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -169.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.09 99.78 2.57 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -172.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -142.72 176.18 9.25 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 123.72 1.724 . . . . 0.0 114.573 -168.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.71 94.62 1.54 Allowed Glycine 0 N--CA 1.477 1.433 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -167.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.931 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 5.8 t -86.96 121.62 29.68 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 110.089 -3.055 . . . . 0.0 111.326 -168.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.507 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 15.6 mm -112.53 136.05 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 166.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.1 m -109.03 -171.84 1.93 Allowed 'General case' 0 CA--C 1.559 1.319 0 CA-C-N 112.73 -2.032 . . . . 0.0 113.912 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 t -115.99 -126.36 0.29 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.918 1.342 . . . . 0.0 110.0 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.2 mm -71.82 -3.34 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 119.079 2.992 . . . . 0.0 119.079 -168.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 20.4 ptp -156.32 -13.0 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.39 -15.37 50.21 Favored Glycine 0 CA--C 1.556 2.636 0 CA-C-N 121.431 1.923 . . . . 0.0 114.83 -165.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.4 p -89.13 -146.59 0.16 Allowed 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 166.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 41.62 36.69 0.61 Allowed 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 169.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.931 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 2.0 t -99.2 -171.34 2.06 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 110.913 -2.858 . . . . 0.0 114.601 -161.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -159.6 148.52 17.86 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 112.22 -2.264 . . . . 0.0 110.56 172.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 13.9 m -103.77 91.57 4.06 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.9 mttt . . . . . 0 CA--C 1.568 1.669 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -169.169 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.479 ' HA ' HG22 ' A' ' 17' ' ' THR 0.308 8.3 p 57.73 169.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 117.411 2.375 . . . . 0.0 117.411 -177.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.592 HG13 ' SG ' ' A' ' 19' ' ' CYS . 32.0 mm -96.6 -64.1 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 124.379 1.072 . . . . 0.0 110.234 -169.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.08 59.04 1.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -173.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -175.88 123.66 0.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -77.42 116.51 18.07 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.474 1.11 . . . . 0.0 109.552 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.309 10.1 m-85 75.71 48.19 0.09 Allowed 'General case' 0 CA--C 1.57 1.737 0 C-N-CA 124.897 1.279 . . . . 0.0 108.084 -167.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.47 -149.77 3.06 Favored Glycine 0 C--N 1.356 1.666 0 CA-C-O 118.472 -1.182 . . . . 0.0 110.541 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -143.78 76.97 1.54 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 124.373 2.035 . . . . 0.0 106.162 -169.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 15.1 p -95.36 -174.33 3.16 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 111.086 -2.779 . . . . 0.0 112.451 -170.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -150.4 142.65 24.19 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.538 167.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -86.33 103.86 15.31 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 168.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.54 50.0 1.47 Allowed Glycine 0 CA--C 1.559 2.783 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.754 -163.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.21 -134.28 1.71 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -169.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -66.99 132.04 93.82 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-N 112.284 -1.958 . . . . 0.0 110.761 170.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -63.47 -34.8 63.92 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 N-CA-C 122.213 3.889 . . . . 0.0 122.213 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.592 ' SG ' HG13 ' A' ' 5' ' ' ILE 0.368 80.2 m 82.31 144.75 0.07 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 111.766 -2.47 . . . . 0.0 108.056 -163.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.74 -68.53 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 118.456 2.761 . . . . 0.0 118.456 -161.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.464 ' HE ' HH12 ' A' ' 23' ' ' ARG . 73.1 mtm180 -111.36 68.5 0.67 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.472 0.653 . . . . 0.0 110.887 -166.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.91 78.13 0.27 Allowed Glycine 0 N--CA 1.484 1.885 0 CA-C-O 119.204 -0.776 . . . . 0.0 113.308 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.464 HH12 ' HE ' ' A' ' 21' ' ' ARG . 40.2 mtt85 -140.81 142.88 34.58 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.452 1.12 . . . . 0.0 111.81 -169.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.05 -86.0 0.02 OUTLIER Glycine 0 N--CA 1.482 1.762 0 N-CA-C 118.16 2.024 . . . . 0.0 118.16 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 36' ' ' CYS 0.417 14.0 t 82.34 38.22 0.05 Allowed 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 109.807 -3.196 . . . . 0.0 115.935 -169.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.9 mt -73.99 143.54 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 123.383 1.563 . . . . 0.0 107.65 168.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 34' ' ' CYS 0.259 96.4 m -93.38 -175.5 3.83 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 111.812 -2.449 . . . . 0.0 116.678 -169.458 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.37 -18.61 64.51 Favored 'General case' 0 N--CA 1.504 2.259 1 N-CA-C 122.297 4.184 . . . . 0.0 122.297 175.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.448 4.2 mp 89.06 77.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.526 0 CA-C-N 109.061 -3.7 . . . . 0.0 105.235 -166.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.2 tpt 177.21 -51.04 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.447 0 CA-C-N 111.144 -2.753 . . . . 0.0 106.986 -167.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.67 -27.33 13.59 Favored Glycine 0 CA--C 1.552 2.363 0 CA-C-O 118.849 -0.973 . . . . 0.0 113.541 -166.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.6 p -90.79 -168.82 2.18 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 167.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 44.98 45.52 8.76 Favored 'General case' 0 N--CA 1.511 2.617 0 CA-C-O 125.724 2.678 . . . . 0.0 117.549 168.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 3.7 m -90.08 -179.35 5.66 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 108.609 -3.905 . . . . 0.0 111.504 -166.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -141.72 147.24 37.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.38 -0.825 . . . . 0.0 110.202 168.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 25' ' ' CYS 0.314 1.5 m -93.03 77.89 4.65 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.189 -177.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.588 -1.196 . . . . 0.0 111.36 -172.467 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.191 0.519 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.59 ' HA ' HG22 ' A' ' 17' ' ' THR 0.347 20.9 p -136.88 -171.75 3.01 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-O 123.215 1.483 . . . . 0.0 114.85 -166.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.36 109.7 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.485 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 169.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.12 69.63 2.03 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.222 1.01 . . . . 0.0 110.204 172.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -165.45 122.33 1.46 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 -173.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -75.96 120.4 21.23 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.765 1.226 . . . . 0.0 109.674 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.314 5.6 m-85 77.99 29.01 0.5 Allowed 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 124.966 1.306 . . . . 0.0 113.601 -170.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.89 117.17 5.73 Favored Glycine 0 N--CA 1.469 0.846 0 O-C-N 120.89 -1.131 . . . . 0.0 112.868 -171.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -22.9 81.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 1 C-N-CA 131.909 4.084 . . . . 0.0 116.233 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.867 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 13.0 p -85.38 -178.87 6.83 Favored 'General case' 0 N--CA 1.491 1.609 1 CA-C-N 106.983 -4.644 . . . . 0.0 112.402 -171.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -146.14 155.17 42.55 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 122.884 1.326 . . . . 0.0 108.757 169.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 49.8 m0 -94.94 100.15 12.05 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.91 53.92 1.25 Allowed Glycine 0 CA--C 1.552 2.388 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.405 -166.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.07 -143.64 3.78 Favored Glycine 0 N--CA 1.477 1.371 0 CA-C-O 123.19 1.439 . . . . 0.0 110.737 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -63.69 132.53 95.23 Favored Pre-proline 0 CA--C 1.576 1.979 0 CA-C-N 112.848 -1.676 . . . . 0.0 110.522 170.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -51.73 -39.02 67.69 Favored 'Trans proline' 0 N--CA 1.498 1.755 1 N-CA-C 123.284 4.302 . . . . 0.0 123.284 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 16.3 m 90.52 139.65 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 111.405 -2.634 . . . . 0.0 104.842 -163.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -85.02 -64.39 1.17 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 120.576 3.547 . . . . 0.0 120.576 -162.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -127.82 80.85 1.98 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.886 0.851 . . . . 0.0 109.608 -164.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.29 66.85 1.98 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 115.152 -0.931 . . . . 0.0 114.391 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.6 mtt85 -141.58 156.44 45.69 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.834 1.302 . . . . 0.0 111.031 -169.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.62 -130.85 6.65 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-O 123.196 1.442 . . . . 0.0 112.029 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.471 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 48.9 t 166.13 107.91 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 102.815 -3.032 . . . . 0.0 102.815 173.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.521 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 29.8 mm -121.2 134.32 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 170.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 33' ' ' ASN . 33.0 m -107.84 -177.78 3.44 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-N 112.775 -2.011 . . . . 0.0 111.235 174.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 t -89.96 -173.34 3.84 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 124.561 2.124 . . . . 0.0 112.567 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 pp -93.38 63.9 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 110.681 -2.963 . . . . 0.0 108.889 166.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.2 tpt 177.71 -49.27 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 112.637 -2.074 . . . . 0.0 110.348 -168.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.35 18.13 69.71 Favored Glycine 0 CA--C 1.568 3.372 0 CA-C-O 118.962 -0.91 . . . . 0.0 114.725 -162.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.301 6.0 p -121.59 114.3 20.99 Favored 'General case' 0 N--CA 1.486 1.352 1 N-CA-C 96.065 -5.531 . . . . 0.0 96.065 158.462 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 27' ' ' CYS 0.304 48.9 p30 -145.45 -90.36 0.1 Allowed 'General case' 0 CA--C 1.559 1.313 1 N-CA-C 134.521 8.712 . . . . 0.0 134.521 -138.635 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.867 ' SG ' ' SG ' ' A' ' 12' ' ' CYS 0.27 0.1 OUTLIER -74.47 -174.61 2.1 Favored 'General case' 0 C--N 1.305 -1.367 1 CA-C-N 106.273 -4.967 . . . . 0.0 119.848 -143.839 . . . . . . . . 5 4 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -170.11 137.25 1.53 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 109.163 -3.653 . . . . 0.0 109.604 -173.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.6 m -84.44 94.41 8.51 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 173.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp . . . . . 0 CA--C 1.573 1.862 0 CA-C-O 117.272 -1.346 . . . . 0.0 112.051 -167.858 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.1 tttt . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 120.662 0.267 . . . . 0.0 111.4 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.6 p 50.37 178.33 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.871 2.175 . . . . 0.0 116.871 -168.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.2 mt -128.04 127.14 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.57 71.01 0.75 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.257 1.027 . . . . 0.0 112.563 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -125.41 177.04 6.4 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 124.845 2.26 . . . . 0.0 116.09 -168.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -118.08 100.73 7.72 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.316 -2.22 . . . . 0.0 105.913 158.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.328 1.1 m-85 79.18 63.4 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 122.885 2.584 . . . . 0.0 107.309 172.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.16 -165.22 3.21 Favored Glycine 0 C--N 1.351 1.413 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.553 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -134.66 75.28 1.57 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.93 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 27.7 p -75.36 -179.17 4.36 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 113.093 -1.867 . . . . 0.0 113.135 -169.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -143.89 151.96 40.51 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 122.994 1.378 . . . . 0.0 108.155 167.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.3 m0 -99.66 93.83 6.04 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 168.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.32 41.02 0.56 Allowed Glycine 0 CA--C 1.56 2.89 0 CA-C-N 113.456 -1.702 . . . . 0.0 112.732 -166.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.79 -142.59 3.43 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.65 139.33 91.29 Favored Pre-proline 0 N--CA 1.499 1.993 0 CA-C-N 113.236 -1.482 . . . . 0.0 107.978 166.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -66.02 -129.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.572 2.38 0 C-N-CA 123.026 2.484 . . . . 0.0 111.19 169.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.2 m -152.63 139.28 18.79 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 165.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.57 160.54 26.4 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 122.889 1.328 . . . . 0.0 111.649 -170.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 38.5 mtt85 47.59 59.63 4.02 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.09 100.37 0.24 Allowed Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.46 -0.775 . . . . 0.0 112.423 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -112.23 169.87 8.56 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -168.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.56 -87.47 1.89 Allowed Glycine 0 CA--C 1.536 1.383 0 CA-C-N 111.67 -2.513 . . . . 0.0 108.686 166.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' SG ' ' SG ' ' A' ' 34' ' ' CYS 0.415 22.4 t 65.66 55.96 0.96 Allowed 'General case' 0 CA--C 1.561 1.391 0 CA-C-N 110.49 -2.855 . . . . 0.0 113.749 -169.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.539 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 54.1 mt -83.2 133.85 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 167.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.1 m -119.34 178.82 4.39 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 118.137 2.643 . . . . 0.0 118.137 -166.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 p -159.5 153.16 22.8 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-O 124.499 2.095 . . . . 0.0 111.986 -167.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.327 2.4 mp 40.27 60.18 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 CA-C-N 109.97 -3.286 . . . . 0.0 113.416 -169.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.274 15.7 mmt 85.37 7.15 0.43 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.02 69.05 1.29 Allowed Glycine 0 N--CA 1.486 1.987 0 CA-C-N 122.122 2.237 . . . . 0.0 111.664 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.1 p -149.96 -76.37 0.15 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 123.763 1.744 . . . . 0.0 109.94 -168.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.77 21.81 0.05 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 119.814 3.264 . . . . 0.0 119.814 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.93 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 8.6 t -59.75 -168.81 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 112.286 -2.233 . . . . 0.0 115.405 -167.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -149.28 144.54 26.55 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.704 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 18.2 m -101.21 116.65 33.31 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? . . . . . 0 CA--C 1.574 1.877 0 CA-C-N 119.988 1.267 . . . . 0.0 109.711 170.038 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.638 ' HA ' HG22 ' A' ' 17' ' ' THR 0.318 14.0 p -119.48 -167.47 1.42 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 126.688 1.995 . . . . 0.0 115.297 -169.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.9 mm -94.65 -70.44 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.723 0 C-N-CA 125.137 1.375 . . . . 0.0 107.94 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.52 67.38 0.65 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.849 1.66 . . . . 0.0 114.652 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -174.6 128.76 0.33 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.06 120.0 15.99 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.108 1.363 . . . . 0.0 109.603 171.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.308 2.2 m-85 72.31 44.6 0.42 Allowed 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 124.82 1.248 . . . . 0.0 109.485 -167.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -75.18 -150.7 2.57 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-O 118.221 -1.322 . . . . 0.0 110.806 173.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.4 mmt-85 -147.35 74.54 1.33 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -171.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.803 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -77.06 -177.38 4.44 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 123.284 1.516 . . . . 0.0 111.09 -169.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -141.97 125.34 16.58 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 166.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 52.1 m0 -76.26 111.69 11.96 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 169.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.31 47.03 5.36 Favored Glycine 0 CA--C 1.558 2.723 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.566 -165.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.72 -135.37 1.81 Allowed Glycine 0 N--CA 1.472 1.098 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -169.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -61.94 140.48 95.69 Favored Pre-proline 0 CA--C 1.573 1.828 0 CA-C-N 112.361 -1.919 . . . . 0.0 112.033 169.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -71.11 -128.05 0.01 OUTLIER 'Trans proline' 0 CA--C 1.567 2.126 0 C-N-CA 123.28 2.653 . . . . 0.0 110.774 167.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.2 8.97 0.64 Allowed 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 119.379 3.103 . . . . 0.0 119.379 167.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 79.41 -67.61 0.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 111.106 -2.77 . . . . 0.0 114.737 169.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -112.56 65.77 0.64 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.86 1.264 . . . . 0.0 110.687 -168.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.5 77.06 0.17 Allowed Glycine 0 CA--C 1.542 1.771 0 N-CA-C 116.673 1.429 . . . . 0.0 116.673 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.6 ttm105 -140.99 141.12 34.41 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 118.013 0.907 . . . . 0.0 111.613 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.35 105.1 3.05 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-O 125.021 2.456 . . . . 0.0 108.727 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.858 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 27.4 t -64.85 128.29 35.16 Favored 'General case' 0 CA--C 1.558 1.266 1 CA-C-N 107.887 -4.157 . . . . 0.0 112.489 170.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.463 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 29.6 mm -115.89 140.12 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 165.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 86.6 m -107.99 -174.71 2.59 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-N 113.831 -1.531 . . . . 0.0 114.786 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.81 -19.04 65.63 Favored 'General case' 0 N--CA 1.502 2.153 1 N-CA-C 122.155 4.132 . . . . 0.0 122.155 175.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.452 4.1 mp 86.91 75.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.487 0 CA-C-N 109.251 -3.613 . . . . 0.0 105.718 -167.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.7 ttt 176.27 -51.33 0.01 OUTLIER 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 111.333 -2.667 . . . . 0.0 106.772 -167.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.89 -32.7 6.19 Favored Glycine 0 CA--C 1.546 1.979 0 CA-C-O 118.585 -1.12 . . . . 0.0 113.709 -168.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 p -79.44 -170.61 2.39 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-O 124.67 2.176 . . . . 0.0 105.384 168.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.6 m120 36.75 55.36 1.17 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 126.117 2.865 . . . . 0.0 115.732 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.858 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 8.0 t -102.67 -163.9 1.04 Allowed 'General case' 0 C--N 1.312 -1.037 1 CA-C-N 108.097 -4.138 . . . . 0.0 113.96 -161.647 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.423 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 10.9 pt-20 -157.78 150.98 23.29 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 112.244 -2.253 . . . . 0.0 112.046 171.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.404 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 16.8 m -90.91 81.39 5.7 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 169.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt . . . . . 0 CA--C 1.567 1.628 0 CA-C-O 117.269 -1.348 . . . . 0.0 110.653 -169.083 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? . . . . . 0 N--CA 1.495 1.806 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.504 ' HA ' HG22 ' A' ' 17' ' ' THR . 16.4 p 51.63 169.02 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 118.542 2.793 . . . . 0.0 118.542 -170.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt -115.42 107.53 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.84 69.62 4.65 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.48 1.133 . . . . 0.0 110.831 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -160.48 112.91 2.0 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 104.281 -2.489 . . . . 0.0 104.281 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -75.79 126.55 31.23 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.894 1.278 . . . . 0.0 110.366 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.298 12.0 m-85 73.41 38.77 0.63 Allowed 'General case' 0 CA--C 1.58 2.108 0 C-N-CA 124.413 1.085 . . . . 0.0 111.149 -167.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.35 132.39 11.11 Favored Glycine 0 N--CA 1.483 1.795 0 O-C-N 120.946 -1.097 . . . . 0.0 110.403 -174.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -74.83 70.35 1.92 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 127.108 3.337 . . . . 0.0 112.457 -167.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.716 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 31.4 p -72.27 -174.78 1.37 Allowed 'General case' 0 N--CA 1.483 1.203 1 CA-C-N 106.088 -5.051 . . . . 0.0 114.232 -173.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -152.61 164.26 38.03 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.595 169.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -97.26 104.14 16.14 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 169.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.69 41.81 1.09 Allowed Glycine 0 CA--C 1.557 2.709 0 CA-C-N 113.904 -1.498 . . . . 0.0 113.025 -166.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.98 -146.66 4.4 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-O 123.417 1.565 . . . . 0.0 111.247 -175.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.504 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -70.11 132.32 88.34 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-N 112.791 -1.705 . . . . 0.0 108.275 167.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -54.89 -34.11 84.54 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 N-CA-C 121.915 3.775 . . . . 0.0 121.915 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . 0.297 74.3 m 87.42 148.0 0.05 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 111.288 -2.687 . . . . 0.0 109.205 -165.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.09 176.31 5.17 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.869 -168.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . 0.254 32.6 ptt180 42.53 56.12 3.91 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 119.433 3.123 . . . . 0.0 119.433 167.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.02 102.64 0.1 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.28 161.97 36.6 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -167.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -178.78 120.25 0.69 Allowed Glycine 0 CA--C 1.529 0.96 0 N-CA-C 106.809 -2.516 . . . . 0.0 106.809 168.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 39.7 t -91.82 81.86 5.2 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 111.446 -2.377 . . . . 0.0 112.827 -169.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.557 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -75.75 134.9 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 168.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.5 m -118.39 178.11 4.57 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 112.944 -1.935 . . . . 0.0 114.523 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.288 57.9 m -79.11 -149.98 0.05 Allowed 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 125.149 1.38 . . . . 0.0 110.808 178.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.82 58.11 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.902 0.858 . . . . 0.0 108.88 169.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.93 -57.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.41 1.084 . . . . 0.0 111.712 -173.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.44 54.15 1.49 Allowed Glycine 0 CA--C 1.548 2.13 0 CA-C-O 119.278 -0.734 . . . . 0.0 112.777 -167.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.8 p -153.73 -73.96 0.13 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 123.824 1.773 . . . . 0.0 111.364 -168.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.314 8.6 m120 -67.34 33.53 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 129.679 3.191 . . . . 0.0 118.01 168.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 30.9 t -77.27 -150.62 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 111.839 -2.437 . . . . 0.0 113.731 -167.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -172.52 143.58 1.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.206 169.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 6.9 m -105.36 98.78 8.44 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.573 1.842 0 CA-C-O 116.943 -1.503 . . . . 0.0 112.802 -168.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.67 ' HA ' HG22 ' A' ' 17' ' ' THR . 17.2 p -24.27 174.32 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.065 1 N-CA-C 127.247 6.017 . . . . 0.0 127.247 -168.311 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mt -109.19 117.3 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 127.823 2.449 . . . . 0.0 104.413 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.65 71.7 1.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.062 0.934 . . . . 0.0 110.25 173.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -169.82 123.2 0.74 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -76.11 128.5 35.1 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.869 1.267 . . . . 0.0 110.602 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.281 13.0 m-85 73.79 38.78 0.58 Allowed 'General case' 0 CA--C 1.578 2.055 0 C-N-CA 124.836 1.254 . . . . 0.0 110.689 -168.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.93 122.5 7.42 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.222 -0.924 . . . . 0.0 111.69 -169.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -33.58 82.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 1 C-N-CA 132.857 4.463 . . . . 0.0 115.246 -172.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 3.8 p -88.65 173.39 8.64 Favored 'General case' 0 N--CA 1.491 1.592 1 CA-C-N 107.471 -4.422 . . . . 0.0 113.8 -167.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -153.59 144.96 23.1 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.936 169.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -86.69 103.2 14.93 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 168.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.71 47.28 1.81 Allowed Glycine 0 CA--C 1.557 2.663 0 CA-C-N 114.526 -1.216 . . . . 0.0 112.733 -165.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.39 -141.4 3.48 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-O 123.29 1.494 . . . . 0.0 109.954 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.67 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -65.41 133.64 95.42 Favored Pre-proline 0 CA--C 1.577 1.985 0 CA-C-N 112.669 -1.765 . . . . 0.0 109.988 169.393 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -55.76 -35.37 93.35 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 N-CA-C 122.423 3.97 . . . . 0.0 122.423 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . 0.314 66.3 m 79.05 143.42 0.08 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 111.635 -2.53 . . . . 0.0 107.28 -163.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.47 -62.78 1.2 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -162.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -126.04 80.46 1.91 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.946 0.879 . . . . 0.0 109.089 -166.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.15 102.19 1.97 Allowed Glycine 0 N--CA 1.476 1.354 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.618 -176.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.54 165.94 18.95 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-O 123.588 1.661 . . . . 0.0 112.577 -169.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -156.88 -81.01 0.03 OUTLIER Glycine 0 N--CA 1.477 1.432 0 CA-C-O 124.31 2.061 . . . . 0.0 109.314 -169.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.415 19.9 t 79.34 50.79 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 109.202 -3.499 . . . . 0.0 115.166 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 76.9 mt -82.68 149.44 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 122.975 1.369 . . . . 0.0 107.421 167.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.419 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 69.3 m -93.14 171.25 9.06 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 -170.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.274 69.6 m -91.09 -147.14 0.2 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.348 1.459 . . . . 0.0 109.635 -174.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 mm -94.2 50.88 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 CA-C-O 122.859 1.314 . . . . 0.0 110.213 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.1 ttt -172.76 -52.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.865 1.266 . . . . 0.0 112.417 -169.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.39 50.3 2.41 Favored Glycine 0 CA--C 1.548 2.154 0 CA-C-N 118.741 0.701 . . . . 0.0 113.749 -168.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.4 p -151.94 -79.11 0.11 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.906 1.336 . . . . 0.0 109.136 -169.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.81 -26.87 68.82 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 121.214 3.783 . . . . 0.0 121.214 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.534 ' HB2' ' SG ' ' A' ' 12' ' ' CYS 0.376 6.7 m 37.27 -151.69 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 130.161 3.385 . . . . 0.0 117.714 172.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -175.75 133.57 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.1 m -89.73 95.47 10.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.193 -0.942 . . . . 0.0 109.246 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? . . . . . 0 CA--C 1.573 1.856 0 CA-C-O 116.763 -1.589 . . . . 0.0 112.027 -170.904 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.5 mttm . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.444 ' HA ' HG22 ' A' ' 17' ' ' THR . 25.6 p 49.21 170.03 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 118.61 2.819 . . . . 0.0 118.61 -169.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mm -102.41 108.45 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.76 72.89 2.29 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.347 1.07 . . . . 0.0 110.053 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -176.6 123.9 0.16 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 -171.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -75.22 127.95 34.35 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 168.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.27 12.1 m-85 74.78 30.09 1.02 Allowed 'General case' 0 CA--C 1.579 2.093 0 C-N-CA 124.903 1.281 . . . . 0.0 113.607 -169.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.96 131.27 10.59 Favored Glycine 0 N--CA 1.474 1.227 0 O-C-N 120.91 -1.119 . . . . 0.0 112.237 -169.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -55.47 82.21 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 130.324 3.45 . . . . 0.0 114.69 -167.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.521 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 22.3 p -90.41 173.15 8.26 Favored 'General case' 0 N--CA 1.494 1.751 1 CA-C-N 106.374 -4.921 . . . . 0.0 113.242 -168.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -150.66 128.85 11.94 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.507 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -77.16 111.13 12.44 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 170.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.54 33.9 5.73 Favored Glycine 0 CA--C 1.559 2.807 0 CA-C-N 114.826 -1.079 . . . . 0.0 114.531 -166.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.24 -139.99 3.63 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-O 123.449 1.583 . . . . 0.0 109.667 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -63.55 137.26 97.03 Favored Pre-proline 0 CA--C 1.573 1.864 0 CA-C-N 112.42 -1.89 . . . . 0.0 109.772 168.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -66.92 -172.91 0.35 Allowed 'Trans proline' 0 CA--C 1.57 2.313 0 CA-C-N 123.546 2.302 . . . . 0.0 110.834 167.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.9 m -101.84 149.16 24.47 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 167.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.71 -60.17 1.76 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.865 -173.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -137.24 87.3 2.26 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.944 1.297 . . . . 0.0 108.128 -169.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.78 116.2 4.15 Favored Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -169.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -138.24 176.23 8.88 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -167.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.37 109.23 2.84 Favored Glycine 0 N--CA 1.475 1.263 0 CA-C-N 112.367 -2.197 . . . . 0.0 109.039 -170.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.8 t -109.77 75.66 0.95 Allowed 'General case' 0 CA--C 1.56 1.327 0 CA-C-N 111.837 -2.182 . . . . 0.0 111.587 -169.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.401 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 36.4 mm -89.45 144.58 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 169.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 34' ' ' CYS 0.304 6.5 m -105.75 161.8 14.09 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 125.023 1.452 . . . . 0.0 113.002 177.045 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.642 ' HA ' ' H ' ' A' ' 31' ' ' GLY 0.823 2.9 t 81.74 -176.52 0.05 OUTLIER 'General case' 0 C--N 1.353 0.736 0 N-CA-C 120.605 3.557 . . . . 0.0 120.605 156.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.311 4.1 mp 70.83 64.08 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.586 2.331 0 CA-C-N 108.468 -3.969 . . . . 0.0 104.002 -158.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.272 0.0 OUTLIER 136.33 -58.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 128.582 2.753 . . . . 0.0 104.073 -162.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.642 ' H ' ' HA ' ' A' ' 28' ' ' SER . . . 62.34 47.65 88.08 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 120.208 2.843 . . . . 0.0 120.208 -169.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.299 22.7 p -98.66 102.79 14.63 Favored 'General case' 0 CA--C 1.553 1.059 1 N-CA-C 94.359 -6.163 . . . . 0.0 94.359 151.798 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.404 ' O ' ' SG ' ' A' ' 27' ' ' CYS 0.62 3.5 p-10 -87.82 70.89 9.59 Favored 'General case' 0 N--CA 1.439 -1.015 2 CA-C-N 105.29 -5.414 . . . . 0.0 122.177 -148.202 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 27' ' ' CYS 0.414 59.3 m 123.19 171.24 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 3 CA-C-N 101.572 -7.104 . . . . 0.0 113.402 160.774 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -150.01 143.17 25.0 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 112.032 -2.349 . . . . 0.0 106.46 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 12.8 m -89.8 86.35 6.64 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -167.994 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.6 tptt . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.585 ' HA ' HG22 ' A' ' 17' ' ' THR 0.284 22.0 p 41.93 -171.46 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 118.87 2.915 . . . . 0.0 118.87 173.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.415 HG13 ' SG ' ' A' ' 19' ' ' CYS . 4.5 mm -113.22 -62.81 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.546 0 CA-C-N 113.449 -1.705 . . . . 0.0 110.25 -164.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.254 . . 66.11 60.64 0.64 Allowed 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 125.278 1.431 . . . . 0.0 114.572 -169.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -169.75 131.44 1.09 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 173.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -68.14 136.07 53.11 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 125.264 1.425 . . . . 0.0 110.235 169.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 66.34 34.61 6.29 Favored 'General case' 0 CA--C 1.581 2.169 0 C-N-CA 124.257 1.023 . . . . 0.0 112.093 -167.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.65 132.16 10.87 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -169.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -73.52 73.77 1.43 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 126.971 3.272 . . . . 0.0 112.116 -167.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 24.3 p -71.02 174.8 5.77 Favored 'General case' 0 N--CA 1.486 1.35 1 CA-C-N 106.056 -5.066 . . . . 0.0 114.074 -176.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.985 ' H ' ' HG2' ' A' ' 18' ' ' PRO . 17.9 ptpt -129.2 159.1 37.11 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 123.42 1.581 . . . . 0.0 111.158 171.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 52.6 m0 -104.61 91.29 3.8 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 168.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.91 -81.11 0.06 OUTLIER Glycine 0 N--CA 1.478 1.442 0 N-CA-C 106.491 -2.644 . . . . 0.0 106.491 -166.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.86 135.87 2.02 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 125.154 2.53 . . . . 0.0 118.093 163.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.645 ' HB ' ' HD3' ' A' ' 18' ' ' PRO . 14.8 m 168.64 -65.12 0.0 OUTLIER Pre-proline 0 CA--C 1.59 2.493 1 CA-C-N 107.266 -4.467 . . . . 0.0 101.393 -168.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.985 ' HG2' ' H ' ' A' ' 13' ' ' LYS 1.105 0.6 OUTLIER -24.85 155.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.827 2 N-CA-C 135.587 9.033 . . . . 0.0 135.587 -156.146 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.439 ' H ' ' HB3' ' A' ' 18' ' ' PRO 0.345 31.4 m -23.92 117.5 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.272 2 CA-C-N 105.167 -5.47 . . . . 0.0 114.873 -156.667 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.33 156.13 39.43 Favored 'General case' 0 C--N 1.297 -1.708 1 CA-C-N 106.378 -4.919 . . . . 0.0 109.373 -163.239 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 58.39 49.28 11.08 Favored 'General case' 0 CA--C 1.586 2.339 0 CA-C-N 112.989 -1.914 . . . . 0.0 113.768 -173.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.23 142.48 6.77 Favored Glycine 0 CA--C 1.556 2.642 0 N-CA-C 115.316 0.886 . . . . 0.0 115.316 -169.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.53 162.81 40.91 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -153.52 105.52 0.28 Allowed Glycine 0 N--CA 1.475 1.268 0 N-CA-C 105.751 -2.94 . . . . 0.0 105.751 164.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.87 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 54.0 t -99.07 125.09 44.51 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 110.787 -2.707 . . . . 0.0 109.568 -174.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.537 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 23.6 mm -117.27 134.07 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 166.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.576 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 68.2 m -121.56 173.25 7.53 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -172.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 p -120.05 135.42 54.94 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 125.072 1.349 . . . . 0.0 111.085 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.296 9.6 mt -5.61 56.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.39 2 CA-C-N 108.264 -4.062 . . . . 0.0 116.571 -168.659 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.8 tpt 172.57 -56.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 113.076 -1.875 . . . . 0.0 113.765 -167.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.36 53.0 1.64 Allowed Glycine 0 CA--C 1.552 2.362 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -163.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 99.6 m -150.77 -69.8 0.18 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 123.124 1.44 . . . . 0.0 111.665 -167.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.283 9.6 m-80 -71.23 30.16 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 118.466 2.765 . . . . 0.0 118.466 169.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.87 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 17.7 t -76.47 -156.79 0.07 Allowed 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 112.496 -2.138 . . . . 0.0 115.061 -166.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.08 147.62 4.74 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 113.658 -1.61 . . . . 0.0 110.666 168.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 20.2 m -100.16 95.89 7.12 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt . . . . . 0 CA--C 1.576 1.969 0 CA-C-O 117.54 -1.219 . . . . 0.0 112.555 -169.195 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.7 tttt . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.2 p 54.41 170.75 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.526 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 31.7 mm -99.47 103.96 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 175.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.46 66.26 1.99 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.234 1.016 . . . . 0.0 112.456 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -174.89 119.83 0.21 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -170.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -75.18 129.38 37.41 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.908 1.283 . . . . 0.0 108.535 169.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 72.47 44.13 0.43 Allowed 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -166.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.498 ' N ' ' H ' ' A' ' 36' ' ' CYS . . . -81.49 -148.03 6.13 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-O 117.428 -1.762 . . . . 0.0 111.416 -173.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -144.75 75.92 1.47 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -175.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.2 p -97.76 -175.44 3.17 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 112.737 -2.029 . . . . 0.0 113.563 -168.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -153.5 160.63 42.58 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.227 -1.352 . . . . 0.0 110.065 166.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -95.9 108.01 20.34 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 169.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.62 38.83 2.0 Allowed Glycine 0 CA--C 1.558 2.764 0 CA-C-N 113.896 -1.502 . . . . 0.0 113.312 -166.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.03 -140.17 3.86 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 123.637 1.687 . . . . 0.0 110.05 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.599 HG23 ' H ' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -62.3 166.13 7.45 Favored Pre-proline 0 CA--C 1.596 2.748 0 CA-C-N 112.052 -2.074 . . . . 0.0 113.0 168.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -62.39 -30.96 81.18 Favored 'Trans proline' 0 CA--C 1.568 2.222 0 N-CA-C 122.401 3.962 . . . . 0.0 122.401 169.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.599 ' H ' HG23 ' A' ' 17' ' ' THR 0.323 6.2 t 78.54 139.64 0.07 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 111.649 -2.523 . . . . 0.0 107.138 -162.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.74 -64.28 1.16 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -164.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . 0.29 40.8 mtm105 -92.11 -130.37 0.11 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.811 1.291 . . . . 0.0 109.116 -168.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.65 94.93 0.25 Allowed Glycine 0 N--CA 1.486 1.994 0 CA-C-N 112.799 -2.0 . . . . 0.0 111.048 169.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -106.47 169.05 8.75 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 123.948 1.832 . . . . 0.0 115.646 -165.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.28 103.62 0.21 Allowed Glycine 0 N--CA 1.471 0.988 0 N-CA-C 105.484 -3.046 . . . . 0.0 105.484 169.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.7 t -88.33 77.33 8.2 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 111.006 -2.597 . . . . 0.0 111.631 -169.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.1 mm -82.36 144.99 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 168.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 32' ' ' THR . 3.1 t -110.58 -176.09 2.89 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -176.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.315 42.5 m -101.97 -142.18 0.35 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.849 1.66 . . . . 0.0 109.195 -169.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.4 mm -72.87 -5.82 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -174.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.0 mmt -141.49 -24.63 0.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.431 ' HA2' ' SG ' ' A' ' 27' ' ' CYS . . . 91.3 58.05 1.5 Allowed Glycine 0 CA--C 1.551 2.283 0 CA-C-N 121.084 1.766 . . . . 0.0 110.929 -166.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.439 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 17.7 p -149.06 -74.93 0.17 Allowed 'General case' 0 CA--C 1.563 1.451 0 CA-C-O 124.2 1.952 . . . . 0.0 111.832 -168.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.358 33.5 m-20 -88.24 40.76 0.97 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 130.381 3.472 . . . . 0.0 115.303 -174.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -64.06 -167.47 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 112.328 -2.215 . . . . 0.0 115.518 -166.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -136.73 150.48 48.44 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.375 -0.828 . . . . 0.0 110.856 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.498 ' H ' ' N ' ' A' ' 10' ' ' GLY . 13.2 m -87.13 52.32 2.48 Favored 'General case' 0 N--CA 1.52 3.074 0 CA-C-O 123.96 1.838 . . . . 0.0 112.364 169.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.428 0.1 OUTLIER . . . . . 0 CA--C 1.557 1.248 0 C-N-CA 127.178 2.191 . . . . 0.0 115.134 169.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.823 0.344 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.468 ' HA ' HG22 ' A' ' 17' ' ' THR . 11.5 p 54.75 -178.15 0.03 OUTLIER 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 173.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.521 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 6.1 mm -133.47 114.09 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 -171.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.6 65.84 4.41 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.01 0.91 . . . . 0.0 112.003 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -163.18 122.67 2.16 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.4 127.25 31.55 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.534 0.734 . . . . 0.0 110.617 167.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 69.59 39.68 1.51 Allowed 'General case' 0 CA--C 1.576 1.968 0 C-N-CA 123.546 0.739 . . . . 0.0 111.831 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.56 126.3 7.33 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -78.83 70.92 5.25 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 127.048 3.308 . . . . 0.0 111.823 -166.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.1 p -74.43 -167.18 0.51 Allowed 'General case' 0 CA--C 1.562 1.404 1 CA-C-N 106.288 -4.96 . . . . 0.0 113.782 -167.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 34' ' ' CYS 0.389 0.1 OUTLIER 105.68 90.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 127.49 2.316 . . . . 0.0 106.841 173.851 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.494 ' NE1' HD11 ' A' ' 5' ' ' ILE 0.341 69.7 m95 -107.61 -140.42 0.37 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 110.502 -3.045 . . . . 0.0 102.963 -169.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.13 43.61 3.15 Favored Glycine 1 CA--C 1.585 4.433 0 N-CA-C 105.836 -2.906 . . . . 0.0 105.836 149.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.87 136.58 0.0 OUTLIER Glycine 0 CA--C 1.557 2.677 0 C-N-CA 126.926 2.203 . . . . 0.0 114.027 -162.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 4' ' ' CYS . 2.5 m -134.66 134.96 22.65 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 170.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -48.44 -37.13 32.55 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 N-CA-C 119.999 3.038 . . . . 0.0 119.999 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.521 ' SG ' ' HB ' ' A' ' 5' ' ' ILE 0.258 16.6 t 74.32 141.4 0.07 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.997 -1.91 . . . . 0.0 106.982 -164.166 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 160.15 19.12 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 113.219 -1.81 . . . . 0.0 112.859 -165.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.6 mtt85 63.81 62.99 0.86 Allowed 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 112.795 -2.002 . . . . 0.0 113.177 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.44 68.81 1.52 Allowed Glycine 0 CA--C 1.545 1.911 0 N-CA-C 115.911 1.125 . . . . 0.0 115.911 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.28 161.41 42.09 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-O 123.222 1.487 . . . . 0.0 112.353 -172.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.86 118.68 1.27 Allowed Glycine 0 N--CA 1.478 1.47 1 N-CA-C 102.935 -4.066 . . . . 0.0 102.935 166.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.616 9.1 t -45.38 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 125.441 1.318 . . . . 0.0 113.857 -166.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.275 60.6 mt 74.13 150.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 123.286 1.517 . . . . 0.0 110.855 172.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 90.6 m -90.64 171.09 9.62 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 119.454 3.131 . . . . 0.0 119.454 -169.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.336 13.3 m -94.79 -142.85 0.25 Allowed 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 126.706 2.002 . . . . 0.0 108.928 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.25 1.9 pp -96.74 59.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 123.132 1.444 . . . . 0.0 111.32 168.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.9 ttt -161.52 -46.27 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.608 -1.633 . . . . 0.0 113.01 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.41 38.25 11.16 Favored Glycine 0 CA--C 1.556 2.638 0 CA-C-O 119.336 -0.702 . . . . 0.0 113.434 -165.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 m -162.28 -59.84 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 123.762 1.744 . . . . 0.0 111.465 -167.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.374 26.0 m-20 -79.11 45.87 0.66 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 129.781 3.232 . . . . 0.0 114.932 171.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 13' ' ' LYS 0.267 36.3 m -69.54 -167.14 0.12 Allowed 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.415 -167.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -163.15 138.11 6.48 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 119.709 -1.869 . . . . 0.0 108.812 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.9 m -51.69 -47.84 63.73 Favored 'General case' 0 N--CA 1.512 2.652 0 CA-C-O 125.557 2.599 . . . . 0.0 117.861 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.391 23.0 mtmm . . . . . 0 CA--C 1.578 2.027 1 CA-C-N 105.727 -5.215 . . . . 0.0 109.57 -165.13 . . . . . . . . 2 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.1 tptm . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.441 ' HA ' HG22 ' A' ' 17' ' ' THR . 13.6 p 50.59 178.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 119.04 2.978 . . . . 0.0 119.04 173.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mt -134.32 119.01 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 -170.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.284 . . -77.38 10.87 2.24 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 119.274 3.065 . . . . 0.0 119.274 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.932 30.7 mtmm 92.39 -136.53 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 1 N-CA-C 124.527 5.01 . . . . 0.0 124.527 161.166 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.442 0.0 OUTLIER 6.3 83.37 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 1 CA-C-N 108.215 -4.084 . . . . 0.0 116.934 -149.461 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.316 29.7 m-85 80.79 62.78 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 -163.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.26 -167.95 0.7 Allowed Glycine 0 CA--C 1.568 3.384 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 168.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -144.66 72.86 1.35 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 121.06 2.43 . . . . 0.0 104.636 -176.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.859 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 28.9 p -88.98 174.03 8.14 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 112.304 -2.225 . . . . 0.0 114.0 -165.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -166.42 126.93 1.67 Allowed 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 103.114 -2.921 . . . . 0.0 103.114 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -79.5 99.78 7.41 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 172.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.73 38.51 1.06 Allowed Glycine 0 CA--C 1.569 3.421 0 CA-C-N 112.393 -2.185 . . . . 0.0 111.525 -163.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -162.44 -149.18 5.59 Favored Glycine 0 N--CA 1.48 1.633 0 C-N-CA 125.376 1.465 . . . . 0.0 109.819 -170.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -69.18 128.52 92.52 Favored Pre-proline 0 N--CA 1.501 2.088 0 CA-C-O 118.189 -0.91 . . . . 0.0 109.321 169.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -63.01 -38.77 44.24 Favored 'Trans proline' 0 N--CA 1.495 1.575 1 N-CA-C 123.207 4.272 . . . . 0.0 123.207 -171.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . 0.331 71.6 m 90.93 144.44 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.451 0 CA-C-N 111.166 -2.743 . . . . 0.0 105.015 -160.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . 0.255 0.1 OUTLIER -85.51 -66.94 0.84 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 119.439 3.126 . . . . 0.0 119.439 -161.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -109.09 67.16 0.65 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -166.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.83 92.92 0.27 Allowed Glycine 0 N--CA 1.49 2.234 0 CA-C-O 119.423 -0.654 . . . . 0.0 112.346 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.59 165.09 11.79 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 -166.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.87 106.27 0.32 Allowed Glycine 0 N--CA 1.471 0.995 0 N-CA-C 106.743 -2.543 . . . . 0.0 106.743 166.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 25.4 t -99.53 94.24 6.29 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 110.032 -3.084 . . . . 0.0 110.676 -173.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.502 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 29.6 mm -92.09 139.28 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 167.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.419 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 79.2 m -117.49 -176.85 3.1 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 -167.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.0 t -145.49 163.85 33.41 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 125.699 2.666 . . . . 0.0 107.689 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.345 7.6 mt 36.71 52.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 1 CA-C-N 108.275 -4.057 . . . . 0.0 114.415 179.684 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.6 tpt 72.61 44.48 0.39 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 125.441 1.496 . . . . 0.0 114.547 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.71 65.06 2.61 Favored Glycine 0 N--CA 1.491 2.346 0 O-C-N 120.321 -1.487 . . . . 0.0 113.074 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.8 p -146.05 -81.51 0.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 124.011 1.862 . . . . 0.0 110.932 -166.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.335 9.1 m120 -70.73 35.75 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 131.093 3.757 . . . . 0.0 118.119 172.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.859 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 7.2 t -71.5 -176.7 1.62 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 124.439 2.066 . . . . 0.0 114.326 -167.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -144.45 153.93 42.42 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 111.22 -2.718 . . . . 0.0 109.828 170.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.595 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 36.2 m -104.26 90.05 3.44 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 171.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp . . . . . 0 CA--C 1.568 1.653 0 CA-C-O 117.657 -1.163 . . . . 0.0 111.482 -169.752 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.25 95.5 mttt . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.64 ' HA ' HG22 ' A' ' 17' ' ' THR 0.318 30.0 p -28.74 -179.11 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.032 1 N-CA-C 125.172 5.249 . . . . 0.0 125.172 177.427 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.8 mm -99.24 110.23 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.54 67.16 2.4 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.242 1.02 . . . . 0.0 111.363 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -166.4 123.19 1.31 Allowed 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -70.25 130.41 41.95 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 167.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.257 0.0 OUTLIER 69.6 46.81 0.69 Allowed 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 122.964 1.364 . . . . 0.0 109.061 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -84.32 -152.59 15.73 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 113.615 -1.629 . . . . 0.0 109.802 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -142.21 75.64 1.5 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 -175.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 28.5 p -91.03 -171.66 3.07 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 112.641 -2.072 . . . . 0.0 112.525 -169.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -153.37 141.91 20.81 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.811 169.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -93.15 99.01 11.67 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.15 -62.98 0.52 Allowed Glycine 0 N--CA 1.484 1.867 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.782 -164.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.41 -142.67 0.3 Allowed Glycine 0 CA--C 1.539 1.587 0 CA-C-N 112.083 -2.058 . . . . 0.0 113.368 167.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -61.56 138.04 94.95 Favored Pre-proline 0 N--CA 1.495 1.821 0 CA-C-N 113.484 -1.358 . . . . 0.0 111.889 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -64.55 -131.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.573 2.429 0 C-N-CA 123.426 2.751 . . . . 0.0 112.34 169.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.3 t -148.81 146.81 28.17 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 164.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.29 -63.15 1.39 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 121.507 3.891 . . . . 0.0 121.507 -162.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.412 ' HE ' HH12 ' A' ' 23' ' ' ARG . 75.8 mtm180 -94.86 70.1 3.38 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.289 1.042 . . . . 0.0 112.715 -164.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.64 62.58 4.92 Favored Glycine 0 N--CA 1.486 2.004 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.925 -176.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.412 HH12 ' HE ' ' A' ' 21' ' ' ARG . 68.8 mtt180 -136.48 163.63 30.06 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 123.963 1.84 . . . . 0.0 112.222 -167.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.87 121.11 2.16 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 106.095 -2.802 . . . . 0.0 106.095 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.664 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 2.9 t -75.44 89.33 2.66 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 109.214 -3.493 . . . . 0.0 110.642 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.456 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 37.5 mm -81.5 136.41 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 122.852 1.311 . . . . 0.0 107.655 172.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.4 m -119.07 -179.0 3.7 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 111.925 -2.398 . . . . 0.0 114.985 -169.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.291 69.6 m -90.78 -144.85 0.18 Allowed 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.942 1.297 . . . . 0.0 109.844 -172.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.4 mm -71.34 -0.63 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.578 2.024 0 N-CA-C 117.596 2.443 . . . . 0.0 117.596 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.9 tpt -148.63 -31.36 0.26 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -172.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.81 61.14 1.11 Allowed Glycine 0 N--CA 1.488 2.119 0 CA-C-N 120.796 1.634 . . . . 0.0 111.671 -167.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.3 p -151.22 -78.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 123.849 1.785 . . . . 0.0 111.25 -167.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.336 37.2 m-80 -71.58 34.91 0.06 Allowed 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 129.953 3.301 . . . . 0.0 118.006 170.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 45.9 t -74.48 -168.52 0.69 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 112.259 -2.246 . . . . 0.0 113.495 -168.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -148.45 162.54 39.38 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 112.837 -1.983 . . . . 0.0 112.142 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.463 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 87.9 m -83.54 56.92 3.79 Favored 'General case' 0 N--CA 1.523 3.183 0 CA-C-O 124.75 2.214 . . . . 0.0 108.847 163.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.477 1.6 ptmm? . . . . . 0 CA--C 1.558 1.253 1 N-CA-C 125.424 5.342 . . . . 0.0 125.424 -163.648 . . . . . . . . 2 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.8 tttm . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.976 0.417 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.488 ' HA ' HG22 ' A' ' 17' ' ' THR . 14.6 p 51.54 171.17 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 118.249 2.685 . . . . 0.0 118.249 -169.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.708 HG22 ' HG3' ' A' ' 7' ' ' LYS . 5.0 mt -121.78 121.41 64.25 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -172.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.55 52.22 1.1 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 116.963 2.209 . . . . 0.0 116.963 -173.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.708 ' HG3' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -122.89 -179.62 4.32 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 127.079 2.152 . . . . 0.0 110.119 175.303 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -115.0 136.43 53.14 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.277 -1.783 . . . . 0.0 106.545 157.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 71.66 35.83 1.35 Allowed 'General case' 0 CA--C 1.58 2.118 0 CA-C-N 122.451 2.387 . . . . 0.0 111.987 168.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.78 125.96 6.62 Favored Glycine 0 N--CA 1.464 0.543 0 O-C-N 120.548 -1.345 . . . . 0.0 112.949 -168.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.413 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 11.4 mpt_? -3.9 79.37 0.0 OUTLIER 'General case' 0 C--O 1.236 0.361 1 C-N-CA 132.378 4.271 . . . . 0.0 116.912 169.292 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.981 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 15.5 p -94.05 -178.46 4.64 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 108.461 -3.972 . . . . 0.0 112.515 -173.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.35 153.96 31.29 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.255 1.026 . . . . 0.0 109.551 167.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -82.96 117.51 22.83 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.136 -173.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.21 39.64 18.7 Favored Glycine 0 CA--C 1.555 2.561 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -167.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.43 -146.87 9.33 Favored Glycine 0 N--CA 1.477 1.393 0 CA-C-O 123.198 1.444 . . . . 0.0 112.822 -174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -64.17 131.83 95.12 Favored Pre-proline 0 CA--C 1.573 1.864 0 CA-C-N 112.586 -1.807 . . . . 0.0 108.469 168.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -47.97 -36.3 27.17 Favored 'Trans proline' 0 N--CA 1.498 1.74 1 N-CA-C 122.595 4.036 . . . . 0.0 122.595 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.4 m 83.48 131.8 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 111.072 -2.785 . . . . 0.0 106.53 -165.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -56.74 3.33 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.944 -168.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -124.62 72.46 1.21 Allowed 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 124.713 1.205 . . . . 0.0 109.752 -170.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.5 73.58 0.51 Allowed Glycine 0 N--CA 1.482 1.735 0 C-N-CA 123.776 0.703 . . . . 0.0 113.107 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -90.23 174.07 7.8 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 170.73 -96.29 0.11 Allowed Glycine 0 N--CA 1.478 1.444 0 CA-C-O 123.732 1.74 . . . . 0.0 109.545 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.667 ' SG ' ' SG ' ' A' ' 34' ' ' CYS 0.39 5.7 t 93.95 94.32 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 109.536 -3.332 . . . . 0.0 110.648 173.549 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.619 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 31.0 mm -119.92 141.31 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 166.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.631 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 12.5 m -136.88 144.92 43.79 Favored 'General case' 0 CA--C 1.58 2.129 1 N-CA-C 123.461 4.615 . . . . 0.0 123.461 -168.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.539 10.2 p 61.11 -84.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 163.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.305 2.1 mp -38.83 -40.09 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.664 0 CA-C-N 108.969 -3.742 . . . . 0.0 116.438 168.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 37.3 ttp -143.49 -24.9 0.58 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.351 -1.75 . . . . 0.0 113.154 166.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 27' ' ' CYS . . . -43.08 -47.91 6.46 Favored Glycine 0 CA--C 1.558 2.724 0 CA-C-O 125.919 2.955 . . . . 0.0 118.451 164.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.776 0.4 OUTLIER 64.86 100.16 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.888 1 CA-C-N 107.42 -4.39 . . . . 0.0 111.552 -169.507 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.811 0.6 OUTLIER 20.37 55.6 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.928 0 CA-C-N 108.802 -3.817 . . . . 0.0 118.445 -155.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.981 ' SG ' ' SG ' ' A' ' 12' ' ' CYS 0.409 0.1 OUTLIER 46.99 173.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 1 CA-C-N 106.528 -4.851 . . . . 0.0 119.573 -168.165 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -158.67 141.67 14.65 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 109.975 -3.284 . . . . 0.0 108.642 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 90.4 m -83.41 81.55 8.67 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 120.885 1.675 . . . . 0.0 107.387 169.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.084 -1.436 . . . . 0.0 109.592 -169.166 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.584 ' HA ' HG22 ' A' ' 17' ' ' THR 0.302 27.8 p -46.83 -174.43 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.997 1 N-CA-C 122.355 4.205 . . . . 0.0 122.355 -177.006 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.505 HG13 ' SG ' ' A' ' 36' ' ' CYS . 24.5 mm -70.79 -49.88 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 C-N-CA 127.533 2.333 . . . . 0.0 111.342 173.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.284 . . 68.71 52.67 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 126.114 1.765 . . . . 0.0 114.215 -171.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -178.66 125.66 0.1 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -176.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -73.49 118.32 16.31 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 166.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.356 0.0 OUTLIER 75.86 80.44 0.1 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 176.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.609 ' H ' ' H ' ' A' ' 36' ' ' CYS . . . -172.66 120.31 0.81 Allowed Glycine 0 N--CA 1.471 1.007 0 CA-C-N 109.323 -3.58 . . . . 0.0 115.364 -165.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . 0.35 20.6 tpt85 1.08 70.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 131.116 3.767 . . . . 0.0 119.26 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.7 p -88.97 170.33 10.77 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 110.04 -3.255 . . . . 0.0 112.647 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -140.62 154.85 46.61 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.566 171.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -97.51 95.12 7.42 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 105.485 -2.042 . . . . 0.0 105.485 170.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.83 54.76 0.91 Allowed Glycine 0 CA--C 1.552 2.359 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.979 -167.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.04 -142.81 3.5 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-O 123.214 1.452 . . . . 0.0 110.172 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -58.46 143.9 79.71 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-N 112.777 -1.711 . . . . 0.0 111.167 168.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.06 -132.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.572 2.416 0 C-N-CA 123.0 2.466 . . . . 0.0 110.818 167.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.6 m -152.82 142.31 21.74 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 166.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.41 -55.88 3.69 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 113.349 -1.751 . . . . 0.0 113.545 -168.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -132.44 82.12 1.99 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.835 1.254 . . . . 0.0 109.025 -169.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.82 110.47 3.36 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -133.04 175.88 8.98 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.818 1.785 . . . . 0.0 115.818 -167.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.02 -81.53 0.13 Allowed Glycine 0 N--CA 1.474 1.188 0 CA-C-N 112.331 -2.213 . . . . 0.0 109.554 -168.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.317 16.4 t 79.81 102.13 0.06 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 109.739 -3.231 . . . . 0.0 109.343 -170.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.2 mm -131.54 152.25 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 169.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 34' ' ' CYS 0.347 85.5 m -77.54 150.95 34.73 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 176.18 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.319 41.1 m -152.9 176.03 12.28 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 126.161 1.784 . . . . 0.0 109.229 -165.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.328 3.9 mp 38.04 63.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 C-N-CA 126.476 1.91 . . . . 0.0 112.257 -173.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.285 16.2 mmt 91.07 -6.84 0.27 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 126.141 1.777 . . . . 0.0 115.044 -169.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.37 58.85 3.23 Favored Glycine 0 CA--C 1.557 2.664 0 CA-C-N 122.772 2.533 . . . . 0.0 109.059 -165.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.3 m -151.57 -52.17 0.12 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 124.657 1.183 . . . . 0.0 112.673 -163.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -61.28 -77.1 0.05 OUTLIER 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 124.806 2.241 . . . . 0.0 111.935 169.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 27' ' ' CYS 0.272 2.4 m 79.65 167.23 0.18 Allowed 'General case' 0 CA--C 1.557 1.228 1 CA-C-N 107.337 -4.483 . . . . 0.0 110.094 -167.829 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -160.91 153.3 20.45 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.99 1.316 . . . . 0.0 107.616 -170.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.609 ' H ' ' H ' ' A' ' 10' ' ' GLY . 87.6 m -67.94 67.41 0.11 Allowed 'General case' 0 N--CA 1.508 2.448 0 CA-C-O 124.652 2.167 . . . . 0.0 114.696 171.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.446 34.8 ttmt . . . . . 0 CA--C 1.572 1.797 1 N-CA-C 123.244 4.535 . . . . 0.0 123.244 -169.511 . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt . . . . . 0 CA--C 1.552 1.039 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.338 65.7 pttt 54.34 86.95 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 171.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.0 tttm 66.2 89.26 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.673 1.189 . . . . 0.0 110.959 -171.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HA ' HG22 ' A' ' 17' ' ' THR 0.274 21.6 p 52.41 167.94 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 -174.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.8 mm -85.42 -62.17 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.673 0 C-N-CA 125.302 1.441 . . . . 0.0 110.852 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.268 . . 72.19 61.6 0.13 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 125.591 1.556 . . . . 0.0 114.051 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -179.5 131.71 0.11 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.4 128.34 35.47 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 166.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 72.58 39.83 0.68 Allowed 'General case' 0 CA--C 1.579 2.09 0 C-N-CA 124.284 1.033 . . . . 0.0 111.745 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.68 134.41 12.31 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -76.89 72.62 3.48 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-O 126.909 3.242 . . . . 0.0 112.869 -165.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.46 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 13.7 p -73.59 -177.72 2.81 Favored 'General case' 0 N--CA 1.489 1.501 1 CA-C-N 106.379 -4.918 . . . . 0.0 114.253 -172.316 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -152.64 154.5 35.46 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.425 1.107 . . . . 0.0 110.055 166.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -90.89 109.19 20.4 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 169.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.02 39.15 2.54 Favored Glycine 0 CA--C 1.558 2.768 0 CA-C-N 114.238 -1.346 . . . . 0.0 113.449 -166.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.81 -139.64 3.11 Favored Glycine 0 N--CA 1.473 1.149 0 CA-C-O 123.838 1.799 . . . . 0.0 109.544 -177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -70.07 143.11 91.07 Favored Pre-proline 0 CA--C 1.578 2.046 0 CA-C-N 111.823 -2.189 . . . . 0.0 108.9 166.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.69 -127.86 0.0 OUTLIER 'Trans proline' 0 CA--C 1.567 2.159 0 C-N-CA 123.378 2.719 . . . . 0.0 111.805 171.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.4 m -149.44 142.95 25.37 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 165.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -64.45 1.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.925 -169.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -139.77 93.71 2.69 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 -173.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.77 100.07 2.56 Favored Glycine 0 N--CA 1.478 1.486 0 N-CA-C 105.938 -2.865 . . . . 0.0 105.938 -167.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -134.13 170.78 15.16 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 123.479 1.609 . . . . 0.0 114.922 -169.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.18 -81.44 0.16 Allowed Glycine 0 N--CA 1.476 1.366 0 CA-C-O 124.673 2.263 . . . . 0.0 110.099 -168.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.491 9.5 t 68.71 44.39 1.17 Allowed 'General case' 0 CA--C 1.559 1.324 0 CA-C-N 109.008 -3.596 . . . . 0.0 116.708 -170.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 66.1 mt -78.36 143.23 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 166.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 97.1 m -92.31 172.95 8.07 Favored 'General case' 0 CA--C 1.559 1.291 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.9 p -79.4 -150.43 0.06 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 114.009 -1.451 . . . . 0.0 110.844 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.3 2.0 pp -98.65 56.87 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 122.934 1.35 . . . . 0.0 111.76 168.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.317 0.0 OUTLIER -168.64 -40.38 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.807 1.643 . . . . 0.0 112.839 178.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.07 50.87 3.53 Favored Glycine 0 N--CA 1.489 2.216 0 CA-C-N 120.476 1.489 . . . . 0.0 114.442 -170.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.0 p -157.93 -72.17 0.09 Allowed 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 124.444 2.069 . . . . 0.0 111.305 -168.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.32 16.9 m-80 -70.31 39.43 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 131.127 3.771 . . . . 0.0 117.677 169.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 13.6 m -68.28 -157.4 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.977 0 CA-C-N 112.873 -1.967 . . . . 0.0 113.459 -170.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -156.65 144.06 19.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 119.913 -1.742 . . . . 0.0 109.116 174.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 16.8 m -96.84 89.71 4.98 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -47.49 153.7 0.97 Allowed Pre-proline 0 CA--C 1.569 1.684 0 N-CA-C 117.236 2.309 . . . . 0.0 117.236 -166.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.22 109.89 2.96 Favored 'Trans proline' 0 CA--C 1.564 2.022 0 C-N-CA 122.126 1.884 . . . . 0.0 113.954 -164.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -163.02 109.77 1.19 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 118.594 0.634 . . . . 0.0 111.098 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.275 52.0 tp -103.8 -67.72 0.88 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 123.921 1.819 . . . . 0.0 113.659 171.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.315 30.1 pt -81.88 24.67 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-N 110.98 -2.827 . . . . 0.0 116.125 167.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.4 mtt -136.56 21.82 3.14 Favored 'General case' 0 CA--C 1.581 2.151 0 C-N-CA 125.741 1.616 . . . . 0.0 111.906 166.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.505 ' HG2' ' H ' ' A' ' 44' ' ' GLY 0.475 22.2 tt0 -108.84 -102.45 0.37 Allowed 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 103.805 -2.665 . . . . 0.0 103.805 -173.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.505 ' H ' ' HG2' ' A' ' 43' ' ' GLU . . . -99.91 -5.55 54.92 Favored Glycine 0 CA--C 1.554 2.483 0 N-CA-C 117.837 1.895 . . . . 0.0 117.837 169.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.1 mt -94.76 -69.34 0.76 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 120.555 2.178 . . . . 0.0 110.86 -173.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.26 -67.36 0.39 Allowed Glycine 0 N--CA 1.482 1.725 0 CA-C-N 119.243 0.928 . . . . 0.0 113.487 -177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -110.0 -59.83 1.88 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.196 0.998 . . . . 0.0 112.675 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 123.916 1.817 . . . . 0.0 110.654 -170.626 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt . . . . . 0 CA--C 1.552 1.028 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -76.13 -58.15 3.45 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 118.628 -0.701 . . . . 0.0 112.559 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.351 63.1 pttt 53.05 72.71 0.4 Allowed 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.369 1.988 . . . . 0.0 116.369 172.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.431 ' HA ' HG22 ' A' ' 17' ' ' THR . 17.9 p 50.36 172.08 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mt -101.56 -63.62 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 C-N-CA 125.252 1.421 . . . . 0.0 110.74 -170.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.3 . . 78.65 60.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.707 1.603 . . . . 0.0 112.65 -169.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -160.16 122.73 3.36 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -73.02 123.15 22.95 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.915 1.286 . . . . 0.0 107.915 168.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.282 23.5 m-85 76.14 36.86 0.39 Allowed 'General case' 0 CA--C 1.581 2.139 0 C-N-CA 124.174 0.99 . . . . 0.0 111.18 -167.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.09 129.07 8.79 Favored Glycine 0 N--CA 1.479 1.511 0 O-C-N 121.12 -0.988 . . . . 0.0 111.138 -174.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.7 tpt85 -75.9 77.0 2.8 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-O 126.588 3.089 . . . . 0.0 109.633 -168.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.817 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 0.9 OUTLIER -73.93 -179.7 3.86 Favored 'General case' 0 N--CA 1.489 1.482 1 CA-C-N 106.821 -4.718 . . . . 0.0 110.544 -169.012 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -142.37 159.74 41.64 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 114.066 -1.424 . . . . 0.0 108.085 163.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -100.23 97.8 8.55 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.51 46.34 0.92 Allowed Glycine 0 CA--C 1.555 2.543 0 CA-C-N 114.245 -1.343 . . . . 0.0 113.296 -167.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.6 -142.36 3.45 Favored Glycine 0 N--CA 1.476 1.312 0 CA-C-O 123.443 1.579 . . . . 0.0 110.349 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.431 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -68.61 142.82 94.49 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-N 112.38 -1.91 . . . . 0.0 109.263 167.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD2' HG22 ' A' ' 17' ' ' THR . 22.3 Cg_endo -68.23 -127.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.57 2.304 0 C-N-CA 123.063 2.508 . . . . 0.0 109.57 168.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 97.8 m -154.01 151.07 28.94 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 163.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.67 -60.35 1.72 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 114.044 -1.434 . . . . 0.0 111.874 -168.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -121.45 81.14 1.76 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -169.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.09 99.78 2.57 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -172.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -142.72 176.18 9.25 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 123.72 1.724 . . . . 0.0 114.573 -168.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.71 94.62 1.54 Allowed Glycine 0 N--CA 1.477 1.433 0 N-CA-C 107.497 -2.241 . . . . 0.0 107.497 -167.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.931 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 5.8 t -86.96 121.62 29.68 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 110.089 -3.055 . . . . 0.0 111.326 -168.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.507 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 15.6 mm -112.53 136.05 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 166.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.1 m -109.03 -171.84 1.93 Allowed 'General case' 0 CA--C 1.559 1.319 0 CA-C-N 112.73 -2.032 . . . . 0.0 113.912 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 t -115.99 -126.36 0.29 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.918 1.342 . . . . 0.0 110.0 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.2 mm -71.82 -3.34 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 119.079 2.992 . . . . 0.0 119.079 -168.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 20.4 ptp -156.32 -13.0 0.1 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.39 -15.37 50.21 Favored Glycine 0 CA--C 1.556 2.636 0 CA-C-N 121.431 1.923 . . . . 0.0 114.83 -165.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.4 p -89.13 -146.59 0.16 Allowed 'General case' 0 CA--C 1.567 1.598 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 166.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 41.62 36.69 0.61 Allowed 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 118.246 2.684 . . . . 0.0 118.246 169.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.931 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 2.0 t -99.2 -171.34 2.06 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 110.913 -2.858 . . . . 0.0 114.601 -161.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -159.6 148.52 17.86 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 112.22 -2.264 . . . . 0.0 110.56 172.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 13.9 m -103.77 91.57 4.06 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -50.52 141.16 17.37 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -169.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -58.18 167.01 5.0 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.181 2.587 . . . . 0.0 117.037 -165.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 161.91 28.49 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.371 1.1 pp -63.22 -18.08 63.14 Favored 'General case' 0 N--CA 1.501 2.102 1 N-CA-C 122.41 4.226 . . . . 0.0 122.41 -169.844 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.2 mm -99.62 48.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 CA-C-N 114.119 -1.401 . . . . 0.0 109.357 167.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 ttt -169.58 -30.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 126.588 1.955 . . . . 0.0 112.364 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.522 ' HG2' ' H ' ' A' ' 44' ' ' GLY 0.506 38.6 tt0 -80.39 -117.87 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 128.113 2.565 . . . . 0.0 107.571 -177.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.522 ' H ' ' HG2' ' A' ' 43' ' ' GLU . . . -89.64 65.34 3.04 Favored Glycine 0 CA--C 1.544 1.853 0 C-N-CA 124.311 0.958 . . . . 0.0 113.012 169.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -71.43 -42.37 68.33 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 116.129 1.899 . . . . 0.0 116.129 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.29 88.3 0.15 Allowed Glycine 0 N--CA 1.478 1.453 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.3 mt -101.12 -61.86 1.32 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.495 0.718 . . . . 0.0 111.014 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 123.883 1.801 . . . . 0.0 112.792 -179.842 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 CA--C 1.554 1.118 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.434 58.7 pttt 48.03 -159.03 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 117.739 2.496 . . . . 0.0 117.739 173.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.43 89.15 2.56 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.479 ' HA ' HG22 ' A' ' 17' ' ' THR 0.308 8.3 p 57.73 169.36 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 117.411 2.375 . . . . 0.0 117.411 -177.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.592 HG13 ' SG ' ' A' ' 19' ' ' CYS . 32.0 mm -96.6 -64.1 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 124.379 1.072 . . . . 0.0 110.234 -169.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.08 59.04 1.36 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -173.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -175.88 123.66 0.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -77.42 116.51 18.07 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.474 1.11 . . . . 0.0 109.552 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.309 10.1 m-85 75.71 48.19 0.09 Allowed 'General case' 0 CA--C 1.57 1.737 0 C-N-CA 124.897 1.279 . . . . 0.0 108.084 -167.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.47 -149.77 3.06 Favored Glycine 0 C--N 1.356 1.666 0 CA-C-O 118.472 -1.182 . . . . 0.0 110.541 175.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -143.78 76.97 1.54 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 124.373 2.035 . . . . 0.0 106.162 -169.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 15.1 p -95.36 -174.33 3.16 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 111.086 -2.779 . . . . 0.0 112.451 -170.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -150.4 142.65 24.19 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.538 167.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -86.33 103.86 15.31 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 168.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.54 50.0 1.47 Allowed Glycine 0 CA--C 1.559 2.783 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.754 -163.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -169.21 -134.28 1.71 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -169.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -66.99 132.04 93.82 Favored Pre-proline 0 CA--C 1.574 1.889 0 CA-C-N 112.284 -1.958 . . . . 0.0 110.761 170.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -63.47 -34.8 63.92 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 N-CA-C 122.213 3.889 . . . . 0.0 122.213 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.592 ' SG ' HG13 ' A' ' 5' ' ' ILE 0.368 80.2 m 82.31 144.75 0.07 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 111.766 -2.47 . . . . 0.0 108.056 -163.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.74 -68.53 0.78 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 118.456 2.761 . . . . 0.0 118.456 -161.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.464 ' HE ' HH12 ' A' ' 23' ' ' ARG . 73.1 mtm180 -111.36 68.5 0.67 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.472 0.653 . . . . 0.0 110.887 -166.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.91 78.13 0.27 Allowed Glycine 0 N--CA 1.484 1.885 0 CA-C-O 119.204 -0.776 . . . . 0.0 113.308 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.464 HH12 ' HE ' ' A' ' 21' ' ' ARG . 40.2 mtt85 -140.81 142.88 34.58 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 122.452 1.12 . . . . 0.0 111.81 -169.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -55.05 -86.0 0.02 OUTLIER Glycine 0 N--CA 1.482 1.762 0 N-CA-C 118.16 2.024 . . . . 0.0 118.16 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 36' ' ' CYS 0.417 14.0 t 82.34 38.22 0.05 Allowed 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 109.807 -3.196 . . . . 0.0 115.935 -169.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.9 mt -73.99 143.54 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 123.383 1.563 . . . . 0.0 107.65 168.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 34' ' ' CYS 0.259 96.4 m -93.38 -175.5 3.83 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 111.812 -2.449 . . . . 0.0 116.678 -169.458 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.37 -18.61 64.51 Favored 'General case' 0 N--CA 1.504 2.259 1 N-CA-C 122.297 4.184 . . . . 0.0 122.297 175.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.448 4.2 mp 89.06 77.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.526 0 CA-C-N 109.061 -3.7 . . . . 0.0 105.235 -166.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 15.2 tpt 177.21 -51.04 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.447 0 CA-C-N 111.144 -2.753 . . . . 0.0 106.986 -167.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.67 -27.33 13.59 Favored Glycine 0 CA--C 1.552 2.363 0 CA-C-O 118.849 -0.973 . . . . 0.0 113.541 -166.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.6 p -90.79 -168.82 2.18 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 167.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 44.98 45.52 8.76 Favored 'General case' 0 N--CA 1.511 2.617 0 CA-C-O 125.724 2.678 . . . . 0.0 117.549 168.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 12' ' ' CYS . 3.7 m -90.08 -179.35 5.66 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 108.609 -3.905 . . . . 0.0 111.504 -166.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -141.72 147.24 37.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.38 -0.825 . . . . 0.0 110.202 168.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 25' ' ' CYS 0.314 1.5 m -93.03 77.89 4.65 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.369 -0.532 . . . . 0.0 112.189 -177.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -48.86 130.2 14.66 Favored Pre-proline 0 N--CA 1.491 1.596 0 CA-C-O 117.588 -1.196 . . . . 0.0 111.36 -172.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -36.79 -52.42 1.27 Allowed 'Trans proline' 0 CA--C 1.563 1.963 1 N-CA-C 122.839 4.131 . . . . 0.0 122.839 -162.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -121.15 126.94 50.98 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.813 0.845 . . . . 0.0 111.201 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 tt -93.27 101.7 13.96 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 123.659 1.695 . . . . 0.0 107.291 167.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.265 0.2 OUTLIER -149.29 56.88 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 CA-C-N 111.175 -2.739 . . . . 0.0 108.265 167.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . 0.334 22.1 ptm 159.26 -44.14 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 126.558 1.943 . . . . 0.0 111.829 -171.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -72.05 -3.44 23.0 Favored 'General case' 0 CA--C 1.561 1.366 1 N-CA-C 122.33 4.196 . . . . 0.0 122.33 -169.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.12 78.35 0.06 OUTLIER Glycine 0 CA--C 1.536 1.405 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.916 169.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 67.79 100.86 0.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.738 1.215 . . . . 0.0 110.605 -171.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -88.63 60.26 3.95 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 115.396 0.918 . . . . 0.0 115.396 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -155.12 -57.18 0.1 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 124.406 1.082 . . . . 0.0 110.105 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 124.07 1.891 . . . . 0.0 107.433 176.42 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? . . . . . 0 CA--C 1.549 0.934 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp 72.39 105.09 0.07 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.803 1.241 . . . . 0.0 111.126 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm 65.8 79.98 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 124.581 1.152 . . . . 0.0 110.062 -169.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.59 ' HA ' HG22 ' A' ' 17' ' ' THR 0.347 20.9 p -136.88 -171.75 3.01 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-O 123.215 1.483 . . . . 0.0 114.85 -166.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 mt -104.36 109.7 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.485 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 169.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.12 69.63 2.03 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.222 1.01 . . . . 0.0 110.204 172.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -165.45 122.33 1.46 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 -173.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -75.96 120.4 21.23 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.765 1.226 . . . . 0.0 109.674 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.314 5.6 m-85 77.99 29.01 0.5 Allowed 'General case' 0 CA--C 1.575 1.908 0 C-N-CA 124.966 1.306 . . . . 0.0 113.601 -170.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.89 117.17 5.73 Favored Glycine 0 N--CA 1.469 0.846 0 O-C-N 120.89 -1.131 . . . . 0.0 112.868 -171.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -22.9 81.3 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 1 C-N-CA 131.909 4.084 . . . . 0.0 116.233 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.867 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 13.0 p -85.38 -178.87 6.83 Favored 'General case' 0 N--CA 1.491 1.609 1 CA-C-N 106.983 -4.644 . . . . 0.0 112.402 -171.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -146.14 155.17 42.55 Favored 'General case' 0 CA--C 1.556 1.199 0 CA-C-O 122.884 1.326 . . . . 0.0 108.757 169.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 49.8 m0 -94.94 100.15 12.05 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.91 53.92 1.25 Allowed Glycine 0 CA--C 1.552 2.388 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.405 -166.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.07 -143.64 3.78 Favored Glycine 0 N--CA 1.477 1.371 0 CA-C-O 123.19 1.439 . . . . 0.0 110.737 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -63.69 132.53 95.23 Favored Pre-proline 0 CA--C 1.576 1.979 0 CA-C-N 112.848 -1.676 . . . . 0.0 110.522 170.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -51.73 -39.02 67.69 Favored 'Trans proline' 0 N--CA 1.498 1.755 1 N-CA-C 123.284 4.302 . . . . 0.0 123.284 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 16.3 m 90.52 139.65 0.03 OUTLIER 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 111.405 -2.634 . . . . 0.0 104.842 -163.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -85.02 -64.39 1.17 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 120.576 3.547 . . . . 0.0 120.576 -162.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -127.82 80.85 1.98 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.886 0.851 . . . . 0.0 109.608 -164.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.29 66.85 1.98 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 115.152 -0.931 . . . . 0.0 114.391 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 39.6 mtt85 -141.58 156.44 45.69 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.834 1.302 . . . . 0.0 111.031 -169.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.62 -130.85 6.65 Favored Glycine 0 CA--C 1.536 1.376 0 CA-C-O 123.196 1.442 . . . . 0.0 112.029 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.471 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 48.9 t 166.13 107.91 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 102.815 -3.032 . . . . 0.0 102.815 173.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.521 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 29.8 mm -121.2 134.32 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 170.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 33' ' ' ASN . 33.0 m -107.84 -177.78 3.44 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-N 112.775 -2.011 . . . . 0.0 111.235 174.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 t -89.96 -173.34 3.84 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 124.561 2.124 . . . . 0.0 112.567 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 pp -93.38 63.9 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 110.681 -2.963 . . . . 0.0 108.889 166.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.2 tpt 177.71 -49.27 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 112.637 -2.074 . . . . 0.0 110.348 -168.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.35 18.13 69.71 Favored Glycine 0 CA--C 1.568 3.372 0 CA-C-O 118.962 -0.91 . . . . 0.0 114.725 -162.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.301 6.0 p -121.59 114.3 20.99 Favored 'General case' 0 N--CA 1.486 1.352 1 N-CA-C 96.065 -5.531 . . . . 0.0 96.065 158.462 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 27' ' ' CYS 0.304 48.9 p30 -145.45 -90.36 0.1 Allowed 'General case' 0 CA--C 1.559 1.313 1 N-CA-C 134.521 8.712 . . . . 0.0 134.521 -138.635 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.867 ' SG ' ' SG ' ' A' ' 12' ' ' CYS 0.27 0.1 OUTLIER -74.47 -174.61 2.1 Favored 'General case' 0 C--N 1.305 -1.367 1 CA-C-N 106.273 -4.967 . . . . 0.0 119.848 -143.839 . . . . . . . . 5 4 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -170.11 137.25 1.53 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 109.163 -3.653 . . . . 0.0 109.604 -173.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.6 m -84.44 94.41 8.51 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 173.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -55.43 125.04 58.14 Favored Pre-proline 0 CA--C 1.573 1.862 0 CA-C-O 117.272 -1.346 . . . . 0.0 112.051 -167.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -42.51 -49.92 6.06 Favored 'Trans proline' 0 C--N 1.369 1.633 0 N-CA-C 122.146 3.864 . . . . 0.0 122.146 -164.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -145.98 103.75 3.78 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.298 60.3 tp -104.19 -74.37 0.65 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 124.026 1.869 . . . . 0.0 113.587 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.251 35.8 pt -77.86 24.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 CA-C-N 110.157 -3.202 . . . . 0.0 117.014 169.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.2 mmt -116.69 -50.54 2.61 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 126.089 1.756 . . . . 0.0 108.903 166.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -69.89 -0.7 7.77 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 120.503 3.52 . . . . 0.0 120.503 166.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.5 85.23 0.14 Allowed Glycine 0 CA--C 1.538 1.516 0 CA-C-N 114.248 -1.342 . . . . 0.0 110.774 169.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.43 -9.67 3.26 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 171.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.47 -85.19 0.15 Allowed Glycine 0 N--CA 1.479 1.539 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 -171.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 47' ' ' LEU . 2.2 pt? -75.25 -33.64 61.32 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 169.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 124.039 1.876 . . . . 0.0 113.248 177.603 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.5 tptm . . . . . 0 CA--C 1.555 1.169 0 CA-C-O 121.161 0.505 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 81.5 tttt 74.11 100.02 0.07 Allowed 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.042 1.337 . . . . 0.0 110.593 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.1 tttt 60.85 78.27 0.29 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 124.676 1.19 . . . . 0.0 111.4 -173.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.6 p 50.37 178.33 0.01 OUTLIER 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.871 2.175 . . . . 0.0 116.871 -168.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.2 mt -128.04 127.14 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.519 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 -168.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.57 71.01 0.75 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.257 1.027 . . . . 0.0 112.563 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.266 0.0 OUTLIER -125.41 177.04 6.4 Favored 'General case' 0 CA--C 1.561 1.376 0 CA-C-O 124.845 2.26 . . . . 0.0 116.09 -168.171 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -118.08 100.73 7.72 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.316 -2.22 . . . . 0.0 105.913 158.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.328 1.1 m-85 79.18 63.4 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 122.885 2.584 . . . . 0.0 107.309 172.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.16 -165.22 3.21 Favored Glycine 0 C--N 1.351 1.413 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.553 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -134.66 75.28 1.57 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.93 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 27.7 p -75.36 -179.17 4.36 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 113.093 -1.867 . . . . 0.0 113.135 -169.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -143.89 151.96 40.51 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 122.994 1.378 . . . . 0.0 108.155 167.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 15.3 m0 -99.66 93.83 6.04 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 168.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 120.32 41.02 0.56 Allowed Glycine 0 CA--C 1.56 2.89 0 CA-C-N 113.456 -1.702 . . . . 0.0 112.732 -166.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.79 -142.59 3.43 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 -176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.65 139.33 91.29 Favored Pre-proline 0 N--CA 1.499 1.993 0 CA-C-N 113.236 -1.482 . . . . 0.0 107.978 166.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -66.02 -129.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.572 2.38 0 C-N-CA 123.026 2.484 . . . . 0.0 111.19 169.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.2 m -152.63 139.28 18.79 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 165.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.57 160.54 26.4 Favored 'General case' 0 CA--C 1.567 1.623 0 CA-C-O 122.889 1.328 . . . . 0.0 111.649 -170.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 38.5 mtt85 47.59 59.63 4.02 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.09 100.37 0.24 Allowed Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.46 -0.775 . . . . 0.0 112.423 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -112.23 169.87 8.56 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -168.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.56 -87.47 1.89 Allowed Glycine 0 CA--C 1.536 1.383 0 CA-C-N 111.67 -2.513 . . . . 0.0 108.686 166.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' SG ' ' SG ' ' A' ' 34' ' ' CYS 0.415 22.4 t 65.66 55.96 0.96 Allowed 'General case' 0 CA--C 1.561 1.391 0 CA-C-N 110.49 -2.855 . . . . 0.0 113.749 -169.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.539 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 54.1 mt -83.2 133.85 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 167.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 58.1 m -119.34 178.82 4.39 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 118.137 2.643 . . . . 0.0 118.137 -166.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 p -159.5 153.16 22.8 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-O 124.499 2.095 . . . . 0.0 111.986 -167.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.327 2.4 mp 40.27 60.18 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 CA-C-N 109.97 -3.286 . . . . 0.0 113.416 -169.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.274 15.7 mmt 85.37 7.15 0.43 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.02 69.05 1.29 Allowed Glycine 0 N--CA 1.486 1.987 0 CA-C-N 122.122 2.237 . . . . 0.0 111.664 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.1 p -149.96 -76.37 0.15 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 123.763 1.744 . . . . 0.0 109.94 -168.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.77 21.81 0.05 Allowed 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 119.814 3.264 . . . . 0.0 119.814 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.93 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 8.6 t -59.75 -168.81 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 112.286 -2.233 . . . . 0.0 115.405 -167.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -149.28 144.54 26.55 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 169.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.704 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 18.2 m -101.21 116.65 33.31 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -61.25 138.1 94.49 Favored Pre-proline 0 CA--C 1.574 1.877 0 CA-C-N 119.988 1.267 . . . . 0.0 109.711 170.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -51.53 162.3 1.58 Allowed 'Trans proline' 0 CA--C 1.556 1.624 0 N-CA-C 120.384 3.186 . . . . 0.0 120.384 -162.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.42 156.48 31.12 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.198 167.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.8 tt -71.8 100.4 2.37 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 123.768 1.746 . . . . 0.0 112.272 -168.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.0 pt -146.17 67.84 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-N 110.461 -3.063 . . . . 0.0 105.207 169.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . 0.306 18.3 ttt 73.67 57.63 0.1 Allowed 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.715 1.206 . . . . 0.0 112.423 -168.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' A' ' 44' ' ' GLY 0.417 18.4 tt0 -99.59 -155.58 0.51 Allowed 'General case' 0 CA--C 1.58 2.1 0 N-CA-C 101.671 -3.455 . . . . 0.0 101.671 165.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.503 ' H ' ' HG2' ' A' ' 43' ' ' GLU . . . 76.46 -57.8 3.33 Favored Glycine 0 CA--C 1.549 2.172 0 C-N-CA 124.713 1.149 . . . . 0.0 114.866 -170.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.68 103.77 6.55 Favored 'General case' 0 CA--C 1.558 1.253 0 N-CA-C 101.867 -3.383 . . . . 0.0 101.867 177.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.5 94.29 1.83 Allowed Glycine 0 N--CA 1.482 1.726 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.232 -177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.23 -66.46 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.761 -171.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 124.066 1.889 . . . . 0.0 112.58 -175.097 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 85.3 tttt . . . . . 0 CA--C 1.555 1.169 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -94.47 -52.37 4.35 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.548 0.739 . . . . 0.0 112.764 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -136.22 98.54 3.88 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.638 ' HA ' HG22 ' A' ' 17' ' ' THR 0.318 14.0 p -119.48 -167.47 1.42 Allowed 'General case' 0 CA--C 1.565 1.535 0 C-N-CA 126.688 1.995 . . . . 0.0 115.297 -169.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.9 mm -94.65 -70.44 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.723 0 C-N-CA 125.137 1.375 . . . . 0.0 107.94 176.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 63.52 67.38 0.65 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.849 1.66 . . . . 0.0 114.652 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -174.6 128.76 0.33 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 -177.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.06 120.0 15.99 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.108 1.363 . . . . 0.0 109.603 171.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.308 2.2 m-85 72.31 44.6 0.42 Allowed 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 124.82 1.248 . . . . 0.0 109.485 -167.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -75.18 -150.7 2.57 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-O 118.221 -1.322 . . . . 0.0 110.806 173.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.4 mmt-85 -147.35 74.54 1.33 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -171.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.803 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 0.8 OUTLIER -77.06 -177.38 4.44 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 123.284 1.516 . . . . 0.0 111.09 -169.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -141.97 125.34 16.58 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 166.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 52.1 m0 -76.26 111.69 11.96 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 169.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.31 47.03 5.36 Favored Glycine 0 CA--C 1.558 2.723 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.566 -165.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.72 -135.37 1.81 Allowed Glycine 0 N--CA 1.472 1.098 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -169.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -61.94 140.48 95.69 Favored Pre-proline 0 CA--C 1.573 1.828 0 CA-C-N 112.361 -1.919 . . . . 0.0 112.033 169.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -71.11 -128.05 0.01 OUTLIER 'Trans proline' 0 CA--C 1.567 2.126 0 C-N-CA 123.28 2.653 . . . . 0.0 110.774 167.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.2 8.97 0.64 Allowed 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 119.379 3.103 . . . . 0.0 119.379 167.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 79.41 -67.61 0.15 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 111.106 -2.77 . . . . 0.0 114.737 169.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -112.56 65.77 0.64 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.86 1.264 . . . . 0.0 110.687 -168.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.5 77.06 0.17 Allowed Glycine 0 CA--C 1.542 1.771 0 N-CA-C 116.673 1.429 . . . . 0.0 116.673 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.6 ttm105 -140.99 141.12 34.41 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 118.013 0.907 . . . . 0.0 111.613 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.35 105.1 3.05 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-O 125.021 2.456 . . . . 0.0 108.727 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.858 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 27.4 t -64.85 128.29 35.16 Favored 'General case' 0 CA--C 1.558 1.266 1 CA-C-N 107.887 -4.157 . . . . 0.0 112.489 170.015 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.463 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 29.6 mm -115.89 140.12 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 165.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 86.6 m -107.99 -174.71 2.59 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-N 113.831 -1.531 . . . . 0.0 114.786 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.81 -19.04 65.63 Favored 'General case' 0 N--CA 1.502 2.153 1 N-CA-C 122.155 4.132 . . . . 0.0 122.155 175.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.452 4.1 mp 86.91 75.21 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.487 0 CA-C-N 109.251 -3.613 . . . . 0.0 105.718 -167.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.7 ttt 176.27 -51.33 0.01 OUTLIER 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 111.333 -2.667 . . . . 0.0 106.772 -167.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.89 -32.7 6.19 Favored Glycine 0 CA--C 1.546 1.979 0 CA-C-O 118.585 -1.12 . . . . 0.0 113.709 -168.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.2 p -79.44 -170.61 2.39 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-O 124.67 2.176 . . . . 0.0 105.384 168.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.6 m120 36.75 55.36 1.17 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 126.117 2.865 . . . . 0.0 115.732 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.858 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 8.0 t -102.67 -163.9 1.04 Allowed 'General case' 0 C--N 1.312 -1.037 1 CA-C-N 108.097 -4.138 . . . . 0.0 113.96 -161.647 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.423 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 10.9 pt-20 -157.78 150.98 23.29 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 112.244 -2.253 . . . . 0.0 112.046 171.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.404 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 16.8 m -90.91 81.39 5.7 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 169.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -55.96 121.52 41.16 Favored Pre-proline 0 CA--C 1.567 1.628 0 CA-C-O 117.269 -1.348 . . . . 0.0 110.653 -169.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -49.72 127.91 19.97 Favored 'Trans proline' 0 C--N 1.368 1.584 0 C-N-CA 123.393 2.729 . . . . 0.0 118.575 -164.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -118.48 149.87 40.56 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.67 0.748 . . . . 0.0 109.302 170.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.13 94.45 5.37 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 124.372 2.034 . . . . 0.0 112.197 -167.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.315 89.0 mt -140.54 -81.98 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 109.737 -3.392 . . . . 0.0 103.527 171.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 23.5 mmt -85.88 11.34 11.54 Favored 'General case' 0 CA--C 1.575 1.907 0 CA-C-N 109.909 -3.314 . . . . 0.0 115.588 167.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -102.45 140.13 37.15 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 101.215 -3.624 . . . . 0.0 101.215 166.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.32 -56.74 5.07 Favored Glycine 0 CA--C 1.548 2.154 1 CA-C-N 108.123 -4.126 . . . . 0.0 115.287 175.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.12 85.89 2.21 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.38 1.072 . . . . 0.0 108.136 -177.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.75 -83.89 0.11 Allowed Glycine 0 N--CA 1.479 1.566 0 O-C-N 121.969 -0.457 . . . . 0.0 112.083 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.469 2.9 pp 51.51 54.49 10.95 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.859 1.663 . . . . 0.0 115.25 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 123.803 1.763 . . . . 0.0 112.136 -176.85 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 61.2 tttm . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.44 25.49 6.29 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 116.26 1.948 . . . . 0.0 116.26 179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? 60.81 85.77 0.11 Allowed 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 124.919 1.288 . . . . 0.0 112.005 -176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.504 ' HA ' HG22 ' A' ' 17' ' ' THR . 16.4 p 51.63 169.02 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 118.542 2.793 . . . . 0.0 118.542 -170.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt -115.42 107.53 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.84 69.62 4.65 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.48 1.133 . . . . 0.0 110.831 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.2 tppt? -160.48 112.91 2.0 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 104.281 -2.489 . . . . 0.0 104.281 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -75.79 126.55 31.23 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.894 1.278 . . . . 0.0 110.366 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.298 12.0 m-85 73.41 38.77 0.63 Allowed 'General case' 0 CA--C 1.58 2.108 0 C-N-CA 124.413 1.085 . . . . 0.0 111.149 -167.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.35 132.39 11.11 Favored Glycine 0 N--CA 1.483 1.795 0 O-C-N 120.946 -1.097 . . . . 0.0 110.403 -174.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -74.83 70.35 1.92 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 127.108 3.337 . . . . 0.0 112.457 -167.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.716 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 31.4 p -72.27 -174.78 1.37 Allowed 'General case' 0 N--CA 1.483 1.203 1 CA-C-N 106.088 -5.051 . . . . 0.0 114.232 -173.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -152.61 164.26 38.03 Favored 'General case' 0 CA--C 1.56 1.348 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.595 169.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -97.26 104.14 16.14 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 169.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.69 41.81 1.09 Allowed Glycine 0 CA--C 1.557 2.709 0 CA-C-N 113.904 -1.498 . . . . 0.0 113.025 -166.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.98 -146.66 4.4 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-O 123.417 1.565 . . . . 0.0 111.247 -175.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.504 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -70.11 132.32 88.34 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-N 112.791 -1.705 . . . . 0.0 108.275 167.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -54.89 -34.11 84.54 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 N-CA-C 121.915 3.775 . . . . 0.0 121.915 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . 0.297 74.3 m 87.42 148.0 0.05 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 111.288 -2.687 . . . . 0.0 109.205 -165.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.09 176.31 5.17 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.869 -168.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . 0.254 32.6 ptt180 42.53 56.12 3.91 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 119.433 3.123 . . . . 0.0 119.433 167.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.02 102.64 0.1 OUTLIER Glycine 0 N--CA 1.488 2.111 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -173.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.28 161.97 36.6 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -167.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -178.78 120.25 0.69 Allowed Glycine 0 CA--C 1.529 0.96 0 N-CA-C 106.809 -2.516 . . . . 0.0 106.809 168.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 39.7 t -91.82 81.86 5.2 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 111.446 -2.377 . . . . 0.0 112.827 -169.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.557 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER -75.75 134.9 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 168.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.5 m -118.39 178.11 4.57 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-N 112.944 -1.935 . . . . 0.0 114.523 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.288 57.9 m -79.11 -149.98 0.05 Allowed 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 125.149 1.38 . . . . 0.0 110.808 178.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.82 58.11 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.902 0.858 . . . . 0.0 108.88 169.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.93 -57.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.41 1.084 . . . . 0.0 111.712 -173.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.44 54.15 1.49 Allowed Glycine 0 CA--C 1.548 2.13 0 CA-C-O 119.278 -0.734 . . . . 0.0 112.777 -167.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.8 p -153.73 -73.96 0.13 Allowed 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 123.824 1.773 . . . . 0.0 111.364 -168.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.314 8.6 m120 -67.34 33.53 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 129.679 3.191 . . . . 0.0 118.01 168.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.764 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 30.9 t -77.27 -150.62 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 111.839 -2.437 . . . . 0.0 113.731 -167.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -172.52 143.58 1.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.206 169.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 6.9 m -105.36 98.78 8.44 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.17 131.86 68.88 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-O 116.943 -1.503 . . . . 0.0 112.802 -168.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -38.38 -54.43 1.49 Allowed 'Trans proline' 0 CA--C 1.561 1.842 0 N-CA-C 121.661 3.677 . . . . 0.0 121.661 -165.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -135.51 121.02 19.31 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 173.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.9 tt -89.51 100.57 13.34 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-O 123.852 1.787 . . . . 0.0 108.011 169.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.8 tp -144.35 47.07 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.575 1.93 0 CA-C-N 110.842 -2.89 . . . . 0.0 110.397 169.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 48.9 ttp -176.75 -59.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.175 1.39 . . . . 0.0 109.145 -170.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -64.9 -18.15 64.94 Favored 'General case' 0 N--CA 1.482 1.173 1 N-CA-C 122.731 4.345 . . . . 0.0 122.731 -169.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.3 74.04 0.24 Allowed Glycine 0 N--CA 1.479 1.556 0 CA-C-N 113.492 -1.686 . . . . 0.0 112.453 169.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -117.04 86.4 2.5 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.21 85.35 0.77 Allowed Glycine 0 N--CA 1.479 1.566 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -174.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.6 mt -129.51 -68.52 0.72 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.536 0.734 . . . . 0.0 109.599 -172.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 123.987 1.851 . . . . 0.0 110.077 179.482 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -75.9 110.44 10.35 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 119.152 0.887 . . . . 0.0 109.974 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -148.43 99.72 3.06 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 -169.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.67 ' HA ' HG22 ' A' ' 17' ' ' THR . 17.2 p -24.27 174.32 0.0 OUTLIER 'General case' 0 CA--C 1.579 2.065 1 N-CA-C 127.247 6.017 . . . . 0.0 127.247 -168.311 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mt -109.19 117.3 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.389 0 C-N-CA 127.823 2.449 . . . . 0.0 104.413 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -104.65 71.7 1.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.062 0.934 . . . . 0.0 110.25 173.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -169.82 123.2 0.74 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -76.11 128.5 35.1 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.869 1.267 . . . . 0.0 110.602 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.281 13.0 m-85 73.79 38.78 0.58 Allowed 'General case' 0 CA--C 1.578 2.055 0 C-N-CA 124.836 1.254 . . . . 0.0 110.689 -168.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.93 122.5 7.42 Favored Glycine 0 CA--C 1.533 1.18 0 O-C-N 121.222 -0.924 . . . . 0.0 111.69 -169.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -33.58 82.81 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.606 1 C-N-CA 132.857 4.463 . . . . 0.0 115.246 -172.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 34' ' ' CYS . 3.8 p -88.65 173.39 8.64 Favored 'General case' 0 N--CA 1.491 1.592 1 CA-C-N 107.471 -4.422 . . . . 0.0 113.8 -167.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -153.59 144.96 23.1 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.936 169.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -86.69 103.2 14.93 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 168.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.71 47.28 1.81 Allowed Glycine 0 CA--C 1.557 2.663 0 CA-C-N 114.526 -1.216 . . . . 0.0 112.733 -165.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.39 -141.4 3.48 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-O 123.29 1.494 . . . . 0.0 109.954 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.67 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -65.41 133.64 95.42 Favored Pre-proline 0 CA--C 1.577 1.985 0 CA-C-N 112.669 -1.765 . . . . 0.0 109.988 169.393 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -55.76 -35.37 93.35 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 N-CA-C 122.423 3.97 . . . . 0.0 122.423 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . 0.314 66.3 m 79.05 143.42 0.08 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 111.635 -2.53 . . . . 0.0 107.28 -163.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.47 -62.78 1.2 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -162.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -126.04 80.46 1.91 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.946 0.879 . . . . 0.0 109.089 -166.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.15 102.19 1.97 Allowed Glycine 0 N--CA 1.476 1.354 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.618 -176.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.54 165.94 18.95 Favored 'General case' 0 CA--C 1.556 1.197 0 CA-C-O 123.588 1.661 . . . . 0.0 112.577 -169.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -156.88 -81.01 0.03 OUTLIER Glycine 0 N--CA 1.477 1.432 0 CA-C-O 124.31 2.061 . . . . 0.0 109.314 -169.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.415 19.9 t 79.34 50.79 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 CA-C-N 109.202 -3.499 . . . . 0.0 115.166 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 76.9 mt -82.68 149.44 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-O 122.975 1.369 . . . . 0.0 107.421 167.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.419 ' HA ' ' CB ' ' A' ' 34' ' ' CYS . 69.3 m -93.14 171.25 9.06 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 117.772 2.508 . . . . 0.0 117.772 -170.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.274 69.6 m -91.09 -147.14 0.2 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 125.348 1.459 . . . . 0.0 109.635 -174.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 mm -94.2 50.88 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 CA-C-O 122.859 1.314 . . . . 0.0 110.213 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.1 ttt -172.76 -52.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.865 1.266 . . . . 0.0 112.417 -169.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.39 50.3 2.41 Favored Glycine 0 CA--C 1.548 2.154 0 CA-C-N 118.741 0.701 . . . . 0.0 113.749 -168.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.4 p -151.94 -79.11 0.11 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.906 1.336 . . . . 0.0 109.136 -169.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.81 -26.87 68.82 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 121.214 3.783 . . . . 0.0 121.214 -176.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.534 ' HB2' ' SG ' ' A' ' 12' ' ' CYS 0.376 6.7 m 37.27 -151.69 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 130.161 3.385 . . . . 0.0 117.714 172.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -175.75 133.57 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.1 m -89.73 95.47 10.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.193 -0.942 . . . . 0.0 109.246 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 12.5 tppt? -51.21 129.58 31.52 Favored Pre-proline 0 CA--C 1.573 1.856 0 CA-C-O 116.763 -1.589 . . . . 0.0 112.027 -170.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.251 80.7 Cg_exo -28.63 -61.02 0.1 Allowed 'Trans proline' 0 C--N 1.371 1.727 0 N-CA-C 122.321 3.931 . . . . 0.0 122.321 -164.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.253 36.9 ptt180 -152.65 102.44 2.71 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 118.891 0.769 . . . . 0.0 109.641 168.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 tt -103.32 106.69 17.27 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 165.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.363 6.5 pt -127.9 -91.49 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 -177.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 23.5 mmt -112.39 72.58 0.78 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 110.205 -3.18 . . . . 0.0 103.719 162.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . 0.728 3.5 pt-20 5.99 85.4 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.03 1 N-CA-C 122.487 4.254 . . . . 0.0 122.487 -166.227 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.64 24.87 76.05 Favored Glycine 0 CA--C 1.553 2.426 0 CA-C-N 110.292 -3.14 . . . . 0.0 119.467 -174.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt -136.2 80.45 1.83 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 120.52 2.16 . . . . 0.0 108.972 -171.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.18 -104.65 0.18 Allowed Glycine 0 N--CA 1.477 1.377 0 O-C-N 122.024 -0.423 . . . . 0.0 112.483 170.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.255 1.1 pt? -149.83 -61.17 0.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 118.642 -0.694 . . . . 0.0 112.048 -169.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 123.923 1.821 . . . . 0.0 110.183 -177.207 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? 73.85 112.81 0.06 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.839 1.256 . . . . 0.0 110.988 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.5 mttm 66.5 89.16 0.1 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 124.679 1.192 . . . . 0.0 110.275 -172.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.444 ' HA ' HG22 ' A' ' 17' ' ' THR . 25.6 p 49.21 170.03 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 118.61 2.819 . . . . 0.0 118.61 -169.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mm -102.41 108.45 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.32 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.76 72.89 2.29 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.347 1.07 . . . . 0.0 110.053 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -176.6 123.9 0.16 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 -171.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -75.22 127.95 34.35 Favored 'General case' 0 CA--C 1.553 1.093 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 168.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.27 12.1 m-85 74.78 30.09 1.02 Allowed 'General case' 0 CA--C 1.579 2.093 0 C-N-CA 124.903 1.281 . . . . 0.0 113.607 -169.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.96 131.27 10.59 Favored Glycine 0 N--CA 1.474 1.227 0 O-C-N 120.91 -1.119 . . . . 0.0 112.237 -169.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -55.47 82.21 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 130.324 3.45 . . . . 0.0 114.69 -167.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.521 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 22.3 p -90.41 173.15 8.26 Favored 'General case' 0 N--CA 1.494 1.751 1 CA-C-N 106.374 -4.921 . . . . 0.0 113.242 -168.654 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -150.66 128.85 11.94 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.507 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -77.16 111.13 12.44 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 170.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.54 33.9 5.73 Favored Glycine 0 CA--C 1.559 2.807 0 CA-C-N 114.826 -1.079 . . . . 0.0 114.531 -166.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -143.24 -139.99 3.63 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-O 123.449 1.583 . . . . 0.0 109.667 -176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -63.55 137.26 97.03 Favored Pre-proline 0 CA--C 1.573 1.864 0 CA-C-N 112.42 -1.89 . . . . 0.0 109.772 168.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -66.92 -172.91 0.35 Allowed 'Trans proline' 0 CA--C 1.57 2.313 0 CA-C-N 123.546 2.302 . . . . 0.0 110.834 167.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.9 m -101.84 149.16 24.47 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 167.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.71 -60.17 1.76 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.865 -173.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -137.24 87.3 2.26 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.944 1.297 . . . . 0.0 108.128 -169.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.78 116.2 4.15 Favored Glycine 0 N--CA 1.482 1.759 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -169.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -138.24 176.23 8.88 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 -167.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.37 109.23 2.84 Favored Glycine 0 N--CA 1.475 1.263 0 CA-C-N 112.367 -2.197 . . . . 0.0 109.039 -170.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 53.8 t -109.77 75.66 0.95 Allowed 'General case' 0 CA--C 1.56 1.327 0 CA-C-N 111.837 -2.182 . . . . 0.0 111.587 -169.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.401 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 36.4 mm -89.45 144.58 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 169.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 34' ' ' CYS 0.304 6.5 m -105.75 161.8 14.09 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 125.023 1.452 . . . . 0.0 113.002 177.045 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.642 ' HA ' ' H ' ' A' ' 31' ' ' GLY 0.823 2.9 t 81.74 -176.52 0.05 OUTLIER 'General case' 0 C--N 1.353 0.736 0 N-CA-C 120.605 3.557 . . . . 0.0 120.605 156.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.311 4.1 mp 70.83 64.08 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.586 2.331 0 CA-C-N 108.468 -3.969 . . . . 0.0 104.002 -158.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.272 0.0 OUTLIER 136.33 -58.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 128.582 2.753 . . . . 0.0 104.073 -162.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.642 ' H ' ' HA ' ' A' ' 28' ' ' SER . . . 62.34 47.65 88.08 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 120.208 2.843 . . . . 0.0 120.208 -169.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.299 22.7 p -98.66 102.79 14.63 Favored 'General case' 0 CA--C 1.553 1.059 1 N-CA-C 94.359 -6.163 . . . . 0.0 94.359 151.798 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.404 ' O ' ' SG ' ' A' ' 27' ' ' CYS 0.62 3.5 p-10 -87.82 70.89 9.59 Favored 'General case' 0 N--CA 1.439 -1.015 2 CA-C-N 105.29 -5.414 . . . . 0.0 122.177 -148.202 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 27' ' ' CYS 0.414 59.3 m 123.19 171.24 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.782 3 CA-C-N 101.572 -7.104 . . . . 0.0 113.402 160.774 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -150.01 143.17 25.0 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-N 112.032 -2.349 . . . . 0.0 106.46 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 12.8 m -89.8 86.35 6.64 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -45.08 145.61 1.67 Allowed Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -167.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -61.19 -73.32 0.02 OUTLIER 'Trans proline' 0 CA--C 1.562 1.9 0 C-N-CA 122.964 2.443 . . . . 0.0 116.226 -163.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.375 27.1 ptt85 41.22 98.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 118.434 2.753 . . . . 0.0 118.434 173.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.8 tt -93.01 105.42 17.53 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 123.779 1.752 . . . . 0.0 108.108 169.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.6 tp -130.43 66.3 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.618 0 CA-C-N 111.103 -2.771 . . . . 0.0 104.601 166.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . 0.468 11.7 ptt? 64.04 10.07 5.11 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 117.386 2.365 . . . . 0.0 117.386 -167.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -80.38 -1.53 41.69 Favored 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 121.058 3.725 . . . . 0.0 121.058 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -96.75 -53.6 1.4 Allowed Glycine 0 CA--C 1.546 2.01 0 C-N-CA 125.088 1.328 . . . . 0.0 114.045 169.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.68 93.82 3.0 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.3 -88.89 0.08 OUTLIER Glycine 0 N--CA 1.478 1.497 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 pp -76.59 -34.07 58.43 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 171.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 122.829 1.3 . . . . 0.0 107.988 173.974 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 121.588 0.709 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . 0.354 51.0 tttp 83.94 -76.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.113 1.365 . . . . 0.0 113.206 173.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -124.95 87.17 2.67 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.585 ' HA ' HG22 ' A' ' 17' ' ' THR 0.284 22.0 p 41.93 -171.46 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 118.87 2.915 . . . . 0.0 118.87 173.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.415 HG13 ' SG ' ' A' ' 19' ' ' CYS . 4.5 mm -113.22 -62.81 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.546 0 CA-C-N 113.449 -1.705 . . . . 0.0 110.25 -164.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.254 . . 66.11 60.64 0.64 Allowed 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 125.278 1.431 . . . . 0.0 114.572 -169.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -169.75 131.44 1.09 Allowed 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 173.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -68.14 136.07 53.11 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 125.264 1.425 . . . . 0.0 110.235 169.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 66.34 34.61 6.29 Favored 'General case' 0 CA--C 1.581 2.169 0 C-N-CA 124.257 1.023 . . . . 0.0 112.093 -167.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.65 132.16 10.87 Favored Glycine 0 N--CA 1.48 1.603 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -169.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -73.52 73.77 1.43 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 126.971 3.272 . . . . 0.0 112.116 -167.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 24.3 p -71.02 174.8 5.77 Favored 'General case' 0 N--CA 1.486 1.35 1 CA-C-N 106.056 -5.066 . . . . 0.0 114.074 -176.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.985 ' H ' ' HG2' ' A' ' 18' ' ' PRO . 17.9 ptpt -129.2 159.1 37.11 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 123.42 1.581 . . . . 0.0 111.158 171.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 52.6 m0 -104.61 91.29 3.8 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 168.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 178.91 -81.11 0.06 OUTLIER Glycine 0 N--CA 1.478 1.442 0 N-CA-C 106.491 -2.644 . . . . 0.0 106.491 -166.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.86 135.87 2.02 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-O 125.154 2.53 . . . . 0.0 118.093 163.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.645 ' HB ' ' HD3' ' A' ' 18' ' ' PRO . 14.8 m 168.64 -65.12 0.0 OUTLIER Pre-proline 0 CA--C 1.59 2.493 1 CA-C-N 107.266 -4.467 . . . . 0.0 101.393 -168.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.985 ' HG2' ' H ' ' A' ' 13' ' ' LYS 1.105 0.6 OUTLIER -24.85 155.28 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.827 2 N-CA-C 135.587 9.033 . . . . 0.0 135.587 -156.146 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.439 ' H ' ' HB3' ' A' ' 18' ' ' PRO 0.345 31.4 m -23.92 117.5 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.272 2 CA-C-N 105.167 -5.47 . . . . 0.0 114.873 -156.667 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.33 156.13 39.43 Favored 'General case' 0 C--N 1.297 -1.708 1 CA-C-N 106.378 -4.919 . . . . 0.0 109.373 -163.239 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 58.39 49.28 11.08 Favored 'General case' 0 CA--C 1.586 2.339 0 CA-C-N 112.989 -1.914 . . . . 0.0 113.768 -173.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.23 142.48 6.77 Favored Glycine 0 CA--C 1.556 2.642 0 N-CA-C 115.316 0.886 . . . . 0.0 115.316 -169.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.53 162.81 40.91 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -153.52 105.52 0.28 Allowed Glycine 0 N--CA 1.475 1.268 0 N-CA-C 105.751 -2.94 . . . . 0.0 105.751 164.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.87 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 54.0 t -99.07 125.09 44.51 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 110.787 -2.707 . . . . 0.0 109.568 -174.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.537 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 23.6 mm -117.27 134.07 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 166.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.576 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 68.2 m -121.56 173.25 7.53 Favored 'General case' 0 CA--C 1.554 1.103 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -172.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.9 p -120.05 135.42 54.94 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 125.072 1.349 . . . . 0.0 111.085 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.296 9.6 mt -5.61 56.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.39 2 CA-C-N 108.264 -4.062 . . . . 0.0 116.571 -168.659 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.8 tpt 172.57 -56.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 113.076 -1.875 . . . . 0.0 113.765 -167.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.36 53.0 1.64 Allowed Glycine 0 CA--C 1.552 2.362 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -163.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 99.6 m -150.77 -69.8 0.18 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 123.124 1.44 . . . . 0.0 111.665 -167.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.283 9.6 m-80 -71.23 30.16 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 118.466 2.765 . . . . 0.0 118.466 169.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.87 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 17.7 t -76.47 -156.79 0.07 Allowed 'General case' 0 CA--C 1.556 1.176 0 CA-C-N 112.496 -2.138 . . . . 0.0 115.061 -166.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.08 147.62 4.74 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 113.658 -1.61 . . . . 0.0 110.666 168.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 20.2 m -100.16 95.89 7.12 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -54.07 131.73 59.34 Favored Pre-proline 0 CA--C 1.576 1.969 0 CA-C-O 117.54 -1.219 . . . . 0.0 112.555 -169.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -47.92 135.32 23.36 Favored 'Trans proline' 0 CA--C 1.556 1.605 0 C-N-CA 124.299 3.333 . . . . 0.0 119.162 -164.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.2 mtp-105 -115.47 -177.34 3.12 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.661 1.22 . . . . 0.0 111.276 -176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.275 35.1 tp -101.12 -65.22 0.99 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 124.378 2.037 . . . . 0.0 116.395 -174.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.285 28.2 pt -74.03 15.45 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-N 110.152 -3.203 . . . . 0.0 118.098 174.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.2 ptm -142.34 33.61 1.49 Allowed 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 124.554 1.141 . . . . 0.0 113.658 166.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . 0.427 29.1 tt0 -110.76 -87.92 0.52 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 -172.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.06 63.38 1.02 Allowed Glycine 0 CA--C 1.545 1.907 0 CA-C-N 113.209 -1.814 . . . . 0.0 113.844 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.358 0.8 OUTLIER 42.9 58.24 3.31 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 117.748 2.499 . . . . 0.0 117.748 -178.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.84 -71.42 0.27 Allowed Glycine 0 N--CA 1.481 1.652 0 O-C-N 122.287 -0.258 . . . . 0.0 112.634 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.265 56.3 mt 68.85 64.98 0.3 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.781 1.232 . . . . 0.0 111.472 -171.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 124.034 1.873 . . . . 0.0 110.093 -177.817 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -96.32 112.65 24.32 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.7 tttt 66.2 92.76 0.07 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.692 1.197 . . . . 0.0 111.705 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 27.2 p 54.41 170.75 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.526 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 31.7 mm -99.47 103.96 15.43 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 175.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.46 66.26 1.99 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 122.234 1.016 . . . . 0.0 112.456 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -174.89 119.83 0.21 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 -170.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -75.18 129.38 37.41 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.908 1.283 . . . . 0.0 108.535 169.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 72.47 44.13 0.43 Allowed 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -166.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.498 ' N ' ' H ' ' A' ' 36' ' ' CYS . . . -81.49 -148.03 6.13 Favored Glycine 0 N--CA 1.476 1.334 0 CA-C-O 117.428 -1.762 . . . . 0.0 111.416 -173.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -144.75 75.92 1.47 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 -175.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 17.2 p -97.76 -175.44 3.17 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 112.737 -2.029 . . . . 0.0 113.563 -168.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -153.5 160.63 42.58 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.227 -1.352 . . . . 0.0 110.065 166.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 19.0 m0 -95.9 108.01 20.34 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 169.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.62 38.83 2.0 Allowed Glycine 0 CA--C 1.558 2.764 0 CA-C-N 113.896 -1.502 . . . . 0.0 113.312 -166.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.03 -140.17 3.86 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 123.637 1.687 . . . . 0.0 110.05 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.599 HG23 ' H ' ' A' ' 19' ' ' CYS . 0.4 OUTLIER -62.3 166.13 7.45 Favored Pre-proline 0 CA--C 1.596 2.748 0 CA-C-N 112.052 -2.074 . . . . 0.0 113.0 168.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -62.39 -30.96 81.18 Favored 'Trans proline' 0 CA--C 1.568 2.222 0 N-CA-C 122.401 3.962 . . . . 0.0 122.401 169.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.599 ' H ' HG23 ' A' ' 17' ' ' THR 0.323 6.2 t 78.54 139.64 0.07 Allowed 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 111.649 -2.523 . . . . 0.0 107.138 -162.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.74 -64.28 1.16 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -164.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . 0.29 40.8 mtm105 -92.11 -130.37 0.11 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.811 1.291 . . . . 0.0 109.116 -168.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.65 94.93 0.25 Allowed Glycine 0 N--CA 1.486 1.994 0 CA-C-N 112.799 -2.0 . . . . 0.0 111.048 169.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -106.47 169.05 8.75 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 123.948 1.832 . . . . 0.0 115.646 -165.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.28 103.62 0.21 Allowed Glycine 0 N--CA 1.471 0.988 0 N-CA-C 105.484 -3.046 . . . . 0.0 105.484 169.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.7 t -88.33 77.33 8.2 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 111.006 -2.597 . . . . 0.0 111.631 -169.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.1 mm -82.36 144.99 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 168.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 32' ' ' THR . 3.1 t -110.58 -176.09 2.89 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -176.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.315 42.5 m -101.97 -142.18 0.35 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 125.849 1.66 . . . . 0.0 109.195 -169.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.4 mm -72.87 -5.82 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -174.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.0 mmt -141.49 -24.63 0.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.431 ' HA2' ' SG ' ' A' ' 27' ' ' CYS . . . 91.3 58.05 1.5 Allowed Glycine 0 CA--C 1.551 2.283 0 CA-C-N 121.084 1.766 . . . . 0.0 110.929 -166.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.439 ' N ' ' SG ' ' A' ' 27' ' ' CYS . 17.7 p -149.06 -74.93 0.17 Allowed 'General case' 0 CA--C 1.563 1.451 0 CA-C-O 124.2 1.952 . . . . 0.0 111.832 -168.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.358 33.5 m-20 -88.24 40.76 0.97 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 130.381 3.472 . . . . 0.0 115.303 -174.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -64.06 -167.47 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 112.328 -2.215 . . . . 0.0 115.518 -166.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -136.73 150.48 48.44 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.375 -0.828 . . . . 0.0 110.856 169.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.498 ' H ' ' N ' ' A' ' 10' ' ' GLY . 13.2 m -87.13 52.32 2.48 Favored 'General case' 0 N--CA 1.52 3.074 0 CA-C-O 123.96 1.838 . . . . 0.0 112.364 169.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.428 0.1 OUTLIER 98.42 93.31 0.01 OUTLIER Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 127.178 2.191 . . . . 0.0 115.134 169.281 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -81.07 170.47 15.09 Favored 'Trans proline' 0 CA--C 1.559 1.744 0 C-N-CA 123.262 2.641 . . . . 0.0 113.747 169.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -71.18 145.97 49.38 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 171.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.555 ' H ' HD23 ' A' ' 40' ' ' LEU 0.434 2.7 pt? -63.22 -33.06 74.67 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 121.296 3.813 . . . . 0.0 121.296 -176.471 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.329 1.9 pp -80.4 6.96 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 N-CA-C 118.344 2.72 . . . . 0.0 118.344 168.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.0 mmt -147.2 50.43 1.09 Allowed 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 125.985 1.714 . . . . 0.0 108.369 167.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -72.01 131.5 42.99 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-O 127.055 3.312 . . . . 0.0 110.642 -171.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.35 38.91 89.23 Favored Glycine 0 CA--C 1.558 2.744 1 CA-C-N 104.94 -5.573 . . . . 0.0 116.853 -167.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.26 7.1 tp 67.06 87.64 0.12 Allowed 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 125.316 1.446 . . . . 0.0 113.333 -175.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.1 106.15 1.24 Allowed Glycine 0 CA--C 1.54 1.628 0 N-CA-C 114.336 0.494 . . . . 0.0 114.336 169.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.2 mt -98.14 -63.61 1.11 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.384 0.674 . . . . 0.0 110.312 169.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 122.837 1.303 . . . . 0.0 108.924 178.386 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 61.9 mttp . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -110.26 106.75 16.27 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? 67.16 87.24 0.12 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.615 1.166 . . . . 0.0 111.413 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.468 ' HA ' HG22 ' A' ' 17' ' ' THR . 11.5 p 54.75 -178.15 0.03 OUTLIER 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 118.367 2.729 . . . . 0.0 118.367 173.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.521 ' HB ' ' SG ' ' A' ' 19' ' ' CYS . 6.1 mm -133.47 114.09 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.397 0 N-CA-C 104.02 -2.585 . . . . 0.0 104.02 -171.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.6 65.84 4.41 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 122.01 0.91 . . . . 0.0 112.003 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -163.18 122.67 2.16 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.4 127.25 31.55 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.534 0.734 . . . . 0.0 110.617 167.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 69.59 39.68 1.51 Allowed 'General case' 0 CA--C 1.576 1.968 0 C-N-CA 123.546 0.739 . . . . 0.0 111.831 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.56 126.3 7.33 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -78.83 70.92 5.25 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 127.048 3.308 . . . . 0.0 111.823 -166.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 14.1 p -74.43 -167.18 0.51 Allowed 'General case' 0 CA--C 1.562 1.404 1 CA-C-N 106.288 -4.96 . . . . 0.0 113.782 -167.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 34' ' ' CYS 0.389 0.1 OUTLIER 105.68 90.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 127.49 2.316 . . . . 0.0 106.841 173.851 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.494 ' NE1' HD11 ' A' ' 5' ' ' ILE 0.341 69.7 m95 -107.61 -140.42 0.37 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 110.502 -3.045 . . . . 0.0 102.963 -169.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.13 43.61 3.15 Favored Glycine 1 CA--C 1.585 4.433 0 N-CA-C 105.836 -2.906 . . . . 0.0 105.836 149.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 55.87 136.58 0.0 OUTLIER Glycine 0 CA--C 1.557 2.677 0 C-N-CA 126.926 2.203 . . . . 0.0 114.027 -162.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 4' ' ' CYS . 2.5 m -134.66 134.96 22.65 Favored Pre-proline 0 N--CA 1.494 1.75 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 170.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -48.44 -37.13 32.55 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 N-CA-C 119.999 3.038 . . . . 0.0 119.999 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.521 ' SG ' ' HB ' ' A' ' 5' ' ' ILE 0.258 16.6 t 74.32 141.4 0.07 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.997 -1.91 . . . . 0.0 106.982 -164.166 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 160.15 19.12 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 113.219 -1.81 . . . . 0.0 112.859 -165.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 52.6 mtt85 63.81 62.99 0.86 Allowed 'General case' 0 CA--C 1.567 1.616 0 CA-C-N 112.795 -2.002 . . . . 0.0 113.177 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.44 68.81 1.52 Allowed Glycine 0 CA--C 1.545 1.911 0 N-CA-C 115.911 1.125 . . . . 0.0 115.911 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.28 161.41 42.09 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-O 123.222 1.487 . . . . 0.0 112.353 -172.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.86 118.68 1.27 Allowed Glycine 0 N--CA 1.478 1.47 1 N-CA-C 102.935 -4.066 . . . . 0.0 102.935 166.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.616 9.1 t -45.38 -82.72 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 125.441 1.318 . . . . 0.0 113.857 -166.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . 0.275 60.6 mt 74.13 150.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 123.286 1.517 . . . . 0.0 110.855 172.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 90.6 m -90.64 171.09 9.62 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 119.454 3.131 . . . . 0.0 119.454 -169.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.336 13.3 m -94.79 -142.85 0.25 Allowed 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 126.706 2.002 . . . . 0.0 108.928 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.25 1.9 pp -96.74 59.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 CA-C-O 123.132 1.444 . . . . 0.0 111.32 168.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.9 ttt -161.52 -46.27 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.608 -1.633 . . . . 0.0 113.01 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.41 38.25 11.16 Favored Glycine 0 CA--C 1.556 2.638 0 CA-C-O 119.336 -0.702 . . . . 0.0 113.434 -165.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 m -162.28 -59.84 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 123.762 1.744 . . . . 0.0 111.465 -167.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.374 26.0 m-20 -79.11 45.87 0.66 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 129.781 3.232 . . . . 0.0 114.932 171.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 13' ' ' LYS 0.267 36.3 m -69.54 -167.14 0.12 Allowed 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.415 -167.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -163.15 138.11 6.48 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 119.709 -1.869 . . . . 0.0 108.812 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.9 m -51.69 -47.84 63.73 Favored 'General case' 0 N--CA 1.512 2.652 0 CA-C-O 125.557 2.599 . . . . 0.0 117.861 175.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.391 23.0 mtmm 86.83 171.63 0.05 OUTLIER Pre-proline 0 CA--C 1.578 2.027 1 CA-C-N 105.727 -5.215 . . . . 0.0 109.57 -165.13 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -78.41 114.55 3.53 Favored 'Trans proline' 0 C--N 1.37 1.668 0 CA-C-N 124.681 2.707 . . . . 0.0 113.824 -167.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -76.54 155.59 33.58 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.492 169.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 tt -77.95 100.48 6.44 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-O 124.233 1.968 . . . . 0.0 111.321 -170.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.8 tt -149.65 42.07 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.579 2.085 0 CA-C-N 110.189 -3.187 . . . . 0.0 110.148 168.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 13.5 tpt 176.97 -53.88 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 125.666 1.587 . . . . 0.0 109.76 -167.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.73 -2.22 8.8 Favored 'General case' 0 CA--C 1.556 1.177 1 N-CA-C 123.317 4.562 . . . . 0.0 123.317 -168.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.72 77.32 0.06 OUTLIER Glycine 0 CA--C 1.535 1.294 0 CA-C-N 114.8 -1.091 . . . . 0.0 112.021 169.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.54 81.44 1.4 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.56 -79.64 0.18 Allowed Glycine 0 N--CA 1.479 1.563 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -172.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.0 mt -79.91 -55.58 4.87 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.231 0.612 . . . . 0.0 111.869 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 122.8 1.286 . . . . 0.0 111.602 175.814 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt . . . . . 0 CA--C 1.555 1.14 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -95.27 -93.69 0.19 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -175.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -153.56 78.87 1.15 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.608 1.094 . . . . 0.0 108.464 171.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.441 ' HA ' HG22 ' A' ' 17' ' ' THR . 13.6 p 50.59 178.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 119.04 2.978 . . . . 0.0 119.04 173.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mt -134.32 119.01 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.149 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 -170.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.284 . . -77.38 10.87 2.24 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 119.274 3.065 . . . . 0.0 119.274 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.932 30.7 mtmm 92.39 -136.53 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 1 N-CA-C 124.527 5.01 . . . . 0.0 124.527 161.166 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.442 0.0 OUTLIER 6.3 83.37 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 1 CA-C-N 108.215 -4.084 . . . . 0.0 116.934 -149.461 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.316 29.7 m-85 80.79 62.78 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.395 0 N-CA-C 102.478 -3.156 . . . . 0.0 102.478 -163.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.26 -167.95 0.7 Allowed Glycine 0 CA--C 1.568 3.384 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 168.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -144.66 72.86 1.35 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 121.06 2.43 . . . . 0.0 104.636 -176.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.859 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 28.9 p -88.98 174.03 8.14 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 112.304 -2.225 . . . . 0.0 114.0 -165.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -166.42 126.93 1.67 Allowed 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 103.114 -2.921 . . . . 0.0 103.114 169.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -79.5 99.78 7.41 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 172.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.73 38.51 1.06 Allowed Glycine 0 CA--C 1.569 3.421 0 CA-C-N 112.393 -2.185 . . . . 0.0 111.525 -163.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -162.44 -149.18 5.59 Favored Glycine 0 N--CA 1.48 1.633 0 C-N-CA 125.376 1.465 . . . . 0.0 109.819 -170.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -69.18 128.52 92.52 Favored Pre-proline 0 N--CA 1.501 2.088 0 CA-C-O 118.189 -0.91 . . . . 0.0 109.321 169.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -63.01 -38.77 44.24 Favored 'Trans proline' 0 N--CA 1.495 1.575 1 N-CA-C 123.207 4.272 . . . . 0.0 123.207 -171.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . 0.331 71.6 m 90.93 144.44 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.451 0 CA-C-N 111.166 -2.743 . . . . 0.0 105.015 -160.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . 0.255 0.1 OUTLIER -85.51 -66.94 0.84 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 119.439 3.126 . . . . 0.0 119.439 -161.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 72.7 mtp180 -109.09 67.16 0.65 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -166.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.83 92.92 0.27 Allowed Glycine 0 N--CA 1.49 2.234 0 CA-C-O 119.423 -0.654 . . . . 0.0 112.346 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.59 165.09 11.79 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 -166.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.87 106.27 0.32 Allowed Glycine 0 N--CA 1.471 0.995 0 N-CA-C 106.743 -2.543 . . . . 0.0 106.743 166.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.737 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 25.4 t -99.53 94.24 6.29 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 110.032 -3.084 . . . . 0.0 110.676 -173.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.502 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 29.6 mm -92.09 139.28 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 167.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.419 ' SG ' ' SG ' ' A' ' 25' ' ' CYS . 79.2 m -117.49 -176.85 3.1 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 -167.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.0 t -145.49 163.85 33.41 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 125.699 2.666 . . . . 0.0 107.689 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.345 7.6 mt 36.71 52.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 1 CA-C-N 108.275 -4.057 . . . . 0.0 114.415 179.684 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.6 tpt 72.61 44.48 0.39 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 125.441 1.496 . . . . 0.0 114.547 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.71 65.06 2.61 Favored Glycine 0 N--CA 1.491 2.346 0 O-C-N 120.321 -1.487 . . . . 0.0 113.074 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.8 p -146.05 -81.51 0.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 124.011 1.862 . . . . 0.0 110.932 -166.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.335 9.1 m120 -70.73 35.75 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 131.093 3.757 . . . . 0.0 118.119 172.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.859 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 7.2 t -71.5 -176.7 1.62 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 124.439 2.066 . . . . 0.0 114.326 -167.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -144.45 153.93 42.42 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 111.22 -2.718 . . . . 0.0 109.828 170.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.595 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 36.2 m -104.26 90.05 3.44 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 171.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -56.98 136.05 80.06 Favored Pre-proline 0 CA--C 1.568 1.653 0 CA-C-O 117.657 -1.163 . . . . 0.0 111.482 -169.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -35.01 -46.34 0.61 Allowed 'Trans proline' 0 CA--C 1.558 1.702 1 N-CA-C 123.469 4.373 . . . . 0.0 123.469 -164.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.24 118.33 14.4 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.27 0.628 . . . . 0.0 110.95 -173.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.9 tt -100.05 101.41 12.48 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 165.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.6 tt -148.77 67.44 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 CA-C-N 111.499 -2.592 . . . . 0.0 105.23 169.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . 0.257 3.5 tmm? 71.74 76.0 0.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.99 1.316 . . . . 0.0 109.984 -168.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.526 ' HG2' ' H ' ' A' ' 44' ' ' GLY 0.488 20.6 tt0 -102.73 -107.54 0.26 Allowed 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 104.246 -2.501 . . . . 0.0 104.246 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.526 ' H ' ' HG2' ' A' ' 43' ' ' GLU . . . -151.14 56.22 0.46 Allowed Glycine 0 CA--C 1.543 1.796 0 CA-C-N 115.158 -0.928 . . . . 0.0 114.573 170.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.1 tp 52.87 87.76 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 174.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.29 63.28 0.29 Allowed Glycine 0 CA--C 1.543 1.791 0 CA-C-N 116.442 -0.345 . . . . 0.0 113.212 169.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.0 mt -134.75 -14.3 2.16 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -174.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 124.013 1.863 . . . . 0.0 110.497 175.972 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -85.76 143.47 28.31 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.211 0.605 . . . . 0.0 111.548 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . 0.25 95.5 mttt 76.23 100.06 0.07 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.008 1.323 . . . . 0.0 110.614 177.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.64 ' HA ' HG22 ' A' ' 17' ' ' THR 0.318 30.0 p -28.74 -179.11 0.0 OUTLIER 'General case' 0 CA--C 1.578 2.032 1 N-CA-C 125.172 5.249 . . . . 0.0 125.172 177.427 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.8 mm -99.24 110.23 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 174.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -96.54 67.16 2.4 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.242 1.02 . . . . 0.0 111.363 176.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -166.4 123.19 1.31 Allowed 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -175.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -70.25 130.41 41.95 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 167.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.257 0.0 OUTLIER 69.6 46.81 0.69 Allowed 'General case' 0 CA--C 1.569 1.709 0 CA-C-O 122.964 1.364 . . . . 0.0 109.061 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' H ' ' HB2' ' A' ' 36' ' ' CYS . . . -84.32 -152.59 15.73 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 113.615 -1.629 . . . . 0.0 109.802 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -142.21 75.64 1.5 Allowed 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 104.797 -2.297 . . . . 0.0 104.797 -175.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 28.5 p -91.03 -171.66 3.07 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 112.641 -2.072 . . . . 0.0 112.525 -169.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -153.37 141.91 20.81 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.811 169.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -93.15 99.01 11.67 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.15 -62.98 0.52 Allowed Glycine 0 N--CA 1.484 1.867 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.782 -164.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.41 -142.67 0.3 Allowed Glycine 0 CA--C 1.539 1.587 0 CA-C-N 112.083 -2.058 . . . . 0.0 113.368 167.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -61.56 138.04 94.95 Favored Pre-proline 0 N--CA 1.495 1.821 0 CA-C-N 113.484 -1.358 . . . . 0.0 111.889 178.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -64.55 -131.13 0.0 OUTLIER 'Trans proline' 0 CA--C 1.573 2.429 0 C-N-CA 123.426 2.751 . . . . 0.0 112.34 169.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.3 t -148.81 146.81 28.17 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 164.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.29 -63.15 1.39 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 121.507 3.891 . . . . 0.0 121.507 -162.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.412 ' HE ' HH12 ' A' ' 23' ' ' ARG . 75.8 mtm180 -94.86 70.1 3.38 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 122.289 1.042 . . . . 0.0 112.715 -164.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.64 62.58 4.92 Favored Glycine 0 N--CA 1.486 2.004 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.925 -176.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.412 HH12 ' HE ' ' A' ' 21' ' ' ARG . 68.8 mtt180 -136.48 163.63 30.06 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 123.963 1.84 . . . . 0.0 112.222 -167.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.87 121.11 2.16 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 106.095 -2.802 . . . . 0.0 106.095 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.664 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 2.9 t -75.44 89.33 2.66 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 109.214 -3.493 . . . . 0.0 110.642 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.456 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 37.5 mm -81.5 136.41 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 122.852 1.311 . . . . 0.0 107.655 172.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 61.4 m -119.07 -179.0 3.7 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 111.925 -2.398 . . . . 0.0 114.985 -169.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.291 69.6 m -90.78 -144.85 0.18 Allowed 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.942 1.297 . . . . 0.0 109.844 -172.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.4 mm -71.34 -0.63 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.578 2.024 0 N-CA-C 117.596 2.443 . . . . 0.0 117.596 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.9 tpt -148.63 -31.36 0.26 Allowed 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -172.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.81 61.14 1.11 Allowed Glycine 0 N--CA 1.488 2.119 0 CA-C-N 120.796 1.634 . . . . 0.0 111.671 -167.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.3 p -151.22 -78.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 123.849 1.785 . . . . 0.0 111.25 -167.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.336 37.2 m-80 -71.58 34.91 0.06 Allowed 'General case' 0 CA--C 1.565 1.524 0 C-N-CA 129.953 3.301 . . . . 0.0 118.006 170.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.767 ' SG ' ' SG ' ' A' ' 12' ' ' CYS . 45.9 t -74.48 -168.52 0.69 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 112.259 -2.246 . . . . 0.0 113.495 -168.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -148.45 162.54 39.38 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 112.837 -1.983 . . . . 0.0 112.142 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.463 ' HB2' ' H ' ' A' ' 10' ' ' GLY . 87.9 m -83.54 56.92 3.79 Favored 'General case' 0 N--CA 1.523 3.183 0 CA-C-O 124.75 2.214 . . . . 0.0 108.847 163.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.477 1.6 ptmm? 30.79 125.31 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.253 1 N-CA-C 125.424 5.342 . . . . 0.0 125.424 -163.648 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.94 152.6 76.83 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 123.646 2.897 . . . . 0.0 114.183 170.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.265 10.3 mtm105 77.7 140.4 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 124.546 1.138 . . . . 0.0 112.246 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.1 tt -100.59 102.76 13.99 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 124.033 1.873 . . . . 0.0 106.824 169.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.468 HG13 ' H ' ' A' ' 42' ' ' MET 0.443 17.9 pt -116.53 -83.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 110.442 -3.072 . . . . 0.0 107.292 169.127 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.468 ' H ' HG13 ' A' ' 41' ' ' ILE . 60.3 mtt -120.26 77.68 1.28 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 110.808 -2.906 . . . . 0.0 106.505 165.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.71 113.39 1.62 Allowed 'General case' 0 C--N 1.356 0.884 0 CA-C-O 126.192 2.901 . . . . 0.0 115.011 -168.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 116.77 -60.07 0.44 Allowed Glycine 0 CA--C 1.541 1.685 1 CA-C-N 105.788 -5.187 . . . . 0.0 115.115 -168.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.65 -73.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 118.157 0.979 . . . . 0.0 110.927 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.77 -84.56 0.22 Allowed Glycine 0 N--CA 1.478 1.459 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.6 mt -122.81 -62.39 1.36 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.886 0.875 . . . . 0.0 109.666 175.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 122.775 1.274 . . . . 0.0 111.389 174.953 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 65.6 pttt . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 121.145 0.498 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? 70.68 98.93 0.06 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.847 1.259 . . . . 0.0 110.4 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.8 tttm 61.08 74.34 0.45 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.455 1.102 . . . . 0.0 111.888 -173.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.488 ' HA ' HG22 ' A' ' 17' ' ' THR . 14.6 p 51.54 171.17 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 118.249 2.685 . . . . 0.0 118.249 -169.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.708 HG22 ' HG3' ' A' ' 7' ' ' LYS . 5.0 mt -121.78 121.41 64.25 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 -172.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.55 52.22 1.1 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 116.963 2.209 . . . . 0.0 116.963 -173.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.708 ' HG3' HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -122.89 -179.62 4.32 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 127.079 2.152 . . . . 0.0 110.119 175.303 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -115.0 136.43 53.14 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 113.277 -1.783 . . . . 0.0 106.545 157.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 71.66 35.83 1.35 Allowed 'General case' 0 CA--C 1.58 2.118 0 CA-C-N 122.451 2.387 . . . . 0.0 111.987 168.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.78 125.96 6.62 Favored Glycine 0 N--CA 1.464 0.543 0 O-C-N 120.548 -1.345 . . . . 0.0 112.949 -168.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.413 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 11.4 mpt_? -3.9 79.37 0.0 OUTLIER 'General case' 0 C--O 1.236 0.361 1 C-N-CA 132.378 4.271 . . . . 0.0 116.912 169.292 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.981 ' SG ' ' SG ' ' A' ' 34' ' ' CYS . 15.5 p -94.05 -178.46 4.64 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 108.461 -3.972 . . . . 0.0 112.515 -173.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.35 153.96 31.29 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.255 1.026 . . . . 0.0 109.551 167.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -82.96 117.51 22.83 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.136 -173.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.21 39.64 18.7 Favored Glycine 0 CA--C 1.555 2.561 0 N-CA-C 115.188 0.835 . . . . 0.0 115.188 -167.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.43 -146.87 9.33 Favored Glycine 0 N--CA 1.477 1.393 0 CA-C-O 123.198 1.444 . . . . 0.0 112.822 -174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -64.17 131.83 95.12 Favored Pre-proline 0 CA--C 1.573 1.864 0 CA-C-N 112.586 -1.807 . . . . 0.0 108.469 168.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -47.97 -36.3 27.17 Favored 'Trans proline' 0 N--CA 1.498 1.74 1 N-CA-C 122.595 4.036 . . . . 0.0 122.595 -176.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.4 m 83.48 131.8 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 111.072 -2.785 . . . . 0.0 106.53 -165.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -85.94 -56.74 3.33 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.944 -168.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -124.62 72.46 1.21 Allowed 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 124.713 1.205 . . . . 0.0 109.752 -170.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.5 73.58 0.51 Allowed Glycine 0 N--CA 1.482 1.735 0 C-N-CA 123.776 0.703 . . . . 0.0 113.107 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -90.23 174.07 7.8 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 170.73 -96.29 0.11 Allowed Glycine 0 N--CA 1.478 1.444 0 CA-C-O 123.732 1.74 . . . . 0.0 109.545 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.667 ' SG ' ' SG ' ' A' ' 34' ' ' CYS 0.39 5.7 t 93.95 94.32 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 109.536 -3.332 . . . . 0.0 110.648 173.549 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.619 ' O ' ' SG ' ' A' ' 34' ' ' CYS . 31.0 mm -119.92 141.31 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 166.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.631 ' HA ' ' HA3' ' A' ' 31' ' ' GLY . 12.5 m -136.88 144.92 43.79 Favored 'General case' 0 CA--C 1.58 2.129 1 N-CA-C 123.461 4.615 . . . . 0.0 123.461 -168.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.539 10.2 p 61.11 -84.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 163.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.305 2.1 mp -38.83 -40.09 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.664 0 CA-C-N 108.969 -3.742 . . . . 0.0 116.438 168.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 37.3 ttp -143.49 -24.9 0.58 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 113.351 -1.75 . . . . 0.0 113.154 166.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 27' ' ' CYS . . . -43.08 -47.91 6.46 Favored Glycine 0 CA--C 1.558 2.724 0 CA-C-O 125.919 2.955 . . . . 0.0 118.451 164.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . 0.776 0.4 OUTLIER 64.86 100.16 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.888 1 CA-C-N 107.42 -4.39 . . . . 0.0 111.552 -169.507 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . 0.811 0.6 OUTLIER 20.37 55.6 0.01 OUTLIER 'General case' 0 CA--C 1.575 1.928 0 CA-C-N 108.802 -3.817 . . . . 0.0 118.445 -155.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.981 ' SG ' ' SG ' ' A' ' 12' ' ' CYS 0.409 0.1 OUTLIER 46.99 173.79 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 1 CA-C-N 106.528 -4.851 . . . . 0.0 119.573 -168.165 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -158.67 141.67 14.65 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 109.975 -3.284 . . . . 0.0 108.642 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 12' ' ' CYS . 90.4 m -83.41 81.55 8.67 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 120.885 1.675 . . . . 0.0 107.387 169.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -66.17 127.45 93.23 Favored Pre-proline 0 N--CA 1.491 1.612 0 CA-C-O 117.084 -1.436 . . . . 0.0 109.592 -169.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -42.57 140.0 2.88 Favored 'Trans proline' 0 CA--C 1.562 1.912 0 N-CA-C 121.89 3.766 . . . . 0.0 121.89 -161.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.403 0.1 OUTLIER 16.45 82.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 1 N-CA-C 121.981 4.067 . . . . 0.0 121.981 179.685 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 tp -106.77 112.25 25.14 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 166.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . 0.366 35.7 mm -111.6 -87.45 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 124.081 1.896 . . . . 0.0 106.952 -171.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.5 ttt -99.11 -9.98 23.13 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 109.703 -3.408 . . . . 0.0 114.991 167.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -64.46 -1.01 1.52 Allowed 'General case' 0 CA--C 1.563 1.458 1 N-CA-C 122.148 4.129 . . . . 0.0 122.148 176.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.57 -76.19 0.03 OUTLIER Glycine 0 CA--C 1.54 1.6 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.384 172.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 mp -133.59 -78.3 0.48 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.67 -99.7 0.17 Allowed Glycine 0 CA--C 1.537 1.423 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 pp -85.41 -32.41 22.36 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 122.817 1.294 . . . . 0.0 110.307 179.971 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.431 ' HG3' ' H ' ' A' ' 3' ' ' LYS 0.277 56.9 pttt -99.01 -92.3 0.27 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 118.427 -0.797 . . . . 0.0 109.14 175.589 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.431 ' H ' ' HG3' ' A' ' 2' ' ' LYS . 32.6 mmtp -141.3 89.27 2.22 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 173.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.584 ' HA ' HG22 ' A' ' 17' ' ' THR 0.302 27.8 p -46.83 -174.43 0.0 OUTLIER 'General case' 0 CA--C 1.577 1.997 1 N-CA-C 122.355 4.205 . . . . 0.0 122.355 -177.006 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.505 HG13 ' SG ' ' A' ' 36' ' ' CYS . 24.5 mm -70.79 -49.88 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 C-N-CA 127.533 2.333 . . . . 0.0 111.342 173.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . 0.284 . . 68.71 52.67 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 126.114 1.765 . . . . 0.0 114.215 -171.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -178.66 125.66 0.1 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -176.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -73.49 118.32 16.31 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 166.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . 0.356 0.0 OUTLIER 75.86 80.44 0.1 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 176.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.609 ' H ' ' H ' ' A' ' 36' ' ' CYS . . . -172.66 120.31 0.81 Allowed Glycine 0 N--CA 1.471 1.007 0 CA-C-N 109.323 -3.58 . . . . 0.0 115.364 -165.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . 0.35 20.6 tpt85 1.08 70.33 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 131.116 3.767 . . . . 0.0 119.26 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 4.7 p -88.97 170.33 10.77 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 110.04 -3.255 . . . . 0.0 112.647 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -140.62 154.85 46.61 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.566 171.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.6 m0 -97.51 95.12 7.42 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 105.485 -2.042 . . . . 0.0 105.485 170.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.83 54.76 0.91 Allowed Glycine 0 CA--C 1.552 2.359 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.979 -167.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.04 -142.81 3.5 Favored Glycine 0 N--CA 1.477 1.386 0 CA-C-O 123.214 1.452 . . . . 0.0 110.172 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -58.46 143.9 79.71 Favored Pre-proline 0 N--CA 1.498 1.953 0 CA-C-N 112.777 -1.711 . . . . 0.0 111.167 168.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.06 -132.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.572 2.416 0 C-N-CA 123.0 2.466 . . . . 0.0 110.818 167.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 59.6 m -152.82 142.31 21.74 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 166.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.41 -55.88 3.69 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 113.349 -1.751 . . . . 0.0 113.545 -168.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -132.44 82.12 1.99 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.835 1.254 . . . . 0.0 109.025 -169.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.82 110.47 3.36 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -133.04 175.88 8.98 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 115.818 1.785 . . . . 0.0 115.818 -167.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.02 -81.53 0.13 Allowed Glycine 0 N--CA 1.474 1.188 0 CA-C-N 112.331 -2.213 . . . . 0.0 109.554 -168.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . 0.317 16.4 t 79.81 102.13 0.06 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 109.739 -3.231 . . . . 0.0 109.343 -170.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 44.2 mm -131.54 152.25 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 169.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 34' ' ' CYS 0.347 85.5 m -77.54 150.95 34.73 Favored 'General case' 0 CA--C 1.567 1.615 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 176.18 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.319 41.1 m -152.9 176.03 12.28 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 126.161 1.784 . . . . 0.0 109.229 -165.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.328 3.9 mp 38.04 63.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 C-N-CA 126.476 1.91 . . . . 0.0 112.257 -173.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . 0.285 16.2 mmt 91.07 -6.84 0.27 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 126.141 1.777 . . . . 0.0 115.044 -169.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.37 58.85 3.23 Favored Glycine 0 CA--C 1.557 2.664 0 CA-C-N 122.772 2.533 . . . . 0.0 109.059 -165.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 74.3 m -151.57 -52.17 0.12 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 124.657 1.183 . . . . 0.0 112.673 -163.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -61.28 -77.1 0.05 OUTLIER 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 124.806 2.241 . . . . 0.0 111.935 169.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 27' ' ' CYS 0.272 2.4 m 79.65 167.23 0.18 Allowed 'General case' 0 CA--C 1.557 1.228 1 CA-C-N 107.337 -4.483 . . . . 0.0 110.094 -167.829 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -160.91 153.3 20.45 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.99 1.316 . . . . 0.0 107.616 -170.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.609 ' H ' ' H ' ' A' ' 10' ' ' GLY . 87.6 m -67.94 67.41 0.11 Allowed 'General case' 0 N--CA 1.508 2.448 0 CA-C-O 124.652 2.167 . . . . 0.0 114.696 171.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . 0.446 34.8 ttmt 46.84 91.97 0.06 OUTLIER Pre-proline 0 CA--C 1.572 1.797 1 N-CA-C 123.244 4.535 . . . . 0.0 123.244 -169.511 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -87.67 -34.6 0.11 Allowed 'Trans proline' 0 CA--C 1.561 1.825 0 C-N-CA 123.792 2.995 . . . . 0.0 118.072 172.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . 0.332 38.7 mmt180 79.65 148.67 0.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.815 1.246 . . . . 0.0 109.741 -166.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . 0.253 6.3 tp -13.04 103.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 119.643 3.201 . . . . 0.0 119.643 -165.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.3 tt -152.17 62.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-N 112.58 -2.1 . . . . 0.0 107.41 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 64.5 mtt 57.71 66.47 1.12 Allowed 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 124.819 1.248 . . . . 0.0 111.472 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . 0.492 13.1 tt0 -118.96 -98.74 0.45 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 -167.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.13 -58.24 4.43 Favored Glycine 0 CA--C 1.547 2.092 0 CA-C-N 114.156 -1.384 . . . . 0.0 115.419 174.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -99.76 -79.25 0.49 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.2 -104.15 0.17 Allowed Glycine 0 CA--C 1.535 1.326 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -120.31 -57.83 1.9 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 118.478 -0.772 . . . . 0.0 111.675 -177.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 123.922 1.82 . . . . 0.0 112.583 179.288 . . . . . . . . 0 0 . 1 stop_ save_